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Abstract 
 Vinigrol (1.1) is a structurally unique diterpenoid natural product featuring a 
tricyclo[4.4.4.0.4a,8a]tetradecene carbon skeleton containing eight contiguous stereocenters and a 
challenging oxygenation pattern. 1.1 has been demonstrated to possess a wide array of biological 
activities including tumor necrosis factor (TNF) antagonism, antihypertensive activity, and platelet 
aggregation inhibitory activity. Our first-generation plan for the synthesis of 1.1 utilized a cascade 
reaction sequence involving: (1) diastereoselective alkylation of α-alkenyl-β-ketoester 1.138, (2) retro-
aldol-aldol equilibration (3) anion-accelerated oxy-Cope rearrangement, and (4) transannular Dieckmann 
condensation to afford the bicyclo[5.3.1]undecene ring system of diketone 1.182 in a single operation. 
Discoveries concerning the limitations of this process are disclosed. Our second-generation approach to 
1.1 employed cis-decalin 1.217 in an alternative cascade reaction sequence, which was expected to 
deliver the complete tricyclo[4.4.4.0.4a,8a]tetradecene carbon skeleton of 1.1 in one step. An unexpected 
deviation from the envisioned reaction pathway instead afforded tricyclic enol silane 1.230. 
  
Hibarimicin B (2.1) is a member of the hibarimicin family of natural products, which are amongst 
the most complex and largest type-II polyketides known. They share a common nonacyclic pseudo-C2-
symmetric aglycon decorated with a variety of deoxy sugars. 2.1 has been demonstrated to potently 
inhibit the proliferation and induce the differentiation of numerous cancer cell lines. We envisioned that 
2.1 or its analogs could be used as molecular probes for determining a potentially unknown biological 
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target for anticancer therapy. The biosynthesis of hibarimicin B and related natural products inspired our 
synthesis plan involving a two-directional unsymmetrical double annulation strategy and a biomimetic 
etherification reaction to construct the polycyclic skeleton of the hibarimicin B aglycon (hibarimicinone). 
As the absolute stereochemistry of hibarimicinone was unknown at the outset of our work, enantiomeric 
enones (+)-2.68 and (–)-2.110 were prepared on multi-gram scale starting from methyl-α-D-
glucopyranoside. Enone (+)-2.68 was used to accomplish the total syntheses of HMP-Y1, atrop-HMP-Y1, 
hibarimicinone, atrop-hibarimicinone, and HMP-P1. With a synthesis route to the aglycon of 2.1 
established, we developed novel glycosylation methods for the synthesis of hibarimicin B model A 
(2.334). Specifically, the 3-thionocarbonate directing group of disaccharide trichloroacetimidate glycosyl 
donor 2.62 was demonstrated to be a useful control element for the stereoselective formation of 2-deoxy-
β-glycosides. Reductive removal of the 3-thionocarbonate group from the product provided access to 2,3-
dideoxy-β-glycosides. Additionally, the 2-iodo directing group of trichloroacetimidate glycosyl donor 
2.64 was used for the first time to induce α-selectivity in the formation of digitoxosides. Progress has 
been made toward applying the glycosylation methods developed for the synthesis of model 2.334 to the 
total synthesis of 2.1. 
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Chapter 1  
Progress Toward a Synthesis of Vinigrol
 2 
 Isolation and Structural Characterization of Vinigrol 1.1
Hashimoto and co-workers reported the isolation of vinigrol (1.1, Figure 1.1) in 1987 from the 
fungal strain Vigaria nigra F-5408. 1   Vinigrol was isolated for its antihypertensive and platelet 
aggregation inhibitory activity. 2  Structurally, 1.1 exhibits an unprecedented diterpenoid 
tricyclo[4.4.4.0.4a,8a]tetradecene3 carbon skeleton containing eight contiguous stereocenters and multiple 
sites of oxygenation. The compact nature of vinigrol’s unusual structure necessitates its depiction from 
multiple viewpoints. 
 
Figure 1.1 Structure of vinigrol.4 
Vinigrol (1.1) was isolated from the F-5408 mycelium fermentation broth through acetone 
extraction. Purification of the organic extract by repeated silica gel chromatography followed by 
recrystallization from a mixture of heptane and ethyl acetate provided pure 1.1 as colorless prisms (mp 
108 °C, [α]D = –96.2°) (c = 1.05, CHCl3)). However, the structure of 1.1 could not be completely 
elucidated through the combined application of IR, MS, 1H, and 13C NMR spectroscopy. Ultimately, 
chemical derivitazation of 1.1 was required to reveal its complete structure (Scheme 1.1). Jones’ 
oxidation of 1.1 provided three compounds: 1.2, 1.3, and 1.4, of which 1.4 gave optimal X-ray crystal 
data. 
                                                      
1 Uchida, I.; Ando, T., Fukami; N., Yoshida, K., Hashimoto, M.; Tada, T.; Koda, S.; Morimoto, Y. J. Org. Chem. 
1987, 52, 5292–5293. 
 
2 (a) Ando, T.; Tsurumi, Y.; Ohata, N.; Uchida, I.; Yoshida, K.; Okuhara, M. J. Antibiot. 1988, 41, 25–30. (b) Ando, 
T.; Yoshida, K.; Okuhara, M. J. Antibiot. 1988, 41, 31–35. 
 
3 Vinigrol’s carbon framework can also been described as a decahydro-1,5-butanonaphthalene skeleton or a cis-
fused [4.4.0] ring system bridged by an 8-membered ring. 
 
4 The numbering convention used in Figure 1.1 will be referred to through out this document. 
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Scheme 1.1 Oxidative derivatization of vinigrol and X-ray crystal structure of vinigrol derivative 1.4. 
 
 Structure 1.4 defined the relative stereochemistry of 1.1 except for the C4 stereocenter, which 
was assigned based on (1) a lack of a 1JH4,H4a coupling, indicating a dihedral angle close to 90°, and (2) 
NOESY correlations depicted in Figure 1.2. 
 
Figure 1.2 NOESY correlations confirming the C4 stereochemistry of vinigrol. 
The absolute stereochemistry of 1.1 was established based on a negative Cotton effect5 in the CD 
spectrum of allylic benzoate derivative 1.5 (Scheme 1.2) (Δε = –14.0 at 230 nm (MeOH)), which 
indicates a counterclockwise relationship between the C4 benzoate and C2–C3 olefin chromophores.
                                                      
5  (a) Harada, N.; Nakanishi. K. Circular Dichroic Spectroscopy: Exiton Coupling in Organic Spectrometry; 
University Science Books: Mill Valley, CA, 1983. (b) Harada, H.; Iwabuchi. J.; Yokota, Y.; Uda, H.; Nakanishi, K. 
J. Am. Chem. Soc. 1981, 103, 5590–5591. 
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Scheme 1.2 Determination of vinigrol’s absolute stereochemistry through CD spectroscopic analysis of allylic 
benzoate derivative 1.5. 
 
  Biological Activity of Vinigrol 1.2
Interest in 1.1 originated in the discovery of its antihypertensive and platelet aggregation 
inhibitory activity.2 Since blood pressure control is an important modern therapeutic area,6 it was 
anticipated that 1.1 might be useful tool for the discovery of new protein targets for the treatment of 
hypertension. Intravenous injection of 1.1 in spontaneously hypertensive rats, produced a dose-dependant 
decrease in mean arterial blood pressure. Studies on the contraction of rat aortic smooth muscle strips 
demonstrated 1.1 to be a potent Ca2+ agonist; however, the precise mechanism by which 1.1 induces 
antihypertensive activity in humans remains to be determined. Uchida and coworkers showed that 1.1 
inhibited human platelet aggregation induced by epinephrine or platelet activating factor (PAF) with IC50 
values of 52 nM and 33 nM, respectively. However, 1.1 did not demonstrate inhibitory activity on 
adenosine diphosphate (ADP), thrombin, or collagen-induced platelet aggregation.  
Vinigrol was later identified by Norris and coworkers to be a tumor necrosis factor (TNF) 
antagonist7 and was therefore investigated as a potential treatment for endotoxic shock, inflammation, 
infection, and cachexia. In an in vitro binding assay on HL-60 cells, 1.1 (310 µM) showed 100% 
inhibition of [I125]-TNF at 2.1 nM. TNF is known to cause lysis of the sensitive L929 cell line at low 
concentrations. At 15.5 µM, 1.1 completely inhibited TNF-induced cytotoxicity yet produced no 
cytotoxic effects in the absence of TNF. These findings prompted the Fujisawa Pharmaceutical Company 
Limited to patent 1.1 as a potential treatment for human immunodeficiency virus (HIV). However, when 
                                                      
6 Krum, H.; Gilbert, R. E. J. Hypertens. 2007, 25, 25–35. 
 
7 Norris, D. B.; Depledge, P.; Jackson, A. P. Tumor Necrosis Factor Antagonist. PCT Int. Appl. WO9107953, 
November 22, 1991. 
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they compared 1.1 to the current standard of care (azidothymidine (AZT)), 1.1 showed only modest 
activity (EC50 for 1.1 = 0.092 mM, EC50 for AZT = 0.2 nM).8 In 1997, building upon the work of Norris, 
patents claiming 1.1 could be used as a cytokine-suppressing anti-inflammatory drug (CSAID) to treat 
various autoimmune diseases including rheumatoid arthritis and type 1 diabetes were filed.9 
  Proposed Biosynthesis of Vinigrol 1.3
 Corey and Goodman proposed a possible biosynthesis for 1.1 based on the established 
biosynthesis of similar terpenoid natural products including lanosterol, arteannuin B, and pseudopterosin 
K–L (Scheme 1.3).10 Specifically, they envisioned 1.1 and the pseudopterosin K–L aglycon (1.11) could 
share a common biosynthetic intermediate, erogorgiaene (1.9). Their proposed biosynthesis begins with 
intramolecular cyclization of diterpenoid building block geranyl geranyl pyrophosphate (GGPP, 1.6), to 
afford 10-membered ring intermediate 1.7. A series of hydride shifts and a transannular cyclization is 
belived to deliver erogorgiaene (1.9). Oxidation of 1.9 likely generates a cationic intermediate 1.10 en 
route to the pseudopterosin K–L aglycon (1.11). In contrast, an alternative series of aromatic oxidations 
could potentially yield phenoxide radical 1.13. Transannular cyclization of the carbon-based radical 
tautomer 1.14 onto the pendant propenyl group could generate the unprecedented decahydro-1,5-
butanonaphthalene carbon skeleton exhibited by postulated intermediate 1.15. Finally, a series of 
enzymatically-controlled oxidations could deliver 1.1. Maimone and Baran have identified several other 
diterpene natural product families isolated subsequent to Corey and Goodman’s initial proposal, which 
                                                      
8 Nakajima, H.; Yamamoto, N.; Kaizu, T.; Kino, T. Therapeautic Agent for Human Immune Deficiency Virus 
Infectious Disease. Japan Patent 07206668, January 11, 1994.  
 
9 (a) A. Guglielmotti, A.; Dionisio, P. A Pharmaceutical Composition for the Treatment of Autoimmune Diseases. 
PCT Int. Appl. WO9716185, October, 26, 1996. (b) Keane, J. T. Combination of Tumor Necrocis Factor (TNF) 
Antagonists and COX-2 Inhibitors for the Treatment of Inflammation. PCT Int. Appl. WO2001000229, June 26, 
2000. 
 
10 (a) Goodman, S. N. Ph.D. Thesis, Harvard University, 2000 and references therein. (b) Ferns, T.; Kerr, R. G. 
Tetrahedron 2005, 61, 12358–12365. (c) Berrué, F.; McCulloch, M. W. B.; Kerr, R. G. Bioorg. Med. Chem. 2011, 
19, 6702–6719. 
 6 
are believed to be formed through transannular oxidative phenoxyl radical-based cyclization, including 
the colombiasin and the elisapterosin natural product families.11 
Scheme 1.3 Corey and Goodman’s proposed biosynthesis of vinigrol. 
 
  Previous Synthesis Efforts Directed Toward Vinigrol 1.4
 Since its original isolation and structural assignment in 1987, 1.1 has been a highly sought after 
synthesis target due to its interesting biological activity and unusual structure. Numerous groups have 
attempted to synthesize 1.1 including Corey,10 Paquette, 12  Hanna,13  Barriault 14  Mehta, 15  Matsuda, 16 
                                                      
11 Maimone, T. J. Ph.D. Thesis, Scripps Research Institute, 2009. 
 
12 (a) Paquette, L. A.; Guevel, R.; Sakamoto, S.; Kim, I. H.; Crawford, J. J. Org. Chem. 2003, 68, 6096–6107. (b) 
Guevel, R. Ph.D. Thesis, The Ohio State University, 1994. (c) Efremov, I. V. Ph.D. Thesis, The Ohio State 
University, 2001. (d) Paquette, L. A.; Efremov, I.; Liu, Z. S. J. Org. Chem. 2005, 70, 505–509. (e) Paquette, L. A.; 
Efremov, I. J. Org. Chem. 2005, 70, 510–513. (f) Paquette, L. A.; Liu, Z. S.; Efremov, I. J. Org. Chem. 2005, 70, 
514–518. 
 
13 (a) Devaux, J.-F.; Hanna, I.; Lallemand, J. Y. J. Org. Chem. 1993, 58, 2349–2350. (b) Devaux, J.-F.; Hanna, I.; 
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 7 
Fallis,17 Doyle,18 Njardarson19, and Baran.20 During the course of our studies directed toward the total 
synthesis of 1.1, the Baran group reported the first racemic total synthesis of 1.1 in 23 steps.20b This work 
was followed by a formal synthesis by Barriault and coworkers14f that intercepts one of Baran’s 
intermediates. More recently, the Njardarson group has disclosed a racemic total synthesis of 1.1, which 
was accomplished in 38 steps.19d The synthesis approaches toward 1.1 have been recently reviewed;21 
therefore, only a selection of the chemistry highlighting the intriguing structural challenges 1.1 presents as 
a synthesis target will be discussed. 
1.4.A Hanna’s Synthesis of Vinigrol’s Tricyclic Carbon Skeleton 
 Hanna and coworkers were the first to report the synthesis of vinigrol’s tricyclic carbon skeleton 
in 1993.13a Their synthesis began with an intermolecular Diels-Alder (IMDA) reaction between 2-
                                                                                                                                                                              
Fraisse, P.; Lallemand, J.-Y. Tetrahedron Lett. 1995, 36, 9471–9474. (c) Devaux, J. F.; Hanna, I.; Lallemand, J. Y.; 
Prange, T. J. Chem. Res. Synth. 1996, 32–33. (d) Devaux, J. F.; Hanna, I.; Lallemand, J. Y. J. Org. Chem. 1997, 62, 
5062–5068. (e) Gentric, L.; Hanna, I.; Ricard, L. Org. Lett. 2003, 5, 1139–1142. (f) Gentric, L.; Hanna, I.; Huboux, 
A.; Zaghdoudi, R. Org. Lett. 2003, 5, 3631–3634. (g) Gentric, L.; Le Goff, X.; Ricard, L.; Hanna, I. J. Org. Chem. 
2009, 74, 9337–9344. 
 
14 (a) Morency, L.; Barriault, L. Tetrahedron Lett. 2004, 45, 6105–6107. (b) Morency, L.; Barriault, L. J. Org. Chem. 
2005, 70, 8841–8853. (c) Morency, L., Ph.D. Thesis, University of Ottawa, 2006. (d) Grise, C. M.; Tessier, G.; 
Barriault, L. Org. Lett. 2007, 9, 1545–1548. (e) Tessier, G.; Barriault, L. Org. Prep. Proc. Int. 2007, 37, 313–353. 
(f) Poulin, J.; Grise-Bard, C. M.; Barriault, L. Angew. Chem. Int. Ed. 2012, 51, 2111–2114. 
 
15 Mehta, G.; Reddy, K. S. Synlett 1996, 625–627. 
 
16 (a) Kito, M.; Sakai, T.; Haruta, N.; Shirahama, H.; Matsuda, F. Synlett 1996, 1057–1060. (b) Kito, M.; Sakai, T.; 
Shirahama, H.; Miyashita, M.; Matsuda, F. Synlett 1997, 219–220. (c) Matsuda, F.; Sakai, T.; Okada, N.; Miyashita, 
M. Tetrahedron Lett. 1998, 39, 863–864. (d) Matsuda, F.; Kito, M.; Sakai, T.; Okada, N.; Miyashita, M.; Shirahama, 
H. Tetrahedron 1999, 55, 14369–14380. 
 
17 Souweha, M. S.; Enright, G. D.; Fallis, A. G. Org. Lett. 2007, 9, 5163–5166. 
 
18 Brekan, J. A. Ph.D. Thesis, State University of New York, 2008. 
 
19 (a) Morton, J. G. M.; Kwon, L. D.; Freeman, J. D.; Njardarson, J. T. Tetrahedron Lett. 2009, 50, 1684–1686. (b) 
Morton, J. G. M.; Kwon, L. D.; Freeman, J. D.; Njardarson, J. T. Synlett. 2009, 23–27. (c) Morton, J. G. M.; 
Draghici, C.; Kwon, L.; Njardarson, J. T. Org. Lett. 2009, 11, 4492–4495. (d) Yang, Q.; Njardarson, J. T.; Draghici, 
C.; Li, F. Angew. Chem. Int. Ed. 2013, 52, 1–5. 
 
20 (a) Maimone, T. J.; Voica, A.-F.; Baran, P. S. Angew. Chem. Int. Ed. 2008, 47, 3054–3056. (b) Maimone, T. J.; 
Shi, J.; Ashida, S.; Baran, P. S. J. Am. Chem. Soc. 2009, 131, 17066–17067. 
 
21 (a) Tessier, G.; Barriault, L. Org. Prep. Proced. Int. 2007, 37, 313–353. (b) Harmata, M.; Calkins, N. L. 
Chemtracts 2009, 22, 205–209. (c) Lu, J.-Y.; Hall, D. G. Angew. Chem. Int. Ed. 2010, 49, 2286–2288. (d) Huters, A. 
D.; Garg, N. K. Chem. Eur. J. 2010, 16, 8586–8595. 
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(trimethylsilyl)oxy-1,3-cyclohexadiene (1.16) and 1,4-benzoquinone (1,4-BQ) followed by Luche 
reduction resulting in tetracycle 1.17 (Scheme 1.4). The secondary carbinol was MOM protected and the 
silyl ether deprotected with BF3•OEt2 to afford hemiacetal 1.18 and ketone 1.19. Dehydration of the 
product mixture with POCl3 gave diene 1.20. Chemoselective hydrogenation of the disubstituted olefin 
was accomplished under a hydrogen atmosphere with Wilkinson’s catalyst22 to provide ketone 1.21. 
Exposure of 1.21 to vinylmagnesium chloride yielded allylic alcohol 1.23, which was a result of 
stereoselective attack of the organometallic reagent on the more sterically hidered endo face of 1.21. 
Hanna rationalized this result by invoking remote chelation-control of the organometallic reagent by the 
C4 alkoxy substituent depicted in 1.22. 23  Interestingly, when the C4–OH was protected as the 
corresponding MOM ether, nucleophilic attack occurred with high selectivity from the opposite exo face 
of the molecule. Heating a mixture of the resultant allylic alcohol 1.23 and potassium hydride with 18-
crown-6 promoted anion-accelerated oxy-Cope rearrangement to supply tricycle 1.24. Unfortunately, 
Hanna and co-workers were never able to complete a total synthesis of 1.1 based on this strategy despite 
the relative ease by which they were able to access its decahydro-1,5-butanonaphthalene skeleton. 
  
                                                      
22 Osborn, J. A.; Jardine, F. H.; Young, J. F.; Wilkinson, G. J. Chem. Soc. A, 1966, 1711–1732. 
 
23 For a review on chelation-controlled reactions, see: Reetz, M. T. Angew. Chem. Int. Ed. 1984, 23, 556–569. 
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Scheme 1.4 Hanna’s synthesis of vinigrol’s tricyclic carbon skeleton. 
 
Reagents and conditions: (a) 1,4-benzoquinone, PhH, reflux; (b) NaBH4, CeCl3, MeOH, 0 °C, 61% (two steps); (c) 
MOMCl, iPr2NEt, 4-DMAP, CH2Cl2, 0 °C → RT, 94%; (d) BF3•OEt2, THF, –78 °C → RT, 93% (mixture of 1.18 
and 1.19); (e) POCl3, Py, 70%; (f) H2, Rh(PPh3)3Cl, PhH, 87%; (g) 4.0 N HCl, THF, 65 °C, 95%; (h) 
vinylmagnesium chloride, THF, 0 °C, 64%, 20:1 d.r.; (i) KH, 18-crown-6, THF, 0 °C → 65 °C, 82%.24 
1.4.B Paquette’s Attempt to Construct Vinigrol’s 8-Membered Ring 
The Paquette group investigated several iterations of a common strategy for the synthesis of 
vinigrol’s decahydro-1,5-butanonaphthalene carbon skeleton. A representative example of his approach is 
illustrated in Scheme 1.5.12 The synthesis commenced with chiral aldehyde 1.25, accessed in four steps 
from (S)-oxazolidinone. Modified Stork enamine alkylation25 of 1.25 with methyl vinyl ketone (MVK) 
provided 2-cyclohexenone 1.26 as a mixture of C1 diastereomers. Methylation of 1.26 followed by 
exposure to LiHMDS in the presence of phenyl vinyl sulfoxide promoted a double-Michael reaction to 
give an intermediate, which when warmed with calcium carbonate underwent an extrusion of benzene 
sulfenic acid to provide bicyclo[2.2.2]octenone 1.27 in 22% overall yield as a mixture of separable C1 
diastereomers. Carbonyl addition of a vinyl organometallic reagent derived from methyl (R)-2-
(hydroxymethyl)propionate occurred with modest diastereoselectivity for the desired endo allylic alcohol 
                                                      
24 Yield based on Hanna’s note stating 1.24 was “almost pure.” 
 
25 (a) Stork, G.; Brizzolara, A.; Landesman, H.; Szmuszkovicz, J.; Terrell, R. J. Am. Chem. Soc. 1963, 85, 207–222. 
(b) Stork, G.; Dolfini, J. E. J. Am. Chem. Soc. 1963, 85, 2872–2873. 
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product 1.29. Deprotonation of 1.29 with KHMDS followed by heating to 120 °C facilitated an anion-
accelerated oxy-Cope rearrangement to construct cis-decalin 1.30. Next, the alkyl substituents at C1 and 
C5 were elaborated to the corresponding tolyl sulfone and alkyl iodide, respectively. Unfortunately, 
attempted formation of vinigrol’s 8-membered ansa bridge via a SN2 reaction of the resultant intermediate 
1.32 failed under various conditions. 
Scheme 1.5 Paquette’s attempted synthesis of vinigrol’s tricyclic carbon skeleton. 
 
Reagents and conditions: (a) pyrolidine, MVK, PhH, reflux, 84%; (b) KOH, dibenzo-18-crown-6, PhH, 80%, 1.7:1.0 
PhMe, reflux, 27%, 2:1 d.r. (two steps); (f) tBuLi, 1.28, Et2O, –78 → 0 °C; MgBr2•OEt2; then 1.27, THF, 0 °C, 63%, 
3:1 d.r.; (g) KHMDS, 18-crown-6, THF, 0 → 120 °C, 72%; (h) 1,2-ethanediol, TsOH, PhH, reflux, 84%; (i) TBAF, 
THF, 100%; (j) TsCl, 4-DMAP, CH2Cl2, 91%; (k) NaI, MEK, reflux; (l) TsNa, DMF, 110 °C 82% (two steps); (m) 
DDQ, CH2Cl2-H2O (18:1), 94%; (n) TsCl, 4-DMAP, CH2Cl2, 81%; (o) NaI, MEK, reflux, 82%. 
Paquette explored several other transannular cyclization strategies to form vinigrol’s 8-membered 
ring including ring-closing metathesis (RCM), carbonyl addition, and Ramburg–Bäcklund ring 
contraction (Figure 1.3); however, none proved successful. 
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Figure 1.3 Paquette’s transannular cyclization strategies. 
MM2 transition structures 1.34 and 1.35, based on ab initio calculations, help explain the failure 
of a transannular cyclization strategy to form the 8-membered ring of the decahydro-1,5-
butanonaphthalene carbon skeleton (Figure 1.4). The pseudo-diaxial substituted cis-decalin conformer 
1.35, which might allow transannular C–C bond formation, is thermodynamically disfavored by 12.5 
kcal/mol relative to the more stable pseudo-diequatorial conformer 1.34. 
 
Figure 1.4 MM2 transition structures calculated by Paquette. 
1.4.C Matsuda’s Approach to the Synthesis of Vinigrol’s 8-Membered Ring 
Matsuda and co-workers have shown that the formation of a similar 8-membered ring contained 
within the bicyclo[5.4.1]undecene portion of vinigrol’s carbon skeleton was possible through a 
transannular SmI2-promoted Barbier coupling reaction (Scheme 1.6).16d Their synthesis began with an 
aldol/dehydration sequence between chlorodihydrocarvone 1.36 and aldehyde 1.37 to give cyclohexenone 
1.38. Treatment of 1.38 with allylmagnesium bromide provided a 5:1 diasteriomeric mixture of tertiary 
carbinols. The desired α-epimer was protected as its corresponding MOM ether. A regioselective 
hydroboration/oxidation sequence then afforded cyclization substrate 1.40. Remarkably, exposure of 1.40 
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to SmI2 promoted an intramolecular Barbier-coupling reaction to construct the bicyclo[5.4.1]undecene 
ring system exhibited by 1.42 in quantitative yield. This reaction was facilitated by the conformational 
rigidification of the cyclohexane intermediate 1.41 and reinforced by A1,3 strain minimization26, which 
placed the intermediate samarium ketyl radical anion and allylic chloride coupling partners in close 
proximity. In contrast to Paquette’s strategy, Matsuda’s approach was not subject to the conformational 
constraints engendered by the cis-decalin core of vinigrol’s carbon skeleton.  
Scheme 1.6 Matsuda’s transannular Barbier coupling strategy. 
 
Reagents and conditions: (a) LDA, THF, –78 °C; then 1.37, 75%; (b) FC5H5NMe•OTs, Et3N, CH2Cl2, reflux, 85%; 
(c) allylmagnesium bromide, Et2O, –78 °C, 5:1 d.r.; (d) MOMCl, iPr2NEt, CH2Cl2, 74% (two steps); (e) ThexylBH2, 
THF, 0 °C; (f) 30% H2O2, 90% (two steps); (g) DMP, Py, CH2Cl2, 90%; (h) SmI2, HMPA, THF, 99%. 
1.4.D Barriault’s Synthesis of Vinigrol’s Carbon Skeleton 
 Barriault and coworkers explored several distinct strategies toward vinigrol’s tricyclic carbon 
skeleton. The first to be discussed involved late-stage Claisen rearrangement to form vinigrol’s 8-
membered ring (Scheme 1.7).14b The synthesis began with a Luche reduction of enone 1.43 followed by 
hydroxyl-directed Diels–Alder reaction (HDDA) with methyl acrylate promoted by MgBr2•OEt2/NEt3 to 
                                                      
26 For a review of A1,3 strain minimization as a control element in organic synthesis, see: Hoffmann, R. Chem. Rev. 
1989, 89, 1841–1860. 
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afford cycloadduct 1.45 as a single diastereomer. Allylic alcohol 1.45 was converted to ketone 1.47 in 
seven steps through a series of oxidation state manipulations and protecting group introductions. 
Treatment of 1.47 with an organocerium reagent derived from vinylmagnesium bromide resulted in 
organometallic addition from the convex face of the molecule to yield allylic alcohol 1.48. Silyl ether 
deprotection and Ley oxidation provided tetracyclic ester 1.49. Exposure of 1.49 to Petasis’ reagent 
furnished exocyclic enol ether 1.50. Unfortunately, all attempts to promote ring expansion of 1.50 
through a Claisen rearrangement were unsuccessful, possibly due to poor orbital overlap of the olefinic 
substituents.  
Scheme 1.7 Barriault's attempt to construct vinigrol’s octalin belt via Claisen rearrangement. 
 
Reagents and conditions: (a) NaBH4, CeCl3•7H2O, MeOH, 90%; (b) methyl acrylate, MgBr2•OEt2, Et3N, CH2Cl2, 
78%, >25:1 d.r.; (c) LiAlH4, THF, –78 °C; (d) TBDPSCl, imidazole, DMF, 78% (two steps); (e) BzCl, Py, 4-
DMAP, CH2Cl2, 97%; (f) OsO4 (4 mol%), NMO, THF-H2O (5:1), reflux, 82%; (g) 2-methoxypropene, PTSA, 
CH2Cl2, 100%; (h) K2CO3, MeOH, PhMe, reflux, 75%; (i) DMP, CH2Cl2, 100%; (j) CH2CHMgBr, CeCl3, THF, –78 
°C, 96%; (k) TBAF, THF, 90%. (l) TPAP, NMO, 4 Å MS, CH2Cl2, 51%; (l) Cp2TiMe2, PhMe, 80 °C, 85%. 
Barriault’s next approach focused on the use of an intramolecular Diels–Alder reaction (IMDA) 
to form the 8-membered ring and one of the six-membered rings of vinigrol’s tricyclic carbon skeleton in 
a single operation (Scheme 1.8). Their synthesis began with propionic acid promoted enol ether formation 
between alcohol 1.52 and dimethylketal 1.53. Thermal Claisen rearrangement of the intermediate enol 
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ether provided ketone 1.55 with excellent diastereoselectivity for C1–C12 bond formation. The 
isopropenyl group was then reduced through hydrogenation and the ketone was converted to diene 1.56 
via a Stille coupling of the corresponding vinyl triflate. At this point, the undesired C3 α-pivaloyl ester 
epimer could be recycled to the β-epimer 1.57 through a Mitsunobu inversion process. Next, the primary 
alcohol was deprotected and converted into enone 1.58. Exposure of 1.58 to SnCl4 facilitated a key 
transannular IMDA reaction to form vinigrol’s tricyclic carbon framework. The C9 methyl stereocenter 
was then introduced through a highly stereoselective Wittig/hydrogenation sequence to give tricycle 1.60, 
which was used to complete a formal total synthesis of 1.1 based on the work of Baran and coworkers 
(vide infra). 20b However, it should be noted that Barriault’s IMDA strategy, disclosed in 2007,14d 
preceded a very similar disconnection published by Baran in 2008. 20a 
Scheme 1.8 Barriault’s synthesis of vinigrol’s tricyclic carbon framework.  
 
Reagents and conditions: (a) propionic acid, neat, 135 °C, 62%, >25:1 d.r. at C1–C12, 1:1 d.r. at C3; (b) PtO2, H2, 
EtOAc, 76%; (c) KHMDS, THF, –78 °C; then PhNTf2, 99%; (d) nBu3SnCHCH2, Pd(PPh3)4 (10 mol%), LiCl, THF, 
60 °C, 80%; (e) DIBAL, CH2Cl2, –78 °C; (f) pNO2C5H4CO2H, DIAD, PPh3, THF, 0 °C; (g) NaOH, MeOH; (h) 
PivCl, Et3N, 4-DMAP, CH2Cl2, 60% (four steps); (i) TBAF, THF, 84%; (j) (COCl)2, DMSO, CH2Cl2, –78 °C; then 
Et3N, –78 → 0 °C; (k) CH2CHMgBr, PhMe, –78 °C; (l) (COCl)2, DMSO, CH2Cl2, –78 °C; then Et3N, –78 → 0 °C; 
(m) SnCl4, CH2Cl2, –78 °C, 65% (four steps); (n) Ph3PCH3I, tBuOK, THF-PhMe (1:1), 88%; (o) PtO2, H2, EtOAc, 0 
°C, 99%, >25:1 d.r.. 
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1.4.E Corey’s Approaches Toward the Total Synthesis of Vinigrol 
 Corey and coworkers investigated two conceptually dissimilar approaches toward the total 
synthesis of 1.1. Their first strategy sought to take advantage of their biosynthesis hypothesis through the 
use of an intramolecular Friedel–Crafts reaction to form vinigrol’s 8-membered ring (Scheme 1.9). 27 The 
synthesis began with conversion of (S)-citronellal (1.61)28 to diol 1.62 in three steps including: (1) 
intramolecular ene reaction promoted by ZnBr2, (2) directed hydroboration, and (3) oxidation. The C9 
methyl stereocenter was inverted through a lactone formation/epimerization sequence to give hemiactal 
1.64 after lactone reduction with DIBAL. Wittig olefination and Ley oxidation of the resultant secondary 
carbinol gave ketone 1.65. Exocyclic enone 1.66 was then prepared in fours steps including: (1) 
regioselective enol silane formation, (2) TiCl4 promoted alkylation with thiophenylchloromethane, (3) 
sulfide oxidation, and (4) sulfoxide elimation. Treatment of 1.66 with lithiated 1-methoxy-3-
phenylsulfanyl-propan-2-one (1.67) gave decalin 1.68 via a Michael-aldol annulation sequence. Oxidative 
elimination of the thiophenyl substituent and dehydration provided phenol 1.69, which was converted to 
the Friedel–Craft cyclization substrate 1.72 in a straightforward manner. Activation of 
α,β-unsaturated aldehyde 1.72 under a variety of Lewis acidic conditions was unable to facilitate 
transannular cyclization, likely due to the strain imparted by the trans-olefin. Consequently, this strategy 
was abandoned. 
  
                                                      
27 A. Palani, Harvard University, unpublished results reported by S. N. Goodman in his Ph.D. Dissertation, Harvard 
University, 2000. 
 
28 The chemistry conducted in this scheme was directed toward ent-vinigrol due to some confusion regarding the 
published ORTEP drawing in Ref. 1. 
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Scheme 1.9 Corey’s unsuccessful Biomimetic Friedel–Craft appoach.29  
 
Corey and Goodman’s strategy to build vinigrol’s unusual decahydro-1,5-butanonaphthalene 
tricyclic carbon skeleton involved a IMDA reaction/Grob fragmentation sequence (Scheme 1.10).30 The 
Baran group later utilized a variation on this strategy to complete the first total synthesis of 1.1 (vida 
infra). Corey’s second-generation synthesis commenced with hydroboration/oxidation of (R)-limonene 
(1.74) to yield aldehyde 1.75 as 1:1 mixture of C9 diastereomers. Since, resolution of the diastereomeric 
aldehydes at this stage proved to be problematic, the product mixture was submitted to a Mukiayama 
aldol reaction with (R)-carvone derived silyl enol ether 1.76 to provide two diastereomeric products, one 
of which possessed the desired C9 stereochemistry. The Felkin-Ahn-Eisenstein model can be invoked to 
                                                      
29 Reaction conditions were not provided. 
 
30 (a) Grob, C. A.; Baumann, W. Helv. Chim. Acta 1955, 38, 594–610; (b) Wharton, P.S.; Hiegel, G. A. J. Org. 
Chem. 1965, 30, 3254–3257. (c) C. A. Grob, Angew. Chem. Int. Ed. 1969, 8, 535–546. (d) Grob, C. A. Chimia 1971, 
25, 87. (e) Grob, C. A. Angew. Chem. Int. Ed. 1976, 15, 569–575. (f) Grob, C. A. Helv. Chim. Acta 1985, 68, 882–
886. (g) Grob, C. A. Angew. Chem. Int. Ed. 1982, 21, 87–96. (h) Ho, T.-L. Heterolytic Fragmentation of Organic 
Molecules; Wiley: New York, 1993. 
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explain the observed facial selectivity for nucleophilic carbonyl addition in this reaction.31  Next, 
sequential silyl protection and enol silane formation gave IMDA substrate 1.78. Unfortunately, the 
proposed IMDA reaction to form 1.80 was unsuccessful under a variety of conditions, ostensibly due to 
the poor frontier molecular orbital (FMO) overlap between the silyl enol ether and the pendant 1-
silyloxydiene subunit in transition state 1.79. Attempts were undertaken to modify the electronic nature of 
the substrate for this reaction, but to no avail. Lack of success in this key transformation prevented the 
Corey group from assessing the viability of a Grob fragmentation strategy for the synthesis of vinigrol’s 
tricyclic carbon skeleton illustrated below. 
Scheme 1.10. Corey’s IMDA/Grob fragmentaion strategy. 
 
Reagents and conditions: (a) ThexylBH2, THF, 0 °C; (b) NaOH, H2O2, EtOH, 0 °C → RT, 91%, 1:1 d.r. at C1; (c) 
(COCl)2, DMSO, CH2Cl2, –78 °C; then Et3N, –60 → –30 °C, 91%; (d) 1.76, BF3•OEt2, CH2Cl2, –78 °C, 31%, 
1.1:1.0 d.r.; (e) TMSCl, imidazole, THF, –78 °C, 85%; (f) LDA, TMSCl, THF, –78 °C, 90%; (g) TMSOTf, Et3N, 
CH2Cl2, –78→ –10 °C, 76%. 
                                                      
31 (a) Anh, N. T. in Topics in Current Chemistry; Boschke, F. L., Ed. Springer-Verlag: New York, 1980; Vol. 88, p 
145. (b) Anh, N. T.; Eisenstein, O. Nouveau J. Chem. 1977, 1, 61. (c) Evans, D. A.; Dart, M. J.; Duffy, J. L.; Yang, 
M. G. J. Am. Chem. Soc. 1996, 118, 4322–4343. 
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1.4.F Baran’s Racemic Total Synthesis of Vinigrol 
 Learning from other’s past mistakes and successes, the Baran group developed the first racemic 
total synthesis of 1.1 in 2009 utilizing an IMDA reaction/Grob fragmentation sequence to construct 
vinigrol’s tricyclic carbon skeleton (Scheme 1.11). Their synthesis began with a Lewis acid promoted 
intermolecular endo-selective Diels–Alder reaction between silyloxy diene 1.83 and α,β-unsaturated ester 
1.84 to provide bicyclo[2.2.2]octane 1.85. The cycloadduct 1.85 was then transformed to the 
corresponding vinyl triflate, which underwent Stille cross-coupling with tributylstannylethylene to give 
diene 1.86. Next, the methyl ester was treated with DIBAL and the resultant aldehyde was exposed to 
allylmagnesium chloride to furnish triene intermediate 1.87. Warming the reaction mixture to reflux 
promoted a facile IMDA reaction to yield tetracycle 1.88. Next, the C9 methyl stereocenter was 
introduced through oxidation of the C10–OH to the ketone followed by enolate alkylation from the 
convex face of the molecule. The C10 mesylate 1.89, required for Grob fragmentation, was accessed in 
three steps via: (1) silyl ether deprotection, (2) C4–OH directed reduction of the C10 ketone with 
Me4NBH(OAc)3, and (3) mesylation. It should be noted that the depicted C10 stereochemistry was 
specifically prepared to optimize orbital overlap during the impending Grob fragmentation process. 
Gratifyingly, treatment of tertiary carbinol 1.89 with KHMDS provided decahydro-1,5-
butanonaphthalene 1.90. The next synthesis challenge was the introduction of the C8 methyl group and 
the C8a tertiary carbinol. Many strategies for syn introduction of these substitents were attempted 
including epoxide opening with bromide or cyanide nucleophiles, however none were successful. This 
obstacle was overcome though the use of a [3+2] dipolar bromonitrile oxide cycloaddition. Exposure of 
1.90 to in situ generated bromonitrile oxide promoted chemoselective formation of the corresponding C8–
C8a cycloadduct. Next, the C10–C11 olefin was found to be resistant to hydrogentation under a variety of 
conditions. It was discovered that reduction of the C4 carbonyl was necessary to facilitate hydrogentation 
of the C10–C11 olefin via C4–OH direction. Accordingly, the intermediate cycloadduct was treated with 
DIBAL to reduce the C4 carbonyl group and a solution of the resultant alcohol was stirred under a 
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hydrogen atmosphere with Crabtree’s catalyst to afford intermediate 1.92.32 The C4 alcohol was then 
dehydrated via xanthate formation and Chugauv elimination33 to give cyclohexene 1.93. Sequential 
reduction of the bromoisoxazole subunit to deliver intermediate 1.94 exhibiting the requisite C8–Me and 
C8a–OH substituents, was accomplished in four steps including: (1) reduction with LiAlH4, (2) 
formylation of the resultant amine, (3) dehydration to the primary isonitrile, and (4) C–N bond reduction 
with nBu3SnH and AIBN.34 The C3–C4 olefin was then dihydroxylated and the resultant C3–OH was 
chemoselectively oxidized with NaOCl to an α-hydroxy ketone intermediate, which underwent hydrazone 
formation with trisylhydrazide to give compound 1.95. Finally, simultaneous installation of the C2–C3 
olefin and the C16 hydroxymethyl group was accomplished via a Shapiro reaction, thereby completing 
the first total synthesis of 1.1 in 23 steps and 3% overall yield.35  
  
                                                      
32 Crabtree, R. H.; Davis, M. W. J. Org. Chem. 1986, 51, 2655–2661. 
 
33 DePuy, C. H.; King, R. W. Chem. Rev. 1960, 60, 431–457. 
 
34 Saegusa, T.; Kobayashi, S.; Ito, Y.; Yasuda, N. J. Am. Chem. Soc. 1968, 90, 4182. 
 
35 Shapiro, R. H.; Heath, M. J. J. Am. Chem. Soc. 1967, 89, 5734–5735. 
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Scheme 1.11 Baran’s strategy for the first racemic total synthesis of vinigrol. 
 
Reagents and conditions: (a) 1.84, AlCl3, CH2Cl2, –78 → –45 °C, 65%, 2:1 d.r.; (b) LDA, Tf2O, THF, –78 °C → 
RT, 76%; (c) nBu3SnCHCH2, LiCl, Pd(PPh3)4, THF, reflux, 90%; (d) DIBAL, CH2Cl2, –78 °C; then DMP, CH2Cl2, 
81% (two steps); (e) allylmagnesium chloride, PhMe, –78 → 105 °C, 81%; (f) DMP, CH2Cl2, 92%; (g) LDA, MeI, 
THF, –78 → 0 °C; (h) TBAF, THF, 50 °C; (i) Me4NBH(OAc)3, HOAc-MeOH-THF (1:1:1), 72% (three steps); (j) 
MsCl, Py, 0 °C; (k) KHMDS, THF, 0 °C → RT, 85% (two steps); (l) 1.91, KHCO3, EtOAc, 88%; (m) DIBAL, 
CH2Cl2, –78 °C → RT, 95%; (n) Crabtree’s catalyst (20 mol%), B(O-iPr)3, H2, ClCH2CH2Cl, 80 °C, 87%; (o) NaH, 
CS2, MeI, THF, 70 °C → RT, 88%; (p) o-DCB, 180 °C, 96%; (q) LiAlH4, THF, 0 °C → RT; (r) HCO2H, CDMT, 
NMM, 4-DMAP (10 mol%), CH2Cl2, 81%, (two steps); (s) COCl2, Et3N, CH2Cl2, –20 °C, 76%; (t) AIBN, nBu3SnH, 
PhMe, 100 °C, 91%; (u) OsO4 (10 mol%), NMO, Me2CO-H2O (3:1), 95%; (v) NaOCl, TEMPO (10 mol%), KBr, 
(10 mol%), 5% aq NaHCO3-CH2Cl2 (2:5), 0 °C, 85%; (w) TrisNHNH2, CH2Cl2; (x) nBuLi, (CH2O)n, TMEDA-THF 
(2:1), –78 °C → RT, 51% (two steps). 
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1.4.G Njardarson’s Racemic Total Synthesis of Vinigrol 
Njardarson and coworkers recently published the second racemic total synthesis of 1.1 (Scheme 
1.12).19d Their synthesis employed several key chemical transformations including an oxidative 
dearomatization/Diels–Alder cycloaddition, a Heck reaction cascade, and a Wharton/Grob fragmentation 
sequence36 to construct vinigrol’s carbocyclic core. Unfortunately, a lengthy series of oxidation state 
manipulations and one-carbon homologations were required to complete the total synthesis. Despite these 
drawbacks the synthesis illustrates a great deal of ingenuity and a number of intriguing reactions. The 
synthesis began with 3-(trimethylsilyl)propargyl alcohol, which was elaborated to cyclization substrate 
1.96 in 11 steps (not depicted). Exposure of phenol 1.96 to iodobenzene diacetate in MeOH promoted an 
oxidative dearomatization reaction to give an intermediatate mixted acetal. The intermediate was heated 
to facilitate an IMDA reaction and afford cycloadduct 1.97, exhibiting the requisite C8a, C1, and C12 
stereochemistry. It should be noted that the use of a trifluoroethyl phenol protecting group was necessary 
to electronically deactivate the aromatic ring and thus guide the oxidative dearomatization reaction to the 
more hindered site of the molecule. Synthesis of pentacycle 1.98 was accomplished through a tandem 
Heck reaction cascade in which the C4a and C5 stereocenters of 1.1 were introduced. Next, the C9 methyl 
stereocenter was set through hydrogenation of the corresponding exocyclic olefin and the intermediate 
ketone was converted to alternative exocyclic olefin 1.99 via carbonyl addition with methylmagnesium 
bromide and dehydration of the resultant tertiary carbinol. Hydrogenation of 1.99 with Pfaltz catalyst 
1.10037 introduced the C8 methyl stereocenter. Presumably the high facial selectivity for hydrogen 
transfer in this reaction was due to coordination of the furan oxygen to the iridium catalyst. Wharton/Grob 
fragmentation substrate 1.102 was then prepared through a series of oxidation state manipulations. 
Treatment of 1.102 with tBuOK stimulated C6–C12 bond fragmentation and ring expansion to yield 
ketone 1.103. The C12 isopropyl substituent was then introduced and the methyl ether at C16 deprotected 
                                                      
36 Wharton, P. S. J. Org. Chem. 1961, 26, 4781–4782. 
 
37 Stenberg, B. W.; Pfaltz, A. Adv. Synth. Catal. 2008, 350, 174–178. 
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to provide allylic alcohol 1.106. Epoxidation of 1.106 followed by iodination of the primary alcohol and 
reductive fragmentation via sonication with activated zinc metal afforded transposed allylic alcohol 1.107. 
Next, the C3–C16 exocyclic olefin was oxidized with concomitant 1,3-transposition by exposure to SeO2. 
Finally, the second racemic total synthesis of of 1.1 was completed through deprotection of the 
trifluoroethyl protecting group via a novel fluoride elimination/oxidation sequence.  
Scheme 1.12 Njardarson’s total synthesis of vinigrol.  
 
Reagents and conditions: (a) PhI(OAc)2, MeOH, 2,6-lutidine, CF3CH2OH, –40 °C; then PhMe, 60 °C, 64%; (b) 
Pd(OAc)2, PPh3, Et3N, PhCF3, 150 °C, 67%; (c) Pd/C (10 mol%), H2 (1000 psi), EtOAc, 92%; (d) MeMgBr, 
MgBr2•OEt2, Et2O, 0 °C → RT, 98%; (e) KH, CS2, MeI, THF, 0 °C → RT; (f) PhMe, 110 °C, 79% (two steps); (g) 
1.100 (1 mol%), H2, CH2Cl2, 94%; (h) LiBF4, H2O-MeCN (2:98), 83 °C; (i) DMP, CH2Cl2, 86% (two steps); (j) 
mCPBA, CH2Cl2, 91%; (k) DIBAL, CH2Cl2, –78 °C, 91%; (l) DMP, CH2Cl2, 94%; (m) Me4NBH(OAc)3, AcOH, 
MeCN, 95%; (n) MsCl, Py, 0 °C, 97%; (o) tBuOK, tBuOH, THF, 92%; (p) Pd/C (5 mol%), H2, EtOAc, 98%; (q) 
1.104, CeCl3, THF, –78 °C, 79%; (r) Burgess’s reagent, PhH, 80 °C, 71%; (s) Pd/C (10 mol%), KOH, H2, EtOH, 
94%; (t) Ph3PCH3Br, nBuLi, PhMe, –80 °C, 81%; (u) Pd/C (10 mol%), H2, EtOAc, 98%; (v) SeO2, PhH, 80 °C, 
73%; (w) DIBAL, PhMe, –78 °C, 98%; (x) mCPBA, NaHCO3, CH2Cl2; (y) I2, PPh3, imidazole, THF, 65 °C, 68% 
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Reagents and conditions for Scheme 1.12 continued: (two steps); (z) Zn, CuI, EtOH, H2O, sonication, 77%; (aa) 
SeO2, CH2Cl2; then 30% aq H2O2, 50%; (bb) LDA, THF, –78 °C; (cc) OsO4, tBuOH, Py, 70% (two steps). 
  First-Generation Synthesis Plan and Retrosynthesis Analysis  1.5
When planning our first-generation synthesis of 1.1 in 2007, we sought to apply a disconnection 
strategy that differed from many of the previously published approaches. Specifically we were interested 
in forming the 6-membered ring highlighted in structures 1.110 and 1.111 (Figure 1.5) at a late-stage in 
the synthesis rather than the 8-membered ring highlighted in structures 1.108 and 1.109, due to the 
problems associated with 8-membered ring closure encountered by Paquette.12 
 
Figure 1.5 Disconnection strategy for vinigrol. 
 Our initial approach to 1.1 therefore focused on formation of the embedded 
bicyclo[5.3.1]undecene ring system, highlighted in structure 1.112 of Figure 1.6, common to the taxane 
family of natural products.38 We were inspired to target this bicyclic architecture by previous work 
conducted in the Shair laboratory on the total synthesis of the natural product (+)-CP-263,114 (1.113)39 
and on the synthesis of bridgehead enone-containing polycyclic ring systems.40,41 
                                                      
38 (a) Woods, M. C.; Chiang, H.-C.; Nakadaira, Y.; Nakanishi, K. J. Am. Chem. Soc. 1968, 90, 522–523. (b) Miller, 
R. W.  J. Nat. Prod. 1980, 43, 425–437. (c) Guéritte-Voegelein, F.; Guénard, D.; Potier, P. J. Nat. Prod. 1987, 50, 
9–18. (d) Appendino, G.; Tagliapietra, S.; Çetin Özen, H.; Gariboldi, P.; Gabetta, B.; Bombardelli, E. J. Nat. Prod. 
1993, 56,  514–520. (e) Hanson, J. R. Nat. Prod. Rep. 1993, 10, 159–174. (f) Baloglu, E.; Kingston, D. G. I. J. Nat. 
Prod. 1999, 62,  1448–1472. (g) Shigemori, H.; Kobayashi, J. J. Nat. Prod. 2004, 67, 245–256. (f) Shi, Q.-W.; 
Kiyota, H. Chem. Biodiversity 2005, 2, 1597–1623. 
39 (a) Chen, C.; Layton, M. E.; Sheehan, S. M.; Shair, M. D. J. Am. Chem. Soc. 2000, 122, 7424–7425. (b) Chen, C.; 
Layton, M. E.; Shair, M. D. J. Am. Chem. Soc. 1998, 120, 10784–10785. (c) Chen, C. Ph.D. Thesis, Harvard 
University, 2001. (d) Layton, M. Ph.D. Thesis, Harvard University, 2002. 
 
40 Sheehan, S. M.; Lalic, G.; Chen, J.; Shair, M. D. Angew. Chem. Int. Ed. 2000, 39, 2714–2715.  
 
41 Oyelaran, O. O. Ph.D. Thesis, Harvard University, 1995. 
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 Juxtaposition of (+)-CP-263,114 (1.113) with vinigrol (1.112, depicted in an orientation 
beneficial for comparison) illustrates their structural similarities (Figure 1.6). The total synthesis of 1.113 
was accomplished in 12 steps from intermediate 1.114, which exhibits a similar bicyclo[4.3.1]-deca-1(9)-
ene ring system. 1.114 was constructed via a fragment coupling/tandem cyclization reaction of vinyl 
Grignard 1.117 and β-ketoester 1.118, comprising: (1) chelation-controlled alkylation, (2) anion 
accelerated oxy-Cope rearrangement, and (3) transannular acylation.  
 
Figure 1.6 Structural comparison of vinigrol with (+)-CP-263,114. 
Based on these initial considerations, our synthesis plan for 1.1 is illustrated in Figure 1.7. In a 
retrosynthetic sense, we anticipated that the C8–C8a bond of the tricyclo[4.4.4.0.4a,8a]tetradecene skeleton 
could be constructed through a diastereoselective 6-exo-trig cyclization of a ketyl radical derived from the 
bridgehead ketone of compound 1.119 on to a pendant terminal olefin.42 The 6-membered ring embedded 
in 1.119 could then be functionalized, following olefin isomerization, through a precedented series of 
oxidations.12d Introduction of the isopropyl subunit at C12 in 1.119 could then be accomplished in a 
stereoselective manner utilizing a cross-coupling/hydrogenation sequence. These simplifications reveal 
compound 1.120, exhibiting the requisite bicyclo[5.3.1]undecene skeleton of vinigrol. We anticipated that 
                                                      
42 For a review of samarium(II) iodide-mediated cyclizations in natural product synthesis, see: Edmonds, D. J.; 
Johnston, D.; Procter, D. J. Chem. Rev. 2004, 104, 3371–3403. 
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a tandem alkylation/retro-aldol-aldol equilibration/anion-accelerated oxy-Cope 
rearrangement/transannular acylation cascade reaction of cyclohexanone 1.121 with vinylmagnesium 
bromide could yield intermediate 1.120.43 Finally, cyclohexanone 1.121 could potentially be accessed 
from chiral enone 1.122 via a three-component coupling protocol. A total synthesis based on this strategy 
would be enantiospecific in nature, wherein the stereochemical information contained in 1.122 could be 
propagated to set all the other stereocenters in the molecule diastereoselectively. 
 
Figure 1.7 Retrosynthetic analysis of vinigrol. 
A brief discussion of our proposed first-generation cascade reaction sequence will help clarify 
several of the reaction design elements (Scheme 1.13). We anticipated that the tandem reaction sequence 
would begin with chelation-controlled diastereoselective vinylmagnesium bromide addition to β-ketoester 
1.121 from the axial face of the depicted chair conformer 1.12344,45 furnishing tertiary allylic alkoxide 
1.124, which notably contains trans-1,2-diaxial alkenyl substituents. We proposed that in order for these 
alkene groups to become geometrically capable of participating in an anion-accelerated oxy-Cope 
                                                      
43 For a review on cascade reactions in natural product total synthesis, see: (a) Tietze, L. F. Chem. Rev., 1996, 96, 
115–136. (b) Nicolaou, K. C. Edmonds, D. J. Bulger, P. J. Angew. Chem. Int. Ed. 2006, 45, 7134–7186. 
 
44 (a) Molander, G. A.; Harris, C. R. J. Org. Chem. 1997, 62, 2944–2956. (b) Eicher, T.; Servet, F.; Speicher, A. 
Synthesis 1996, 863–870. (c) Molander, G. A. J. Am. Chem. Soc. 1995, 117, 3705–3716. 
 
45 For a review on the stereochemistry of organometallic addition to ketones, see: Ashby, E. C.; Laemmle, J. T. 
Chem. Rev., 1975, 75, 521–546. 
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rearrangement,46,47,48 a retro-aldol-aldol equilibration step must first take place. This equilibration event 
would avoid two 1,3-diaxial interactions in chair conformer 1.125, which orients the alkenyl substituents 
in trans-1,2-diequitorial positions.49 The push-pull arrangement of the alkoxide and the α-ester was 
expected to promote fragmentation via a retro-aldol reaction50 and facilitate the subsequent anion-
accelerated oxy-Cope rearrangement. 51  The dynamic retro-aldol-aldol process would allow for the 
generation of several products, all of which are theoretically capable of undergoing oxy-Cope 
rearrangement. However, since anion accelerated oxy-Cope rearrangement will likely be the rate-
determining step,49 only the retro-aldol-aldol product with the lowest activation barrier was expected to 
proceed through the transannular acylation step of the cascade sequence. In this way, the success of the 
cascade sequence completely relies on the Curtin─Hammett principle;52 the retro-aldol-aldol product with 
the lowest activation barrier to anion-accelerated oxy-Cope rearrangement will most likely have a chair-
                                                      
46 For the discovery of the anionic oxy-Cope rearrangement, see: Evans, D. A.; Golob, A. M. J. Am. Chem. Soc. 
1975, 97, 4765–4766. 
 
47 For recent reviews on the oxy-Cope rearrangement, see: (a) Paquette, L. A. Tetrahedron 1997, 53, 13971–14020. 
(b) Paquette, L. A. Angew. Chem., Int. Ed. 1990, 29, 609–626. (c) Hill, R. K. In Comprehensive Organic Synthesis; 
Trost, B. M.; Fleming, I. Eds.; Pergamon Press: Oxford, 1991; vol. 5, ch. 7.1. (d) Wilson, S. R. Org. React. 1993, 43, 
93–250.  
48 For recent applications of the oxy-Cope rearrangement in medium-ring syntheses, see: (a) Yang, J.; Long, Y. O.; 
Paquette, L. A. J. Am. Chem. Soc. 2003, 125, 1567–1574. (b) Banwell, M. G.; Hockless, D. C. R.; McLeod, M. D. 
New J. Chem. 2003, 27, 50–60. (c) Hashimoto, H.; Jin, T.; Karikomi, M.; Seki, K.; Haga, K.; Uyehara, T. 
Tetrahedron Lett. 2002, 43, 3633–3636. (d) Banwell, M. G.; McRae, K. J.; Willis, A. C. J. Chem. Soc., Perkin Trans. 
1 2001, 2194–2203. (e) Njardarson, J. T.; Wood, J. L. Org. Lett. 2001, 3, 2431–2434. (f) Chu, Y.; White, J. B.; 
Duclos, B. A. Tetrahedron Lett. 2001, 42, 3815–3818. (g) Jansma, M. J.; Hoye, T. R. Org. Lett., 2012, 14, 4738–
4741. (h) Hu, D. X.; Clift, M. D.; Lazarski, K. E.; Thomson, R. J. J. Am. Chem. Soc. 2011, 133, 1799–1804. 
 
49 Xu, K.; Lalic, G.; Sheehan, S. M.; Shair, M. D.; Angew. Chem. Int. Ed. 2005, 44, 2259–2261. 
 
50 (a) Tomooka, K.; Nagasawa, A. Wei, S.-Y.; Nakai, T. Tetrahedron Lett. 1996, 37, 8899–8900. (b) Black, W. C.; 
Giroux, A.; Greidanus, G. Tetrahedron Lett. 1996, 37, 4471–4474. (c) Schneider, C.; Rehfeuter, M.; Synlett 1996, 
212–214. 
 
 
51 Evans, D. A.; Baillargeon, D. J.; Nelson, J. V. J. Am. Chem. Soc. 1978, 100, 2242–2244. 
 
52 (a) Curtin, D. Y. Rec. Chem. Prog. 1954, 15, 111–118; (b) Winstein S.; Holness, N. J. J. Am. Chem. Soc. 1955, 77, 
5562–5578; (c) Eliel, E. L. Stereochemistry of Carbon Compounds; McGraw-Hill: New York, 1962. (d) Hammett, L. 
P. Physical Organic Chemistry; McGraw-Hill: New York, 1970; ch 5; (e) Seeman, J. I. Chem. Rev. 1983, 83, 83–
134; (f) Seeman, J. I. J. Chem. Educ. 1986, 63, 42–48. 
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chair-chair-like transition state.53 For this reason, we anticipated that intermediate 1.128, which possesses 
alkene substituents positioned in a trans-1,2-diequatorial orientation, should outcompete all other retro-
aldol-aldol pathways for anion-accelerated oxy-Cope rearrangement to give intermediate 1.129. 
Stereodefined 10-membered ring enolate 1.129, can then participate in transannular acylation reaction 
with the pendant methyl ester, liberating an equivalent of methoxide, to yield bicyclo[5.3.1]undecene 
1.120.  
Scheme 1.13 Proposed first-generation cascade reaction sequence. 
 
                                                      
53 For previous examples of oxy-Cope rearrangements which proceed through boat or chair transition states, see: (a) 
Evans, D. A.; Nelson, J. V. J. Am. Chem. Soc. 1980, 102, 774–782. (b) Paquette, L. A.; Guevel, R.; Sauer, D. R. 
Tetrahedron Lett. 1992, 33, 923–926. (c) Chu, Y.; Colclough, D.; Hotchkin, D.; Tuazon, M.; White, J. B. 
Tetrahedron 1997, 53, 14235–14246. (c) White, B. H.; Snapper, M. L. J. Am. Chem. Soc. 2003, 125, 14901–14904. 
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 Synthesis of First-Generation Cascade Reaction Precursor  1.6
 In order assess the viability of our proposed tandem reaction sequence we undertook a synthesis 
of the cascade precursor (±)-1.138 (Scheme 1.14). Our initial forays into the synthesis of (±)-1.138 
targeted the cascade substrate as a racemic mixture. Accordingly, commercially available cyclohexane-
1,3-dione (1.130) was converted to racemic 4-methyl-2-cyclohexen-1-one ((±)-1.132) on multi-gram 
scale through a precedented series of transformations based on the work of Stork and Danheiser.54 While 
we elected to utilize racemic (±)-1.132 in the developmental stages of the project, enantiomerically pure 
4-methyl-2-cyclohexene-1-one ((+)-1.132) is available on multi-gram scale through a catalytic 
enantioselective meso-epoxide opening procedure developed by Feringa55 or from (R)-pulegone in six 
steps.56 Treatment of (±)-1.132 with iodine and pyridine resulted in the formation of α-iodoenone (±)-
1.133 through a modification of Johnson’s procedure in 53% yield over three steps.57 Suzuki-Miyaura 
cross-coupling58 between (±)-1.133 and (E)-propenylboronic acid (1.134)59 resulted in a 74% yield of α-
propenyl cyclohexenone (±)-1.122. Addition of higher order cuprate 1.13560 to (±)-1.122 in the presence 
of TMSCl61 furnished enol silane (±)-1.13662 with high levels of diastereoselectivity. While (±)-1.136 was 
                                                      
54 (a) Stork, G.; Danheiser, R. L. J. Org. Chem. 1973, 38, 1775–1776. (b) Kende, A. S.; Fludzinski, P. Org. Synth. 
1986, 64, 68–71. (c) Trost, B. M. Bream, R. N.; Xu, J. Angew. Chem. Int. Ed. 2006, 45, 3109–3112. 
 
55 Bertozzi, F.; Crotti, P.; Feringa, B. L.; Macchia, F.; Pineschi, M. Synthesis 2001, 483–486. 
 
56 Lee, H. W.; Ji, S. K.; Lee, I.-Y. C.; Lee, J. H. J. Org. Chem. 1996, 61, 2542–2543. 
 
57 (a) Johnson, C. R.; Adams, J. P.; Braun, M. P.; Senanayake, C. B. W.; Wovkulich, P. M.; Uskokovich, M. R. 
Tetrahedron Lett. 1992, 33, 917–918. (b) Scott, T. L.; Burke, N.; Carrero-Martínez, G.; Söderberg, B. C. G. 
Tetrahedron, 2007, 63, 1183–1190. 
 
58 (a) Miyaura, N.; Yamada, K.; Suginome, H.; Suzuki, A. J. Am. Chem. Soc. 1985, 107, 972–980. (b) Urdaneta, N.; 
Ruíz, J.; Zapata, A. J. J. Organomet. Chem. 1994, 464, C33–C34. 
 
59 Braun, J.; Normant, H. Bulletin de la Société Chimique de France 1966, 8, 2557–2564. 
 
60 (a) Lipshutz, B. H.; Wilhelm, R. S.; Kozlowski, J. A. Tetrahedron, 1984, 40, 5005–5038. 
 
61 (a) Frantz, D. E.; Singleton, D. A. J. Am. Chem. Soc. 2000, 122, 3288–3295. (b) Lipshutz, B. H.; Dimock, S. H.; 
James, B. J. Am. Chem. Soc. 1993, 115, 9283–9284. (c) Gooding, O. W. J. Org. Chem. 1990, 55, 4209–4211. (d) 
Nakamura, E.; In Organocopper Reagents: A Practical Approach, Tayler, R. J. K., Ed; Oxford University Press: 
Oxford, 1994; pp 129–142. (e) Matsuzawa, S.; Horiguchi, Y.; Nakamura, E.; Kuwajima, I. Tetrahedron 1989, 45, 
349–362. (f) Hutchinson, D. K.; Fuchs, P. L. J. Am. Chem. Soc. 1987, 109, 4930–4939. (g) Linderman, R. J.; 
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unstable to purification, it could be treated directly with methyl lithium in THF at –78 °C to regenerate 
the lithium enolate63 for the proposed C-acylation reaction with methyl cyanoformate.64 Unfortunately, 
efforts to affect this transformation were unsuccessful in both Et2O and THF and in the presence of 
various additives such as HMPA. 
 Scheme 1.14 Attempted synthesis of cascade substrate (±)-1.138. 
 
Reagents and conditions: (a) LDA, THF, –78 °C; then MeI, –78 °C →  RT; (b) LiAlH4, Et2O; then HCl; (c) I2, Py, 
Et2O, 0 °C →  RT, 54% (three steps); (d) 1.134, 2.0 M Na2CO3, Pd(PPh3)4 (10 mol%), THF, 60 °C, 76%; (e) 
thiophene, nBuLi, THF, –78 °C; CuCN, –78 →  0 °C; BnO(CH2)3I, tBuLi, Et2O-pentane, –78 °C → RT; TMSCl, –
78 °C; (±)-1.122, –78 °C; (f) MeLi, Et2O, –78 → 0 °C; CH3OC(O)CN (1.137), –78 → 0 °C. 
 The three-component coupling of a cyclic enone with an organometallic reagent and an 
electrophile generally results in trans relative stereochemistry of the incorporated nucleophile and 
electrophile.65 Two potential low energy cyclohexene half-chair conformations exist for the intermediate 
lithium enolate (Figure 1.8). Putative enolate conformer 1.139 places the C5 and C9 alkyl substituents in 
                                                                                                                                                                              
Godfrey, A. Tetrahedron Lett. 1986, 27, 4553–4556. (h) Nakamura, E.; Matsuzawa, S.; Horiguchi, Y.; Kuwajima, I. 
Tetrahedron Lett. 1986, 27, 4029–4032. (i) Corey, E.J.; Boaz, N. W. Tetrahedron Lett. 1985, 26, 6015–6018. 
 
62 Cyclohexane numbering based on vinigrol’s numbering, Scheme 1.1. 
 
63Stork, G.; Hudrlik, P. F. J. Am. Chem. Soc. 1968, 90, 4464–4465. 
 
64 Crabtree, S. R.; Chu, W. L. A.; Mander L. N. Synlett 1990, 3, 169–170. 
 
65 For a review on the application of the three component coupling strategy to prostaglandin syntheses, see: Noyori, 
R.; Suzuki, M. Angew. Chem. Int. Ed. 1984, 23, 847–876. 
O
OEt
a. LDA; MeI
O
OEt
1.130 (±)-1.131
Me b. LiAlH4;
O
(±)-1.132
Me
c. I2, Py
(54%, 3 steps)
O
(±)-1.133
Me
I
O
(±)-1.122
Me
B(OH)2Me
Pd(PPh3)4,
Na2CO3
Me
1.134
BnO Cu(CN)Li2
S
1.137
(quantitative)
OTMS
(±)-1.136
Me
Me
OBn
3
NC OMe
O
f. MeLi;
O
(±)-1.138
Me
Me
OBn
3
CO2Me
9 5
4a
TMSCl
e.
d.
(76%)
HCl
1.135
 30 
a pseudoequitorial orientation, but in doing so engenders steric congestion between the C4a-propenyl 
substituent and the C5-alkyl side chain. This interaction likely pushes the conformational equilibrium 
towards half-chair 1.40. The substrate’s overall lack of reactivity may be attributed to the pseudoaxial C9 
methyl substituent in 1.140, which hinders the Si face of the lithium enolate and disfavors substitution by 
methyl cyanoformate. 
 
Figure 1.8 Rationalization for failed C-acylation. 
 Due to these difficulties, an alternative strategy to construct the C4a quaternary carbon stereocenter 
of the first-generation cascade reaction substrate was developed (Scheme 1.15). Specifically, we 
anticipated that a Claisen rearrangement66 could be applied to address this issue. The revised synthesis of 
(±)-1.138 began with commercially available racemic methyl 2-hydroxy-5-methylcyclohex-1-
enecarboxylate ((±)-1.141). α-Phenylselenation of (±)-1.141 followed by oxidation and selenoxide 
elimination gave α,β-unsaturated  β-ketoester (±)-1.142. Conjugate addition of alkyl Grignard 1.144, 
promoted by catalytic CuBr•SMe2, occurred anti to the C9 methyl substituent to the provide  β-ketoester 
(±)-1.144 in a 10:1 diastereomeric ratio for the newly formed C5 stererocenter. The enol tautomer of (±)-
1.144 was then selectively O-allylated by treatment with NaH and allyl bromide to provide O-allyl-
β-ketoester (±)-1.145 in 42% over four steps on multi-gram scale. Allylation of cyclic β-ketoester sodium 
or potassium enolates generally provides a mixture of C-allylated and O-allylated products, favoring the 
former.67 The exclusive O-allylation observed in this reaction can be explained by a steric interaction 
                                                      
66 For reviews on the Claisen rearangement, see: (a) Wipf, P. Comprehensive Organic Synthesis; Trost, B. M. Ed.; 
Pergamon: Oxford, 1991; vol 5; pp 827–873. (b) Castro, A. M. M. Chem. Rev. 2004, 104, 2939−3002. (c) 
Hiersemann, M.; Nubbemeyer. U. Eds. The Claisen Rearrangement; Wiley-VCH: Weinheim, 2007. 
67 (a) Uyeda, C.; Jacobsen, E. N. J. Am. Chem. Soc. 2008, 130, 9228–9229. (b) Uyeda, C.; Rötheli, A. R.; Jacobsen, 
E. N. Angew. Chem. Int. Ed. 2010, 49, 9753–9756. 
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between the incoming allyl electrophile and an axially disposed C9 methyl substituent of a half-chair 
enolate conformer analogous to 1.140 (Figure 1.8). Next, microwave irradiation of neat allyl vinyl ether 
(±)-1.145 for 15 min at 185 °C afforded C-allyl-β-ketoester (±)-1.146 in 87% yield, in which the C4a 
quaternary center was formed as a 1:1 mixture of diastereomers. Finally, exposure of the desired C-allyl-
β-ketoester diasteomer (±)-1.146 to catalytic PdCl2(MeCN)2 and K2CO3 in warm PhMe promoted olefin 
isomerization to give cascade substrate (±)-1.138 in 70% yield. Notaly, the Pd(II) catalyzed olefin 
isomerization process preferentially gave the thermodynamically favored internal trans olefin isomer. 68,69 
Scheme 1.15 First-generation cascade substrate synthesis via Claisen rearrangement. 
 
Reagents and conditions: (a) PhSeCl, CH2Cl2, 0 °C → RT; (b) 30% aq H2O2, CH2Cl2, 0 °C; (c) BnO(CH2)3Br, 
Mg(0), THF, reflux; then CuBr•SMe2, –78 °C; then (±)-1.144; (d) allyl bromide, NaH, DMF, 0 °C, 42%, 10:1 d.r. 
(four steps); (e) neat, µwave, 185 °C, 87%, 1:1 d.r.; (f) PdCl2(MeCN)2 (5 mol%), K2CO3, PhMe, 80 °C, 70%, 20:1 
E:Z. 
 First-Generation Cascade Reaction Sequence 1.7
 With cascade substrate (±)-1.138 in hand, we investigated the proposed alkylation/retro aldol-
aldol/anion-accelerated oxy-Cope rearrangement/transannular acylation cascade reaction sequence. C-
propenyl-β-ketoester (±)-1.138 was exposed to reaction conditions previously developed for a similar 
                                                      
68 For mechanism, see: Sen, A; Lai, T. W. Inorg. Chem., 1984, 23, 3257–3258. 
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Compounds; Cornils, B.; Herrmann, W. A. Eds.; Wiley-VCH: Weimheim, 2nd ed., 2002; vol 3; p. 1119. (b) 
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tandem reaction sequence (Scheme 1.16).39,40,41 A freshly prepared solution of vinylmagnesium bromide 
in THF was added to a 0.10 M solution (±)-1.138 in PhMe at –78 °C and warmed to 0 °C over 1 h; after 
1,2-addition had taken place,70 the resultant reaction mixture was transferred via cannula into a solution of 
PhMe and THF (4:1 by volume) to generate a 0.010 M solution of the intermediate allylic alkoxide. The 
reaction vessel was then sealed and heated to 60 °C for 12 h. Unfortunately, the only product observed 
upon work-up was 2-cyclohexenone (±)-1.147, formed through a retro-Dieckmann condensation of 
bicycle 1.148. Methoxide liberated during the final transannular acylation step of the cascade sequence 
underwent irreversible 1,2-addition into the non-bridgehead carbonyl group of 1.148. The dilution process 
employed in the cascade reaction sequence had been shown in previous examples to suppress the 
bimolecular retro-Dieckmann condensation process. One possible explanation for the observed reactivity 
difference could be ascribed to the elevated temperatures (i.e. 60 °C) required to encourage the key anion-
accelerated oxy-Cope rearrangement step of this particular cascade reaction. In contrast, previous 
examples of the anion-accelerated oxy-Cope rearrangement proceeded at ambient temperature. 
Additionally, compared to the structure of the expected casade reaction product (1.120, Scheme 1.13), the 
alkyl substituentents at C5 and C9 of the putative bicyclic intermediate 1.148 were inverted relative to the 
bridgehead carbonyl group. This issue will be addressed in a subsequent section of the document.  
Scheme 1.16 Cascade reaction under standard conditions. 
 
 We speculated whether application of a ZnBr+ rather than a MgBr+ counter ion to the tandem 
reaction sequence might mitigate the retro-Dieckmann condensation process since Mg2+ can be considered 
                                                      
70 Reaction progress monitored by TLC. 
O
Me
OBn
CO2Me
Me
(±)-1.138 (±)-1.147
O
MeO
O
MeOBn
Me
Me
O
OBn
Me
O H
Mg
MeO–
Br OMe
+
1.148
via:
9 5
5
9
PhMe-THF [0.10 M], 
–78 → 0 °C, 1 h;
then PhMe-THF (4:1),
[0.10 → 0.010 M],
0 → 60 °C, 12 h
MgBr+MgBr
 33 
a hard metal while Zn2+ is often considered to be soft.71 Interestingly, the reactivity of magnesium 
alkoxide catalysts for ring-opening polymerization of L-lactide has been shown to exceed the analogous 
zinc alkoxide in a head-to-head comparison.72 Other counter ions such as Li+, Na+, or K+ had previously 
been demonstrated to be incapable of promoting the transannular acylation step of the tandem reaction 
sequence;39d MgBr+ was considered to be unique in its ability to facilitate both the oxy-Cope 
rearrangement and the transannular acylation steps of the cascade reaction sequence. Generally, the 
anion-accelerated oxy-Cope rearrangement of unstrained systems requires elevated temperatures and a 
highly dissociated counterion (e.g. K+ with 18-crown-6).47 The relatively mild conditions under which 
MgBr+ has been shown to facilitate oxy-Cope rearrangement was attributed to two effects: (1) ground 
state destabilization by the bromomagnesium alkoxide (highly dissociated counterions accentuate this 
effect); and (2) transition state stabilization by the α-ester substituent.51 We anticipated that application of 
a ZnBr+ counterion to the oxy-Cope rearrangement could replicate these effects.  
 To test this hypothesis, (±)-1.138 was exposed to vinylmagnesium bromide at –78 °C and the 
initial chelation-controlled 1,2-carbonyl addition adduct (±)-1.149 was isolated in 89% yield as a single 
C12 diasteomer (Scheme 1.17). The relative stereochemistry of (±)-1.149 was established though 
NOESY.73 The resultant allylic alcohol was then deprotonated through exposure to tert-butylzinc bromide 
at –78 °C and warmed to 0 °C to ensure deprotonation. Following the dilution procedure, the intermediate 
zinc alkoxide was transferred to a solution of PhMe and THF, sealed, and heated to 50 °C. After only 1 h, 
the reaction had reached completion. Unfortunately, the only product observed in this transformation 
again was 2-cyclohexenone (±)-1.147, isolated in 53% yield.  
  
                                                      
71 (a) Huheey, J. E.; Keiter, E. A.; Keiter, R. L. Inorganic Chemistry: Principles of Structure and Reactivity, 4th ed.; 
Harper Collins College Publishers: New York, 1993; pp 344–348. 
 
72 Chisholm, M. H.; Eilerts, N. W.; Huffman, J. C.; Iyer, S. S.; Pacold, M.; Phomphrai, K. J. Am. Chem. Soc. 2000, 
122, 11845–11854. 
 
73 See compound (±)-1.149 experimental section. 
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Scheme 1.17 Unsuccessful application of a zinc counter ion toward suppression of retro-Dieckmann condensation. 
 
 Our next strategy to suppress the retro-Dieckmann reaction was to scavenge the methoxide 
nucleophile liberated in the tranannular acylation step of the cascade sequence. A variety of electrophilic 
reagents were investigated including TIPSCl, ethyl β-iodoacrylate, bromodiphenylmethane, and di-tert-
butyl dicarbonate. Gratifyingly, addition of five equivalents of pivalic anhydride after deprotonation of 
allylic alcohol (±)-1.149 with tert-butylzinc bromide at 0 °C followed by heating the sealed reaction 
mixture to 70 °C for 4 h provided bicyclo[5.3.1]undecene (±)-1.152 in 42% yield (Scheme 1.18). Three 
attributes of pivalic anhydride underlie its ability to scavange methoxide in this reaction: (1) it is more 
electrophilic than the non-bridgehead ketone of bicycle (±)-1.152, (2) the zinc pivalate byproduct 1.153 is 
less nucleophilic than zinc methoxide, and (3) its hindered nature prevents pivalation of either the initial 
tertiary zinc alkoxide or the 10-membered zinc enolate intermediates. 
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Scheme 1.18 Successful use of pivalic anhydride to suppress of retro-Dieckmann condensation. 
 
 The next challenge in the synthesis of 1.1 was the installation of the C12 isopropyl substituent. 
Kinetic enolization of bicyclic diketone (±)-1.152 with KHMDS followed by addition of Comins’ reagent 
(1.155) provided alkenyl triflate (±)-1.156 (Scheme 1.19). Negishi sp2-sp3 cross-coupling with 
isopropylzinc chloride afforded crystalline product (±)-1.157 in 40% yield over two steps, which 
appeared to have the correct bond connectivity by NMR analysis. However, X-ray crystallographic 
analysis of (±)-1.15774 surprisingly revealed that we had formed an undesired bicyclic diastereomer, in 
which the alkyl substituents at C5 and C9 were opposite relative to the bridgehead carbonyl group when 
compared to the desired diastereomer (exemplified by 1.120, Figure 1.7). Regrettably, a synthesis 
intermediate derived from bicycle (±)-1.157 would be geometrically incapable of participating in a 
reductive ketone/olefin coupling reaction at a later-stage of the total synthesis.  
Scheme 1.19 Determination of undesired bicyclic stereochemistry. 
 
Reagents and conditions: (a) KHMDS, THF, –78 °C; then 1.155; (b) Pd(dppf)Cl2, LiCl, isopropylmagnesium 
bromide, ZnCl2, THF, 40 °C. 
 Based on these findings, the cascade sequence was reevaluated. Formation of bicycle (±)-1.152 
                                                      
74 See experimental section for X-ray crystal structure of (±)-1.157. 
Me
(±)-1.149
OBn
Me
CO2Me
HO
PhMe-THF [0.050 M], 
–78 → 0 °C, 1 h;
(±)-1.152
Me
Me
ZnBr
Me
(42%)
0 → 70 °C, 4 h
O
O
O
Me
MeMe
Me
MeMe
Me
O
OBn
H
Me
O H MeO–
via:
ZnBr+ O
O
O
Me
MeMe
Me
MeMe
Zn
Br OMe
+
BrZnO
O
Me
MeMe
OMe
O
Me
MeMe
1.153
1.154
(±)-1.156
Me
O
OBn
H
Me
TfO H
(±)-1.152
Me
O
OBn
H
Me
O H
Me
Me
ZnCl
(±)-1.157
(40%)
Me
O
OBn
H
Me
HMe
Me
a. KHMDS; then
N
Cl
N SO2CF3
SO2CF3
Pd(dppf)Cl2 9 5
b.
1.155
 36 
with the observed relative stereochemistry can be explained if one removes the predicted dynamic retro-
aldol-aldol equilibration step from the proposed cascade reaction sequence (Scheme 1.20). An alternative 
cascade reaction that explains the formation of bicycle (±)-1.152 involves: (1) deprotonation of allylic 
alcohol (±)-1.149 with tert-butylzinc bromide to provide zinc alkoxide 1.158, (2) an unexpected chair-
boat interconversion that places the trans-1,2-dialkenyl substituents in a pseudoequitorial orientation (i.e. 
1.159), (3) anion-accelerated oxy-Cope rearrangement to afford 10-membered zinc enolate 1.160, and (4) 
transannular acylation with concomitant expulsion of ZnBrOMe. 
Scheme 1.20 Explanation for undesired relative stereochemistry of (±)-1.152: hypothetical cascade reaction 
sequence. 
 
A brief comparison of two previously studied cascade reaction sequences will help elucidate the 
substrate requirements for retro-aldol-aldol equilibration. A typical substrate known to be capable of 
retro-aldol-aldol equilibration during the tandem reaction sequence is illustrated in Scheme 1.21.49 In this 
example, the use of enantiopure β-ketoester 1.161 and alkenyl Grignard 1.162 for the cascade reaction 
sequence resulted in racemic bicyclic 1.163 via a retro-aldol-aldol equilibration mechanism. Chelation 
controlled 1,2-addition of Grignard 1.162 to α-alkenyl-β-ketoester 1.161 provided a trans-1,2-dialkenyl 
adduct 1.164. The push-pull arrangement of the alkoxide and the α-ester in 1.164 both facilitated the 
subsequent anion-accelerated oxy-Cope rearrangement and promoted fragmentation via a retro-aldol 
reaction to generate acyclic intermediate 1.167. An intramolecular aldol reaction then produced trans-1,2-
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dialkenyl alkoxides 1.164 and 1.168 as a racemic mixture. Procession of 1.164 and 1.168 through the 
anion-accelerated oxy-Cope and transannular Dieckmann steps of the cascade reaction sequence afforded 
a racemic mixture of bicycle-[4.3.1]deca-1(9)-ene product 1.163. This fragmentation/recombination 
pathway was later exploited in a dynamic kinetic resolution of racemic α-alkenyl-β-ketoesters with 
enantiopure alkenyl Grignard reagents.49 
Scheme 1.21 Previously reported cascade reaction sequence involving a retro-aldol-aldol equilibration step. 
 
 In contrast, if the cyclic α-alkenyl-β-ketoester substrate was substituted at the 3- or 4-positions, 
the retro-aldol-aldol equilibration step of the cascade reaction sequence was found to be drastically 
suppressed. For example, when α-alkenyl-β-ketoester 1.171, substituted with a C14 alkyl sidechain, was 
submitted to the cascade reaction conditions, bicycles 1.175 and 1.177 were formed in 58% and 2% yield, 
respectively (Scheme 1.22). These structures were isomeric in respect to the C14 stereocenter. A 
mechanism that can account for the observed product distribution begins with chelation-controlled 
addition of (E)-alkenylmagnesium bromide 1.172 to α-alkenyl-β-ketoester 1.171 to generate alkoxide 
1.173, possessing pseudoaxial trans-1,2-dialkenyl substituents, which are not geometrically capable of 
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undergoing oxy-Cope rearrangement. Instead, it is likely that a ring flip took place to alleviate steric 
congestion between the C15 and C14 substituents. This conformational adjustment then allowed for oxy-
Cope rearrangement to proceed through the energetically favored chair transition state 1.174 and 
eventually provide the major isomeric product 1.175. Alternatively, retro-aldol-aldol equilibration of 
alkoxide intermediate 1.173 could generate intermediate 1.176 possessing equatorial trans-1,2-dialkenyl 
substituents. Advancement of 1.176 through the anion-accelerated oxy-Cope rearrangement/transannular 
acylation steps of cascade reaction sequence then furnished the minor isomeric product 1.177. The 
observed product ratio implies that only a small percentage of the intermediate trans-1,2-dialkenyl 
alkoxide 1.173 participated in retro-aldol-aldol equilibration. It is therefore not surprising that our tandem 
reaction sequence, described in Scheme 1.20, did not include a retro-aldol-aldol equilibration step. 
Scheme 1.22 β-Ketoester substitution impedes retro-aldol-aldol equilibration. 
 
 Revised First-Generation Cascade Reaction Sequence  1.8
 Based on the aforementioned results, we continued to pursue the synthesis of bicycle 1.182, 
depicted in Scheme 1.23, exhibiting the desired stereochemistry at C9 and C15 relative to the bridgehead 
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carbonyl group. We envisaged an alternative cascade reaction sequence that omitted a retro-aldol-aldol 
equilibration step. The first step in the amended reaction sequence involved diastereoselective 1,2-
addition of a vinyl organometallic reagent on the Re face of α-alkenyl-β-ketoester (±)-1.178 to yield 
alkoxide 1.180, which possesses trans-1,2-dialkenyl equatorial substituents. Intermediate 1.180 was 
expected to undergo a direct anion-accelerated oxy-Cope rearrangement/transannular acylation sequence 
without the necessity for retro-aldol-aldol equilibration. 
Scheme 1.23 Revised first-generation cascade reaction sequence.  
 
 Cascade substrate (±)-1.178 was accessed from previously prepared O-allyl β-ketoester (±)-1.145 
through a modified Claisen rearrangement (Scheme 1.24). Exposure of (±)-1.145 to achiral N,N'-
diphenylguanidinium catalyst 1.183, developed by Jacoben and Uyeda,67 promoted Claisen rearrangement 
at 85 °C to deliver C-allyl β-ketoester (±)-1.184 in 75% yield as a 5:1 mixture of diastereomers at C4a, 
favoring the stereochemistry necessary for the revised cascade reaction sequence. This reaction could be 
performed on gram-scale and the catalyst could be isolated and recycled through column chromatography. 
Isomerization of the allyl group to the trans-propenyl substituent was accomplished by exposure of (±)-
1.184 to PdCl2(MeCN)2 in 56% yield. Interestingly, while the opposite C4a diastereomer required only 5 
mol% catalyst loading to complete isomerization, (±)-1.184 required an equivalent of Pd(II) to reach full 
conversion. 
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Scheme 1.24 Synthesis of revised first-generation cascade reaction substrate via N,N'-diphenylguanidinium-
catalyzed Claisen rearrangement of O-allyl β-ketoester (±)-1.145. 
 
Reagents and conditions: (a) 1.183 (30 mol%), heptane, 85 °C, 75%, 5:1 d.r.; (b) PdCl2(MeCN)2 (1.0 equiv), K2CO3, 
PhMe, 90 °C, 56%, 20:1 E:Z. 
 Next, α-alkenyl-β-ketoester (±)-1.178 was submitted to the previously optimized reaction 
conditions to test the revised cascade reaction sequence (Scheme 1.25). Addition of vinylmagnesium 
bromide to a cold solution of (±)-1.178 in PhMe (0.10 M) resulted in 1,2-addition, as discerned by TLC 
analysis. The resultant alkoxide was then diluted to suppress retro-Dieckmann condensation and the 
reaction vessel was sealed and stirred at ambient temperature for 12 h to give cis-cyclodecene (±)-1.188 
in 65% yield. The cis-olefin geometry of (±)-1.188 was confirmed by NOESY. Based on our 
understanding of the cascade reaction sequence, the events leading to (±)-1.188 were as follows: (1) 
diastereoselective 1,2-addition to the Si face of α-alkenyl-β-ketoester (±)-1.178 to give magnesium 
alkoxide 1.186, which notably possesses cis-1,2-dialkenyl substituents, (2) anion-accelerated oxy-Cope 
rearrangement through a chair-boat-chair transition state, and (3) protonation of the intermediate 
macrocyclic bromomagnesium enolate upon work-up with HOAc. 
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Scheme 1.25 Synthesis of cis-cyclodecene (±)-1.188. 
 
 Several important facets of this reaction sequence are important to note. First, given that axial 
attack on cyclohexanones by relatively small nucleophiles is generally favored,45,75 it was not surprising 
that vinylmagnesium bromide preferentially underwent axial carbonyl addition on the lowest energy chair 
conformer of α-alkenyl-β-ketoester (±)-1.178. This hypothesis was confirmed through isolation and 
characterization of the initial carbonyl addition adduct corresponding to 1.186. 76  Second, it was 
interesting to note that anion-accelerated oxy-Cope rearrangement of this particular substrate occurred at 
ambient temperature, whereas the previous substrate required temperatures as high as 70 °C to undergo 
[3,3] sigmatropic rearrangement. The cis-orientation of the 1,2-dialkenyl substituents of 1.186, which 
presumably resulted in a low energy chair-boat-chair transition state, is likely responsible for this 
reactivity difference. Finally, the inability of the intermediate 10-membered ring enolate 1.187 to undergo 
transannular acylation reaction is likely a result of geometric constraints placed on the macrocycle by the 
cis-olefin. Even when this reaction was conducted at elevated temperatures, the only product isolated was 
(±)-1.188. 
 Confident in our analysis of the reaction mechanism, we questioned whether an appropriate vinyl 
organometallic reagent or Lewis acid additive might favor equatorial attack on α-alkenyl-β-ketoester (±)-
                                                      
75 Trost, B. M.; Florez, F.; Jebaratnam, D. J. J. Am. Chem. Soc. 1987, 109, 613–615. 
 
76 See experimental section for full details (compound (±)-S1.2). 
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1.178. Two main factors generally dictate the course of organometallic addition to cyclohexanones: (1) 
the steric interaction of the incoming nucleophile with the 3- or 5-diaxial substituents and (2) the torsional 
strain engendered by the nucleophile with the 2- or 6-diaxial substituents.45 Equatorial attack by bulky 
nucleophiles is favored, as steric interactions encountered with the 3- or 5-diaxial substituents out-
compete torsional effects. Additionally, bulky Lewis acids are also known to favor equatorial approach of 
organometallic nucleophiles on cyclohexanones. In this case, the steric interactions of the Lewis acid with 
the 3- or 5-diaxial substituents dominate and control the trajectory of carbonyl addition. A variety of 
metals and Lewis acids were investigated for vinyl organometallic addition including: Yb(OTf)3,77 CuI,78 
(iPrO)3TiCl,79 CeCl3,80 LiClO4,81 Mn(OCOtBu)2,82 SmI283 and MAD.84 After extensive experimentation, it 
was discovered that addition of freshly prepared vinyl lithium in dibutylether to a solution of α-alkenyl-β-
ketoester (±)-1.178 in dibutyl ether at –78 °C afforded cascade substrate (±)-1.189 in 57% yield as a 1:1 
mixture of diastereomers with respect to C12 (Scheme 1.26). Exposure of the revised cascade substrate 
(±)-1.189 possessing equatorial trans-1,2-dialkenyl substituents to tert-butylzinc bromide at 0 °C, 
followed by addition of pivalic anhydride and warming the reaction mixture to 50 °C in a sealed vessel 
                                                      
77 Molander, G. A.; Burkhardt, E. R.; Weinig, P. J. Org. Chem. 1990, 55, 4990–4991. 
 
78 (a) Macdonald, T. L.; Still, W. C. J. Am. Chem. Soc. 1975, 97, 5280–5281. (b) Ashby, E. C.; Lin, J. J.; Watkins, J. 
J. Tetrahedron Lett. 1977, 18, 1709–1711. 
 
79 (a) Reetz, M. T. Organotitanium Reagents in Organic Synthesis; Springer-Verlag: Berlin, 1986. (b) Reetz, M. T.; 
Steinbach, R.; Westermann, J.; Peter, R.; Wenderoth, B. Chem. Ber. 1985, 118, 1441–1454. (c) Reetz, M. T. 
Tetrahedron 1986, 42, 2931–2935. (d) Weidmann, B.; Seebach, D. Angew. Chem. Int. Ed. 1983, 12, 31–45. 
 
80 (a) Imamoto,T.; Kusumoto,T.; Tawarayama,Y.; Sugiura,Y.; Mite, T.; Hatanaka, Y.; Yokoyama, M. J. Org. Chem. 
1984, 49, 3904–3912. (b) Imamoto, T.; Takiyama, N.; Nakamura, K.; Hatajima, T.; Kamiya, Y. J. Am. Chem. Soc., 
1989, 111, 4392–4398. 
 
81 Ashby, E. C.; Noding, S. A. J. Org. Chem. 1979, 44, 4371–4377. 
 
82 Reetz, M. T.; Haning, H.; Stanchev, S. Tetrahedron Lett. 1992, 33, 6963–6966. 
 
83 Evans, W. J.; Allen, N. T. J. Am. Chem. Soc. 2000, 122, 2118–2119. 
 
84 Maruoka, K.; Itoh, T.; Sakurai, M.; Nonoshita, K.; Yamamoto, H. J. Am. Chem. Soc. 1988, 110, 3588–3597. 
 43 
gratifyingly resulted in the desired bicyclo[5.3.1]undecene (±)-1.152 in a modest 40% yield. The relative 
stereochemistry of the byciclic product was confirmed by NOESY. 
Scheme 1.26 Synthesis of allylic alcohol (±)-1.189 and a successful cascade reaction sequence. 
 
Reagents and conditions: (a) tetravinyltin, C6H5Li, nBu2O; then (±)-1.178, –78 °C, 57%, 1:1 d.r.; (b) tert-butylzinc 
bromide, PhMe-THF (4:1), [0.050 M], –78 → 0 °C; pivalic anhydride, 40 °C, 40%. 
 Although it was possible to access bicyclo[5.3.1]undecene (±)-1.182 for additional studies toward 
the total synthesis of 1.1, the poor yields in the final two steps of the synthesis (i.e. 29% and 40%) made 
us reevaluate our synthesis route to this point. Additionally, computational studies indicated that the 
proposed late-stage ketone/olefin reductive cyclization reaction to complete the decahydro-1,5-
butanonaphthalene tricyclic carbon skeleton of 1.1 would be extremely challenging. These considerations 
accompanied by a desire to increase the complexity that our cascade reaction sequence could potentially 
generate, prompted us to develop an alternative strategy for the total synthesis of 1.1.  
 Second-Generation Synthesis Plan and Retrosynthetic Analysis 1.9
 Our second-generation retrosynthesis plan for 1.1 is outlined below in Figure 1.9. In devising a 
revised synthesis of 1.1 we hoped to make use of the knowledge gleaned from our previous route. We 
envisioned introduction of hydroxyl substituents at C4 and C16 could be realized following bridgehead 
olefin isomerization of a tricyclic precursor 1.192, through a precedented series of oxidations.12d 
Introduction of the isopropyl subunit at C12 could then be accomplished in a stereoselective manner via a 
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cross-coupling/hydrogenation strategy. These transformations simplify the synthesis of 1.1 to the 
construction of tricycle 1.193, which notably possesses vinigrol’s tricyclo[4.4.4.0.4a,8a]tetradecene carbon 
framework. We anticipated that an alternative cascade reaction sequence involving anion-accelerated oxy-
Cope rearrangement of tertiary allylic alcohol 1.194 followed by a transannular aldol cyclization would 
provide 1.193 in a single operation. We expected that the requisite stereochemistry at C12 of allylic 
alcohol cascade substrate 1.194 could be set through an alkylation/C12-isomerization protocol. Finally, 
conjugate addition of an alkyl cuprate derived from 1.197 on to chiral enone 1.196 followed by 
intramolecular Mukaiyama aldol cyclization could potentially afford cis-decalin 1.195 after olefin 
isomerization. 
 
Figure 1.9. Second-generation synthesis plan for vinigrol. 
 The proposed second-generation cascade reaction sequence is outlined in Scheme 1.27. We 
anticipated deprotonation of tertiary allylic alcohol 1.194, which was expected to be several orders of 
magnitude more acidic than the α-position of the carbonyl group, could be accomplished by exposure to a 
suitable organometallic base. Following deprotonation, alkoxide 1.198 could undergo an anion-
accelerated oxy-Cope rearrangement to regiospecifically generate macrocyclic enolate intermediate 
1.199. The efficiency of this rearrangement was expected to benefit from the polarizing capacity of the 
carbonyl functionality vicinal to the C–C bond broken during the oxy-Cope process. However, we were 
apprehensive that the same push-pull arrangement of the alkoxide and the α-ketone, which was expected 
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to facilitate the anion-accelerated oxy-Cope rearrangement, might also promote undesired fragmentation 
via a retro-aldol reaction. Nevertheless, we predicted 10-membered enolate 1.199 would participate in a 
transannular aldol cyclization to furnish tricyclic alkoxide 1.200. While it is well known that the 
equilibrium developed during aldol cyclization of an enolate onto a ketone generally favors the 
reactants,85 we hoped that a judicious choice of metal counterion or silylating reagent would allow us to 
favor the formation of the desired tricycle 1.193. 
Scheme 1.27 Proposed second-generation cascade reaction sequence. 
 
 Synthesis of Second-Generation Cascade Reaction Precursor and Attempted Cascade 1.10
Reaction 
 The synthesis of cascade precursor 1.194 began with Stork–Danheiser alkylation followed by 
reduction and hydrolysis of readily available 2-allyl-3-methoxycyclohex-2-enone (1.201) 86  to give 
racemic enone (±)-1.196 on multi-gram scale (Scheme 1.28). Alkyl bromide 1.203 was converted to the 
corresponding Grignard reagent, which underwent CuI promoted 1,3-addition with (±)-1.196 in the 
presence of TMSCl. The resultant enol silane 1.204 was formed as a 10:1 diastereomeric mixture with 
respect to the C9 and C5 stereocenters. Exposure of 1.204 to TiCl4 facilitated an intramolecular 
                                                      
85 (a) Bartroli, J.; Turmo, E. Belloc, J. Forn, J. J. Org. Chem. 1995, 60, 3000–3012. (b) Iseki, K.; Oishi, S.; 
Taguchi,T.; Kobayashi, Y. Tetrahedron Lett. 1993, 34, 8147–8150. 
 
86 2-allyl-3-methoxycyclohex-2-enone (1.194) was prepared according to the literature procedure: Mphahlele, M. J.; 
Modro, T. A. J. Org. Chem. 1995, 60, 8236–8240. 
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Mukaiyama-aldol reaction to afford cis-decalin C8a diastereomers (±)-1.205 and (±)-1.206 in 45% and 
15% yield, respectively. The C8a diastereomers were separated and carried through the subsequent steps 
of the cascade reaction substrate synthesis independently. 
Scheme 1.28 Synthesis of cis-decalins (±)-1.205 and (±)-1.206. 
 
Reagents and conditions: (a) LDA, THF, –78 °C; MeI, –78 → 0 °C, 68%; (b) DIBAL, CH2Cl2, 0 °C; HCl, 0 °C 
→ RT, 95%; (c) 1.203, Mg(0), THF; CuI, –30 °C; (±)-1.196, TMSCl, –78 °C; (d) TiCl4, CH2Cl2, –78 °C, 45% for 
(±)-1.205 and 15% for (±)-1.206 (two steps). 
 Exposure of (±)-1.205/(±)-1.206 to catalytic rhodium trichloride in warm benzene promoted 
isomerization of the C4a allyl moiety to funish propenyl substituted cis-decalin (±)-1.207/(±)-1.208 
(Scheme 1.29). Interestingly, there was a notable difference in the relative reactivities of the C8a 
diastereomers towards olefin isomerization. Nevertheless, addition of (±)-1.207/(±)-1.208 to a slurry of 
vinylcerium chloride in THF delivered (±)-1.209/(±)-1.210 as a single diastereomer with respect to C12, 
where the organocerium reagent had added exclusively from the convex face of the cis-decalin core. The 
stereochemistry of C12 tertiary allylic alcohol was inverted at this point to generate a trans-relationship 
between the 1,2-dialkenyl substitutents required for the proposed cascade reaction sequence. Accordingly, 
treatment of (±)-1.209/(±)-1.210 with thionyl chloride and pyridine provided primary allylic chloride (±)-
1.211/(±)-1.212. Chemo- and diastereoselective epoxidation of (±)-1.211/(±)-1.212, again from the 
convex face of the cis-decalin skeleton, generated epoxy chloride (±)-1.213/(±)-1.214. Addition of (±)-
1.213/(±)-1.214 to a mixture of sodium metal in ether at ambient temperature facilitated reductive epoxide 
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opening to supply C12 inverted allylic alcohol (±)-1.215/(±)-1.216 on multi-gram scale. 
Scheme 1.29 Synthesis of allylic alcohols (±)-1.215 and (±)-1.216. 
 
Reagents and conditions for (±)-1.215: (a) RhCl3•H2O, K2CO3, EtOH, 85 °C, 4.5 h, 58% and 17% recovered (±)-
1.205; (b) CeCl3, CH2CHMgBr, THF, –78 °C, 93%; (c) SOCl2, Py, hexanes, 0 °C → RT; (d) mCPBA, NaHCO3, 
CH2Cl2, –60 → –30 °C; (e) Na(0), Et2O, 77% (three steps). 
Reagents and conditions for (±)-1.216: (a) RhCl3•H2O, K2CO3, EtOH, 95 °C, 1.5 h, 93%; (b) CeCl3, CH2CHMgBr, 
THF, –78 °C, 92%; (c) SOCl2, Py, hexanes, 0 °C → RT; (d) mCPBA, NaHCO3, CH2Cl2, –60 → –30 °C; (e) Na(0), 
Et2O, 55% (three steps). 
 Next, (±)-1.215 was treated with LiDBB to facilitate benzyl deprotection and the resultant alcohol 
was oxidized with DMP to afford model cascade reaction substrate (±)-1.217 (lacking the C8 methyl 
substituent) (Scheme 1.30). The cascade reaction sequence was tested by exposing of (±)-1.217 to a 
variety of bases, all of which caused immediate decomposition of (±)-1.217 presumably through a retro-
aldol pathway. The bases tested for this reaction included: TMPZnCl•LiCl,87 TMPMgCl•LiCl,88 tert-
butylzinc bromide, 2-mesitylmagnesium bromide, LDA, LDA/ZnCl2, NaHMDS, and KH. 
  
                                                      
87 Mosrin, M.; Knochel, P. Org. Lett. 2009, 11, 1837–1840. 
 
88 Lrasovskiy, A.; Krasovskaya, V.; Knochel, P. Angew. Chem., Int. Ed. 2006, 45, 2958–2961. 
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Scheme 1.30 Preparation of a second-generation model cascade reaction substrate (±)-1.217 and attempted cascade 
reaction. 
 
Reagents and conditions: (a) LiDBB, THF, 0 → –78 °C, 98%; (b) DMP, CH2Cl2, 96%. 
 Revised Second-Generation Cascade Reaction  1.11
 An alternative strategy for the construction of vinigrol’s carbon skeleton was envisioned 
involving a Lewis acid-accelerated silyloxy-Cope rearrangement/transannular Mukaiyama aldol reaction 
sequence  illustrated in Scheme 1.31. We wondered if exposure of silyl protected cis-decalin 1.219 to a 
Lewis acid might promote [3,3] sigmatropic rearrangement through coordination of the carbonyl 
substituent,51 thereby weakening the C–C bond broken during the proposed Cope rearrangement to 
generate 10-membered enol silane 1.221 as a single regioisomer. At this point, we imagined that 
intermediate 1.221 might engage in a transannular Mukaiyama aldol reaction to form tricyclic 
intermediate 1.222, which possesses vinigrol’s decahydro-1,5-butanonaphthalene carbon skeleton. 
Finally, we expected that the corresponding tricyclic product (1.223) could potentially be isolated though 
either protonation or silyl transfer. 
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Scheme 1.31 Proposed Lewis acid-accelerated silyloxy-Cope rearrangement/transannular Mukaiyama aldol cascade 
reaction sequence. 
 
 A model substrate for the proposed Lewis acid-accelerated silyloxy-Cope 
rearrangement/transannular Mukaiyama aldol reaction sequence ((±)-1.225) was prepared in two steps 
from ketone (±)-1.217 in 93% yield (Scheme 1.32). Adddition of TMSOTf to a solution of (±)-1.217 in 
pyridine at ambient temperature resulted in bis-silylated product (±)-1.224. The enol silane moiety was 
then selectively cleaved by treatment of (±)-1.224 with tBuOK to afford (±)-1.225 in quantitative yield.89 
Scheme 1.32 Preparation of Silyloxy-Cope rearrangement substrate (±)-1.225. 
 
Reagents and conditions: (a) TMSOTf, Py, 93%; (b) tBuOK, THF, 0 °C, quantitative. 
 Ketone (±)-1.225 was exposed to a variety of Lewis acids in order to promote the desired cascade 
reaction sequence (Scheme 1.33). Addition of BF3•OEt2 to a solution of (±)-1.225 in CH2Cl2 at –78 °C 
exclusively provided trans-decalin (±)-1.226 in 71% yield. Formation of (±)-1.226 can be rationalized by 
a low energy open synclinal transition state 1.227.90 In contrast, use of TiCl4 as a promotor afforded trans-
decalin (±)-1.228 in 83% yield, presumably through a closed synclinal transition state (1.229). 
                                                      
89 Quesnel, Y.; Bidois-Sery, L.; Poirie, J.-M.; Duhamel, L. Synlett 1998, 413–415. 
 
90 Denmark, S. E.; Wheeseong; L. J. Org. Chem. 1994, 59, 707–709. 
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Scheme 1.33 Lewis acid-promoted retro-aldol-aldol reaction. 
 
Reagents and conditions: (a) BF3•OEt2, CH2Cl2, –78 °C → RT, 71%; (b) TiCl4, CH2Cl2, 0 °C→ RT, 83%. 
 Next, we attempted to promote each step of the reaction sequence independently in order to avoid 
the undesired Lewis acid-mediated retro-aldol-aldol reaction (Scheme 1.34). Therefore, thermal 
conditions for the silyloxy-Cope rearrangement were evaluated to synthesize a 10-membered enol silane 
analogous to intermediate 1.221 (Scheme 1.31). We then planned on treating resultant enol silane with a 
variety of Lewis acids to promote the desired transannular Mukaiyama aldol reaction. However, heating a 
solution of (±)-1.225 in PhMe in a sealed vessel to 240 °C for 12 h afforded unexpected tricyclic enol 
silane (±)-1.230 in 56% yield. The structure of (±)-1.230 was elucidated through a comination of 2D 
NMR spectroscopy and X-ray crystallographic analysis of the enol silane hydrolysis product (±)-1.231. 
Scheme 1.34 Synthesis of tricycle (±)-1.230 and X-ray crystal structure of enol silane hydrolysis product (±)-1.230. 
  
 One possible explanation for the formation (±)-1.230 is based on a cascade reaction sequence 
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spontaneously isomerized to the regioisomeric enol silane 1.233. This process was potentially catalyzed 
by an unknown source of acid.63 Next, a facile transannular Mukaiyama–Michael reaction took place to 
construct the C4–C11 bond of zwitterionic intermediate 1.234, which potentially provided the observed 
tricyclic product (±)-1.230 after silyl transfer. 91  We hypothesized that the extreme temperatures 
necessitated by the silyloxy-Cope rearrangement caused the normally unfavorable enol silane 
isomerization to take place. This result prompted us to investigate a milder method for the formation of 
1.233 or an analogous 10-membered enol silane, thereby avoiding the isomerization process. 
Scheme 1.35 Mechanism to account for the formation of tricycle (±)-1.230. 
 
 We chose to study the anion-accelerated oxy-Cope rearrangement of C8a benzyl ether 
diastereomers (±)-1.215 and (±)-1.216 since both (±)-1.215 and (±)-1.216 benefited from a functional 
group arrangement that rendered them incapable of retro-aldol fragmentation (Scheme 1.36). Independent 
subjection of (±)-1.215 and (±)-1.216 to standard anion-accelerated oxy-Cope rearrangement conditions 
with KH and 18-crown-6 in anhydrous THF at room temperature for only 10 min provided tricycle (±)-
1.235 as the only isolable product in 52% and 56% yields, respectively. The structure of (±)-1.235 was 
elucidated by 2D NMR analysis. 
  
                                                      
91 It is likely that the Mukaiyama–Michael reaction may also have been facilitated by acid. 
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Scheme 1.36 Synthesis of tricycle (±)-1.235. 
 
Reagents and conditions: (a) KH, I2 (50 mol%),92 18-crown-6, THF, 52%; KH, I2 (50 mol%), 18-crown-6, THF, 
56%. 
 A potential pathway for the formation of tricycle (±)-1.235 is depicted in Scheme 1.37. 
Deprotonation of the tertiary allylic alcohol (±)-1.215 with KH facilitated an anion-accelerated oxy-Cope 
rearrangement through a chair-like transition state to generate 10-membered potassium enolate 1.237. We 
had anticipated that it would be possible to trap this enolate and regenerate it at a later point in the 
synthesis; instead, it immediately underwent facile enolate isomerization to give regioisomeric enolate 
1.238. Next, we believe a transannular SN´ reaction of the intermediate enolate onto the opposing allylic 
benzyloxy group provided tricycle (±)-1.235. In retrospect, the observed reaction sequence might have 
been predicted based on the work of Paquette and Schreiber.93 
  
                                                      
92 Treatment of KH with catalytic iodine is know to improve the yield and reproducibility of anion-accelerated oxy-
Cope rearrangement by reducing trace potassium metal before the reaction, see: Macdonald, T. L.; Natalie, K. J.; 
Prasad, G.; Sawyer, J. S. J. Org. Chem. 1985, 51, 1124–1126. 
 
93 (a) Paquette, L. A.; Oplinger J. A. Tetrahedron 1989, 45, 107–124. (b) Paquette, L. A.; Reagan, J.; Schreiber, S. 
L.; Teleha, C. A. J. Am. Chem. Soc. 1989, 111, 2331–2332. 
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Scheme 1.37 Mechanism to account for the formation of tricycle (±)-1.235. 
 
 Screening conditions for the previous transformation yielded an interesting observation; the 
combined use of NaHMDS as a base and TBSCl as an in situ enolate trapping reagent was capable of 
fully suppressing transannular SN´ reaction (Scheme 1.38). Instead, a mixture of macrocyclic TMS and 
TBS enol silanes ((±)-1.239) were isolated. 1D TOCSY studies on the product mixture indicated that 
isomerization of the intermediate macrocyclic sodium enolate ((±)-1.241) had occurred before silyl 
trapping by HMDS or TBSCl could take place to yield an undesired olefin regioisomer. The enol silane 
product mixture could be hydrolyzed with PTSA to afford 10-membered bicyclic ketone (±)-1.243 in 
80% yield over two steps.  
Scheme 1.38 Synthesis of bicycle (±)-1.243 via anion-accelerated oxy-Cope rearrangement/enolate silylation. 
 
Reagents and conditions: (a) NaHMDS, TBSCl, THF; (b) PTSA, THF-H2O, 80% (two steps). 
 The opposing C8a diastereomer ((±)-1.216) was converted to the corresponding 10-membered 
bicyclic ketone (±)-1.244 under analogous conditions. Kinetic deprotonation of ketone (±)-1.244 at 
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cryogenic temperatures was attempted in order to avoid thermodynamic equilibration of the 10-membered 
enolate intermediate (Scheme 1.39).94 Accordingly, (±)-1.244 was exposed to LiHMDS at –50 °C in THF 
for 45 minutes to promote enolate formation. The resultant enolate was treated with N-phenyl triflimide to 
yield a single regioisomeric alkenyl triflate (±)-1.245 in 47% yield. Key TOCSY and NOESY correlations 
indicated that we had again obtained the undesired olefin regioisomer, which was a result of selective 
deprotonation of C11 over C1 followed by trapping with N-phenyl triflimide. 
Scheme 1.39 Alkenyl triflate (±)-1.245 formation via kinetic deprotonation. 
 
Reagents and conditions: (a) NaHMDS, TBSCl, THF; (b) PTSA, THF-H2O, 45% (two steps); (c) LiHMDS, THF, –
78 → –50 °C; then PhN(SO2CF3)2, –78 °C → RT, 47%. 
 Examination of the calculated ground state conformations (MMF) of model macrocyclic enols 
1.247 and 1.248 help explained the observed trend for formation of the undesired regioisomeric 10-
membered enolate (Figure 1.10).95 Our calculations revealed that 1.248 is 15-20 kcal/mol lower in energy 
than 1.247, indicating that there is a substantial thermodynamic benefit for enolate isomerization. The 
energy difference between conformation 1.247 and 1.248 is likely due to added ring strain engendered by 
placement of the olefins in a 1,5- vs. 1,6-relationship to one another. A top-down view of the molecular 
models illustrates the unfavorable strain placed on the 10-membered ring in model 1.247 relative to 1.248. 
                                                      
94 Schreiber, S. L.; Santini, C. J. Am. Chem. Soc. 1984, 106, 4038–4039. 
 
95 Single point calculations were performed using Spartan ’02: DFT/6-31G*/MMFF. 
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Figure 1.10 Model ground state energy conformations: rationale for enolate isomerization. 
 Finally, an interesting discovery was made during an attempt to understand the propensity the 
cascade reaction substrate (±)-1.217 has for retro-aldol fragmentation. Heating (±)-1.217 to 110 °C for 6 h 
resulted in rupture of the C4a–C12 bond and formation of two isomeric enones (±)-1.249 and (±)-1.250 in 
15% and 57% yield, respectively (Scheme 1.40). Exposure of the major enone isomer ((±)-1.250) to 
TMSCl and Et3N at 75 °C furnished enol silane (±)-1.251 in 66% yield. Inspection of this product 
prompted us to consider an alternative IMDA disconnection strategy for the synthesis of vinigrol’s 
tricyclo[4.4.4.0.4a,8a]tetradecene carbon framework. 
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Scheme 1.40 Access to a potential IMDA reaction substrate via thermal-Cope rearrangement. 
 
Reagents and conditions: (a) PhMe, 110 °C, 15% for (±)-1.249 and 57% for (±)-1.250; (b) TMSCl, NEt3, THF, 
75 °C, 66%.  
 Suggestive illustrations of the potential IMDA reaction are depicted in Figure 1.11a. It is 
conceivable that this reaction could be promoted thermally or by an appropriate Lewis acid since the endo 
transition state (1.252) has the proper electronic arrangement for a normal demand Diels–Alder reaction.96 
Unfortunately, concurrent with this analysis, the Baran group completed the first total synthesis of 1.1 
through an IMDA reaction strategy.20 Given the similarities of our IMDA disconnection and Barran and 
Barriault’s disconnections (1.254 and 1.255, respectively), we abandoned this strategy. 
 
Figure 1.11 (a) Potential IMDA reaction disconnection for vinigrol. (b) Barriault and Barran’s IMDA reaction 
disconnections. 
                                                      
96 For a review on the Diels–Alder reaction in natural product total synthesis, see: Nicolaou, K. C.; Snyder, S. A.; 
Montagnon, T.; Vassilikogiannakis, G. Angew. Chem., Int. Ed. 2002, 41, 1668–1698. 
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 Conclusion 1.12
 Progress toward a total synthesis of vinigrol (1.1) has been presented. In our first-generation 
synthesis approach we prepared cascade reaction substrates (±)-1.149 and (±)-1.189 in 7 steps and 21% 
and 4% yield, respectively. Pivalic anhydride was utilized as a methoxide sequestration reagent in the key 
anion-accelerated/oxy-Cope rearrangement/transannular acylation reaction sequence, which allowed for 
isolation of the corresponding bicyclo[5.3.1]undecene containing products (±)-1.152 and (±)-1.182 in 
42% and 40% yield, respectively. An important discovery made during the development of this tandem 
reaction sequence was the observation that an expected retro-aldol-aldol equilibration step was non-
operative.  
 Our second-generation approach toward 1.1 was anticipated to involve a key anion-accelerated 
oxy-Cope rearrangement/transannular aldol cyclization reaction sequence to form vinigrol’s 
tricyclo[4.4.4.0.4a,8a]tetradecene carbon framework in a single operation. In accordance with this plan, we 
prepared gram-quantities of a cis-decalin containing model cascade reaction precursor (±)-1.217 in 10 
steps and 15% overall yield. Unfortunately, the desired tandem reaction sequence was not observed. 
Alternatively, silyl protected cascade reaction substrate (±)-1.225 underwent a silyloxy-Cope 
rearrangement/transannular Michael reaction sequence to form tricycle (±)-1.230 in 56% yield. The 
observed deviation from the desired reaction pathway was attributed to a facile enol silane isomerization 
fostered by macrocyclic ring strain. 
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Chapter 2  
Progress Toward the Synthesis of Hibarimicin B
 59 
 Isolation and Biological Activity of Hibarimicin B (Angelmicin B) 2.1
 Angelmicin B (2.1, Figure 2.1) was first isolated in 1993 by Uehara and coworkers from the 
culture broth extract of the rare actinomycete Microbispora subsp. AA9966 for its inhibitory activity 
against oncogenic Src signal transduction.97 The hibarimicin family of natural products (hibarimcins A–
K) were later isolated from the actinomycete Microbispora rosea subsp. hibaria TP-A0121.97,99h The 
structure of angelmicin B (2.1) was found to match that of hibarimicin B (2.1) and will be referred to as 
such henceforth. 
 
Figure 2.1 Structure of hibarimicin B (angelmicin B). 
 Hibarimicin B (2.1) was demonstrated to selectively inhibit ν-Src protein tyrosine kinase (PTK) 
(IC50 = 1.8 µM) over protein kinase A and C.97,99g Additionally, 2.1 was found to possess the greatest anti-
proliferative activity in human myeloid leukemia HL-60 cells (IC50 = 58 nM) amongst the hibarimicin 
family of natural products.98,99g Perhaps more importantly, 2.1 significantly induced the differentiation of 
                                                      
97 Uehara, Y.; Li, P. M.; Fukazawa, H.; Mizuno, S.; Nihei, Y.; Nishio, M.; Hanada, M.; Yamamoto, C.; Furumai, T.; 
Oki, T. J. Antibiot. 1993, 46, 1306–1308. 
 
98 Yokoyama, A.; Okabekado, J.; Uehara, Y.; Oki, T.; Tomoyasu, S.; Tsuruoka, N.; Honma, Y. Leuk. Res. 1996, 20, 
491–497. 
 
99 (a) Hori, H.; Higashi, K.; Ishiyama, T.; Uramoto, M.; Uehara, Y.; Oki, T. Tetrahedron Lett. 1996, 37, 2785–2788. 
(b) Kajiura, T.; Furumai, T.; Igarashi, Y.; Hori, H.; Higashi, K.; Ishiyama, T.; Uramoto, M.; Uehara, Y.; Oki, T. J. 
Antibiot. 1998, 51, 394–401. (c) Hori, H.; Igarashi, Y.; Kajiura, T.; Furumai, T.; Higashi, K.; Ishiyama, T.; Uramoto, 
M.; Uehara, Y.; Oki, T. J. Antibiot. 1998, 51, 402–417. (d) Hori, H.; Kajiura, T.; Igarashi, Y.; Furumai, T.; Higashi, 
K.; Ishiyama, T.; Uramoto, M.; Uehara, Y.; Oki, T. J. Antibiot. 2002, 55, 46–52. (e) Kajiura, T.; Furumai, T.; 
Igarashi, Y.; Hori, H.; Higashi, K.; Ishiyama, T.; Uramoto, M.; Uehara, Y.; Oki, T. J. Antibiot. 2002, 55, 53–60. (f) 
Igarashi, Y.; Kajiura, T.; Furumai, T.; Hori, H.; Higashi, K.; Ishiyama, T.; Uramoto, M.; Uehara, Y.; Oki, T. J. 
Antibiot. 2002, 55, 61–70. (g) Cho, S. I.; Fukazawa, H.; Honma, Y.; Kajiura, T.; Hori, H.; Igarashi, Y.; Furumai, T.; 
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HL-60 cells at a concentration of 174 nM. The discrepancy between hibarimicin B’s effective 
concentration for kinase inhibition and anti-cancer activity suggests ν-Src is not the target responsible for 
growth-inhibition or proliferation-inducition of HL-60 cells. To date, the cellular target and biological 
mechanism of action of 2.1 remain undetermined. It is interesting to note that the aglycon of 2.1, 
hibarimicinone 2.2 (Figure 2.3), is a more potent inhibitor of PTK (IC50 = 1.2 µM), yet showed no anti-
cancer activity.99g Furthermore, the differentiation-inducing and the growth-inhibitory actions of 
hibarimicins A–E (Figure 2.2) appear qualitatively similar. Therefore, the presence of the sugar 
componenets of 2.1 is critical for its anti-cancer activity, however the specific nature of those sugars does 
not appear to be as important. 
 Structural Determination of Hibarimicin B and Related Natural Products 2.2
 The two-dimensional structure of hibarimicin B (2.1) was first elucidated by Hori and coworkers 
in 1996 through the combination of DEPT, DQF-COSY, TOCSY, HMQC, HMBC and ROESY NMR 
experiments.99a Subsequent isolation of hibarimicins C–K indicated they shared a common highly 
oxidized aglycon and differ in respect to their disaccharide components (A and A´, Figure 2.2).99g 
                                                                                                                                                                              
Oki, T.; Uehara, Y. J. Antibiot. 2002, 55, 270–278. (h) Hori, H.; Igarashi, Y.; Kajiura, T.; Sato, S.; Furumai, T.; 
Higashi, K.; Ishiyama, T.; Uehara, Y.; Oki, T. Tennen Yuki Kagobutsu Toronkai Koen Yoshishu 2004, 46, 49–54. 
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Figure 2.2 Positional numbering system for hibarimicin B and structures of hibarimicins A–K. 
 The hibarimicins are among the most complex and largest type-II polyketides known. Their 
common aglycon, hibarimicinone 2.2 (Figure 2.3), is pseudo-C2-symmetric in nature; The C2-symmetry 
of 2.2 is broken by oxidation of the B-, C-, and D-rings relative to the G-, F-, and E-rings, respectively. 
Specifically, the B-ring contains a cyclic ether bridging C8' and C13', the C-ring contains a hydroxyl 
group at C6', and the D-ring is a quinone. Additionally, the aglycon is decorated with six intriguing 2-
deoxyglycosides including: two α-L-digitoxosyl (DG/DG') monosaccharide subunits and two 
disaccharide subunits comprised of a 4-C-acetyl-2,3,6-trideoxy-α-L-threo-hexoside (AT/AT') linked to 
the 4-postion of a β-D-amicetoside (AM/AM'). The absolute stereochemistry of the aforementioned 2-
deoxyglycosides was determined by comparison of the optical rotations of the DG-, AM-, and AT-methyl 
glycosides, obtained from 2.1 through acid mediated methanolysis, to analogous known or synthetically 
accessible methyl glycosides. 
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Figure 2.3 Structure of hibarimicinone. 
 However, many of the structural questions concerning 2.1 could not be addressed through NMR 
spectroscopy or chemical degradation, leaving several features of the molecule undetermined at the outset 
of our synthesis.100 First, it was unkown whether 2.1 exhibited axial chirality about its highly congested 
C2–C2' bond. Second, the absolute stereochemistry of hibarimicinone (2.2) had yet to be established. 
 Biosysynthesis of Hibarimicin Related Natural Products 2.3
 The biosynthesis of 2.1 was elucidated through the combination of feeding experiments with 13C 
labeled sodium acetate and cosynthesis using blocked mutants. Fermentation of Microbispora rosea 
subsp. hibaria TP-A0121 with [1-13C], [2-13C], or [1,2-13C] labeled sodium acetate provided differentially 
labeled hibarimicin B (2.3).99d An illustrative compilation of the data collected from this experiment is 
depicted in Figure 2.4. 
 
Figure 2.4 Incorporation pattern of 13C-labeled sodium acetate. 
                                                      
100 The absolute stereochemistry of 2.2 had been determined by the Mosher method and through CD spectroscopy in 
Ref. 99h. Unfortunately we were unaware of this work prior to the publication of Ref. 107. 
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 Three important deductions were made from this experiment: (1) the alternation of isotopically 
enriched carbons provided by feeding experiments with either [1-13C] or [2-13C] sodium acetate 
demonstrated that the aglycon of 2.1 is polyketide derived; (2) the symmetric distribution of 13C between 
the two halves of 2.1, indicated that the C2–C2' bond was formed through the dimerization of a tetracyclic 
monomer; (3) unobserved 1J13C,13C coupling for C10/C10', C14/C14', and C15/C15' combined with 
observed long range 3J13C,13C (three bond) coupling between C10/C10' and C15/C15' provided insight in to 
the polyketide cyclization pathway illustrated in Figure 2.5. In this pathway, undecaketide precursor 2.4 
cyclizes to form tetracycle 2.5 with concomitant skeletal rearrangement involving cleavage of the 
C10/C10'–C15/C15' bond. The derivation of C10/C10' and C15/C15' from a common acetate unit 
explains their long range 3J13C,13C coupling and their lack of 1J13C,13C coupling. Next, oxidative cleavage of 
an extra carbon atom from C14/C14' could install the C14/C14'–OH substituent and would explain the 
lack of 1J13C,13C coupling to C14/C14'. Finally, a dimerization/methylation/glycosylation sequence could 
provide hibarimicin B (2.1). The specific nature of this process was elucidated by cosynthesis using 
blocked mutants. 
 
Figure 2.5 Partial proposed biosynthesis of hibarimicin B 
 Incubation of Microbispora rosea subsp. hibaria TP-A0121 with N-methyl-N'-nitro-N-
nitrosoguanidine (NTG) resulted in the production of a multitude of blocked mutant actinomycete strains. 
Five stable mutant strains (AN-0416, AN-0554, AN-0623, AN-0763, and AN-0772) were selected as 
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hibarimicin B non-producing strains based on their lack of red pigmentation.101 Interestingly, incubation 
of mutant strain AN-0554 with 13C enriched sodium acetate afforded isotopically labeled metabolite 
HMP-Y6 (2.7, Scheme 2.1), which is a fully symmetrical dimer of the western half of 2.1. Exposure of 
2.7 to HCl in MeOH at 30 °C for 3 h promoted methanolysis of the sugar subunits to deliver the 13C-
enriched symetrical aglycon HMP-Y1 (2.8). Incubation of mutant strain AN-0554 with 13C enriched 
HMP-Y1 (2.8) afforded isotopically labeled hibarimicin B (2.3). In contrast, utilization of 13C enriched 
HMP-Y6 (2.7) in the same experiment did not provide 2.3. Additionally, in a separate experiment AN-
0554 was able to convert hibarimicinone (2.2) to 2.1. Taken together, these findings suggested that HMP-
Y1 (2.9, Figure 2.6) and hibarimicinone (2.2) are biosynthetic precursor to hibarimicin B (2.1). 
  
                                                      
101 The color of agar plates containing hibarimicin B was found to be pH-dependant, showing red under acidic and 
green under basic conditions.99e 
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Scheme 2.1 Cosynthesis experiments using blocked mutant strains AN-0416 and AN-0554.102 
 
 A plausible biosynthetic pathway for the conversion of C2-symmetric precursor HMP-Y1 (2.9) to 
hibarimicione (2.2) is illustrated in Scheme 2.2. We envisioned that the C2-symmetry of 2.9 could be 
broken via oxidation of the C-ring to hypothetical quinone 2.10. Tautomerization of 2.10 to C8'-ortho-
quinone methide 2.11 followed by oxy-Michael addition of the pendant C13'–OH could then install the B-
ring cyclic ether bridge. Finally, re-oxidation of the C-ring to a quinone followed by transposition to the 
D-ring with concomitant demethylation could afford 2.2. Enzymatic glycosylation of 2.2 could then 
provide acesss to hibarimins A-K.103 Lastly, HMP-P1 (2.12), which is believed to be an artifact of 
isolation rather than a natural product, is presumed to arise from 2.2 via cyclization of C1–OH onto C3' of 
the D-ring quinone with subsequent expulsion of methanol. 
  
                                                      
102 The strereochemistry of the HMP-Y6 atropisomeric linkage was assigned based on analogy to HMP-Y1. 
 
103 For reviews on the biosynthesis of 2-deoxy sugars, see: (a) Thibodeaux, C. J.; Melançon III, C. E.; Liu, H.-W. 
Nature, 2007, 446, 1008–1016. (b) Thibodeaux, C. J.; Melançon III, C. E.; Liu, H.-W. Angew. Chem. Int. Ed. 2008, 
47, 9814–9859. 
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Scheme 2.2 Proposed biosynthetic pathway for converstion of HMP-Y1 to hibarimicinone. 
 
 Previous Synthesis Efforts Toward Hibarimicin B 2.4
 The potential importance of hibarimicin B’s biological activity combined with its structural 
complexity and stereochemical ambiguities have made 2.1 an attractive target for total synthesis. Since its 
isolation in 1993, several groups have reported progress towards this goal including: Roush, 104 
                                                      
104 (a) Narayan, S.; Roush, W. R. Org. Lett. 2004, 6, 3789–3792. (b) Lambert, W. T; Roush, W. R. Org. Lett. 2005, 
7, 5501–5504. (c) Narayan, S. Ph.D. Thesis, The University of Michigan, 2003.  
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Sulikowski,105 Mootoo,106 and Tatsuda.107 To date, a total synthesis of 2.1 has not been achieved. 
2.4.A Roush’s Synthesis of Model CD–E Arylnapthoquinone and AB-Subunit of Hibarimicin B 
 The Roush group’s approach for the total synthesis of 2.1 focused on the central C2–C2' bond as 
a key strategic disconnection (Scheme 2.3).104a Model studies were directed toward formation of the 
ortho, ortho'-tetrasubstituted biaryl C2–C2' bond through known transition metal catalyzed processes. A 
Suzuki-Miyaura cross-coupling reaction between highly electron rich naphthol boronic acid CD-ring 2.13 
and EF-ring naphthol triflate 2.14 was attempted, but yield only proto-deborylated product 2.15. An 
analogous Stille reaction with aryl triflate 2.17 formed a product containing the desired C2–C2' bond 
(2.18), albeit in poor yield. In contrast, when electron poor bromonaphthoquinone CD-ring coupling 
partener 2.19 was employed in a Suzuki-Miyaura cross-coupling reaction with aryl boronic acid 2.20, 
model CD–E arylnapthoquinone 2.21 was formed in 59% yield. Presumably the electron deficient nature 
of 2.19 facilitated oxidative addition of Pd(0). Unfortunately, when a more complex naphthol boronic 
ester cross-coupling partener 2.22 was employed in this transformation no reaction was observed.104c  
  
                                                      
105 (a) Lee, C.-S.; Audelo, M. Q.; Reibenpies, J.; Sulikowski, G. A. Tetrahedron 2002, 58, 4403–4409. (b) 
Maharoof, U. S.; Sulikowski, G. A. Tetrahedron Lett. 2003, 44, 9021–9023. (c) Kim, K.; Mahroof, U. S.; Raushel, 
J.; Sulikowski, G. A. Org. Lett. 2003, 5, 2777–2780. (d) Lee, W. D.; Kim, K.; Sulikowski, G. A. Org. Lett. 2005, 7, 
1687–1689. (e) Romaine, I. M.; Hempel, J. E.; Shanmugam, G.; Hori H.; Igarashi, Y.; Polavarapu, P. L.; 
Sulikowski, G. A. Org. Lett. 2011, 13, 4538–4541. 
 
106 (a) Li, J.; Todaro, L. J.; Mootoo, D. R. Org. Lett. 2008, 10, 1337–1340. (b) Li, J.; Todaro, L.; Mootoo, D. R. Eur. 
J. Org. Chem. 2011, 6281–6287. (c) Li, J. Ph.D. Thesis, The City University of New York. 
 
107 Tatsuta, K.; Fukuda, T.; Ishimori, T.; Yachi, R.; Yoshida, S.; Hashimoto, H.; Hosokawa, S. Tetrahedron Lett. 
2012, 53, 422–425. 
 68 
Scheme 2.3 Roush’s Synthesis of Model CD–E Arylnapthoquinone. 
 
Reagents and conditions: (a) Pd2(dba)3, PCy3, KF, THF; (b) Pd(PPh3)4, CuCl, LiCl, DMSO, 60 °C, <10%; (c) 
Pd(dppf)Cl2, K3PO4, H2O/DME, 60 °C, 59%; (d) Pd(dppf)Cl2, K3PO4, DMSO, 80 °C. 
 Roush’s synthesis of the AB-subunit of 2.1 took advantage of a γ-silylallylborane/aldehyde [3+2] 
annulation strategy to form the tetrahydrofuran ring found in 2.36 (Scheme 2.4).104b Their synthesis began 
with hydroboration of allene 2.23 with (dIpc)2BH to furnish intermediate organoborane 2.24. Addition of 
aldehyde 2.25 to a solution of 2.24 in THF afford allylsilane 2.26 with moderate diastereoselectivity. Next, 
2.26 was silyl protected and exposed to aldehyde 2.28 in the presence of SnCl4 to provide tetrahydrofuran 
2.29 via a modestly diastereoselective [3+2] annulation. Tamao–Fleming oxidation108 of alkylsilane 2.29 
followed by protecting group manipulations gave diol 2.31. Swern oxidation of 2.31 and exposure of the 
resultant keto-aldehyde to Na2CO3 promoted an aldol reaction to yield a mixture of isomeric bicycles 2.32 
                                                      
108 (a) Tamao, K.; Ishida, N.; Tanaka, T.; Kumada, M. Organometallics 1983, 2, 1694–1696. (b) Fleming, I.; 
Henning, R.; Plaut, H. J. Chem. Soc., Chem. Commun. 1984, 29–31. 
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and 2.33. The undesired C10' diastereomer 2.32 was recycled to give sufficient quantities of 2.33. 
Chemoselective hydrogenolysis of the C8' benzyl group and a two carbon homologation provided 
aldehyde 2.34. Exposure of 2.34 to AIBN and nBu3SnH in refluxing benzene promoted a Pinacol 
cyclization to generate tricycle 2.35 as an epimeric mixture of C15' secondary carbinols. Finally, 2.35 was 
converted to the AB-subunit of hibarimicin B (2.36) through sequential Swern and Sharpless-Reich109 
oxidations. Overall 2.36 was prepared in 16 steps and 2% overall yield. 
Scheme 2.4 Roush’s Synthesis of the AB-subunit of hibarimicin B. 
 
Reagents and conditions: (a) (dIpc)2BH, THF –50 °C; THF, –78 °C → RT, 52%, 1.6:1 d.r.; (b) TBSOTf, Et3N, 
CH2Cl2, –20 °C → RT, 70%; (c) 2.28, SnCl4, 4 Å MS CH2Cl2, –78 °C, 81%, 3.3:1 d.r.; (d) KH, tBuOOH, TBAF, 
TBAF, NMP, 50 °C, 68%; (e) TBSCl, imidazole, DMF, 91%; (f) TIPSOTf, 2,6-lutidine, CH2Cl2, 0 °C → RT, 99%; 
(g) PTSA, MeOH, 0°C → RT, 81%; (h) (COCl)2, DMSO CH2Cl2, –50 °C; Et3N, –50 °C → RT; (i) Na2CO3, MeOH-
H2O-THF (4:3:3), 35% for 2.32 and 46% for 2.33 (two steps); (j) Na2CO3, MeOH-H2O-THF (4:3:3), 99%, 2.32:2.33 
= 1.3:1; (k) TESCl, imidazole, CH2Cl2, 0 °C, 97%; (l) H2, 10% Pd/C, EtOH, 99%; (m) (COCl)2, DMSO, Et3N, 
                                                      
109 (a) Sharpless, K. B.; Lauer, R. F.; Teranishi, A. Y. J. Am. Chem. Soc. 1973, 95, 6137–6139. (b) Reich, H. J.; 
Renga, J. M.; Reich, I. L. J. Am. Chem. Soc. 1975, 97, 5434–5447. 
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Reagents and conditions for Scheme 2.4 continued: CH2Cl2, –78 °C → RT; Ph3P=CHCHO, 90% (n) H2, 10% Pd/C, 
EtOAc-EtOH (10:1), 79%; (o) nBu3SnH, AIBN, PhH, reflux, 80 %, 5:1 d.r.; (p) (COCl)2, DMSO, Et3N, CH2Cl2, –78 
°C → RT, 74%; (q) PhSeCl, HCl, EtOAc; aq H2O2, 41%. 
2.4.B Mootoo’s Synthesis of the AB-Subunit of Hibarimicin B 
 The Mootoo group reported an efficient synthesis of the AB-subunit of 2.1 that utilized a ring 
closing enyne metathesis (RCEM)/IMDA reaction sequence to form the decalin ring system of 2.44 and 
set the challenging C9' stereocenter (Scheme 2.5).106 Their synthesis commenced with known lactone 
2.37, which was available in 6 steps and 80% overall yield from methyl-α-D-glucopyranoside. A three 
step double alkylation sequence delivered propargylic alcohol RCEM substrate 2.38 in good yield. 
Exposure of 2.38 to Grubbs’ second generation olefin metathesis catalyst under an ethylene atmosphere 
affected the desired annulation to provide diene 2.39. Esterification of the C10' hydroxyl substituent with 
acroyl chloride and heating the resulting ester in xylene facilitated an exo-selective IMDA reaction to 
afford tricycle 2.40. The use of the C10' carbinol to control the facial selectivity of the IMDA reaction 
was critical in setting the C9' stereocenter. The stereochemistry at C9' was then relayed to C14' through a 
diastereoselective OsO4 catalyzed dihydroxylation reaction. TES protection of the resultant C15'–OH and 
reduction of the ester supplied lactol 2.41 in 87% overall yield. The C8'–C13' ether bridge was then 
formed by exposure of 2.41 to (diacetoxyiodo)benzene (DIB) and iodine in cyclohexane at ambient 
temperature. The precise mechanism of this transformation is unclear, however Mootoo suggests that 2.42 
is formed though a radical-based iodination/displacement pathway. Finally, protecting group 
manipulation and oxidation of the B-ring, following a similar protocol to that employed by Roush, 
afforded the AB-subunit of hibarimicin B (2.44). Overall, Mootoo was able to prepare 2.44 in 15 steps 
and 9% yield from 2.37. 
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Scheme 2.5 Mootoo’s Synthesis of the AB-subunit of hibarimicin B. 
 
Reagents and conditions: (a) nPrMgCl, THF –78 °C, 95%; (b) Me3SiCCH, nBuLi, THF –78 → 0 °C; (c) K2CO3, 
MeOH, 79% (two steps); (d) Grubbs II, CH2Cl2, 50%; (e) acroyl chloride, DIPEA, CH2Cl2, –78 °C, 81%; (f) xylene, 
reflux, 85%; (g) OsO4, NMO, H2O, Me2CO, 0 °C, 95%; (h) TESCl, imidazole, DMF, quantitative; (i) DIBAL, 
CH2Cl2, –78 °C, 95%; (j) DIB, I2, cyclohexane, 63%; (k) K2CO3, MeOH, CH2Cl2, 0 °C, quantitative; (l) TBDMSCl, 
TBAI, imidazole, DMF, 98%; (m) TBAF, THF, 0 °C, 99%; (n) IBX, DMSO, PhF, 75 °C, 90%; (o) PhSeCl, EtOAc, 
HCl; mCPBA, NaHCO3, 66% (two steps). 
2.4.C Tatsuda’s Synthesis of Hibarimicinone 
 Tatsuta and coworkers completed the first total synthesis of hibarimicinone (2.2) in 2012.107 Their 
synthesis of the AB/HG enone (2.54) is illustrated in Scheme 2.6. Their synthesis began with 1-
phenylsulphonyl enone 2.45 which was available in 9 steps and 42% yield from D-arabinose. Thermal 
intermolecular Diels-Alder (DA) reaction of 2.45 with 1-silyloxydiene 2.46 gave a single cis-decalin 
diastereomer 2.48 in 90% yield. The observed relative stereochemistry of the product, specifically at C9 
and C15, can be explained by approach of 2.46 opposite the bulky C10 silyloxy substituent through exo 
transition state 2.47. Exposure of 2.48 to CrO3 and H2SO4 resulted in hydrolysis of the C15 silyl ether and 
oxidation of the resultant allylic alcohol to provide a 1,3-diketone intermediate. Treatment of the product 
with SmI2 promoted reduction of the phenylsulphonyl group to generate a Sm(III) enolate which was 
oxidized by in situ treatment with Oxone to furnish α-hydroxy-1,3-diketone 2.49. The C10 secondary 
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carbinol, whose stereochemistry was required to induce the desired facial selectivity in the DA reaction, 
was inverted through a four step sequence involving: (1) chemoselective cleavage of the C10 silyl 
protecting group with SnCl4, (2) oxidation of the resultant alcohol with IBX to give trione 2.50, (3) 
chemo- and stereoselective C14–OH directed reduction of the C10 carbonyl with NaBH(OAc)3, and (4) 
TMS protection of the C10–OH afforded 1,3-dienyl silane 2.51 in 61% overall yield. Protection of the 
C15 carbonyl through enol silane formation allowed for subsequent organometallic addition to the C13 
carbonyl. Accordingly, treatment of 2.51 with allylmagnesium chloride provided homoallylic alcohol 
2.52 as a single diastereomer, in which the nucleophile had approached from the convex face of the cis-
decalin carbon framework. The resultant C13–OH was protected with TMSOTf and the dienolsilane 
functional group was hydrolyzed with DBU in warm iPrOH to supply enone 2.53. Finally, chemoselective 
hydrogenation of the allyl moiety over the enone delivered AB/HG enone 2.54 for the total synthesis of 
2.2 in 20 steps and 11% overall yield. 
Scheme 2.6 Tatsuda’s synthesis of AB/HG Enone. 
 
Reagents and conditions: (a) 1-trimethylsiloxy-1,3-butadiene (2.46), DTBC, PhMe, 90 °C, 4 d, 90%; (b) aq H2SO4, 
CrO3, Me2CO, 94%; (c) SmI2, THF, –78 °C; then Oxone, –78 °C → RT; aq NaHCO3, 89%; (d) SnCl4, CH2Cl2, 
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Reagents and conditions for Scheme 2.6 continued: –30 °C, 83%; (e) IBX, PhMe-DMSO, 50 °C, 87%; (f) 
NaBH(OAc)3, EtOH, 0 °C → RT, 96%; (g) TMSOTf, 2,6-lutidine, ClCH2CH2Cl, 80 °C, 88%; (h) allylmagnesium 
chloride, Et2O, 0 °C, 86%; (i) TMSOTf, 2,6-lutidine, ClCH2CH2Cl, 80 °C, 87%; (j) DBU, iPrOH, PhMe, 80 °C, 
90%; (k) H2, 10% Pd/C, PhMe, 88%. 
 Tatsuda’s synthesis of hibarimicinone (2.2) continued with a two-directional annulation reaction 
between AB/HG enone 2.54 and enantiopure unsymmetrical DE-biaryl bis-thiolactone 2.55 (Scheme 2.7), 
which was available from 2,4,5-trimethoxybenzoic acid in 12 steps and 3% overall yield. They discovered 
that exposure of 2.54 and 2.55 to NaHMDS in PhMe-THF-pyridine followed by in situ methylation 
facilitated a two-directional double annulation reaction to afford octacycle 2.56 and 2.57 as a mixture of 
keto and enol tautomers in 39% and 18% yield, respectively. Pyridine was found to be critical to suppress 
the formation of polymerization side products. The keto tautomer 2.56 was converted to enol 2.57 in the 
presence of LiCl. The hemithioacetal was then hydrolyzed by treatment with AgNO3 in warm PhMe–
acetone–H2O and the product was enolized with DBU to provide C-ring hydroquinone 2.58. Next, C-ring 
oxidation and F-Ring aromatization, to deliver octacycle 2.59, were accomplished through sequential 
addition of Ag2CO3 and MeI to a solution of 2.58 in PhMe–acetone–H2O. The C8'–C13' ether bridge was 
then formed by treatment of 2.59 with LiI via a two step process involving: (1) quinone tautomerization 
with simultaneous MOM deprotection to generate orthoquinone methide intermediate 2.60 and (2) 
cyclization of the pendant C13' silyl ether onto the electrophilic C8' position with concomitant cleavage of 
the silicon protecting group to yield hydroquionone 2.61. Finally, The C-ring hydroquinone was 
reoxidized with DDQ and the resultant quinone stirred with 1 N HCl in MeOH at 40 °C for 10 h to 
promote tautomerization to the D-ring and cleavage of the C1' methyl ether to deliver hibarimicinone 
(2.2) as a single atropisomer in 56% yield over three steps. Coincidentally, Tatsuda’s synthesis of 2.2 
took advantage of similar disconnection strategy to our own and was published shortly before ours. 
However, their protecting group strategy is not likely to be amenable to the completion of hibarimicin B 
(2.1) due to the acid labile nature of its 2-deoxyglycosidic linkages.  
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Scheme 2.7 Tatsuda’s synthesis of hibarimicinone. 
 
Reagents and conditions: (a) NaHMDS, MeI, THF-PhMe-Py, –20 °C, 57% (39% for 2.56 and 18% for 2.57); (b) 
LiCl, THF, 97%; (c) AgNO3, PhMe-Me2CO-H2O, 40 °C; (d) DBU, PhMe, 0 °C; (e) Ag2CO3, PhMe-Me2CO-H2O, 
40 °C; then MeI, 63% (three steps); (f) LiI, MeCN, ClCH2CH2Cl, 50 °C; (g) DDQ, THF-PhMe, 0 °C, 70% (two 
steps); (h) 1 N HCl, MeOH, 40 °C, 80%. 
 Hibarimicin B Retrosynthesis Plan 2.5
 Our synthesis plan for 2.1 is outlined in Figure 2.6. We envisioned the AT-AM/AT'-AM' 
dissacharide and the DG/DG' monosaccharide subunits could be retrosynthetically disconnected from the 
aglycon to provide four potential synthesis precursors: disaccharide trichloroacetimidate glycosyl donor 
2.62, monosaccharide glycosyl donors 2.63 or 2.64, and orthogonally protected aglycon 2.65. In a 
forward sense, we anticipated that the two-directional stereocontrolled introduction of the β-glycosidic 
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linkages between the AM/AM' subunits and aglycon 2.65 could be accomplished through the functional 
group addition of a phenyl thionocarbonate directing group at AM3/AM3'. After protecting group 
manipulation, we envisioned that glycosyl donor 2.63 or 2.64 could be used to stereoselectively construct 
the α-glycosidic linkages between the DG/DG' subunits and the intermediate partially glycosylated 
aglycon. 2-Deoxy thiophenyl donors such as 2.63 generally rely on reagent control to induce α-selective 
glycosidic bond formation. Alternatively, we anticipated that the functional group addition of an axial 
iodo directing group at DG2/DG2' of 2.64 could be exploited to favor α-glycoside formation. Next, 
aglycon 2.65 was retrosynthetically simplified to pseudo-C2-symmetric octacycle 2.66 through a series of 
biosynthetically inspired oxidations. The reaction sequence developed for 2.65 could potentially be 
modified to afford hibarimicinone (2.2). The C2-symmetry of intermediate 2.66 is perturbed by the 
presence of the C4'–OBn group and the C6'–OH (highlighted in red). The use of a C4'–OBn rather than 
C4'–OMe (used by Tatsuda) was choosen to allow for late stage oxidation of the D-ring hydroquinone in 
the presence of the highly acid labile 2-deoxyglycosidic linkages. The addition of the C6'–OH was 
expected to facilitate chemoselective C-ring oxidation to a quinone, which could then undergo our 
proposed biomimetic relay oxidation sequence. Most importantly, the retrosynthetic excision of the B-
ring cyclic ether bond makes the AB- and HG-ring systems identical. Consequently, we envisioned 
octacycle 2.66 could be assembled in one step via a two-directional double annulation reaction between 
the dianion of unsymmetrical DE-biaryl 2.67 and two equivalents of AB/HG-enone 2.68.110 In this 
process, the C-ring would be constructed through a Hauser annulation111 and the F-ring would be built 
though a Michael–Claisen condensation.112 This convergent strategy circumvents the need to form the 
hindered C2–C2' bond of 2.1 at a late stage in the synthesis, which was a transformation that we expected 
                                                      
110 For other examples of two-directional double annulation reactions, see: (a) Hauser, F. M.; Gauuan, P. J. Org. 
Lett. 1999, 1, 671–672. (b) Ref. 105e. (c) Ref.107, and references therein. 
 
111 Hauser, F. M.; Rhee, R. P. J. Org. Chem. 1978, 43, 178–180.  
 
112 (a) Leeper, F. J.; Staunton, J. J. Chem. Soc., Chem Commun. 1978, 406–407. (b) Dodd, J. H.; Weinreb, S. M. 
Tetrahedron Lett. 1979, 20, 3593–3596. (c) For other uses of Michael–Dieckmann reaction sequences to construct 
naphthalene derivatives, see: Sun, C.; Wang, Q.; Brubaker, J. D.; Wright, P. M.; Lerner, C. D.; Noson, K.; Charest, 
M.; Siegel, D. R.; Wang, Y.-M.; Myers, A. G. J. Am. Chem. Soc. 2008, 130, 17913–17927, and references therein. 
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would be problematic based on the efforts of Roush (vide supra). At the outset of our study, the absolute 
configuration of the C2–C2' axis of 2.1 and 2.2 was ambiguous.99h Consequently, we elected to proceed 
with racemic biaryl annulation donor (±)-2.67 in order to prepare and characterize both atropisomers of 
2.2. Additionally, as the absolute stereochemistry of 2.2 was unknown,99h we designed a synthesis of both 
potential enantiomers of the AB/HG enone annulation acceptor 2.68. 
 
Figure 2.6 Retrosynthesis of hibarimicin B. 
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 The total synthesis of hibarimicin B (2.1) was anticipated to be an extremely labor and time 
intensive endeavor due to its size and structural complexity. For this reason, Brian B. Liau joined me 
early on and we divided the labor necessary for the completion of this goal. My initial focus was the 
synthesis of both AB/HG-enone 2.68 and ent-AB/HG-enone 2.69 (Figure 2.7) annulation acceptors in 
order to determine the absolute stereochemistry of the aglycon of 2.2. Brian’s primary focus was the 
synthesis of the racemic DE-biaryl annulation donor (±)-2.67 and the development of robust naphthol and 
hydroquinone annulation reactions necessary to complete a synthesis of the 2.2. Once these goals had 
been met, my objective was to accomplish a synthesis of both the AM/AM'-AT/AT' dissacharide and the 
DG/DG' monosacharride glycosyl donors and to develop methods for their installation onto a suitably 
protected aglyon. Realization of these aims would potentially enable the first total synthesis of 
hibarimicin B (2.1). 
  AB/HG-Enone Synthesis 2.6
  Without knowing the absolute stereochemistry of the hibarimicin B aglycon, we were forced to 
make an arbitrary decision regarding which AB/HG-enone enantiomer to target. Our first-generation 
retrosynthesis for what was later determined to be the ent-AB/HG-enone (2.69) is outlined in Figure 2.7. 
Our plan for the synthesis of 2.69 relied on a key Lewis acid-catalyzed contrasteric Diels–Alder reaction 
between cyclohexenone 2.71 and 1-alkoxy-1,3-butadiene 2.70 to set the challenging C9 stereochemistry 
and assemble the cis-decalin carbon framework of 2.69 in a single operation. We anticipated that the 
C14–OH could be installed through the oxidative decarboxylation of the corresponding ester. We 
expected that diastereoselective introduction of the n-propyl substituent could be accomplished through a 
organometallic addition to a C13 carbonyl group from the convex face of the rigid cis-decalin carbon 
framework. Finally, cyclohexenone 2.71 could be constructed through a Robinson annulation of an 
orthogonally protected linear precursor 2.72 derived from readily available methyl α-D-glucopyranoside 
(2.73). 
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Figure 2.7 First-generation ent-AB/HG-enone retrosynthesis. 
 A reaction first reported by Danishefsky and coworkers in 1991113 inspired us to take advantage 
of a Lewis acid-promoted contrasteric Diels–Alder reaction in our synthesis plan for 2.69 (Scheme 2.8). 
They demonstrated that 2-cyclohexenone 2.74, bearing a γ-OTBS group, participated in a contrasteric 
intermolecular Diels–Alder reaction with 1,3-butadiene when catalyzed by AlCl3 to afford cis-decalin 
2.75 in 76% yield. In this transformation, the β-C–C bond was formed syn relative to the γ-OTBS group 
in high diastereoselectivity (13:1 syn:anti). We anticipated similar stereoselectivity in our proposed 
Diels–Alder reaction, despite the additional Lewis basic groups in our substrate (2.71). 
Scheme 2.8 Danishefsky’s Lewis acid-promoted contrasteric Diels–Alder reaction. 
 
Reagents and conditions: (a) 1,3-butadiene (20 equiv), AlCl3 (0.9 equiv), PhMe, 23 °C, 1 h, 76%, 13:1 syn:anti. 
 The first-generation synthesis of ent-AB/HG-enone (2.69) began with silylation of methyl α-D-
glucopyranoside (2.73) followed by FeCl3 catalyzed regioselective benzylation of the resultant 
triemethylsilyl protected glucopyranoside 2.76 according to a modified literature procedure (Scheme 
2.9).114 Recrystallization of the product mixture supplied benzylidene acetal (–)-2.77 on multi-gram scale 
in 50% yield. Next, the C12 secondary carbinol was protected as a pivalate ester and the benzylidene 
acetal was hydrolyzed by treatment with HOAc to deliver diol (+)-2.78 in 86% yield over two steps. 
                                                      
113 Jeroncic, L. O.; Cabal, M. P.; Danishefsky, S. J.; Shulte G. M. J. Org. Chem. 1991, 56, 387–395.  
 
114 Bourdreux, Y.; Lemétais, A. Urban, D.; Beau, J.-M. Chem. Commun., 2011, 47, 2146–2148. 
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Formation of the primary iodide and protection of the C10 secondary carbinol as a silyl ether gave iodide 
(+)-2.79 in excellent yield. Sonication of (+)-2.79 with activated zinc powder promoted reductive 
fragmentation to generate an aldehyde intermediate (2.80), 115  which upon treatment with ethyl 
diazoacetate and SnCl2 furnished β-ketoester 2.81.116 Finally, ozonolysis of 2.81 followed by reductive 
workup with PPh3 gave another aldehyde intermediate. Exposure of this aldehyde to thionyl chloride and 
pyridine promoted a Robinson annulation to provide enone 2.82 in 56% yield over three steps. 
Scheme 2.9 Synthesis of first-generation Diels–Alder substrate 2.82. 
 
Reagents and conditions: (a) TMSCl, Py, 45 °C, 98%; (b) PhCHO, Cu(OTf)2, MeCN-CH2Cl2 (1:4), 0 °C; then 
Et3SiH, 0 °C → RT, 50%; (c) PivCl, Et3N, 4-DMAP, CH2Cl2, 0 °C → RT, 95%; (d) HOAc-H2O (4:1), 80 °C, 94%; 
(e) PPh3, imidazole, PhMe; then I2; then (+)-2.78, RT → 45 °C, 97%; (f) TBSOTf, 2,6-lutidine, 0 °C → RT, 99%; 
(g) Zn(0), THF-H2O (4:1), sonication, 40 °C; (h) ethyl diazoacetate, SnCl2, CH2Cl2, 81% (two steps); (i) O3, CH2Cl2, 
–78 °C; PPh3; SOCl2, Py, –78 °C → RT, 70%. 
 With a route to enone 2.82 established, we attempted the proposed Lewis acid-catalyzed 
contrasteric Diels–Alder reaction with 1-acetoxy-1,3-butadiene (2.83),117 which was known to be stable in 
                                                      
115 (a) Skaanderup, P. R.; Hyldtoft, L.; Madsen, R. Monatsh. Chem. 2002, 133, 467–472. (b) Hyldtoft, L.; Madsen, 
R. J. Am. Chem. Soc. 2000, 122, 8444–8452. (c) Bernet, B.; Vasella, A. Helv. Chim. Acta 1979, 62, 2411–2431. (c) 
Nakane, M.; Hutchinson, C. R.; Gollman, H. Tetrahedron Lett. 1980, 21, 1213–1216. (c) Fürstner, A.; Jumbam, D.; 
Teslic, J.; Weidmann, H. J. Org. Chem. 1991, 56, 2213–2217. 
 
116 Holmquist, C. R.; Roskamp, E. J. J. Org. Chem. 1989, 54, 3258–3260. 
 
117 Bailey, W. J.; Barclay, R. J. Org. Chem. 1956, 21, 328–331. 
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the presence of a variety of Lewis acids (Scheme 2.10).118 Unfortunately, an extensive screen of potential 
reaction conditions and Lewis acids did not yield a Diels–Alder product. The major product formed under 
a variety of reaction conditions was phenol 2.84, which was a result of β-elimination of the benzyloxy 
group and tautomerization of the resultant cyclohexadienone. In contrast, heating a solution of 2.82 and 
2.83 in xylene to 130 °C for 12 h promoted a thermal Diels–Alder reaction to provide cis-decalin isomers 
2.85 and 2.86. Independent NOESY analysis of the cycloadducts indicated that we had produced a 1:1 
mixture of the desired syn and undesired anti diasereomers. Additionally, the stereochemistry of the C15 
acetoxy group indicated that the syn diastereomer (2.85) was presumably formed through an endo 
transition state. The lack of facial selectivity in the thermal Diels–Alder reaction prompted us to devise an 
alternative Lewis acid compatible substrate. 
Scheme 2.10 First-generation Diels–Alder reaction. 
 
  
                                                      
118 (a) Kraus, G. A.; Fulton, B. S. J. Org. Chem. 1985, 50, 1782–1784. (b) Mikami, K.; Motoyama, Y.; Terada, M. J. 
Am. Chem. Soc. 1994, 116, 2812–2820. (c) Evans, D. A.; Barnes, D. M.; Johnson, J. S.; Lectka, T. von Matt, P.; 
Miller, S. J.; Murry, J. A.; Norcross, R. D. Shaughnessy, E. A.; Campos, K. R. J. Am. Chem. Soc. 1999, 121, 7582–
7594. (c) Imagawa, H. Saijo, H.; Yamaguchi, H.; Maekawa, K.; Kurisaki, T.; Yamamoto, H.; Nishizawa, M.; Oda, 
M.; Kabura, M.; Nagahama, M.; Sakurai, J.; Kubo, M.; Nakai, M.; Makino, K.; Ogata, M.; Takahashi, H.; 
Fukuyama, Y. Bioorg. Med. Chem. Lett. 2012, 22, 2089–2093.  
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 We reasoned that the electron withdrawing C14 ester substituent of 2.82 increased the acidity of 
the C12–H bond and thereby facilitated β-elimination of the benzyloxy substituent upon exposure to a 
Lewis acid. Furthermore, in the process of screening Lewis acids for the Diels–Alder reaction we 
observed significant diene polymerization, which we attributed to the 1-acetoxy substitution. A variety of 
alternative 1-substituted dienes were also investigated for this reaction, all of which showed a similar 
trend toward Lewis acid-mediated decomposition via polymerization. Consequently, a second-generation 
ent-AB/HG-enone (2.69) synthesis plan was developed that continued to rely on a Lewis acid-catalyzed 
contrasteric Diels–Alder reaction, but utilized substrates pair that lacked the aforementioned substituents. 
 Our second-generation retrosynthesis of ent-AB/HG-enone (2.69) is outlined in Figure 2.8. We 
anticipated that the enone functionality in 2.69 could be installed through the oxidation of the 
corresponding allylic silane 2.87. Additionally, stereocontrolled introduction of the n-propyl substituent at 
C13 could be accomplished through an organometallic addition to α-hydroxy ketone 2.87 from the 
convex face of the rigid cis-decalin carbon framework. Next, 2.87 could be accessed via a regio- and 
diastereoselective silyl zincate 1,6-addition to dienone 2.88, followed by in situ oxidation of the resultant 
extended zinc enolate. A key Lewis acid-catalyzed contrasteric Diels–Alder reaction between 
cyclohexenone 2.89 and 1,3-butadiene could then be employed to assemble decalin 2.88 with the requisite 
relative stereochemistry at the challenging C9 stereocenter. Finally, suitably protected cyclohexenone 
2.89 could be prepared through ring-closing metathesis (RCM) of a linear precursor derived from readily 
available methyl α-D-glucopyranoside (2.73).  
 An analogous sequence of stereospecific transformations on cyclohexenone enantiomer 2.90 
could potentially furnish AB/HG-enone (2.68). We imagined cyclohexenone 2.90 could be prepared by 
taking advantage of the latent C2-symmetry exhibited by methyl α-D-glucopyranoside (2.73). Rather than 
a RCM-type annulation, a type-II Ferrier rearrangement could be employed to construct 2.90. The ability 
to produce gram quantities of both AB/HG-enone (2.68) and ent-AB/HG-enone (2.69) was deemed 
essential for a successful total synthesis of hibarimicin B (2.1). Recognition of the common 
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stereochemical elements shared by 2.68, 2.69, and methyl α-D-glucopyranoside (2.73) will help enable 
the realization of this goal. 
 
Figure 2.8 Second-generation retrosynthesis of ent-AB/HG-enone 2.69 and AB/HG-enone 2.68. 
 The synthesis of ent-AB/HG-enone (2.69) began with iodide (+)-2.79 prepared according to the 
previously described procedure (Scheme 2.11).119 Sonication of (+)-2.79 with activated zinc powder 
promoted reductive fragmentation to generate an aldehyde intermediate (2.80), which upon treatment with 
an organocerium reagent derived from vinylmagnesium bromide furnished allylic alcohol 2.91 as an 
inconsequential diastereomeric mixture in 75% yield over two steps.120  Exposure of 2.91 to first-
generation Grubbs olefin metathesis catalyst121 in dilute CH2Cl2 followed by Parikh–Doering oxidation122 
of the resultant diastereomeric cyclohexenols afforded cyclohexenone (–)-2.89  in 82% yield over two 
steps. Over thirty grams of (–)-2.89 was synthesized through this protocol. 
  
                                                      
119 Milgram, B. C.; Liau, B. B.; Shair, M. D. Org. Lett. 2011, 13, 6436–6439. 
 
120 Hyldtoft, L.; Madsen, R. J. Am. Chem. Soc. 2000, 122, 8444–8452. 
 
121 (a) Schwab, P.; France, M. B.; Ziller, J. W.; Grubbs, R. H.  Angew. Chem., Int. Ed. 1995, 34, 2039–2041. (b) 
Schwab, P.; Grubbs, R. H.; Ziller, J. W. J. Am. Chem. Soc. 1996, 118, 100–110. 
 
122 Parikh, J. P.; Doering, W. E. J. Am. Chem. Soc. 1967, 89, 5505–5507.  
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Scheme 2.11 Synthesis of Diels–Alder substrate (–)-2.89. 
 
Reagents and conditions: (a) Zn(0), THF-H2O (4:1), sonication, 40 °C; (b) CH2CHMgBr, CeCl3, THF, –78 °C, 75%, 
3:1 d.r. at C13 (two steps); (c) Grubbs I (5 mol %), CH2Cl2, 85%; (d) SO3•Py, iPr2NEt, DMSO, CH2Cl2, 0 °C, 97%. 
 Following our synthesis of (–)-2.89, we attempted a Lewis acid-catalyzed contrasteric Diels–
Alder reaction depicted in Scheme 2.12. The variety of Lewis acids we screened for this reaction include: 
AlCl3, AlMeCl2, AlMe2Cl, BCl3, TBSOTf, and TiCl4. Eventually we discovered that addition of a freshly 
prepared solution of TiCl4 in PhMe to (–)-2.89 at –78 °C followed by dropwise addition of liquid 1,3-
butadiene and warming the reaction mixture to 5 °C for 3.5 h afforded a 10:1 mixture of cycloaddition 
adducts, favoring the desired syn diastereomer (–)-2.92. The use of PhMe as a solvent was critical to 
suppress the formation of a benzyl deprotected side product. This reaction was performed on multi-gram 
scale with similarly high levels of diastereoselectivity and is to our knowledge the most complex example 
of a contrasteric Diels–Alder yet reported. 
Scheme 2.12 Second-generation Lewis acid-promoted contrasteric Diels–Alder reaction. 
 
 The stereoselectivity of this reaction is likely governed by subtle steric and stereoelectronic 
effects. Approach of 1,3-butadiene to (–)-2.89 syn to the γ-OTBS substituent is sterically occluded by 
both the γ-OTBS and α-OPiv groups and is thus counterintuitive (transition state 2.93, Figure 2.9). 
However, stereoelectronic considerations suggest that pseudo-axial approach of 1,3-butadiene to C9 of 
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the chair-like ground state conformation of 2.94 is kinetically favored.123 Additionally, the Cieplak model 
has been invoked to rationalize the stereochemical outcome for the aforementioned Diels–Alder 
reaction.124 In accordance with this line of reasoning, formation of the β-C–C bond syn with the electron-
withdrawing γ-OTBS group stabilizes the forming σ*-C–C orbital through hyperconjugation with the 
electron-donating σ-C–H bond (transition state 2.94, Figure 2.9). It is plausible that a synergism of 
individually small stereoelectronic effects bias the reaction pathways towards the observed major product 
diastereomer (–)-2.92.125,126 
 
Figure 2.9 Possible explaination for contrasteric outcome of Lewis Acid-promoted Diels–Alder reaction. 
 The next challenge in the synthesis of 2.69 was the installation of the C14–OH and C15 carbonyl 
groups. Exposure of (–)-2.92 to TMSI, generated in situ from TMSCl and NaI, promoted thermodynamic 
enolization of the ketone to afford enol silane 2.95 as a single regioisomer (Scheme 2.13).127 This 
regioselection is particularly noteworthy since C12–H is presumably more acidic than C14–H.128 
                                                      
123 Angell, E. C.; Fringuelli, F.; Pizzo, F.; Porter, B.; Taticchi, A.; Wenkert, E. J. Org. Chem. 1986, 51, 2642–2649. 
124 (a) Cieplak, A. S.  J. Am. Chem. Soc. 1981, 103, 4540–4552. (b) Ohkata, K.; Tamura, Y.; Shetuni, B. B.; Takagi, 
R.; Miyanaga, W. Kojima, S.; Paquette, L. A. J. Am. Chem. Soc. 2004, 126, 16783–16792. (c) Carreño, M. C.; 
González, M. P.; Houk, K. N. J. Org. Chem. 1997, 62, 9128–9137. 
 
125 A similar sense of facial selectivity was observed for copper(I) mediated 1,4-addition of organometallic reagents 
to a benzyl protected inositol derivative in the presence of BF3•OEt2: Bian, J.; Schneider, S. R.; Maguire, R. J. 
Tetrahedron Lett. 2011, 52, 5417–5420. 
 
126 A similar sense of facial selectivity was observed for LiClO4 catalyzed conjugate addition of an O-silylated 
ketene acetal on a benzyl protected inositol derivative: Lastdrager, B.; Timmer, M. S. M.; van der Marel, G. A.; 
Overkleeft, H. S.; Overhand, M. J. Carbohydr. Chem. 2007, 26, 41–59. 
 
127 (a) Miller, R. D.; McKean, D. R. Synthesis 1979, 9, 730–732. (b) Moher, E. D.; Collins J. L.; Grieco, P. A. J. Am. 
Chem. Soc. 1992, 114, 2764–2765. (c) Krafft, P. A.; Holton, R. A. Tetrahedron Lett. 1983, 24, 1345–1348. 
 
128 Interestingly, deprotonation of (–)-2.92 with KHMDS at –78 °C followed by quenching the resultant enolate with 
D2O or DOAc resulted in equivalent deuterium incorporation at C9 and C12. 
OBn
OPiv
O
OTBS
O
OTBS
PivO
OBn
H
σ C-H→σ∗ C-C
donation
Cl4Ti
Cl4Ti
H
H
2.93 2.94
 85 
Oxidation of 2.95 was accomplished through exposure to DDQ to furnish dienone (–)-2.88 in 78% overall 
yield, again as a single regioisomer.129 
Scheme 2.13 Synthesis of dieneone (–)-2.88. 
 
Reagents and conditions: (a) TMSCl, NaI, HMDS, MeCN, 82 °C; (b) DDQ, CH2Cl2, 78% (two steps). 
 Several conceptually similar stratigies were considered for introduction of oxygen at C14 and 
C15 (Scheme 2.14). Chemoselective dihydroxylation of the C14–C15 olefin of (–)-2.88 was attempted 
using catalytic OsO4, but led to only substrate decomposition. Alternatively, treatment of (–)-2.88 with 
tBOOH and Triton B was expected to promote nucleophilic epoxidation of the C14–C15 olefin; instead, 
an unexpected dieneone 2.97 was formed in 80% yield. The formation of 2.97 presumably occured via: 
(1) C12–H deprotonation, (2) pivaloyl migration, and (3) reprotonation of the resultant extended enolate 
at the terminal position. This finding prompted us to attempt electrophilic epoxidation of (–)-2.88. 
Exposure of (–)-2.88 to NaOCl, under phase transfer conditions, furnished epoxide 2.98 in 87% yield. 
While 2.98 was not regarded as a potential intermediate for the synthesis of 2.68, the apparent selectivity 
demonstrated for distal epoxidation in this reaction inspired us to imagine an alternative reaction sequence 
that could utilize this discovery.  
  
                                                      
 
129 (a) Ryu, I.; Murai, S.; Hatayama, Y.; Sonoda, N. Tetrahedron Lett. 1978, 19, 3455–3458. (b) Corey, E. J.; 
Guzman–Perez, A.; Loh, T.-P. J. Am. Chem. Soc. 1994, 116, 3611–3612. 
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Scheme 2.14 Attempted oxidation of dienone (–)-2.88. 
 
 Reagents and conditions: (a) OsO4 (10 mol%), NMO, Me2CO-H2O (3:1); (b) tBOOH, Triton B, PhH, 80%; (c) 
NaOCl, TBAB, PhMe-H2O (2:1), 87%. 
 Based on the previous observation, we anticipated addition of a silyl nulcleophile to (–)-2.88 
would occur in a diastero- and regioselective fasion from the convex face of the molecule at C7 to 
generate an extended enolate intermediate, which could in turn be diastero- and regioselectively oxidized 
to introduce the C14–OH. Several important discoveries were made in the process of developing this 
concept into an efficient process (Scheme 2.15). First, we found the use of a silyl zincate nucleophile 
rather than a silyl cuprate was critical to prevent base mediated pivaloyl migration. Second, the steric bulk 
of the silyl nucleophile was essential for controlling the facial selectivity of conjugate addition. Exposure 
of (–)-2.88 to a trimethylsilyl zincate derived from trimethylsilyl lithium and diethyl zinc furnished 
conjugate addition adduct 2.100 upon trapping the resultant enolate with TMSCl in only 2:1 d.r. at C7. In 
contrast, dimethylphenylsilyl zincate added exclusively from the convex face of (–)-2.88 to yield a single 
stereoisomer at C7.130,131 
                                                      
130 It was usefull to isolate the intermediate enolate as its cooresponding enol silane to assess the diastereo- and 
regioselectivity of the process. 
  
131 (a) Dunn, T. B.; Ellis, J. M.; Kofink, C. C.; Manning, J. R.; Overman, L. E. Org. Lett. 2009, 11, 5658–5661. (b) 
Vaughan, A.; Singer, R. D. Tetrahedron Lett. 1995, 36, 5683–5686. (c) Lipshutz, B. H.; Sclafani, J. A.; Takanami, 
T. J. Am. Chem. Soc. 1998, 120, 4021–4022. (d) Crump, R. A. N. C.; Fleming, I.; Urch, C. J. J. Chem. Soc., Perkin 
Trans. 1 1994, 701–706. (e) Tckmantel, W.; Oshima, K.; Nozaki, H. Chem. Ber. 1986, 119, 1581–1593. 
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Scheme 2.15 Development of an efficient silyl 1,6-addition. 
 
Reagents and conditions: (a) Me2PhSiLi, CuCN, THF, –78→ 0 °C; then (–)-2.88; (b) Si2Me6, nBuLi, HMPA, THF –
78→ 0 °C; then ZnEt2, PhMe, –78 °C; then (–)-2.88, –78→ 0 °C; then TMSCl, 31%, 2:1 d.r.; (b) Me2PhSiLi, ZnEt2, 
THF-PhMe, –78 °C; then (–)-2.88, –78 → 0 °C; then TMSCl, 69%. 
 Next, the oxidation of the extended zinc enolate intermediate (2.102) was studied with a variety 
of known oxidants including: mCPBA, Oxone, DMDO (2.105), Davis oxaziridine ((±)-2.106), and 
MoOPH (2.107). The product formed in this transformation depended on the oxidant that was employed 
(Scheme 2.16). The use of mCPBA or Oxone in this reaction afforded C16 peroxide 2.203 as the sole 
product. Interestingly, addition of aqueous ammonium chloride solution to the intermediate extended zinc 
enolate 2.102 also resulted in exclusive formation of 2.203.132 Utilization of Davis oxaziridine ((±)-2.106) 
as an oxidant133 supplied the desired α-hydroxy ketone (+)-2.87; unfortunately it was difficult to separate 
(+)-2.87 from the Davis oxiziridine by-products through silica gel chromatography or acid extraction.134 
Oxidation of (–)-2.88 using an anhydrous solution of DMDO in acetone cleanly afforded (+)-2.87 on 
                                                      
132 The presence of a peroxide functional group in 2.103 was confirmed by O–O bond reduction through treatment 
with PPh3 to afford the cooresponding C16 alcohol 1.104. 
 
133 (a) Davis, F. A.; Abdul-Malik, N. F.; Awad S. B.; Harakal, M. E. Tetrahedron Lett. 1981, 22, 917–923. (b) 
Davis, F. A.; Vishwakarma, L. C.; Billmers, J. G.; Finn, J. J. Org. Chem. 1984, 49, 3241–3243. (c) Davis, F. A.; 
Chen, B. C. Chem. Rev. 1992, 92, 919–934. (d) Kummer, D. A.; Li, D.; Dion, A.; Myers, A. G. Chem. Sci. 2011, 2, 
1710–1718. 
 
134 Work-up of the reaction with acid was attempted in order to remove the oxidation by-products formed by Davis 
oxaziridine, however this procedure caused immediate decomposition of the α-hydroxy ketone product (+)-2.87. 
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milligram scale; however, on gram-scale, C16 alcohol 2.104 became the major product of the reaction. 
Eventually we discovered MoO5•pyr•HMPA (MoOPH) (2.107)135 was an ideal oxidant for the preparation 
of α-hydroxy ketone (+)-2.87 on gram-scale. 
Scheme 2.16 Development of an efficient in situ enolate oxidantion proceedure. 
 
 The synthesis of C14-hydroxy ent-AB/HG-enone ((–)-2.110) is depicted in Scheme 2.17. Regio- 
and diastereoselective addition of dimethylphenylsilyl zincate to the δ-position of dienone (–)-2.88 
generated an extended zinc enolate intermediate, which upon treatment with (MoOPH, 2.107), underwent 
in situ α-oxidation to deliver cis-decalin (+)-2.87 as a single regio- and diastereoisomer in 82% yield on 
gram-scale. Overall, this reaction sequence installed the sterically congested C14 tertiary carbinol and 
introduced an allylic silane functional group, which was planned to serve as a latent enone surrogate. 
Next, exposure of (+)-2.87 to an organocerium reagent derived from n-propylmagnesium chloride led to 
carbonyl addition exclusively from the convex face of the molecule and promoted cleavage of the 
pivaloyl ester upon warming the reaction mixture to 0 °C.136 The use of a organocerium reagent was 
required to avoid ketone enolization and reduction.137 The resultant 1,2-diol was protected as an acetonide 
                                                      
135 (a) Vedejs, E. J. Am. Chem. Soc. 1974, 96, 5944–5946. (b) Vedejs, E.; Larsen, S. Org. Synth. 1986, 64, 127–132 
and references therein. 
 
136 (a) Martin, C. L.; Overman, L. E.; Rohde, J. M. J. Am. Chem. Soc. 2010, 132, 4894–4906. (b) Trost, B. M.; 
Waser, J.; Meyer, A. J. Am. Chem. Soc. 2008, 130, 16424–16434. (c) Dimitrov, V.; Kostova, K.; Genov, M. 
Tetrahedron Lett. 1996, 37, 6787–6790. 
 
137 Imamoto, T.; Takiyama, N.; Nakamura, K.; Hatajima, T.; Kamiya, Y. J. Am. Chem. Soc. 1989, 111, 4392–4398. 
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to afford (+)-2.108 in 71% yield over two steps. Addition of mCPBA to a cold mixture of (+)-2.108 and 
NaHCO3 in CH2Cl2 induced epoxidation of the allylic silane. The intermediate epoxide underwent 
subsequent 1,5-silyl migration with concomitant epoxide opening to provide silyl ether (–)-2.109 in 85% 
yield.138 Chemoselective removal of the dimethylphenylsilyl group with TBAF at –78 °C followed by 
Swern oxidation139 of the resultant allylic alcohol delivered (–)-2.110 in 91% yield over two steps on 
gram-scale. An X-ray structure of (–)-2.110 confirmed the relative stereochemistry of the cis-decalin 
carbon skeleton. 
Scheme 2.17 Completion of C14-hydroxy ent-AB/HG-enone (–)-2.110. 
 
Reagents and conditions: (a) Me2PhSiLi, ZnEt2, THF-PhMe, –78 °C; then (–)-2.88, –78 → 0 °C; then MoOPH, –78 
→ –20 °C, 20 min, 82%; (b) CeCl3, LiCl, THF; then nPrMgCl, –78 ºC; then (+)-2.105, –78 → 0 °C, 85%; (c) 2-
methoxypropene, PPTS (10 mol %), PhH, 84%; (d) mCPBA, NaHCO3, CH2Cl2, –78 → –5 °C, 85%; (e) TBAF, THF, 
–78 ºC, 99%; (f) (COCl)2, DMSO, CH2Cl2, –78 °C; then diol, –78 °C; then Et3N, –78 → 0 °C, 92%. 
 The synthesis of the AB/HG-enone enantiomer ((+)-2.68), which corresponds to the absolute 
stereochemistry of 2.2, is illustrated in Scheme 2.18. The route began with benzylidine acetal 2.77, which 
was also a key intermediate in our synthesis of ent-AB/HG-enone 2.69. The benzylidine acetal was 
                                                      
138 Lee, K.-S.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 2898–2900. 
 
139 Omura, K.; Swern, D. Tetrahedron, 1978, 34, 1651–1660. 
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hydrolyzed by exposure of 2.77 to warm aqueous HOAc and the resultant primary alcohol was iodinated 
to afford diol (+)-2.111 in 76% yield over two steps. Next, chemoselective monosilylation of (+)-2.111 
with TBSCl was accomplished by exploiting a subtle steric difference between its two secondary 
hydroxyl groups. The remaining secondary hydroxyl group was then pivoylated under forcing conditions 
to furnish differentially protected pyranose (+)-2.112. Addition of DBU to a warm solution of (+)-2.112 
in MeCN promoted elimination of the primary iodide. The resultant exocyclic enol ether (+)-2.113 
underwent type-II Ferrier rearrangement upon treatment with catalytic Hg(OCOCF3)2140 to yield a β-
hydroxy-cyclohexanone intermediate which was dehydrated with methanesulfonyl chloride and pyridine 
to provide (+)-2.90 on multi-gram scale. Following the previously described procedure, cyclohexenone 
(+)-2.90 was converted to (+)-2.119. Finally, deprotonation of (+)-2.119 with LiHMDS followed by 
exposure of the resultant alkoxide to TMSOTf delivered AB/HG-enone (+)-2.68 for the key two-
directional annulation reaction. 
  
                                                      
140 Ferrier, R. J. J. Chem. Soc., Perkin Trans. 1 1979, 1455–1458. 
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Scheme 2.18 Synthesis of AB/HG-Enone (+)-2.68. 
 
Reagents and conditions: (a) AcOH/H2O, 80 °C; (b) PPh3, I2, imidazole, PhMe-CH2Cl2, RT → 45 °C, 76% (two 
steps); (c) TBSCl, imidazole, CH2Cl2, 0 °C → RT, 99%; (d) PivCl, 4-DMAP, ClCH2CH2Cl, 50 °C, 94%; (e) DBU, 
MeCN, 80 °C, 75%; (f) Hg(OCOCF3)2 (30 mol%), Me2CO-H2O; (g) MsCl, Et3N, CH2Cl2, 0 °C → RT, 74% (two 
steps); (h) TiCl4, 1,3-butadiene, PhMe, –78 → 5 °C, 64%, 10:1 syn:anti; (i) TMSCl, NaI, HMDS, MeCN, 82 °C; (j) 
DDQ, CH2Cl2, 75% (two steps); (k) Me2PhSiLi, ZnEt2, THF-PhMe, –78 °C; then (–)-2.115, –78 → 0 °C; then 
MoOPH, –78 → –20 °C, 20 min, 78%; (l) CeCl3, LiCl, THF; then nPrMgCl, –78 ºC; then (–)-2.116, –78 → 0 °C, 
80%; (m) 2-methoxypropene, PPTS (10 mol %), PhH, 82%; (n) mCPBA, NaHCO3, CH2Cl2, –78 → –5 °C, 88%; (o) 
TBAF, THF, –78 ºC, quantitative; (p) (COCl)2, DMSO, CH2Cl2, –78 °C; then diol, –78 °C; then Et3N, –78 → 0 °C, 
94%. (q) LiHMDS, THF, 0 °C; then TMSOTf, 0 °C → RT, 99%. 
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 Total Synthesis of Hibarimicin Aglycons 2.7
 As previously mentioned, the size and complexity of hibarimicin B (2.1) necessitated that Brian 
B. Liau and I work as a team toward the completion of its total synthesis. While I developed and scaled 
the the synthesis of both the AB/HG- and ent-AB/HG-enone annulation acceptors, Brian developed an 
efficient synthesis of the DE-biaryl annulation donor, explored model napthol and hydroquinone 
annulation reactions, and applied the methods he established toward the synthesis of what we later learned 
to be ent-hibarimicinone. While working on the synthesis of the AM-AT dissacharide and DG-
monosaccharide glycosyl donors, I helped Brian complete enantioselective total syntheses of 
hibarimicinone (2.2) and atrop-hibarimicinone (2.135, Scheme 2.20), and the first total syntheses of the 
biosynthetically related natural product aglycons HMP-Y1 (2.9), atrop-HMP-Y1, and HMP-P1 (2.12).141 
Specifically, my contributions were (1) to provide Brian with enough AB/HG-enone to accomplish the 
total synthesis of 2.2 and 2.135 and (2) to complete the total syntheses of HMP-Y1 (2.9) and atrop-HMP-
Y1 and investigate their respective barriers to atropismerism. The chemical transformations described in 
this section of the text were developed by Brian B. Liau. 
 Brian’s synthesis of the DE-biaryl annulation donor (±)-2.67 is depicted in Scheme 2.19. For a 
detailed description of this work see Reference 141. Key steps in the synthesis of (±)-2.67 included a 
regioselective ortho-lithiation of 2.121 at C2' followed by an FeCl3-mediated oxidative dimerization of 
the intermediate aryllithium species to form the sterically hindered ortho, ortho'-tetrasubstituted biaryl 
C2–C2' bond as a mixture of atropisomers. The ability to form this bond early in the synthesis allowed us 
to avoid issues associated with a napthol cross-coupling strategy encountered by Roush.104a,c Additionally, 
Brian was able to desymmetrize bis-ortho-toluate intermediate (±)-2.123 through treatment with 1.25 
equiv of LiTMP followed by a short exposure to (BrCF2)2 to furnish benzyl bromide (±)-2.125 in 82% 
yield. (±)-2.125 was then elaborated to the DE-biaryl annulation donor 2.67 through an effiecient series of 
chemical trasformations. 
                                                      
141 Liau, B. B.; Milgram, B. C.; Shair, M. D. J. Am. Chem. Soc. 2012, 134, 16765–16772. 
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Scheme 2.19 Synthesis of unsymmetrical DE-biaryl annulation donor. 
 
Reagents and conditions: (a) Me2SO4, K2CO3, Me2CO, 98%; (b) mCPBA, NaHCO3, CH2Cl2; then Na2CO3, MeOH; 
(c) NaH, MOMCl, DMF, 0 °C → RT, 91% (two steps); (d) nBuLi, TMEDA, THF, –78 → 0 °C; then FeCl3, 0 °C → 
RT, 76%; (e) Br2, Py, CH2Cl2, 0 °C, 91%; (f) nBuLi, THF, –78 °C; then ClC(O)OMe, –78 °C → RT, 89%; (g) 
LiTMP, THF, –78 °C; then (BrCF2)2, 82%; (h) iPr2NEt, DMSO, 70 °C, 87%; (i) TFA, CH2Cl2, 0 °C → RT; (j) BCl3, 
CH2Cl2, –78 → 0 °C; (k) BnBr, K2CO3, DMF, 0 → 60 °C, 94% (three steps); (l) Me2C(OH)CN, Et3N, CHCl3, 97%; 
(m) LiTMP, THF, –78 °C; then Ph(O)2SSPh, 71%. 
 The total synthesis of hibarimicinone (2.2) and atrop-hibarimicinone (2.135) is depicted in 
Scheme 2.20. The synthesis began with a two-directional annulation reaction between DE-biaryl 
annulation donor (±)-2.67 and two equivalents of the AB/HG-enone annulation acceptor (+)-2.68. 
Specifically, contruction of the C-ring hydroquinone was anticipated to involve a Kraus annulation of the 
lithiated cyanothalide of (±)-2.67 with one equivalent of (+)-2.68 and the F-ring was expected to be 
assembled through a Michael–Claisen annulation of the lithiated benzyl phenyl sulfide of (±)-2.67 with a 
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second equivalent of (+)-2.68. Treatment of a deoxygenated solution of (±)-2.67 and (+)-2.68 in THF at –
78 °C with LiHMDS promoted double-deprotonation of (±)-2.67. Warming the intermediate bis-anion to 
0 °C for 16 h facilitated the desired Kraus annulation142 and the Michael step of the proposed F-ring 
annulation sequence. The final Claisen condentation step of the F-ring annulation was accomplished by 
addition of KHMDS to the reaction mixture, which was warmed to ambient temperature for 12 h. Overall, 
this protocol reliably provided octacycle (–)-2.128 and (+)-2.129 as a ~1.3:1 mixture of atropisomers in 
34% and 25% yield, respectively. At this stage, the atropisomers were separated via silica gel 
chromatography and carried through the subsequent steps of the total synthesis independently. 
Aromatization of the F-ring, via elimination of the C6 thiophenyl substituent, was accomplished by 
exposure of the annulation products to dimethyl(methylthio)sulfonium tetrafluoroborate (DMTSF) to 
afford binaphthalenes (–)-2.130 and (+)-2.131 in good yield. The C-ring was then oxidized with DDQ and 
the resultant quinone was treated with anhydrous HCl to furnish nonacycle (–)-2.133 and (+)-2.134 via 
biomimetic formation of the C8'–C13' ether bridge. This transformation presumably occured via 
intramolecular attack of the proximal acetonide oxygen atom on the ortho-quinone methide of 
intermediate 2.132 with concomitant acetonide cleavage. Finally, Brian was able to complete the total 
synthesis of 2.2 and 2.135 through a three step sequence involving: (1) deprotection of the acid-labile 
protecting groups with HF, (2) hydrogenolysis of the benzyl groups, and (3) exposure to air to promote 
oxidation of the D-ring hydroquione. It was discovered that addition of acidic methanol to the reaction 
mixture prior to aerobic oxidation was critical to suppress isomerization between 2.2 and 2.135 and 
formation of HMP-P1 (2.12). In this way, we revealed that rotation of the molecule about the C2'–C2 
bond is pH dependent.143  
  
                                                      
142 Kraus, G. A.; Sugimoto, H. Tetrahedron Lett. 1978, 19, 2263–2266. 
 
143 For additional information regaurding the pH dependence of atrop-isomerization, see: Ref. 141 and experimental 
section. 
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Scheme 2.20 Total synthesis of hibarimicinone and atrop-hibarmicinone. 
 
Reagents and conditions: (a) LiHMDS, THF, –78 → 0 °C; then KHMDS, 0 °C → RT; for (–)-1.128, 34%; for (+)-
2.129, 25%; (b) DMTSF, DTBMP, MeCN, 0 °C → RT; for (–)-2.130, 75%; for (+)-2.131, 89%; (c) for (–)-2.130: 
DDQ, PhMe, 0 °C; for (+)-2.131: DDQ, PhMe, 0 °C → RT; (d) HCl, ClCH2CH2Cl, 5 °C; for (–)-2.133, 77% (two 
steps); for (+)-2.134, 86% (two steps); (e) aq. HF, MeCN-THF; (f) H2, Pd(OH)2/C, EtOAc; then HCl, MeOH, air; 
for 2.2, 81% (two steps); for 2.135, 60% (two steps); (g) aq. pH 7.5 NaH2PO4-NaOH buffer, MeOH, RT; from 2.2, 
84%; from 2.135, 84%. 
 Many aspects of the synthesis of 2.2 are anticipated to be important for completion of the total 
synthesis of 2.1. Specifically, we expect 2.2 and 2.1 to share a common absolute stereochemistry for their 
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C2'–C2 axis. Therefore, chiral resolution of the DE-biaryl annulation donor (±)-2.67 might allow us to 
improve the efficiency of the annulation step of the synthesis. Additionally, we anticipate that 2.1 will 
also exhibit pH-dependent atrop-isomerization. However, the use of acidic methanol in the synthesis of 
2.1 to suppress atrop-isomerization will be incompatible with the 2-deoxyglycosidic linkages and will 
require the development of alternative reaction conditions.  
 2-Deoxyglycosides in Natural Product Total Synthesis  2.8
 Many classes of biologically active molecules are conjugated to carbohydrates including: 
proteins, lipids, and secondary metabolites.144 Within the secondary metabolite natural product class, 
glycol-conjugated subclasses include: glycopeptides, enediynes, anthracyclines, polyenes, macrolides, 
vitamins, alkaloids, steroids, terpenes, and polyphenols. A broad array of structural diversity within the 
carbohydrate subunit is also observed; prokaryotic organisms produce glycosylated natural products 
which exhibit over one hundred different sugars.103,145 These sugars vary in terms of their oxidation level 
and functionalization. Secondary metabolite glycosides display a diversity of biological activities 
including: antibiotic,146 antitumor147, and ionotropic activity.148 However, the role the glycosyl unit plays 
with respect to the molecule’s activity widely differs. Certain biological targets are known to bind the 
overall molecular structure of the glycoside.149 In other cases, the glycosyl unit simply improves the 
                                                      
144 (a) Kennedy, J. F.; White, C. A. In Bioactive Carbohydrates in Chemistry, Biochemistry, and Biology; Horwood, 
E., Ed.: Chichester, 1983. (b) Kirschning. A.; Bechthold, A. F. W.: Rohr, J. Top. Curr. Chem. 1997, 188, 1–84. (c) 
Ernst, B.; Hart, G. W.; Sinaý, P. Carbohydrates in Chemistry and Biology; Wiley-VCH: Weinheim, 2000. Thorson, 
J. S.; Hosted, T. J.; Jiang, J.; Biggins, J. B.; Ahlert, J. Curr. Org. Chem. 2001, 5, 139–167. 
 
145 Rale, M.; Schneider, S.; Sprenger, G. A.; Samland, A. K. Fessner, W.-D. Chem. Eur. J. 2011, 17, 2623–2632. 
 
146 Levine, D. P. Clin Infect Dis. 2006, 42, S5–S12. 
 
147 La Ferla, B.; Airoldi, C. Zona, C.; Orsato, A.; Cardona, F.; Merlo, S. Sironi, E. D’Orazio, G.; Nicotra, F. Nat. 
Prod. Rep. 2011, 28, 630–648. 
 
148 (a) Weymouth-Wilson A. C. Nat Prod Rep. 1997, 14, 99–110. V. Kren, L. Martinkova, Curr. Med. Chem. 2001, 
8, 1303–1328. 
 
149 (a) Silva, D. J.; Kahne, D. E. J. Am. Chem. Soc. 1993, 115, 7962–7970. (b) Silva, D. J.: Goodnow, R.; Kahne, D. 
Biochemistry 1993, 32, 463–471. (c) Waller, G.R., Yamasaki, K. Adv. Exp. Med. Biol., 1996, 40, 1–11. 
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pharmacokinetics of the molecule.150 Additionally, it is interesting to note that glycoconjugation of 
several non-glycosylated therapeutics such as mitomycin,151 colchicine,152and taxol153 has improved their 
biological activity through enhanced target delivery. 
 2-Deoxyglycosides are of particular pharmacological importance. Figure 2.10 depicts the 
structures of several representative 2-deoxyglycosides. Vancomycin (2.136) is a glycopeptide antibiotic 
used in the treatment of infections caused by Gram-positive bacteria. 2.136 binds the D-alanyl-D-
alanine terminus of  mucopeptide precursors of bacterical cell walls, thus preventing their 
polymerization and cross-linking.154 The dissacharide is believed to enhance the activity of 2.136 by 
anchoring to the cell membrane.155 Calichaemicin γ1 (2.137) is a highly toxic enedyine antibiotic known to 
bind to the minor groove of DNA with a high level of sequence specificity and cause double strand 
cleavage through H-atom abstraction.156 The sequence specificity exhibited by 2.137 has been attributed 
to the oligosaccharide subunit.157 Digtoxin (2.138) is a steroidal glycoside that has historically been used 
for the treatment of cardiac failure. 2.138 elicits a positive ionotropic effect on heart muscle cells through 
inhibition of the α-subunit of the Na+/K+-ATPase pump.158 Interestingly, the trisaccharide portion of 2.138 
                                                      
150 Thorson, J. S.; Vogt, T. In Carbohydrate-Based Drug Discovery; Wong, C. H., Ed.; Wiley-VCH: Weinheim, 
2003. 
151 Ghiorghis, A.; Talebian, A.; Clarke, R. Cancer Chemother. Pharmacol. 1992, 29, 290–296. 
 
152 Ahmed, A.; Peters, N. R.; Fitzgerald, M. K.; Watson, J. A.; Hoffmann, F. M.; Thorson, J. S. J. Am. Chem. Soc. 
2006, 128, 14224–14225. 
 
153 Liu, D.; Sinchaikeul, S.; Reddy, P. V. G.; Chang, M.; Chen, S. Bioorg. Med. Chem. Lett. 2007, 17, 617–620. 
 
154 Hammes, W. P.; Neuhaus, F. C. Antimicrob Agents Chemother. 1974, 6, 722–728. 
 
155 Nicas, T. I.; Mullen, D. L.; Flokowitsch, J. E.; Preston, D. A.; Snyder, N. J.; Zweifel, M. J.; Wilkie, S. C.; 
Rodriquez, M. J.; Thompson, R. C.; Cooper, R. D. G. Antimicrob. Agents Chemother. 1996, 40, 2194–2199. 
 
156 Walker, S. L.; Andreotti, A. H.; Kahne, D.E. Tetrahedron, 1994, 50, 1351–1360. 
 
157 Drak, J.; Iwasawa, N.; Danishefsky, S.; Crothers, D.M. Proc. Natl. Acad. Sci. USA, 1991, 88, 7464–7468. 
 
158 (a) Fullerton, D. S.; Kihara, M.; Deffo, T.; Kitatsuji, E.; Ahmed, K.; Simat, B.; From, A. H. L.; Rohrer, D. C. J. 
Med. Chem., 1984, 27, 256–261. (b) Schmidt, T. A.; Kjeldsen, K. Prog. Exp. Cardiol. 2003, 5, 501–510. (c) 
Wasserstrom, J. A.; Aistrup, G. L. Am. J. Physiol. 2005, 289, H1781–H1793. 
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is believed to be important for uptake and distribution by impoving the molecule’s aqueous solubility.159 
Erythromycin A (2.139) is a macrolide antibiotic generally administered for the treatment of various 
infections in patients with penicillin allergies. 2.139 and other macrolide antibiotics inhibit protein 
synthesis by binding to the 50S subunit of the bacterial ribosome, thereby blocking the exit of the 
growing peptide chain.160 The overall molecular structure of the glycoside is important for protein target 
recognition.161 Finally, landomycin (2.140) is a potent antitumor angucycline antibiotic. While the precise 
mechanism of action of 2.140 remains to be determined, it appears to be directly linked to the 
oligosaccharide component of the molecule. 162  The 2-deoxyglycoside natural products presented 
constitute only a small portion of known molecules with potential biological activity. For this reason, the 
synthesis of 2-deoxyglycoside natural products and their structural analogues is essential for the discovery 
of new biological targets with therapeutic activity. 
                                                      
159 (a) Wallick, E. T.; Pitts, B. J. R.; Lane, L. K.; Schwartz, A.; Arch. Biochem. Biophys., 1980, 202, 442–449. (b) 
Williams, J. D.; A. M. Sefton. J. Antimicrob. Chemother. 1993. 31, 11–26. (c) Kanoh, S.; Rubin, B. K. Clin. 
Microbiol. Rev. 2010, 23, 590–615 and references therein. 
160 (a) Menninger, J. R.; Otto, D. P. Antimicrob Agents Chemother. 1982, 21, 811–818. (b) Abu-Gharbieh, E.; 
Vasina, V.; Poluzzi, E.; De Ponti, F. Pharmacol. Res. 2004, 50, 211–222. 
 
161 Tu, D.; Blaha, G.; Moore, P. B.; Steitz, T. A. Cell, 2005, 121, 257–270 and references therein. 
 
162 (a) Crow, R. T.; Rosenbaum, B.; Smith, R., III; Guo, Y.; Ramos, K. S.; Sulikowski, G. A. Bioorg. Med. Chem. 
Lett. 1999, 9, 1663–1666. (b) Korynevska, A.; Heffeter, P.; Matselyukh, B.; Elbling, L.; Micksche, M.; Stoika, R.; 
Berger, W. Biochem. Pharmacol. 2007, 74, 1713–1726. 
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Figure 2.10 Representative biologically important 2-deoxyglycoside natural products. 
 The efficient, stereocontrolled formation of 2-deoxyglycosides presents two fundamental 
synthesis challenges. First, in the absences of a C2 oxygen substituent, which provides stereocontrol 
through anchimeric assistance, glycosylation often leads to an anomeric mixture. Second, 2-
deoxyglycosidic bonds are easily hydrolyzed under acidic conditions as a result of the absence of a C2 
electron-withdrawing oxygen substituent.163 Numerous methods have been developed to overcome these 
obstacles and have been thoroughly reviewed on multiple occasions.164 The six conceptually distinct, 
                                                      
163 Overend, W. G.; Rees, C. W.; Sequeira, J. S. J. Chem. Soc. 1962, 3429–3440. 
 
164 (a) Thiem, J.; Klaffke, W. Top. Curr. Chem. 1990, 154, 285–333. (b) Schmidt, R. R. in Comprehensive Organic 
Synthesis; Trost, B. M.; Fleming, I.; Winterfeld, E., Eds.; Pergamon Press: Oxford, 1991; Vol. 6; pp 33–64. (c) Rohr, 
J.; Thiericke, R. Nat. Prod. Rep. 1992, 9, 103–137. (d) Toshima, K.; Tatsuta, K. Chem. Rev. 1993, 93, 1503–1531. 
(e) Schmidt, R. R.; Kinzy, W. Adv. Carbohydr. Chem. Biochem. 1994, 50, 21–123. (f) Danishefsky, S. J. in Modern 
Methods in Carbohydrate Synthesis; Khan, H.; O'Neill, R.A. Eds.; Harwood Academic Publishers: Amsterdam, 
1996; pp 171–193. (g) Kirschning, A.; Rohr, J.; Bechthold, A. Top. Curr. Chem. 1997, 188, 1–84. (h) Marzabadi, C. 
H.; Franck, R. W. Tetrahedron 2000, 56, 8385–8417. (i) Pellissier, H. Tetrahedron 2005, 61, 2947–2993. (j) 
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primary strategies for the synthesis of 2-deoxy-β-glycosidic bonds are depicted in Figure 2.11 and 
include: (1) direct substitution of a C1 leaving group (Lg) activated by an electrophilic reagent, (2) use of 
a removable C2 directing group capable of participating in anchimeric assistance, (3) activation of a 
glycal precursor with an electrophilic reagent (generally this occurs through the in situ incorporation of a 
removable C2 directing group), (4) use of an axial C3 directing group capable of participating in 
anchimeric assistance, (5) application of structural constraints, and (6) the de-novo synthesis of the 2-
deoxyglycoside following formation of the β-glycosidic bond. 
  
Figure 2.11 General strategies for the synthesis of 2-deoxy-β-glycosides. 
 The five common stratagies for the stereocontrolled construction of 2-deoxy-α-glycosides 
delineated in Figure 2.12 are similar to those utilized for the synthesis of 2-deoxy-β-glycosides. While the 
formation of 2-deoxy-α-glycosidic bonds through the direct substitution of a leaving group is generally 
considered to be favorable, the reasons for this stereochemical outcome are disputed.165 Application of 
most of these strategies for the stereoselective formation of α- and β-linked 2-deoxyglycosides in the 
context of natural product total synthesis have been reported. A brief description of a selection of these 
examples will help the reader choose an approach that best suits his or her needs. 
                                                                                                                                                                              
Toshima, K. Carbohydr. Res. 2006, 341, 1282–1297. (k) Gin, D. Y.; Galonić, D. P. Nature 2007, 446, 1000–1007. 
(l) Zhu, X.; Schmidt, R. Angew. Chem., Int. Ed. 2009, 48, 1900–1934. (m) Hou, D.; Lowary T. L. Carbohydr. Res. 
2009, 344, 1911–1940. 
 
165 (a) Cumpstey, I. Org. Biomol. Chem., 2012, 10, 2503–2508 and references therein. (b) Beaver, M. G.; Woerpel, 
K. A. J. Org. Chem. 2010, 75, 1107–1118. 
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Figure 2.12 General strategies for the synthesis of 2-deoxy-α-glycosides. 
2.8.A Direct Synthesis of 2-Deoxyglycosides 
 An acetal exchange process for the direct synthesis of 2-deoxyglycosides is outlined in Figure 
2.13a. In this strategy, a suitably protected carbohydrate glycosyl donor 2.141 possessing a C1 leaving 
group is activated by an electrophilic reagent (El+) to undergo C–O bond formation with a nucleophilic 
coupling partner (glycosyl acceptor, R'OH) though an SN1 or SN2 pathway. This procedure allows for the 
potential formation of both α- and β-glycosides, 2.142 and 2.143, respectively, depending on the 
mechanism through which the reaction proceeds. Many factors influence this mechanistic selection, 
including: (1) the type of leaving group used, (2) the type of electrophilc reagent used, (3) the conditions 
under which the reaction is conducted (e.g. solvent, temperature, etc.), (4) the substitution pattern of the 
glycosyl donor, (5) the protecting groups on the glycosyl donor, and (6) the nucleophilicity of the 
glycosyl acceptor. For this reason, the reliability and predictability of stereoselection for this strategy is 
highly variable. Figure 2.13b illustrates a variety of leaving groups and electrophilic promotors that have 
been used for this transformation. The application of this strategy in natural product total synthesis has 
been reported on numerous occasions.  
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Figure 2.13 (a) Direct glycoslyation of 2-deoxyglycosyl donors. (b) Leaving groups (Lg, red) and electrophilic 
promotors (El+, blue) for direct glycosylation.166 
 During the course of synthesizing analogs of the anticancer agent mithramycin,167  Binkley 
observed that treatment of α-bromo glycosyl donor 2.144 and glycosyl acceptor 2.145 with silver silicate 
(standard Koenigs and Knorr conditions) 168 afforded 2-deoxy-β-glycoside 2.147 with high anomeric 
selectivity (Scheme 2.21). Presumably, insoluble silver in this reaction activated the bromide for direct 
substitution by 2.145 with inversion of configuration at C1 through an SN2 pathway (2.146). Interestingly, 
it was previously reported by Van Boeckel and Beetz that the type of protecting group used under these 
conditions greatly influenced the anomeric selecitivity of the transformation.169 
                                                      
166 Figure 2.13 is a modified version of a figure found in Ref. 164k. 
 
167 Binkley, R. W.; Koholic, D. J. J. Org. Chem. 1989, 54, 3577–3581. 
 
168 Koenigs, W.; Knorr, E. Chem. Ber. 1901, 34, 957–981. 
 
169 Van Boeckel, C. A.; Beetz, T.; van Aelst, S. F. Tetrahedron 1984, 40, 4097–4107. 
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Scheme 2.21 Koenigs and Knorr synthesis of 2-deoxy-β-glycosides. 
 
Reagents and conditions: Ag2O-SiO2, PhMe, 84%, α:β = 8:92. 
 Evans and coworkers reported an intriguing example of an acid catalyzed β-selective formation of 
a 2-deoxyglycosidic bond during their synthesis of the macrolide antibiotic cytovaricin (2.152, Scheme 
2.22). They discovered that addition of catalytic trityl perchlorate to a solution of hydroxy amide 2.148 
and glycosyl acetate 2.149 in PhMe at –20 °C resulted in the formation of a 1:3 distribution of glycosides 
favoring the α-anomer 2.151. However, warming the reaction mixture to –3 °C resulted in equilibration of 
the glycosidic linkage to favor the β-anomer 2.150. The α-anomer was recycled through repetition of this 
process to provide a 70% yield of 2.150. Evans and coworkers later confirmed that the reaction was 
catalyzed by perchloric acid. This example illustrates the highly acid-labile nature of the 2-
deoxyglycosidic linkage and is an interesting case of β-anomeric selectivity under thermodynamic 
control; generally, the α-anomer is favored by the anomeric effect under thermodynamic control.170,171 
  
                                                      
170 Deslongchamps, P. Stereoelectronic Effects in Organic Chemistry; Pergamon: Oxford, 1983. 
 
171 The β-anomer in this particular example is likely favored due to a 1,3-diaxial interaction with the C3–OMe 
substituent in the α-anomer. 
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Scheme 2.22 Reversible formation of 2-deoxy-β-glycosides. 
 
 More recently, Takahashi and coworkers have developed a highly β-selective method for the 
direct synthesis of 2-deoxyglycosides. 172  During their synthesis and structural reassignment of 
versipelostatin, a cold solution of aglycon 2.154 and trichloroacetimidate glycosyl donor 2.153 in PhMe 
was treated with iodine and triethylsilane to afford 2-deoxy-β-glycoside 2.155 in 40% yield (Scheme 
2.23). The reaction conditions used in this transformation appear to be generally useful for 2-deoxy-β-
glycoside synthesis irrespective of the substitution pattern of the glycosyl donor.173 However, the 
mechanism and rational for high β-selectivity has not been determined. 
  
                                                      
172 Tanaka, H.; Yoshizawa, A.; Chijiwa, S.; Ueda, J.-y.; Takagi, M.; Shin-ya, K.; Takahashi, T. Chem. Asian J. 
2009, 4, 1114–1125. 
 
173 Tanaka, H.; Yoshizawa, A.; Takahashi, T. Angew. Chem., Int. Ed. 2007, 46, 2505 –2507. 
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Scheme 2.23 Takahashi’s method for direct stereoselective synthesis of 2-deoxy-β-glycosides. 
 
Reagents and conditions: I2, Et3SiH, 4 Å MS, PhMe, –94 °C, 40%, α:β = 5:95. 
 Kahne and Raghavan reported an impressive one-step synthesis of the ciclamycin trisaccharide 
(2.160, Scheme 2.24) that takes advantage of the differential reactivity of aryl sulfoxide glycosyl 
donors.174 Previous studies had shown that p-methoxyphenyl sulfoxide donors underwent glycosylation 
faster than their unsubstituted phenyl sulfoxide counterparts.  Addition of TfOH to a solution of phenyl 
sulfoxide 2.156, p-methoxyphenyl sulfoxide 2.157, and phenyl sulfide 2.158 promoted initial α-selective 
glycosidic bond formation between 2.157 and 2.158 with concominant trimethylsilyl cleavage to yield 
dissacharide glycosyl acceptor 2.159. A slower second α-selective glycosylation then took place with 
2.156 to deliver thiophenyl trisaccharide 2.160 in 25% overall yield.175 Notably, no other products 
containing a β-glycosidic linkage were detected. This example demonstrates the inherent propensity of 2-
deoxyglycosyl donors of the L-olivose substitution pattern to undergo α-selective glycosylation ostensibly 
through pseudo-axial attack on the half-chair oxocarbenium intermediate 2.162. 
  
                                                      
174 (a) Raghavan, S.; Kahne, D. J. Am. Chem. Soc. 1993, 115, 1580–1581. (b) Gildersleeve, J.; Smith, A.; Sakurai, 
K., Raghavan, S.; Kahne, D. J. Am. Chem. Soc. 1999, 121, 6176–6182. 
 
175 Optimization of this process was reported in a subsequent publication: Ref. 165b. 
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Scheme 2.24 Iterative α-selective 2-deoxyglycoside formation using anomeric phenyl sulphoxide glycosyl donors. 
 
Reagents and conditions: Et2O-CH2Cl2 (1:1), methyl propiolate, TfOH, –78 → –70 °C, 25%. 
 Woodward and coworkers reported the first total synthesis of erythromycin A (2.139) in 1981.176 
Their synthesis utilized a late-stage solvent dependent α-selective glycosylation reaction to install the L-
cladinosyl monosaccharide (Scheme 2.25). They discovered that treatment of a solution of L-cladinoside 
thiopyridine glycosyl donor 2.165 and protected aglycon 2.164 in acetonitrile with Pb(ClO4)2 facilitated 
α-selective formation of 2-deoxyglycoside 2.167 in 55% yield (based on consumed 2.164) after NaOMe 
mediated protecting group removal. The anomeric selectivity of this process was attributed to 
participation of the solvent (i.e. MeCN), which promoted a double inversion process via intermediate 
2.166. 
  
                                                      
176 Woodward, R. B.; et. al. J. Am. Chem. Soc. 1981, 103, 3215–3217. 
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Scheme 2.25 Solvent controlled α-selective formation of 2-deoxyglycosides via an acetal exchange strategy in the 
synthesis of erythromycin A. 
 
 Myers and coworkers utilized two interesting α-selective glycosylation reactions in their total 
synthesis and structural revision of the kedarcidin chromophore (Scheme 2.26).177 A variety of different 
glycosyl donors (e.g. trichloroacetimidate, thiophenyl, acetate, and fluoride) were investigated for the 
synthesis 2-deoxy-α-glycoside intermediate 2.170 (Scheme 2.26a). Eventually, fluoro glycoside 2.168 
was found to be the most effective donor. Treatment of alcohol 2.169 and fluoride 2.168 with Cp2HfCl2-
AgClO4, according to Suzuki’s protocol,178 afforded 2-deoxy-α-glycoside 2.170 in 74% yield with 4:1 α/β 
selectivity. The stereochemical origin for α-anomeric selectivity in this transformation is likely due to 
substrate control via pseudo-axial attack by 2.169 on a half-chair oxocarbenium intermediate 2.171 or 
attack on ammonium intermediate 2.172. Next, completion of kedarcidin was accomplished though a 
second α-selective glycosylation using Hirama’s method (Scheme 2.26b).179 Accordingly, AgPF6 was 
added to a solution of thioglycosyl donor 2.174, aglycon 2.173, and 2,6-di-tert-butyl-4-methylpyridine 
(DTBMP) at 0 °C to give 2-deoxy-α-glycoside 2.175 in 50% yield. Hirama’s protocol seems to be highly 
α-selective over a broad range of 2-deoxyglycosyl donors and acceptors and relies on the use of a PF6 
counterion for silver to obtain high α-selectivity. 
                                                      
177 (a) Ren, F.; Hogan, P. C.; Anderson, A. J.; Myers, A. G. Org. Lett. 2007, 9, 1923–1925. (b) Ren, F.; Hogan, P. 
C.; Anderson, A. J.; Myers, A. G. J. Am. Chem. Soc. 2007, 129, 5381. (c) Ren, F. Ph.D. Thesis, Harvard University, 
2007 and references therein. 
 
178 (a) Matsumoto, T.; Maeta, H.; Suzuki, K.; Tsuchihashi, G. Tetrahedron Lett. 1988, 29, 3567–3570. (b) Suzuki, 
K.; Maeta, H.; Matsumoto, T.; Tsuchihashi, G. Tetrahedron Lett. 1988, 29, 3571–3574. 
 
179 Lear, M. J.; Yoshimura, F.; Hirama, M. Angew. Chem., Int. Ed. 2001, 40, 946–946. 
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Scheme 2.26 α-Selective formation of 2-deoxyglycosides using an acetal exchange strategy in the synthesis of the 
kedarcidin chromophore. 
 
Reagents and conditions: (a) Cp2HfCl2, AgClO4, CH2Cl2, 0 °C; (b) K2CO3, MeOH, 74%, α:β = 4:1 (two steps); (c) 
2.174, AgPF6, DTBMP, CH2Cl2, 0 °C; Py, 59%. 
2.8.B Synthesis of 2-Deoxyglycosides Through Electrophilic Glycal Activation 
 Glycals have served as competent glycosyl donors for the stereoselective synthesis of 2-
deoxyglycosides since Lemieux first report glycal iodoglycosylation in 1964.180 The general mechanism 
for this process is outlined in Figure 2.14. The first step involves activation of the glycal 2.176 by an 
electrophilic promotor to generate two potential reactive intermediates 2.177 and 2.178. Next, 
nucleophilic attack on 2.177 and 2.178 by a glycosyl acceptor provides C2 substituted β- or α-glycoside 
2.179 or 2.180, respectively. When X ≠ H, the C2 substituent can be subsequently removed through C–X 
bond reduction. Overall, the anomeric selectivity induced by this strategy is governed by the facial 
selectivity of the initial electrophilic glycal activation step and is thus highly substrate specific. 
                                                      
180 Lemieux, R. U.; Levine, S. Can. J. Chem. 1964, 42, 1473–1480. 
O
OTBSMe2N
Me
F
AcO
OH
OH
TES
H
a. Cp2HfCl2,
    AgClO4
(74%, α:β = 4:1,
2 steps)
HO
O
OH
TES
H
O
Me
OTBS
NMe2
α
2.168 2.169 2.170
(a)
b. K2CO3, 
    MeOH
HN
O
O
N
Cl
O
OPiviPrO
MeO
OMe
O O
OH
OHO
O
Me
ODEIPS
NMe2
(b)
OTESO
Me
Me
OH SPh
HN
O
O
N
Cl
O
OPiviPrO
MeO
OMe
O O
OH
OO
O
Me
ODEIPS
NMe2
OTESO
Me
Me
OH
α
c. 2.174, AgPF6, 
    DTBMP
(59%, α only)
2.173 2.175
2.174
O
NMe2
Me
OTBS
ROH
O
N
Me
Me Me
OTBS
ROH
via: or
2.171
2.172
 109 
 
Figure 2.14 Synthesis of 2-deoxyglycosides through electrophilic glycal activation. 
 Figure 2.15 depicts a selection of known reagents for electrophilic glycal activation and the 
products they can form. Specifically, haloglycosylation of a glycal (2.176) with a reagent such as NIS or 
NBS generally provides 2-deoxy-α-glycosides after C2–X bond reduction. In contrast, glycosylation 
using sulphur- or selenium-based reagents typically yields 2-deoxy-β-glycosides after C2–X bond 
reduction. Alternatively, glycals can be directly activated by an acid or metal catalyst in the presence of a 
glycosyl acceptor to yield either 2-deoxy-α-glycosides or 2-deoxy-β-glycosides. An interesting variation 
on electrophilic glycal activation is the allylic substitution of a glycal by glycosyl acceptor promoted by a 
Lewis acid or a metal catalyst, also known as a Ferrier reaction.181 The anomeric selectivity in this process 
is generally controlled by the stereochemistry of the C3 leaving group and has been primarily used to 
prepare 2-deoxy-α-glycosides after olefin hydrogenation. Overall, the facial selectivity for electrophilic 
glycal activation is based on a combination of reagent and substrate control. 
 
Figure 2.15 Methods for electrophilic glycal activation. 
                                                      
181 (a) Ferrier, R. J. J. Chem. Soc. Perkin Trans 1, 1979, 1455–1458. (b) Ferrier, R. J.; Zubkov, O. A. Org. React. 
2003, 62, 569–736. 
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 Danishefsky and coworkers have utilized glycal iodoglycosylation extensively for the synthesis 
of 2-deoxy-α-glycoside natural products as part of broader research program aimed at the assembly of 
oligosaccharides and glycoconjugates.182 An example of this strategy can be found in their synthesis of 
avermectin A1a (2.188, Scheme 2.27), which utilized an iterative glycal iodoglycosylation sequence.183 
Exposure of glycal 2.181 and methyl glycoside 2.182 to NIS promoted iodoglycosylation ostensibly 
through trans-diaxial attack of 2.182 on iodonium interemediate 2.183 to afford 2-iodo-α-glycoside 2.184 
in 65% yield as a single stereoisomer. Exposure of methyl glycoside 2.184 to Me3SiSPh, ZnI2 and TBAI 
provided thioglycoside 2.185. Notably, the C2–I substituent is believed to prevent cleavage of the α-
glycosidic linkage under these conditions. Next, glycal 2.186 was obtained through thiophenyl oxidation, 
sulfoxide elimination, and C–I bond reduction with nBu3SnH. Finally, a second NIS mediated 
iodoglycoylation reaction between avermectin A1a aglycon 2.187 and 2.186 followed by C–I bond 
reduction and deprotection yielded avermectin A1a (2.188) as a single anomeric stereoisomer. 
  
                                                      
182 Danishefsky, S. J.; Bilodeau, M. T. Angew. Chem. Int. Ed. 1996, 35, 1380–1419. 
 
183 (a) Danishefsky, S. J.; Selnick, H. G.; Armistead, D. M.; Wincott, F. E. J. Am. Chem. Soc. 1987, 109, 8119–8120. 
(b) Danishefsky, S. J.; Armistead, D. M.; Wincott, F. E.; Selnick, H. G. J. Am. Chem. Soc. 1989, 111, 2961–2980. 
 111 
Scheme 2.27 An iterative glycal iodoglycosylation strategy for the synthesis of 2-deoxy-α-glycosides. 
 
Reagents and conditions: (a) NIS, MeCN, 0 °C, 65%; (b) Me3SiSPh, ZnI2, TBAI, CH2Cl2, reflux; (c) mCPBA, 
CH2Cl2, 0 °C, 72% (two steps); (d) nBu3SnH, AIBN, PhH, reflux, 81%; (e) NIS, MeCN, 64%; (f) nBu3SnH, AIBN, 
PhMe, reflux, 78%; (g) LiEt3BH, THF, –78 °C, 97%. 
 In pursuit of a total synthesis of aureolic acid, Franck and coworkers reported a method for β-
selective 2-deoxyglycoside synthesis through electrophilic glycal activation with an 
arylbis(arylthio)sulfonium salt (2.191, Scheme 2.28). 184  This method required an increase in the 
nucleophilicity of the glycosyl acceptor through conversion to the corresponding tin alkoxide. 
Accordingly, the tin alkoxide of methyl glycoside 2.190 was prepared by refluxing with (nBu3Sn)2O in 
PhH for 12 h. A solution of the resultant tin alkoxide and glycal 2.189 in CH2Cl2 was cooled to –60 °C 
before arylbis(arylthio)sulfonium reagent 2.191 was added to the reaction mixture leading to the 
formation of 2-thioaryl-β-glycoside 2.193 in 48% yield. The β-anomer was presumably favored by attack 
                                                      
184 Franck, R. W.; Kaila, N.; Carbohydrate Research, 1993, 239, 71–83. 
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on episulphonium ion intermediate 2.192. Finally, the C2–SAr substituent was reductively excised with 
Raney-Ni to furnish 2-deoxy-β-glycoside 2.194. Not suprisingly, the stereoselectively of this method was 
found to be highly variable depending on the substitution pattern of the glycal.185 
Scheme 2.28 Synthesis of 2-deoxy-β-glycosides via electrophilic glycal activation. 
 
Reagents and conditions: (a) 2.190, (nBu3Sn)2O, PhH, 4 Å MS, reflux; 2.189, CH2Cl2, –60 °C; 2.291, 48%. (b) 
Raney-Ni, THF, 64%. 
 In the course of a formal synthesis of C2-symmetric macrolide elaiophylin (2.199),186 Wakamatsu 
and coworkers utilized an acid catalyzed glycal activation strategy for the synthesis of an intermediate 2-
deoxy-α-glycoside 2.198 (Scheme 2.29). Treatment of silyl protected glycal 2.195 and glycosyl acceptor 
2.196 with CSA afforded 2-deoxy-α-glycoside 2.198 as a single stereoisomer in 57% yield. The α-
selective nature of this transformation was likely a result of kinetically favored pseudo-axial attack by 
2.196 on oxocarbenium ion intermediate 2.197. However, it was not reported whether glycosidic bond 
formation in this reaction was reversible; therefore, the anomeric product distribution might simply have 
been a result of a thermodynamic preference for the α-anomer based on the anomeric effect. 
  
                                                      
185 (a) Ramesh, S.; Kaila, N.; Grewal, G.; Franck, R. W. J. Org. Chem. 1990, 55, 5–7. (b) Grewal, G.; Kaila, N.; 
Franck, R. W. J . Org. Chem. 1992, 57, 2084–2092. 
 
186 (a) Wakamatsu, T.; Nakamura, H.; Naka, E. Tetrahedron Lett. 1986, 27, 3895–3898. (b) Nakamura, H.; Arata, 
K.; Wakamatsu, T.; Ban, Y.; Shibasaki, M. Chem. Pharm. Bull. 1990, 38, 2435–2441.  
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Scheme 2.29 Direct synthesis of 2-deoxy-α-glycosides via acid-catalyzed glycal activation. 
 
Reagents and conditions: (a) CSA, CH2Cl2, 57%. 
 2-deoxy-α-glycosides have also been directly accessed through an acid catalyzed electrophilic 
glycal activation strategy. As part of a research program directed toward the total synthesis of 
saccharomicin A (2.204) and B (2.205) (Scheme 2.30), the McDonald group developed an iterative 
tungsten-catalyzed cycloisomerization/acid-catalyzed glycosylation methodology for the synthesis of 2-
deoxyoligosaccharides.187 Exposure of glycal 2.200 and rhamanose glycosyl acceptor 2.201 to CSA in the 
presence of molecular sieves afforded the fucose-saccharosamine-rhamnose unit of saccharomicin B 
(2.203) in 90% yield as a single stereoisomer. The stereochemical outcome of this reaction is believed to 
be a result of neighboring group participation by the axial C3 carbamate group via bridged intermediate 
2.202. The α-face of intermediate 2.202 is shielded from nucleophilic attack, which concequently favors 
the formation of the 2-deoxy-β-glycoside 2.203. Axial C3 ester substituents have also been known to 
induce β-selective 2-deoxyglycosyl bond formation through 1,3-anchimeric assistance (vide infra).188 
                                                      
187 (a) Balthaser, B. R.; McDonald, F. E. Org. Lett., 2009, 11, 4850–4853. (b) Kong, F.; Zhao, N.; Siegel, M. M.; 
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(d) Thiem, J.; Kopper, S. Tetrahedron 1990, 46, 113–138. (e) Chiba, S.; Kitamura, M.; Narasaka, K. J. Am. Chem. 
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Scheme 2.30 Direct synthesis of 2-deoxy-β-glycosides via acid-catalyzed glycal activation. 
 
Reagents and conditions: (a) CSA, 3 Å MS, PhMe, 90%. 
 Koert and coworkers utilized a Ferrier reaction of a glycal to synthesize the challenging 2,3-
dideoxy-β-glycosidic linkage of their revised structure of the antibacterial agent fulicineroside (2.212) 
(Scheme 2.31)189 Exposure of glycal 2.206 and glycosyl acceptor 2.207 to Pd(OAc)2, ZnEt2, and DTBBP 
provided β-glycoside 2.209 in 86% yield as a single anomer through allylic displacement of the C3–OAc. 
Presumably, the stereochemical outcome of this reaction can be attributed to nucleophilic attack by the 
                                                                                                                                                                              
Soc. 2006, 128, 6931–6937. (f) Baek, J. Y.; Lee, B.-Y.; Jo, M. G.; Kim, K. S. J. Am. Chem. Soc. 2009, 131, 17705–
17713. 
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glycosyl acceptor on π-allyl palladium interemediate 2.208.190 The Zn2+ ion in this transformation is 
believed to serve both to activate the acetate group for allylic substitution and activate the glycosyl 
acceptor through the in situ formation of the corresponding zinc alkoxide.191 Unfortunately, the Ferrier 
reaction required equatorial orientation of the C4 silyloxy substituent in 2.206; therefore, a Mitsunobu 
inversion process was necessary. After C4 inversion, 2,3-dideoxy-β-glycoside 2.211 was accessed via 
diimide reduction of the C2–C3 olefin. 
Scheme 2.31 Synthesis of 2-deoxy-β-glycosides via transition-metal catalyzed Ferrier reaction. 
 
Reagents and conditions: (a) Pd(OAc)2, DTBBP, ZnEt2, 3 Å MS, THF, 86%; (b) K2CO3, MeOH, 92%. (c) BzCl, Py, 
CH2Cl2, 96%; (d) TBAF, THF, 93%; (e) ClCH2COOH, PPh3, DIAD, THF, 0 °C → RT; (f) Et3N, MeOH, 65% (two 
steps); (g) TsNHNH2, NaOAc, DME, 90%. 
2.8.C Synthesis of 2-Deoxyglycosides Using a Preinstalled C2 Directing Group 
 The utilization of a preinstalled C2 directing group as a stereocontrolling element for the 
synthesis of 2-deoxyglycosides has proven to be an extremely versatile and reliable strategy (Figure 2.16). 
                                                      
190 The use of a bulky DTBBP ligand generally results in a double inversion net retention mechanism for transition 
metal-catalyzed allylic alkylation reactions: Trost, B. M.; Van Vranken, F. L. Chem. Rev. 1996, 96, 395–422. 
 
191 Steinhuebel, D. P.; Fleming, J. J.: Du Bois, J. Org. Lett. 2002, 4, 293–295. 
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This method generally allows for the stereoselective formation of either α- or β-anomer depending on the 
orientation of the preinstalled C2 heteroatom directing group (equatorial gives β and axial gives α). 
Treatment of the appropriate glycosyl donor 2.213 or 2.218 with an electrophilic reagent promotes 
formation of oxocabenium ion intermediate 2.214 or 2.219, respectively. The C2 heteroatom substituent 
is capable of stabilizing this high energy intermediate through neighboring group participation to generate 
intermediates 2.215 and 2.220. In doing so, it controls the facial sense of nucleophilic substitution to give 
either β- or α-glycoside (2.217 or 2.222) after C2–X bond reduction.  
 
Figure 2.16 Synthesis of 2-deoxyglycosides using a preinstalled C2 directing group. 
 The use of a preinstalled C2 directing group to control the anomeric selectivity of 2-
deoxyglycoside formation is often preferable to the previously described approaches. First, it circumvents 
the selectivity issues observed for the direct substitution glycosylation approach. Second, it affords direct 
access to the either intermediate 2.215 or 2.220 (Figure 2.16), which generally controls the stereochemical 
course of the glycosylation event. In contrast, electrophilic glycal activation often generates a mixture of 
both 2.215 and 2.220, depending on the substitution patern of the glycosyl donor, which leads to the 
formation of a mixture of both 2-deoxy-β- and α-glycosides 2.216 and 2.221, respectively. In effect, this 
method serves to decouple glycal activation from glycosylation. Third, this method can utilize mild 
electrophilic promotors, such as TMSOTf or SnCl2, which makes it particularly valuable for the late-stage 
glycosylation of highly sensitive natural product aglycons. 
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 The Roush group has explored many of the intricacies of the C2 directing group strategy for 
stereocontrolled synthesis of 2-deoxyglycosides.192 ,193  They have applied this approach to the total 
synthesis of a variety of natural products. In particular, their total synthesis of olivomycin A (2.239)194 
illustrates the versatility of this technique for the construction of both 2-deoxy-α- and β-glycosides 
(Schemes 2.32 and 2.33). Their synthesis of the AB-dissacharide glycosyl donor 2.230 is depicted below 
in Scheme 2.32. Treatment of glycal 2.223 with NIS and HOAc resulted in the formation of two major 
isomeric products: 2-iodo-β-glycosyl acetate 2.224 and 2-iodo-α-glycosyl acetate 2.225 in 13% and 77% 
yield, respectively after HPLC separation. Next, addition of TMSOTf to a cold solution of 2.225 and 
glycal 2.226 afforded 2-iodo-α-glycoside 2.228 in 74% yield as a single stereoisomer. The anomeric 
selectivity observed in this transformation can be explained by α-selective nucleophilic attack by 2.226 on 
iodonium intermediate 2.227. Importantly, the mild nature of the reaction conditions prevented 
decomposition of the sensitive glycal functional unit. Glycal 2.228 was then converted to 
trichloacetimidate glycosyl donor 2.230 through a three step sequence involving: (1) thiochlorination, (2) 
glycosyl chloride hydrolysis, and (3) trichloroacetimidate formation. Notably, installation of the 
equatorial C2 thiophenyl substituent was critical for a future β-selective glycosylation reaction (vide 
infra). 
  
                                                      
192 For synthesis of 2-deoxy-β-glycosides see: (a) Roush, W. R.; Sebesta, D. P.; Bennett, C. E. Tetrahedron 1997, 
53, 8825–8836. (b) Roush, W. R.; Sebesta, D. P.; James, R. A. Tetrahedron 1997, 53, 8837–8852. (c) Roush, W. R.; 
Gung, B. W.; Bennett, C. E. Org. Lett. 1999, 1, 891–893. (d) Roush, W. R.; Bennett, C. E. J. Am. Chem. Soc. 1999, 
121, 3541–3542. (e) Roush, W. R.; Bennett, C. E. J. Am. Chem. Soc. 2000, 122, 6124–6125. (f) Chong, P. Y.; Roush, 
W. R. Org. Lett. 2002, 4523–4526. (g) Blanchard, N.; Roush, W. R. Org. Lett. 2003, 5, 81–84. (h) Durham, T. B.; 
Roush, W. R. Org. Lett. 2003, 5, 1871–1874. (i) Durham, T. B.; Roush, W. R. Org. Lett. 2003, 5, 1875–1878. 
 
193 For synthesis of 2-deoxy-α-glycosides see: (a) Roush, W. R.; Briner, K.; Sebesta, D. P. Synlett 1993, 264–266. 
(b) Roush, W. R.; Narayan, S.; Bennett, C. E.; Briner, K. Org. Lett. 1999, 1, 895–897 (c) Roush, W. R.; Narayan, S. 
Org. Lett. 1999, 1, 899–902. (d) Handa, M.; Smith III, W. J.; Roush, W. R.; J. Org. Chem. 2008, 73, 1036–1039. 
 
194 Roush, W. R.; Hartz, R. A.; Gustin, D. J. J. Am. Chem. Soc. 1999, 121, 1990–1991. 
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Scheme 2.32 Stereoselective synthesis of a 2-deoxy-2-iodo-α-glycoside using a 2-deoxy-2-iodo-glycosyl acetate 
donor. 
 
Reagents and conditions: (a) NIS, HOAc, EtCN, –78 °C, 77% for 2.225 and 13% for 2.224; (b) 2.226, TMSOTf, 
CH2Cl2, –78 °C, 4 Å MS, 74%; (c) PhSCl, CH2Cl2, 0 °C → RT; (d) AgOTf, TMU, THF-H2O; (e) NaH, Cl3CCN, –
40 → –20 °C, 38% (3 steps). 
 The CDE-trisaccharide unit of olivomycin A was then attached to aglycon 2.231 through two 
sequential β-selective glycosylation reactions using a C2-thiophenyl directing group (Scheme 2.33). β-
selective glycosylation based on this strategy depended on two primary factors: (1) the nature of the 
substituent at C6 (C6–Br being the most selective donor) and (2) the steric requirements of the glycosyl 
acceptor (optimal α-selectivity was observed for sterically unhindered alcohols).192a,b Addition of catalytic 
TBSOTf to a cold solution of trichloroacetimidate glycosyl donor 2.232 (prepared in a similar fashion to 
2.230) and aglycon 2.231 provided 2-thiophenyl-2-deoxy-β-glycoside 2.233 in good yield and anomeric 
selectivity. Protecting group manipulation and a second β-selective glycosylation gave CDE-glycoside 
2.235. Next, the challenging aryl 2-deoxy-β-glycosidic linkage of olivomycin A was constructed utilizing 
a Mitsunobu glycosylation protocol.195 Coupling of 2.235 and AB-disaccharide 2.236 was accomplished 
by exposure to PPh3 and DEAD to afford pentasaccharide 2.238 in 73–79% yield. Interestingly, the β-
glycosidic linkage appears to have been formed though an SN2-like substitution process of the activated 
α-hydroxy hemiacetal intermediate 2.237. In this way, the equatorial 2-selenophenyl substituent imparted 
β-selectivity by increasing the α/β anomeric ratio of the pyranose starting material (2.236). Finally, the 
                                                      
195 Roush, W. R.; Lin, X.-F. J. Am. Chem. Soc. 1995, 117, 2236–2250. 
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total synthesis of olivomycin A (2.239) was completed through: (1) protecting group manipulations, (2) 
reduction of the 6-bromo, 2-iodo, and 2-selenophenyl substituents with nBu3SnH and catalytic Et3B, (3) 
reduction of the 2-thiophenyl substituents with Raney-Ni, and (4) silyl ether deprotection using HFPy. 
Scheme 2.33 Stereoselective synthesis of a 2-deoxy-β-glycosides using a 2-deoxy-2-thiophenyl glycosyl 
trichloroacetimidate donor and a Mitsunobu glycosylation process. 
 
Reagents and conditions: (a) TBSOTf, CH2Cl2-hexanes (1:2), 4 Å MS, –60 °C, 58%, α:β = 1:8; (b) Pd(PPh3)4, 
nBu3SnH, HOAc, 90%; (c) (ClAc)2O, CH2Cl2, Py, –30 °C, 84%; (d) HF•Py, THF, 0 °C, 95%; (e) 2.230, TBSOTf, 
CH2Cl2-hexanes (1:1), 4 Å MS, –35 °C; (f) NH3, MeOH, 78% (two steps); (g) 2.236, PPh3, DEAD, CH2Cl2, 4 Å 
MS, 0 °C, 79%; (h) CSA, MeOH-THF, 0 °C, 54% and 14% 2.238; (i) TESOTf, Py, CH2Cl2, –60 °C, 95%; (j) NH3, 
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Reagents and conditions for Scheme 2.33 continued: MeOH-CH2Cl2, 0 °C, 78%; (k) nBu3SnH, Et3B, 45 °C, 84%; (l) 
Raney-Ni, THF-EtOH, sonication, 57%; (m) HF•Py, THF, Py, 0 °C, 76%. 
 The Roush group has also demonstrated the utility of an equatorial 2-iodo substituent as a 
stereocontrolling element for the formation of 2-deoxy-β-glycosides in their synthesis of the CDE-
trissacharide subunit of Durahamycin A and B (2.249) (Scheme 2.34).192i Their synthesis began with 
addition of NIS and HOAc to a solution of 6-deoxyglycal 2.240 to provide a mixture of α- and β-glycosyl 
acetates, 2.241 and 2.242 after TES deprotection. While this method for the installation of a 2-iodo 
directing group was relatively inefficient, it provided sufficient quantities of the equatorial iodide 
diastereomer 2.242 to carry out the remainder of their synthesis. Next, 2.242 was coupled with 2-bromo-
galactopyranosyl trichloroacetimidate donor 2.243 to afford β-glycoside 2.245 in 94% through exposure 
to TBSOTf. Interestingly, the glycosyl trichloroacetimidate leaving group was selectively activated by 
TBSOTf in the presence of the glycosyl acetate leaving group at low temperatures. Additionally, the 
rigidifying 3,4-carbonate protecting group for 2,6-dideoxy-2-bromo-galactosyl donor 2.243 was critical to 
obtain high β-selectivity in the glycosylation reaction, presumably through the nucleophilic substitution of 
unusual oxocarbenium ion intermediate 2.244. Next, glycosyl acetate 2.245 was converted to the 
corresponding glycosyl fluoride 2.246 and a second β-selective glycosylation with glycosyl donor 2.247 
furnished the CDE-trisaccharide 2.249 in good yield and anomeric selectivity. 
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Scheme 2.34 Stereoselective synthesis of a 2-deoxy-β-glycosides using a 2-deoxy-2-iodo-glycosyl 
trichloroacetimidate. 
 
Reagents and conditions: (a) NIS, HOAc, PhMe, reflux; (b) Et3N•3HF, MeCN, 0 °C, 86%, 37% for 2.241, 63% for 
2.242; (c) 2.243, TBSOTf, CH2Cl2, –78 °C, 94%; (d) HF•Py, CH2Cl2, 0 °C, 79%–89%; (e) K2CO3, MeOH, 0 °C, 
93%; (f) CH3C(OCH3)3, CH2Cl2, 0 °C, 91%; (g) 2.247, TBSOTf, CH2Cl2, –78 °C, 86%, α:β = 7:93. 
 Roush has utilized a 2-iodo-glycosyl fluoride donor to stereoselectivly introduce the 2-
deoxyglycosyl subunit of the macrolide natural product formamicin (2.254) (Scheme 2.35). The use of a 
fluoride glycosyl donor (2.251) was necessitated by the highly acid sensitive nature of the aglycon 
(2.250), which decomposed in the presence of various Lewis acids such as TMSOTf and BF3•OEt2. 
Exposure of 2.250 and 2.251 to SnCl2 and AgClO4 (Mukaiyama’s conditions)196 furnished the desired 2-
iodo-β-glycoside (2.252) in 68% yield with excellent anomeric selectivity. The synthesis of formamicin 
(2.254) was completed through reductive removal of the 2-iodo substituent with nBu3SnH, Et3B, and O2 
followed by global deprotection with Et3N•HF. 
  
                                                      
196 Mukaiyama, T.; Murai, Y.; Shoda, S.-i. Chem. Lett. 1981, 431–440. 
 
OAcO
Me
TESO
a. NIS, HOAc
b. Et3N•3HF
OAcO
Me
HO
I
OAc
OAcO
Me
HO
I OAc
2.241 (33%) 2.242 (53%, α:β = 1:4)
O
Me
Br
O
O
O
O NH
CCl3
c. TBSOTf, 2.243
2.243
O
Me
OO
O
Br
H
H H
ROH
via:
OO
Me
I OAc
O
Me
Br
O
O
O
O
2.245
Ac
OAcO
Me
AcO
I O
2.247
NH
CCl3
OAcO
Me
AcO
I
H H
HOR
2.248
β
d. HF•Py
e. K2CO3, MeOH
f. CH3C(OCH3)3
(75%, 3 steps)
OO
Me
I F
O
Me
Br
AcO
HO O
2.246
Ac
g. TBSOTf, 2.247OO
Me
I F
O
Me
Br
AcO
O
Ac
OAcO
Me
AcO
I
CDE-Trisaccharide Subunit 
of Durhamycin A and B 
(2.249)
O (86%, α:β = 7:93)
β
2.244
(94%, β only)2.240
 122 
Scheme 2.35 Stereoselective synthesis of a 2-deoxy-β-glycosides using a 2-deoxy-2-iodo-glycosyl fluoride donor. 
 
Reagents and conditions: (a) 2.251, SnCl2, AgClO4, Et2O, 4 Å MS, –20 → –15 °C, 68%, α:β = 2:98; (b) nBu3SnH, 
Et3B, O2, 93%; (c) Et3N•3HF, Et3N, MeCN-THF (1:1), 3 days; Et3N•3HF, Et3N, MeCN, 11 days, 58%. 
 Schmidt and coworkers have employed a 2-O-thiocarbonyl directing group to prepare 2-deoxy-α- 
and β-glycosides after C2–O bond reduction (Scheme 2.36).197 Treatment of axial 2-O-thiocarbonyl-
glycosyl trichloroacetate donor 2.255 and glycosyl acceptor 2.256 with TMSOTf resulted in the formation 
of the corresponding α-glycoside 2.258 in good yield (Scheme 2.36a). Presumably, the stereochemical 
outcome of this reaction was dictated by nucleophilic attack on intermediate 2.257. Reductive removal of 
the 2-O-thiocarbonyl substituent was accomplished using nBu3SnH and catalytic AIBN to afford 2-deoxy-
α-glycoside 2.259. The corresponding 2-deoxy-β-glycoside 2.263 was prepared in an analogous fashion 
starting from equatorial 2-O-thiocarbonyl-glycosyl donor 2.260 (Scheme 2.36b). While this method has 
not been utilized in the context of natural product total synthesis, it helped inspire our stereocontrolled 
glycosylation strategy for the installation of the hibarimicin B AT-AM and AT'-AM' dissacharides (vide 
infra). 
  
                                                      
197 Castro-Palomino, J. C.; Schmidt, R. R. Synlett 1998, 501–502. 
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Scheme 2.36 Stereoselective synthesis of 2-deoxy-α-glycosides and 2-deoxy-β-glycosides using a 2-O-thiocarbonyl 
directing group. 
 
Reagents and conditions: (a) TMSOTf, CH2Cl2, 0 °C, 73%; (b) nBu3SnH, AIBN, PhMe, 110 °C, 72%; (c) TMSOTf, 
CH2Cl2, 0 °C, 78%; (d) nBu3SnH, AIBN, PhMe, 110 °C, 75%. 
2.8.D Synthesis of 2-Deoxy-β-glycosides Using a C3 Directing Group 
 As previously mentioned, C3 directing groups have been utilized in several instances for the 
stereoselective synthesis of 2-deoxy-β-glycosides.188 Conceptually, this strategy mirrors that of a 
preinstalled C2 directing group; however, in certain cases, the synthesis of the corresponding glycosyl 
donor is often more direct and efficient. Weisner and coworkers have exploited an axial C3 para-
methoxybenzoyl ester as a directing group in their synthesis of the cardiac glycoside digitoxin (2.138) 
(Scheme 2.37). Treatment of thioethyl glycoside 2.264 and glycosyl acceptor 2.265 with HgCl2, CdCO3, 
and a catalytic amount of DMF supplied 2-deoxy-β-glycoside 2.267 in 60% yield with excellent β-
anomeric selectivity. This procedure was reiterated to achieve a total synthesis of digitoxin (2.138). It is 
important to note that not all axial 3-O-esters are capable of neighboring group assistance and in certain 
cases this strategy is unreliable.188c,198 
                                                      
198 (a) Hashimoto, S.; Sano, A.; Sakamoto, H.; Nakajima, M.; Yanagiya, Y.; Ikegami, S. Synlett 1995, 1271–1273. 
(b) Guo, Y.; Sulikowski, G. A. J. Am. Chem. Soc. 1998, 120, 1392–1397. (c) Pongdee, R.; Wu, B.; Sulikowski, G. A. 
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Scheme 2.37 Synthesis of 2-deoxy-β-glycosides using an axial 3-O-para-methoxybenzoyl ester directing group. 
 
2.8.E Synthesis of 2-Deoxy-α-glycosides and 2-Deoxy-β-glycosides Using Conformation Control 
 Tatsuda and Toshima199 have developed a strategy for the synthesis of both of 2-deoxy-α-
glycosides and 2-deoxy-β-glycosides based on conformational control of the glycosyl donor. By 
introducing a thioether bridge between C2 and C6, they have prepared a variety of bicyclic glycosyl 
donors such as 2.268, 2.269, and 2.270 (Scheme 2.38). They discovered that 2,6-anhydro-2-thio-α-
glycoside 2.272 could be stereoselectively prepared via two independent glycosylation methods using a 
common glycosyl acceptor 2.271, including: (1) treatment of thiophenyl glycosyl donor 2.268 with NBS 
or (2) exposure of an analogous fluoro glycosyl donor 2.269 to SnCl2 and AgClO4. In contrast, addition of 
TMSOTf to a solution of glycosyl acetate 2.270 and glycosyl acceptor 2.271 provided 2,6-anhydro-2-
thio-β-glycoside 2.274. Tatsuda and coworkers rationalized the stereochemical outcome of these reactions 
                                                                                                                                                                              
Org. Lett. 2001, 3, 3523–3525. 
199 (a) Toshima, K.; Mukaiyama, S.; Ishiyama, T.; Tatsuta, K. Tetrahedron Lett. 1990, 31, 3339–3342. (b) Toehima, 
K.; Mukaiyama, S.; Ishiyama, T.; Tatauta, K. Tetrahedron Lett. 1990, 31, 6361–6362. (c) Toshima, K.; Mukaiyama, 
S.; Yoehida, T.; Tamai, T.; Tatauta, K. Tetrahedron Lett. 1991, 32, 6155–6158. (d) Toehima, K.; Nozaki, Y.; 
Mukaiyama, S.; Tatsuta, K. Tetrahedron Lett. 1992, 33, 1491–1494. (e)Toshima, K.; Nozaki, Y.; Inokuchi, H.; 
Nakata, M.; Tatsuta, K.; Kinoshita, M. Tetrahedron Lett. 1993, 34, 1611–1614. (f) Toshima, K.; Nozaki, Y.; 
Mukaiyama, S.; Tamai, T.; Nakata, M.; Tatsuta, K. J. Am. Chem. Soc. 1994, 116, 9042–9051. (g) Toshima, K.; 
Nozaki, Y.; Mukaiyama, S.; Tamai, T.; Nakata, M.; Tatsuta, K. Kinoshita, M. J. Am. Chem. Soc. 1995, 117, 3717–
3727. 
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through two primary interactions of the approaching alcohol with oxocarbenium ion intermediate 2.276. 
They proposed that formation of the α-glycosidic linkage is kinetically favored by repulsive electronic 
interaction with sulfur atom. Alternatively, formation of 2.274 was shown to be reversible in the presence 
of TMSOTf and CH2Cl2 as a solvent. Therefore, the β-selectivity observed under these conditions is 
likely a result of minimization of a potential 1,3-diaxial interaction in the corresponding α-anomer (2.272). 
Finally, 2-deoxy-α-glycoside 2.273 and 2-deoxy-β-glycoside 2.275 were accessed via C–S bond reduction 
with Raney-Ni or through radical desulfurization using nBu3SnH and AIBN.  
Scheme 2.38 Synthesis of 2-deoxy-α-glycosides and 2-deoxy-β-glycosides using conformation control. 
 
Reagents and conditions: (a) 2.270, TMSOTf, CH2Cl2, –10 °C, 89%, α:β = 2:98; (b) 2.269, SnCl2, AgClO4, Et2O, –
10 °C, 98%, α:β = 97:3; (c) 2.268, NBS, 4 Å MS, Et2O, –25 °C, 96%; (d) H2, Raney-Ni, EtOH, 80 %; (e) nBu3SnH, 
AIBN, PhMe, 71%; (f) H2, Raney-Ni, EtOH, 74 %; (g) nBu3SnH, AIBN, PhMe, 86%. 
 Tatsuda was able to apply this method to the synthesis of erythromycin A (2.139) (Scheme 2.39). 
Exposure of aglycon 2.277 and 2,6-anhydro-2-thio-β-glycosyl donor 2.278 to NIS and TfOH promoted 
formation of the kinetically favored α-glycoside 2.279 in 90% yield. Next, the acetal protecting group was 
hydrolyzed and the 2-deoxy-α-glycoside 2.280 was obtained via desulfurization with Raney-Ni. Three 
additional steps delivered erythromycin A (2.139).199g 
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Scheme 2.39 Application of conformation control for the synthesis of 2-deoxy-α-glycosides to the total synthesis of 
erythromycin A. 
 
Reagents and conditions: (a) 2.278, NIS, TfOH, CH2Cl2, 4 Å MS, –35 °C, 90%; (b) HOAc-H2O (1:1), 40 °C, 66%; 
(c) H2, Raney-Ni, EtOH, 40 °C, 54%. 
2.8.F De Novo Synthesis of 2-Deoxy-α-glycosides and 2-Deoxy-β-glycosides 
 De novo synthesis has become an extremely powerful strategy for the construction of 2-
deoxyglycosides.200 In particular, the O’Doherty group has demonstrated the utility of this approach in the 
context of natural product and oligosaccharide total synthesis.201 Their synthesis of the trisaccharide 
subunit of landomycin A (2.290) (Scheme 2.40) exemplifies this tactic for the formation of both 2-deoxy-
α- and β-glycosidic linkages. The first step of their synthesis featured a palladium-catalyzed β-selective 
glycosylation reaction between β-Boc-pyranone 2.282 and β-D-olivose glycosyl acceptor 2.281. 
Treatment of 2.282 and 2.281 with catalytic Pd2(dba)3•CHCl3 and PPh3 furnished β-glycoside 2.283 in 
85% yield as a single diastereomer. The stereochemical outcome of this reaction is believed to be a result 
of a double inversion net retention process, wherein attack by the Pd(0) catalyst on 2.282 provides α-π-
allyl Pd intermediate 2.291 followed by a second nucleophilic substitution reaction by 2.281 to afford β-
                                                      
200 For a review on the de novo synthesis of 2-deoxyglycosides see: (a) Kirschning, A.; Jesberger, M.; Schöning K.-
U. Synthesis 2001, 507–540 and references therein. (b) Harris, J. M. Li, M. Scott, J. G.; O’Doherty, G. A. Strategy 
and Tactics in Organic Synthesis, 2004, 5, 221–253. 
 
201 Babu, R. S.; Chen, Q.; Kang, S.–W.; Zhou, M.; O’Doherty, G. A. J. Am. Chem. Soc. 2012, 134, 11952−11955 
and references therein. 
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glycoside 2.283. Next, disaccharide 2.285 was prepared through a multi step sequence involving: (1) 
Luche reduction202 of the enone, (2) Myers’ reductive 1,3-allylic transposition,203 (3) protecting group 
exchange, and (4) dihydroxylation. Mitsunobu204 inversion of the 2.285 C3–OH and protecting group 
manipulations provided glycosyl acceptor 2.286 for the second glycosylation reacton. In this case, 
exposure of 2.286 and α-Boc-pyranone 2.287 to catalytic Pd2(dba)3•CHCl3 and PPh3 afforded α-glycoside 
2.288 in excellent yield via β-π-allyl Pd intermediate 2.292. Finally, the landomycin A trisaccharide 2.290 
was completed through: (1) Luche reduction, (2) C3–OH Mitsunobu inversion/deprotection, (3) Myers’ 
reductive 1,3-allylic transposition, (4) diimide reduction with NBSH, and (5) global deprotection using 
TBAF. 
 While de novo synthesis has been demonstrated to be a reliable strategy for the construction of 2-
deoxy-α-glycosidic and 2-deoxy-β-glycosidic bonds, it is not without liabilities. The requirement for 
sequential introduction of the C3 and C4 hydroxyl substituents after glycosylation makes this strategy 
problematic for the synthesis of natural products exhibiting complex and highly sensitive aglycons. 
Therefore, this approach appears to be best suited for building the 2-deoxyoligosaccharide glycosyl 
donor, which can then be incorporated at a late-stage of a total synthesis by employing one of the 
previously described strategies for stereoselective glycosylation (e.g. direct substitution of an anomeric 
leaving group or C2/C3 neighboring group assistance). 
  
                                                      
202 Luche, J. L. J. Am. Chem. Soc. 1978, 100, 2226–2227. 
 
203 Myers, A. G.; Zheng, B. J. Am. Chem. Soc. 1996, 118, 4492–4493. 
 
204 For reviews on the Mitsunobu reaction, see: (a) Mitsunobu, O. Synthesis 1981, 1–28. (b) Hughes, D. L. Org. 
Prep. 1996, 28, 127–164. 
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Scheme 2.40 De novo synthesis of 2-deoxy-α-and β-glycosides. 
 
Reagents and conditions: (a) 2.282, Pd2(dba)3•CHCl3, PPh3, CH2Cl2, 0 °C, 85%; (b) NaBH4, CeCl3, MeOH, –78 °C, 
95%; (c) PPh3, DIAD, NMM; NBSH, –30 °C → RT, 85%; (d) K2CO3, MeOH, 98%; (e) TBSCl, imidazole, DMF-
ClCH2CH2Cl (1:1), 72%; (f) OsO4, NMO, CH2Cl2-H2O (10:1), 0 °C, 95%; (g) PPh3, DIAD, para-nitrobenzoic acid, 
0 °C → RT, 85%; (h) TBSCl, imidazole, DMF-ClCH2CH2Cl (1:1), 82%; (i) DIBAL, CH2Cl2, –78 °C, 99%; (j) 
2.287, Pd2(dba)3•CHCl3, PPh3, CH2Cl2, 0 °C, 95%; (k) NaBH4, CeCl3, MeOH, –78 °C, 93%; (l) PPh3, DIAD, para-
nitrobenzoic acid, 0 °C → RT, 97%; (m) K2CO3, MeOH, 98%; (n) NBSH, Et3N, CH2Cl2, 86%; (e) TBAF, THF, 
97%. 
 Retrosynthesis of AM-AT/AM'-AT' and DG/DG' Glycosyl Donors for the Total Synthesis of 2.9
Hibarimicin B 
 We were inspired by the work of Hirama and Roush in considering two potential glycosylation 
strategies for bidirectional installation of the C10–DG1/C10'–DG1' 2-deoxy-α-glycosidic linkages found 
in hibarimicin B (2.1, Figure 2.17). We anticipated that treatment of suitably protected thiophenyl 
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glycosyl donor 2.293 and an orthogonally protected aglycon (R'OH, green) with AgPF6 and DTBMP at 
low temperature, according to Hirama’s procedure,179 would preferentially afford the 2-deoxy-α-glycoside 
2.294 (Figure 2.17a). Alternatively, if oxidative glycosyl activation conditions were found to be 
incompatible with the aglycon we could potentially employ a C2 directing group strategy illustrated in 
Figure 2.17b; this approach involves: (1) concurrent installation of an axial C2 directing group and a C1 
leaving group (Lg) via electrophilc activation of glycal 2.295, (2) Lewis acid-promoted α-selective 
glycosylation via C2 anchimeric assistance, and (3) C–X bond reduction using nBu3SnH and AIBN. 
Decoupling the electrophilic glycal activation from glycosylation was expected to allow for the use of 
relatively mild reaction conditions to install the C10–DG1/C10'–DG1' 2-deoxy-α-glycosidic bonds. 205 
 
Figure 2.17 Proposed synthesis of the hibarimicin B C10–DG1/C10'–DG1' 2-deoxy-α-glycosidic linkages via: (a) 
application of Hirama’s method or (b) use of a preinstalled C2 directing group. 
 Next, the work of Weisner188a,b and Schmidt197 inspired the development of a novel C3 directing 
group strategy for the synthesis of the C12–AM1/C12'–AM1' 2,3-dideoxy-β-glycosidic linkages of 2.1 
                                                      
205 Theim and coworkers utilized a NIS mediated glycal activation strategy for the synthesis of the kijanimicin 
oligosaccharides: Thiem, J.; Köpper, S. Tetrahedron 1990, 46, 113–138. However, we anticipated that NIS, like 
AgPF6, might promote decomposition of the sensitive aglycone. 
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(Figure 2.18). Specifically, we hypothesized that a C3 phenyl thionocarbonate substituent could 
encourage β-selective glycosylation via 1,3-neighboring group participation illustrated in intermediate 
2.300. Additional, the phenyl thionocarbonate group could potentially be removed directly after the 
glycosylation reaction with nBu3SnH and AIBN to access the corresponding 2,3-dideoxy-β-glycoside 
2.302. 
 
Figure 2.18 Development of a C3 phenyl thionocarbonate directing group for the synthesis of the hibarimicin B 
C12–AM1/C12'–AM1' 2,3-dideoxy-β-glycosidic linkages. 
 Application of the aformentioned strategies provided AM-AT/AM'-AT' disaccharide glycosyl 
donor 2.62 and DG/DG' monosaccharide glycosyl donors 2.63 and 2.64 (Figure 2.19). A 
trichloroacetimidate leaving group was chosen for 2.62 and 2.64 due to its high reactivity toward Lewis 
acids, reliability, and ease of formation. We elected to employ benzyl protecting groups for the DG/DG' 
monosaccharide glycosyl donors 2.63 and 2.64 to allow for late-stage global benzyl deprotection via 
hydrogenolysis under conditions similar to those used for hibarimicinone (2.2). Additionally, the axial 
DG3/DG3' hydroxyl group in 2.63 was left unprotected due to literature precedent, which suggested that 
protection might hinder formation of the desired α-anomeric linkage.179 Comparison of the AM/AM' and 
DG/DG' ring precursors, 2.304 and 2.305, revealed their shared relative stereochemistry (digitoxose). 
This prompted us to consider application of O’Doherty’s de novo strategy for their synthesis.206 
Additionally, we anticipated that the AM4–AT/AM4'–AT' α-glycosidic linkages could be formed via Pd-
catalyzed glycosylation between α-Boc-pyranone 2.303 and a protected version of 2.304. Next, we 
envisioned that stereoselective installation of the AT4/AT4' C-acyl substituent could be accomplished 
through an isopropenyl organometallic carbonyl addition/oxidative cleavage sequence. Finally, we 
                                                      
206 (a) Zhou, M. O’Doherty, G. A. Org. Lett. 2006, 8, 4339–4342. (b) Zhou, M. O’Doherty, G. A. J. Org. Chem. 
2007, 72, 2485–2493. 
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expected α-Boc-pyranone 2.303 and the enantiomeric β-Boc-pyranone precursors to benzyl digitoxosides 
2.304 and 2.305 ((+)-2.282 and (–)-2.309 respectively, Scheme 2.41) could be obtained through a three 
steps sequence from 2-furyl methyl ketone (2.306). 207 
 
Figure 2.19 Retrosynthesis or AM-AT/AM'-AT' dissacharide glycosyl donor 2.62 and DG/DG' monosaccharide 
glycosyl donors 2.63 and 2.64. 
 Synthesis of AM-AT/AM'-AT' and DG/DG' Glycosyl Donors 2.10
 Our synthesis of the AM-AT/AM'-AT' and DG/DG' glycosyl donors began with asymmetric 
hydrogenation of 2-furyl methyl ketone (2.306) under Noyori’s conditions on multi-gram scale (Scheme 
2.41). 208 A solution of 2.306, Ru-catalyst (R,R)-2.307, and tBuOK in iPrOH-tBuOH were stirred under a 
H2 atmosphere at 900 psi to afford alcohol (S)-alcohol 2.308 as a single enationmer in 63% yield after 
distillation. Next α- and β-Boc-pyranones ((+)-2.287 and (–)-2.309) were then prepared in two steps 
including: (1) NBS promoted Achmatowicz rearrangement209 and (2) Boc protection of the resultant 
hemiacetal. The enantiomeric α- and β-Boc-pyranones (–)-2.311 and (+)-2.282 were obtained through an 
analogous reation sequence beginning with asymmetric hydrogenation of 2.306 using Ru-catalyst (S,S)-
                                                      
207 (a) Fujii, A.; Hashiguchi, S.; Uematsu, N.; Ikariya, T.; Noyori, R. J. Am. Chem. Soc. 1996, 118, 2521–2522. (b) 
Li, M.; Scott, J. G.; O’Doherty, G. A. Tetrahedron Lett. 2004, 45, 1005–1009. (c) Li, M.; O’Doherty, G. A. 
Tetrahedron Lett. 2004, 45, 6407–6411. 
 
208 Ohkuma, T.; Koizumi, M.; Yoshida, M.; Noyori, R. Org. Lett. 2000, 2, 1749–1751. 
 
209 Achmatowicz, O.; Bielski, R. Carbohydr. Res. 1977, 55, 165–176. 
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2.307. Three of the four Boc-pyranone products ((+)-2.287, (–)-2.309, and (+)-2.282) were carried 
forward to prepare the AM-AT/AM'-AT' and DG/DG' glycosyl donors. 
Scheme 2.41 Synthesis of α- and β-Boc-pyranone building blocks. 
 
Reagents and conditions: (a) (R,R)-2.307, H2 (900 psi), tBuOK, iPrOH-tBuOH, 63%, 99% ee; (b) NBS, NaOAc, 
NaHCO3, THF-H2O (3:1), 0 °C; (c) (Boc)2O, NaOAc, NaHCO3, PhH, 80 °C, 27% for (+)-2.287 and 49% for (–)-
2.309; (d) (S,S)-2.307, H2 (900 psi), tBuOK, iPrOH-tBuOH, 65%, 99% ee; (e) NBS, NaOAc, NaHCO3, THF-H2O 
(3:1), 0 °C; (f) (Boc)2O, NaOAc, NaHCO3, PhH, 80 °C, 26% for (–)-2.311 and 46% for (+)-2.282.  
 Synthesis of DG/DG' 2-deoxy-thiophenyl glycosyl donor 2.63 is depicted in Scheme 2.42. The first 
step in the sequence involved a Pd-catalyzed glycosylation between β-Boc-pyranone (–)-2.309 and benzyl 
alcohol to afford β-benzyl pyranone (+)-2.312 as a single diastereomer in 82% yield. Next, Luche 
reduction of (+)-2.312 afforded allylic alcohol 2.313 as an inconsequential mixture of C4 diastereomers. 
Reductive allylic 1,3-transposition was accomplished by exposure of 2.313 to PPh3, DEAD, and NBSH to 
provide dihydropyran (+)-2.314 in 82% yield on multi-gram scale. Treatment of (+)-2.314 with OsO4 and 
NMO furnished diol (+)-2.305 as a single diastereomer. Regioselective protection of the C4–OH as its 
corresponding benzyl ether was accomplished through a four step sequence involving: (1) formation of 
cyclic othoester 2.315, (2) regioselective orthoester hydrolysis, (3) benzyl protection of the resultant C4–
OH, and (4) reductive deprotection of the C3–OAc group with DIBAL. Finally, treatment of benzyl 
glycoside (+)-2.318 with thiophenol and SnCl4 at –78 °C delivered 2.63 in 84% yield as an anomeric 
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mixture of thiophenylglycosides. 
Scheme 2.42 Synthesis of 2-deoxy-thiophenyl-glycosyl donor 2.63 
 
Reagents and conditions: (a) Pd2(dba)3•CHCl3, PPh3, BnOH, CH2Cl2, 0 °C, 82%; (b) NaBH4, CeCl3•7H2O, CH2Cl2-
H2O (1:1), –78 °C, 91%, 1.7:1.0 d.r.; (c) PPh3, DEAD, THF, –15 °C; then 2.313; then NBSH, –15 °C → RT; (d) 
OsO4, NMO, CH2Cl2-H2O (4:1), 82%; (e) CH3(COCH3)3, PTSA, PhH; (f) PTSA, THF-H2O (1:1), 97% (two steps); 
(g) BnOC(=NH)CCl3 (2.317), TfOH, CH2Cl2-cyclohexane (2:1), 4 Å MS, –20 → –10 °C, 82%; (h) DIBAL, CH2Cl2, 
–78 °C, 81% (two steps); (g) PhSH, SnCl4, CH2Cl2, –78 °C, 84%, α:β = 2:1.  
 The synthesis of DG/DG' 2-deoxy-2-iodo-glycosyl trichloroacetimidate donor 2.64 is depicted in 
Scheme 2.43. Diol (+)-2.305 was benzyl protected with sodium hyride and benzyl bromide to afford bis-
benzyl ether (–)-2.319 in 94% yield. Exposure of (–)-2.319 to warm aqueous HOAc promoted hydrolysis 
of the benzyl glycoside. The resultant hemiacetal was dehydrated with MsCl and Et3N to furnish glycal (–
)-2.320. Iodoacetoxylation of (–)-2.320 with NIS and HOAc provided 2-deoxy-2-iodo-glycosyl acetate (–
)-2.322 in 96% yield as a single diastereomer. Stereoselective introduction of the requisite axial C2 iodide 
was likely a result of nucleophilic attack by acetic acid on iodonium intermediate 2.321. The synthesis of 
2.64 was completed by cleavage of the anomeric acetate with hydrazine and exposure of the resultant 
hemiacetal to trichloroacetonitrile and DBU. 
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Scheme 2.43 Synthesis of 2-deoxy-2-iodo-glycosyl trichloroacetimidate donor 2.64. 
 
Reagents and conditions: (a) BnBr, NaH, THF, 0 °C → RT, 94%; (b) HOAc-H2O (3:1), 80 °C, 99%; (c) MsCl, Et3N, 
THF, 0 °C → RT, 51% (two steps); (d) NIS, HOAc, –78 → 0 °C, 96%; (e) NH2NH2•H2O, MeOH; (f) Cl3CCN, 
DBU, CH2Cl2, –10 → 0 °C, 93% (two steps). 
 Our synthesis of the AM-AT/AM'-AT' disaccharide glycosyl trichloroacetimidate 2.62 is 
illustrated in Scheme 2.44. Tetrahydropyran (–)-2.324 was synthesized in six steps from β-Boc-pyranone 
(+)-2.282 through our previously established route. Exposure of (–)-2.324 and α-Boc-pyranone (+)-2.287 
to catalytic Pd2(dba)3•CHCl3 and PPh3 afford α-glycoside (+)-2.326 in 97% yield as a single anomer. 
Next, olefin reduction and benzyl deprotection was accomplished via hydrogentation with Pd/C and the 
resultant hemiactetal was subsequently TBS protected to afford β-silyl glycoside (–)-2.327 as a single 
anomer in 72% yield. Addition of (–)-2.327 to a solution of an organocerium reagent derived from 
isopropenylmagnesium bromide and CeCl3 furnished allylic alcohol (–)-2.328 as a single diastereomer. 
As we had anticipated, the sterically bulky organocerium reagent had undergone equatorial nucleophilic 
attack on the C4 carbonyl group, opposite the C5 methyl substituent.210 Additionally, the use of excess 
organocerium reagent in this transformation conviently cleaved the acetate protecting group. Next, the C3 
phenyl thionocarbonate directing group was introduced using O-phenyl chlorothionoformate, pyridine 
and NHS to provide disaccharide (–)-2.329. OsO4 catalyzed dihydroxylation of the isopropenyl 
substituent and Pb(OAc)4 promoted oxidative cleavage of the resultant diol, delivering α-hydroxyketone 
                                                      
210 The relative stereochemistry of organometallic addition was assigned based on a X-ray crystal structure of a 
benzyl glycoside analog (compound (–)-S2.22). See experimental section for further detail. 
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(–)-2.330 in 62% yield over two steps. The synthesis of AM-AT/AM'-AT' disaccharide glycosyl donor 
2.62 was completed through removal of the anomeric silyl protecting group with HF•Py followed by 
formation of the corresponding glycosyl trichloroacetimidate using trichloroacetonitrile and Cs2CO3. 
Glycosyl trichloroacetimidate 2.62 was unstable to silica gel chromatography and to aqueous workup, but 
could be used directly in the subsequent glycosylation reaction after filteration through neutral Celite with 
excess CH2Cl2. 
Scheme 2.44 Synthesis of AM-AT/AM'-AT' disaccharide glycosyl trichloroacetimidate 2.62. 
 
Reagents and conditions: (a) Pd2(dba)3•CHCl3, PPh3, BnOH, CH2Cl2, 0 °C, 84%; (b) NaBH4, CeCl3•7H2O, CH2Cl2-
H2O (1:1), –78 °C, 91%, 1.7:1.0 d.r.; (c) PPh3, DEAD, THF, –15 °C; then allylic alcohol; then NBSH, –15 °C → RT, 
82%; (d) OsO4, NMO, CH2Cl2-H2O (4:1), 89%; (e) CH3(COCH3)3, PTSA, PhH; (f) PTSA, THF-H2O (1:1), 98% 
(two steps); (g) (+)-2.287, Pd2(dba)3•CHCl3, PPh3, BnOH, CH2Cl2, 0 °C, 97%; (h) Pd/C, H2, MeOH; (i) TBSCl, 
imidazole, 4-DMAP, CH2Cl2, 72% (two steps); (j) CeCl3, LiCl, –78 → 0 °C, 91%; (k) PhO(S)Cl, N-
hydroxysuccinimide, Py, PhH, 85%; (l) OsO4, NMO, CH2Cl2-H2O (16:1); (m) Pb(OAc)4, MeOH-PhH (1:1), 0 °C, 
62% (two steps); (n) HF•Py, Py, 0 °C; (o) Cl3CCN, Cs2CO3, CH2Cl2, 92% (two steps). 
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 Synthesis of Hibarimicin B Models and the Development of 2-Deoxy-α- and β-selective 2.11
 Glycosylation Methods 
 With AM-AT/AM'-AT' glycosyl donor 2.62 and DG/DG' glycosyl donors 2.63 and 2.64 in hand, 
we were in a position to study their respective glycosylation chemistries. A detailed retrosynthesis plan 
for hibarimicin B (2.1) is outlined in Figure 2.20. We envisioned tetraglycosylated precursor 2.331 could 
be converted to 2.1 in three steps including: (1) simultaneous reductive cleavage of the iodide and 
thionocarbonate directing groups or the thionocarbonate group alone, (2) global benzyl deprotection, and 
(3) D-ring oxidation under mildly acidic conditions. In turn, 2.331 could potentially be obtained via α-
selective two-directional double glycosylation of bis-glycosylated precursor 2.332 with DG/DG' glycosyl 
donors 2.63 or 2.64. Lastly, a β-selective two-directional double glycosylation of orthogonally protected 
aglycon 2.333 with AM-AT/AM'-AT' glycosyl donor 2.62 could provide 2.332.  
 
Figure 2.20 Detailed retrosynthesis of hibarimicin B. 
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 We anticipated that the development of conditions for our key two-directional glycosylation 
reactions would be extremely challenging due to the pseudo-C2-symmetric nature of hibarimicin B (2.1). 
Therefore, we elected to first investigate the synthesis of hibarimicin B models A (2.334) and B (2.335) 
from which the C2–C2' bond of 2.1 had been exsized (Figure 2.21). We imagined targeting 2.334 and 
2.335 would simplify our analysis of the stereoselectivity in the proposed glycosylation reactions. 
Additionaly, the biological activity of 2.334 and 2.335 could be compared to hibarimicin B (2.1) in order 
to help ascertain the pharmacophore of the natural product. 
 
Figure 2.21 Hibarimicin B Models A and B. 
 Our first approach to the synthesis of hibarimicin B model A (2.334) began with known aldehyde 
2.336, which was accessed in three steps on multi-gram scale from 2,4,5-trimethoxybenzoic acid (Scheme 
2.45a).211 Exposure of 2.336 to BCl3 was expected to promote chemoselective deprotection of the C1' and 
C4' methyl ethers based on the potential ortho directing effect of the aldehyde and amide substituents. We 
then planned to elaborate the prospective hydroquinone product 2.337 to cyanothalide annulation donor 
2.338 in the usual manner. Unfortunately, treatment of 2.336 with BCl3 at low temperature facilitated 
only mono-deprotection of the C4' methyl ether. Warming the reaction mixture to ambient temperature, in 
order to facilitate the second deprotection, led to decomposition of the intermediate bis-methyl ether. 
Therefore an alternative strategy for the synthesis of 2.338 was developed (Scheme 2.45b). Our revised 
synthesis of 2.338 began with trialkoxytoluene 2.339, which was accessed in five steps from vanillin on 
                                                      
211 Evans, J. C.; Klix, R. C.; Bach, R. D. J. Org. Chem. 1988, 53, 5519–5527. 
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multi-gram scale.212 Chemoselective bromination of 2.339 with NBS occurred at C18' rather than C2' to 
give aryl bromide 2.340.213 Next, the C18' carbomethoxy group was installed through lithium–halogen 
exchange followed by acylation to afford ortho-toluate 2.341. The methyl substituent was mono-
brominated under free-radical halogenation conditions and the resultant benzylic bromide 2.342 was 
converted to the corresponding aldehyde 2.343 through Kornblum oxidation. 214  Chemoselective 
deprotection of 2.343 with BCl3 provided hydroquinone 2.344, which was reprotected with BnBr to 
afford bis-benzyl ether 2.345 in 97% over two steps. Finally, treatment of 2.345 with a controlled source 
of hydrogen cyanide afforded hibarimicin B model A cyanophthalide annulation donor 2.338. 
Scheme 2.45 Synthesis of hibarimicin B model A cyanophthalide annulation donor. 
 
Reagents and conditions: (a) BCl3, CH2Cl2, –78 °C → RT; (b) NBS, DMF, 75%; (c) nBuLi, THF, –78 ºC; then 
ClCO2Me, –78 ºC → RT, 94%; (d) NBS, AIBN, CCl4, reflux, 89%; (e) iPr2NEt, DMSO, 70 °C, 77%; (f) BCl3, 
                                                      
212 Trialkoxytoluene 2.339 was prepared according to the protocol detailed in Ref. 141. 
 
213 The same selectivity trend was observed for similar 1,3,4-trialkoxybenzene substrates and was attributed to 
increased steric hinderence of the C2' position relative to the C18' position, see Ref. 104c. 
 
214 Kornblum, N.; Jones, W. J.; Anderson, G. J. J. Am. Chem. Soc. 1959, 81, 4113–4114. 
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Reagents and conditions for Scheme 2.45 continued: CH2Cl2, –78 → 0 °C; (g) BnBr, K2CO3, DMF, 0 → 60 °C, 
97% (two steps); (h) Me2C(OH)CN, Et3N, CHCl3, 81%. 
 Synthesis of the hibarimicin B model A aglycon (–)-2.348, comprising the ABCD-rings of 2.1, 
was accomplished via a protocol used for the synthesis of hibarimicinone (2.2) (Scheme 2.46). Kraus 
annulation of cyanophthalide 2.338 with AB-/HG-enone (+)-2.68 under rigorously oxygen-free 
conditions afforded ABCD-tetracycle (+)-2.346 in 84% yield. The C-ring hydroquinone of (+)-2.346 was 
then oxidized with DDQ to the corresponding C-ring quinone (2.347), which upon exposure to anhydrous 
HCl underwent biomimetic etherification to furnish pentacycle (–)-2.348 in 79% yield over two steps. 
Scheme 2.46 Synthesis of hibarimicin B model A aglycon. 
 
Reagents and conditions: (a) LiHMDS, THF, –78 → 0 °C, 84%; (b) DDQ, CH2Cl2, –10 °C; (c) HCl, ClCH2CH2Cl, 
0 °C, 79% (two steps). 
 Our first approach to the synthesis of hibarimicin B model B (2.335) began with conversion of the 
previously prepared MOM protected ortho-toluate 2.341 to the corresponding benzyl protected ortho-
toluate 2.350 via: (1) acid-promoted hydrolysis of the MOM group with TFA and (2) reprotection with 
BnBr (Scheme 2.47). Bromination of the C5–Me group was attempted under standard conditons; 
treatment of 2.350 with NBS and AIBN at an elevated temperature led to selective bromination of the C1 
benzyl ether rather than the C5–Me, followed by cyclization of the pendant methyl ester onto the resultant 
benzylic bromide with concomitant loss of a methyl substituent to give acetal 2.351. Alternatitvely, a 
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lithiation/bromination sequence was attempted by exposure of 2.350 to LiTMP at –78 °C followed by 
addition of (BrCF2)2. Under these conditions, the C1 benzyl ether was selectively lithiated and the 
resultant benzylic anion cyclized onto the methyl ester to give ketone 2.352 after loss of lithium 
methoxide. 
Scheme 2.47 Attempted synthesis of hibarimicin B model B annulation donor. 
 
Reagents and conditions: (a) TFA, CH2Cl2, 0 °C → RT, quantitative. (b) BnBr, K2CO3, DMF, 0 → 60 °C, 89%. (c) 
NBS, AIBN, CCl4, reflux, 3 h (d) LiTMP, THF, –78 °C; then (BrCF2)2, –78 °C.  
 Our second approach to the synthesis of 2.335 began with previously prepared MOM protected 
benzyl bromide 2.342 (Scheme 2.48). The MOM group was hydrolyzed with TFA to afford phenol 2.353 
in 85% yield. The electrophilic nature of the C6 benzyl bromide substituent prevented the use of base for 
the installation of the corresponding C1 benzyl ether (2.354). Instead, benzyl protection of 2.353 was 
accomplished under Mitsunobu conditions with BnOH, PPh3, and DIAD. Finally 2.354 was converted to 
benzyl fluoride annulation donor 2.355 using TBAT in 93% yield. 
Scheme 2.48 Synthesis of hibarimicin B model B benzyl fluoride annulation donor. 
 
Reagents and conditions: (a) TFA, CH2Cl2, –78 → 0 °C, 85%. (b) BnOH, PPh3, DIAD, 0 °C → RT, 59%. (c) TBAT, 
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Reagents and conditions for Scheme 2.48 continued: MeCN, 82 °C, 93%. 
 Synthesis of the hibarimicin B model B aglycon 2.335, which comprises the EFGH-rings of 2.1, 
was attempted using a benzyl fluoride Michael–Claisen reaction sequence developed for the synthesis of 
HMP-Y1 (2.9) (Scheme 2.49a).141 In accordance with this protocol, a cold solution of (+)-2.68 and 2.355 
in THF was treated with LiTMP to facilitate the Michael addition step of the proposed tandem reaction 
sequence. Next, HMDS and MgBr2•OEt2 were sequentially introduced and the reaction mixture was 
warmed to facilitate a Claisen condensation and thereby generate tetracycle 2.356. Unfortunately, this 
procedure afforded multiple products, none of which corresponded to 2.356. Therefore, C6 thiophenyl 
substituted ortho-toluate annulation donor 2.357 (Scheme 2.49b) was prepared through substitution of 
benzyl bromide 2.354 with thiophenol. Exposure of 2.357 and (+)-2.68 to LiHMDS at –78 °C followed 
by warming the reaction mixture to 0 °C over three hours promoted an alternative Michael–Claisen 
reaction sequence to supply tetracycle 2.358. Aromatization of the F-ring was accomplished using 
precisely one equivalent of DMTSF and excess DTBMP to give naphthalene 2.359 in 75% yield over two 
steps. The use of greater than one equivalent DMTSF in this reaction promoted thiomethylation of the C6 
position of (+)-2.359. In contrast, the analogous octacyclic intermediates for the synthesis of 
hibarimicinone (2.2) ((–)-2.130 and (+)-2.131) could be exposed to excess DMTSF without the formation 
of any thioalkylated by-products. This observation was the first of many that demonstrated the differential 
reactivity of the hibarimicin B model B intermediates relative to the octacyclic intermediates for the 
synthesis of 2.2. Next, hydrolysis of the acetonide protecting group was found to be extremely 
challenging due to three complicating factors: (1) hydrolylis of the acetonide and the trimethylsilyl ether 
were competitive, (2) the desired triol product (–)-2.360 was extremely sensitive to oxidative 
decomposition, and (3) (–)-2.360 was also sensitive to acid promoted decomposition via ionization of the 
C13 tertiary carbinol. A variety of Brønsted acids were screened for this transformation including: HCl, 
Cl3CCO2H, Cl2HCCO2H, ClH2CCO2H, PPTS, PTSA and TFA. After extensive experimentation, it was 
found that (–)-2.360 could be reliably obtained by treatment of a rigorously deoxygenated solution of (+)-
2.359 in 1,2-dichloroethane with a deoxygenated aqueous solution of TFA for 2-3 h at ambient 
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temperature. Purification of the resultant yellow residue via semi-preparatory HPLC afforded pure (–)-
2.360 in 58% yield. 
Scheme 2.49 Synthesis of hibarimicin B model B aglycon. 
 
Reagents and conditions: (a) LiTMP, THF, –78 °C; then HMDS, –78 → –35 °C; then MgBr2•OEt2, –35 → 0 °C; (b) 
PhSH, Cs2CO3, DMF, 87%; (c) LiHMDS, THF, –78 → 0 °C; (d) DMTSF, DTBMP, MeCN, 0 °C → RT, 75% (two 
steps); (e) TFA-H2O-ClCH2CH2Cl (4:1:1), 3 h, 58%. 
 With a route to hibarimicin B model A and B aglycons established, we attempted β-selective 
installation of the AM'-AT' disaccharide (Scheme 2.50). We imagined that the AM3' axial 
thionocarbonate group would induce a β-selective glycosylation reaction between trichloroacetimidate 
glycosyl donor 2.62 and aglycon (–)-2.348 through neighboring group assistance. Specifically, we 
anticipated that exposure of 2.62 to a suitable Lewis acid would generate stabilized oxocarbenium ion 
2.362 in which the α-face of the intermediate would be blocked by the bridging thionocarbonate group, 
thereby favoring β-selective glycosylation. AM'-AT' glycosyl donor 2.62 was freshly prepared from 
hemiacetal 2.361 using Cl3CCN and Cs2CO3. A solution of 2.62 and algycon (–)-2.348, in a 2.5:1.0 molar 
ratio, was treated with a stoichiometric quantity of TBSOTf at –78 °C to afford 2-deoxyglycoside (–)-
OBn
OMe
OMe
O
MeO
F
a. LiTMP; HMDS
OMe
OMe
OBnOOnPr
BnO
TBSO
OH
F
O
OMe
Me
H
SiMe3
GH
OO
nPr
BnO
TBSO
O
OMe
Me
H
SiMe3
+
(+)-2.68
E
2.355 2.356
GH E
F
H
(a)
2 2
2.354
OBn
MeO
OMe
O
OMe
Br
2.357
OBn
MeO
OMe
O
OMe
SPh
b. PhSH,
    Cs2CO3
(87%)
OMe
OMe
OBnOO
nPr
BnO
TBSO
OH
O
OMe
Me
H
2.358
SiMe3
H
SPh
c. (+)-2.68, 
    LiHMDS
OMe
OMe
OBnOO
nPr
BnO
TBSO
OH
O
OMe
Me
H
(+)-2.359
SiMe3
d. DMTSF,
    DTBMP (75%, 2 steps)
F
E
e. TFA-H2O
(58%)
OMe
OMe
OBnOO
nPr
BnO
TBSO
OH
HO
HO
H
(–)-2.360
SiMe3
FGH E
(b)
13
MgBr2•OEt2
6
 143 
2.363 in 93% yield over two steps with a < 5:95 α:β anomeric ratio. 
Scheme 2.50 Formation of model AM'-AT' glycoside. 
 
Reagents and conditions: (a) Cl3CCN, Cs2CO3, CH2Cl2, 12 h; (b) TBSOTf, CH2Cl2, –78 °C, 5 h, 93%, α:β < 5:95 
(two steps). 
 Next, silyl ether deprotection and installation of the remaining DG' α-glycosidic linkage were 
investigated. The C-ring hydroquinone subunit of (–)-2.636 rendered it sensitive to base promoted 
decomposition by reagents such as TBAF, TASF, or TBAT. Alternatively, we discovered that exposure 
of (–)-2.636 to a deoxygentated solution of Et3N•2HF215 in MeCN cleanly removed the TMS and TBS 
ethers after 36 h at ambient temperature (Scheme 2.51).216 A solution of the resultant pentaol 2.364, DG' 
thiophenyl glycosyl donor 2.63, DTBMP, and 4 Å MS was prepared in CH2Cl2 and cooled to –78 °C 
before AgPF6 was added to the reaction mixture according to Hirama’s procedure in order to generate 
DG' α-glycoside 2.365.179 Unfortunately, under these conditions the C-ring hydroquinone was readily 
                                                      
215 Giudicelli, M. B.; Picq, D.; Veyron, B. Tetrahedron Lett. 1990, 31, 6527–6530. 
 
216 The TMS ether was completely removed within the first 90 min of the reaction as ascertained by 1H NMR of the 
unpurified product mixture. 
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oxidized and the resultant quinone underwent decomposition. Use of the analogous C-ring quinone 
starting material in this reaction similarly led to the formation of an indiscernable product mixture. 
Additionally, we hypothesized that the presence of the AM3' thionocarbonate group during the Ag(I) 
promoted glycosylation might contribute to substrate decomposition. Therefore we decided to reductively 
remove the AM3' thionocarbonate group and to benzyl protect the C-ring hydroquinone, in order to 
suppress oxidative decomposition pathways during DG' glycoside formation. 
Scheme 2.51 Attempted DG' glycoside formation. 
 
Reagents and conditions: (a) Et3N•3HF, Et3N, MeCN, 36 h; (b) 2.63, AgPF6, DTBMP, 4 Å MS, CH2Cl2, –78 °C, 1 h. 
 Penta-benzyl protected aglycon 2.366 (Scheme 2.52) was prepared according to the following 
procedure: a deoxygentated solution of (–)-2.348 and BnBr in DMF was frozen in the liquid nitrogen 
cooled well of a glovebox and charged with Cs2CO3; the reaction vessel was sealed and immediately 
removed from the glovebox and placed in a ice-water bath; the resultant heterogeneous reaction mixture 
was vigorously stirred for 3 h to provide 2.366, after aqueous work-up, in 88% yield. Next, the AM'–AT' 
dissacharide subunit was installed in a β-selective fashion according to the previously described 
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procedure to afford 2-deoxy-β-glycoside 2.367 in 72% yield. Unexpectedly, exposure of 2.367 to AIBN 
and nBu3SnH at 80 °C for 1 h promoted simultaneous reductive removal of the AM3' thionocarbonate 
group and undesired cleavage of the C17'–OBn ether to provide C17' phenol 2.368. 
Scheme 2.52 Attempted preparation of penta-benzyl protected model aglycon . 
 
Reagents and conditions: (a) BnBr, Cs2CO3, DMF, 0 °C, 88%; (b) Cl3CCN, Cs2CO3, CH2Cl2; (b) TBSOTf, CH2Cl2, 
–78 °C, 72%, α:β < 5:95 (two steps); (d) AIBN, nBu3SnH-PhH (1:1), 80 °C. 
 Given this result, we elected to protect the C-ring hydroquine after reductive removal of the AM3' 
thionocarbonate group. A dry/deoxygenated mixture of AM'-AT' β-glycoside (–)-2.363, AIBN, nBu3SnH, 
and PhH was heated to 80 °C for 1 h to afford 2,3-dideoxy-β-glycoside 2.369 (Scheme 2.53). Next, 
treatment of 2.396 with BnBr and Cs2CO3 furnished penta-benzyl protected disaccharide (+)-2.370 in 
52% yield over two steps. Unfortunately, exposure of (+)-2.370 to Et3N•2HF, under previously optimized 
conditions for silyl ether deprotection, resulted in the formation of two regioisomeric products, 2.371 and 
2.372, in which one of the two C-ring benzyl ethers had been removed. This observation prompted us to 
reexamine the use of TBAF for silyl ether deprotection. 
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Scheme 2.53 Protection of C-ring hydroquinone and attempted silyl deprotection. 
 
Reagents and conditions: (a) AIBN, nBu3SnH-PhH (1:1), 80 °C, 1 h; (b) BnBr, Cs2CO3, DMF, 0 °C, 3 h, 52% (two 
steps); (c) Et3N•3HF, Et3N, MeCN, 36 h. 
 Accordingly, (+)-2.370 was treated with TBAF at ambient temperature for 26 h to provide 
sufficient quanitities of triol 2.373 to test DG' glycoside formation (Scheme 2.54). Exposure of 2.373 and 
2.63 to Hirama’s conditions afforded 2-deoxy-α-glycoside 2.374 as an inseperable mixture with glycosyl 
acceptor 2.373 (2.374:2.373 = 1.0:1.6). Attempts to improve the conversion in this reaction included: (1) 
lengthening the reaction time, (2) increasing the stoichiometry of glycosyl donor 2.63, (3) increasing the 
stoichiometry of AgPF6 and DTBMP, (4) increasing the reaction temperature to 0 °C, and (5) slowly 
adding the glycosyl donor 2.63 to a solution of 2.373, AgPF6, and DTBMP over several hours via syringe 
pump. Unfortunately, none of these operational modifications improved the efficiency of the 
glycosylation. Based on these observations we hypothesized that steric hinderence around C10'–OH was 
impeding glycosylation and causing self-condensation of the glycosyl donor 2.63. We anticipated that 
benzyl protection of the free DG3'–OH would prevent unproductive substrate degradation. 
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Scheme 2.54 Successful silyl deprotection and attempted glycosylation of penta-benzyl protected aglycon 2.373. 
 
Reagents and conditions: (a) TBAF, THF, 0 °C → RT, 48%. (b) 2.63, AgPF6, DTBMP, 4 Å MS, CH2Cl2, –78 °C → 
0 °C, (38% conversion based on 2.373). 
 Benzyl glycoside (–)-2.319 was treated with PhSH and SnCl4 to furnish bis-benzyl protected 
thiophenyl glycosyl donor (–)-2.375 in 80% yield with a 1:4 α/β anomeric ratio (Scheme 2.55). The 
potential anomeric selectivity of the desired DG' glycoside formation was assessed using 2,4-dimethyl-3-
pentanol (2.376) as a model glycosyl acceptor. Exposure of β-thiophenyl glycoside (–)-2.375 and 2.376 to 
Hirama’s conditions cleanly afforded 2-deoxy-α-glycoside (–)-2.377 in 83% yield with a >95:5 α:β 
anomeric ratio. 
Scheme 2.55 Preparation of bis-benzyl protected thiophenyl glycosyl donor (–)-2.375 and α-selective model 
glycosylation reaction. 
 
Reagents and conditions: (a) PhSH, SnCl4, CH2Cl2, –78 °C, 80%, α:β = 1:4. (b) 2,4-dimethyl-3-pentanol (2.376), 
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Reagents and conditions for Scheme 2.55 continued: AgPF6, DTBMP, 4 Å MS, CH2Cl2, 0 °C, 83%, α:β > 95:5. 
 While the DG' model glycosylation result was promising, concurrent investigations concerning 
benzyl protection of hibarimicin B model B discouraged us from pursuing this approach (Scheme 2.56). 
Exposure of the napthol triol (–)-2.360 to BnBr and Cs2CO3 under oxygen-free conditions at 0 °C resulted 
in a complex mixture of products (Scheme 2.56a). Alternatively, acetonide (+)-2.359 could be protected 
to afford benzyl ether 2.379 in 40% yield under the same conditions. However, exposure of 2.379 to 
TFA-H2O, under previously optimized conditions for acetonide hydrolysis, provided benzyl-deprotected 
napthol (+)-2.359 as the major product (Scheme 2.56b). These results indicated that benzyl protection of 
an analogous hibarimicin B (2.1) precursor would be problematic. Therefore, an alternative strategy for α-
selective DG/DG' monosaccharide installation was investigated. 
Scheme 2.56 Unsuccessful hibarimicin B model B benzyl protection. 
 
Reagents and conditions: (a) BnBr, Cs2CO3, DMF, 0 °C. (b) BnBr, Cs2CO3, DMF, 0 °C, 40%. (c) ClCH2CH2Cl-
TFA-H2O (4:1:1). 
 Our revised aproach for formation of the remaining 2-deoxy-α-glycosidic linkage relied on the use 
of an axial 2-iodo directing group to control anomeric selectivity (Scheme 2.57). 2-Iodo-glycosyl 
trichloroacetimidate 2.64 was prepared from hemiacetal 2.380 under standard conditions. Exposure of a 
solution of 2.64 and 2,4-dimethyl-3-pentanol (2.376) in CH2Cl2 to TBSOTf at –78 °C provided 2-deoxy-
2-iodo-α-glycoside (–)-2.382 in 83% yield with >95:5 α:β anomeric ratio. Presumably the high level of α-
selectivity in this transformation was due to nucleophilic attack of 2.376 on iodonium intermediate 2.381. 
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Finally, the 2-iodo substituent was reductively cleaved with AIBN and nBu3SnH at 80 °C to give 2-deoxy-
α-glycoside (–)-2.377 in 92% yield. 
Scheme 2.57 Preparation of model DG/DG' α-glycoside. 
 
Reagents and conditions: (a) Cl3CCN, DBU, CH2Cl2, –10 → 0 °C; (b) TBSOTf, 4 Å MS, CH2Cl2, –78 °C, 83%, α:β 
> 95: 5 (two steps); (c) AIBN, nBu3SnH-PhH (1:1), 80 °C, 92%. 
 Given this promising result, the same conditions were applied toward glycosylation of the 
hibiramicin B model A algycon 2.364, which was prepared through silyl deprotection of (–)-2.363, under 
previously optimized conditions (Scheme 2.58). A solution of 2.364 and trichloroacetimidate glycosyl 
donor 2.63 in CH2Cl2 was exposed to a variety of Lewis acids including: BF3•OEt2, ZnCl2•OEt2, 
TIPSOTf, and TBSOTf, resulting in the α-selective formation of mono- and bis-glycosylated products 
2.383 and 2.384, respectively. Complete consumption of 2.364 was achieved using all of the 
aformentioned Lewis acids. However, it was surprising to observe that the C14' tertiary carbinol of the 
mono-glycosylated product (2.383) underwent a second glycosylation reaction at a rate commensurate 
with the first glycosylation of 2.364. Under optimized conditions, a solution of 2.64 (3.7 equiv) in CH2Cl2 
was added via syringe pump to a solution of 2.364 (1.0 equiv) and TBSOTf (1.0 equiv) in CH2Cl2 at –
78 °C over 90 min to afford mono- and bis-α-glycosides 2.383 and 2.384 in a 5:1 ratio. Next, the DG2' 
iodo and AM3' thionocarbonate directing groups were simultaneously removed from 2.383 using AIBN 
and nBu3SnH at 80 °C to give compound (–)-2.385 in 27% yield over three steps. The poor overall yield 
for these transformations stems from the unstable nature of the intermediates toward purification and 
handling, combined with the marginal selectivity for mono- over bis-glycosylation. Finally, global benzyl 
deprotection/D-ring oxidation of (–)-2.385 was attempted via hydrogenolysis in EtOAc with Pearlman’s 
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catalyst217 followed by filtering and exposure to air to yield a product which we have tentatively assigned 
as hibarimicin B model A (2.334) based on the 1H NMR and the mass spectrum of the unpurified product 
mixture.  
Scheme 2.58 Synthesis of hibarimicin B model A. 
 
Reagents and conditions: (a) Et3N•3HF, Et3N, MeCN. (b) 2.64, TBSOTf, 4 Å MS, CH2Cl2, –78 °C, 2.383:2.384 (5:1 
ratio)218 (c) AIBN, nBu3SnH-PhH (1:1), 80 °C, 27% (three steps). (d) H2, Pd(OH)2/C, EtOAc; then air. 
 With a tentative route to the hibarimicin B model A (2.334) established, we sought to apply the 
same reaction conditions toward the synthesis of hibarimicin B model B (2.335) (Scheme 2.59). 
Glycosylation of aglycon (–)-2.360 and trichloroacetimidate 2.62 was accomplished with TBSOTf to 
yield β-glycoside 2.386. However, 2.386 was extremely unstable to purification on silica gel, which 
prevented accurate determination of the product yield. Treatment of 2.386 with a deoxygenated solution 
                                                      
217 Pearlman, W. M. Tetrahedron Lett. 1967, 8, 1663–1664. 
 
218 Relative product distribution based on the intergration of 1H NMR spectrum of unpurified product mixture. 
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of Et3N•2HF at ambient temperature resulted in the formation of a variety of undesired products, 
including several in which the disaccharide had been cleaved from the aglycon based on mass 
spectroscopy. While this result was discouraging, we anticipated the corresponding pseudodimeric 
substrate would be much more stable to silyl deprotection conditions based on our previous experience 
with intermediates toward the synthesis of hibarimicinone (2.2). 
Scheme 2.59 Hibarimicin B model B glycosylation and attempted silyl deprotection. 
 
Reagents and conditions: (a) Cl3CCN, Cs2CO3, CH2Cl2; (b) TBSOTf, CH2Cl2, –78 °C, α:β < 5:95 (two steps); (c) 
Et3N•3HF, Et3N, MeCN. 
 Progress Toward a Total Synthesis of Hibarimicin B 2.12
 Satisfied with our model studies, we turned our attention to the synthesis of hibarimicin B (2.1). 
While the absolute stereochemistry of the C2–C2' biaryl linkage of 2.1 had not yet been confirmed, we 
assumed that it corresponded to the stereochemistry of hibarimicinone (2.2). Therefore, the atropisomers 
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of unsymmetrical biaryl annulation donor precursor 2.388a and 2.388b219 were separated through chiral 
semi-preparatory HPLC (Scheme 2.60). 220 Unsymmetrical biaryl annulation donor 2.67a was then 
prepared via double deprotonation of enantiopure 2.388a with LiTMP followed by a short exposure to S-
phenyl benzenethiosulfonate to chemoselectively install the phenyl sulfide moiety at C6. Treatment of 
2.67a and AB-/HG-enone (+)-2.68 with LiHMDS under rigorously oxygen-free conditions followed by 
addition of KHMDS after 20 h at 0 °C and warming the rection mixture to ambient temperature for an 
additional 12 h yielded octacycle (–)-2.128 as a single atropisomer in 69% yield.  
  
                                                      
219 The absolute stereochemistry of biaryl precursor 2.388a was assigned based on its corresponding annulation 
product ((–)-2.128).  
 
220 Direct chiral resolution of the racemic unsymmetrical biaryl annulation donor (±)-2.67 was inefficient due to 
solubility issues. 
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Scheme 2.60 Chiral HPLC resolution of unsymmetrical biaryl annulation donor precursor (±)-2.388 and two-
directional double annulation reaction. 
 
Reagents and conditions: (a) LiTMP, THF, –78 °C; then Ph(O)2SSPh, 69%. (b) LiHMDS, THF, –78 → 0 °C; then 
KHMDS, 0 °C → RT, 69%. 
 Next, octacycle (–)-2.128 was converted to nonacycle (–)-2.133 in three steps including: (1) F-
ring aromatization via elimination of the C6-benzylic phenyl sulfide with DMTSF, (2) DDQ oxidation of 
the C-ring hydroquinone to quinone, and (3) biomimetic etherification promoted by anhydrous HCl 
(Scheme 2.61). Next, the H-ring acetonide diol protecting group was hydrolyzed by exposure of (–)-2.133 
to a deoxygenated solution of 1,2-dichloroethane-TFA-H2O (4:1:1) at ambient temperature for 2 h to 
furnish hibarimicin B aglycon (–)-2.389 in 50% yield. 
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Scheme 2.61 Synthesis of hibarimicin B algycon (–)-2.389. 
 
Reagents and conditions: (a) DMTSF, DTBMP, MeCN, 0 °C → RT, 88%; (b) DDQ, PhMe, 0 °C; (c) HCl, 
ClCH2CH2Cl, 4 °C, 72% (two steps); (c) ClCH2CH2Cl-TFA-H2O (4:1:1), 50%. 
 Proposed Completion of the Total Synthesis of Hibarimicin B  2.13
 Our proposed completion of hibarimicin B (2.1) follows the steps developed for the synthesis of 
hibarimicin B model A (2.334) and is outlined in Scheme 2.62. We anticipate that a two-directional 
double glycosylation between algycon (–)-2.389 and trichloroacetimidate 2.62 promoted by TBSOTf will 
provide bis-glycoside 2.390 with high levels of β-selectivity. Preliminary studies on this transformation 
indicated that full conversion to a bis-glycosylated product was possible using five equivalents of 2.62. 
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Additionally, one major diasteromeric product was formed in this reaction, which we assumed 
corresponded to the structure of 2.390. Once this procedure has been optimized and the product fully 
assigned, we plan to remove the silyl ether protecting groups with Et3N•2HF to provide aglycon 2.391 for 
the second key two-directional double glycosylation reaction. α-Selective glycosylation between 2.391 
and 2-iodo-glycosyl trichloroacetimidate 2.64 will then be attempted to potentially access tetra-glycoside 
2.392. One problem we anticipate in this transformation is the undesired glycosylation of the C14 and 
C14' tertiary carbinols. However, we expect these byproducts will be easily separated from 2.392. Next, 
the AM3/AM3' and DG2/DG2' directing groups will be removed using AIBN and nBu3SnH to give 
hibarimicin B precursor 2.393. Finally, global benzyl ether deprotection of 2.393 via hydrogenation 
followed by mild acidification of the reaction mixture to prevent atropisomerism and exposure of the 
resultant D-ring hydroquinone to air is expected to afford hibarimicin B (2.1) as a single atropisomer. 
Further progress towards the completion of this goal will be reported in due course. 
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Scheme 2.62 Proposed completion of hibarimicin B. 
 
 Conclusion  2.14
 In conclusion, Brian B. Liau and I have made significant progress toward the completion of the 
total synthesis of hibarimicin B (2.1). We have prepared C14-hydroxy ent-AB/HG-enone (–)-2.110 and 
AB-/HG-enone annulation acceptor (+)-2.68 on multi-gram scale starting from methyl-α-D-
glucopyranoside. The synthesis of (–)-2.110 and (+)-2.68 featured a key Lewis acid-promoted contrasteric 
Diels–Alder reaction to set the relative stereochemistry of the cis-decalin carbon framework and a tandem 
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silyl-zincate 1,6-addition/enolate oxidation sequence to functionalize the carbon skeleton. Additionally, 
we have completed enantioselective syntheses of hibarimicinone (2.2), atrop-hibarimicionone (2.135), 
HMP-Y1 (2.9), atrop-HMP-Y1, and HMP-P1 (2.12) via a two-directional double annulation strategy. The 
use of a racemic biaryl annulation donor for the synthesis of 2.2 and 2.135 enabled assessment of their 
barriers to atropisomerism, which was anticipated to be critical for the total synthesis of 2.1. Chiral 
resolution of a biaryl annulation donor precursor has enabled the synthesis of the orthogonally protected 
aglycon of hibarimicin B ((–)-2.389) as a single atropisomer.  
 In order to develop conditions for two-directional installation of the sugar subunits of 2.1, the 
synthesis of hibarimicin B models A (2.334) and B (2.335) were been investigated. Towards this end, 
AM-AT/AM'-AT' and DG/DG' glycosyl donors were prepared. A 3-thionocarbonate directing group was 
demonstrated to be a useful stereocontrolling element for the formation of 2-deoxy-β-glycosidic bonds. 
Furthermore, reductive removal of the 3-directing group provided access to 2,3-didexoy-β-glycosides, 
typified by the AM-AT/AM'-AT' glycosidic linkage, in high overall efficieny. The highly oxidizable 
nature of the hibarimicin B model A aglycon necessitated the development of an axially oriented 2-iodo 
directing group for the α-selective installation of the DG/DG' sugar subunits of 2.1 under Lewis acidic 
conditions. This well-known strategy has been applied for the first time to the stereoselective installation 
of a digitoxose sugar after reductive removal of the 2-iodo directing group. We are currently pursuing the 
completion of 2.1 using the methods developed for the synthesis of hibarimicin B model A (2.334). 
 Future Goals 2.15
 Ultimately, our goal is to determine the cellular target of 2.1 in order to understand the mechanism 
by which it elicits growth-inhibitory and proliferation-inducing activity on various cancer cell lines. One 
approach to achieve this goal is to compare the biological activity of hibarimicin B (2.1) with its model 
2.334. If 2.334 exhibits commensurate activity and selectivity with 2.1, we plan to perform affinity 
chromatography on a matrix bond analog of 2.334 in order to identify its molecular target.221 To do so, a 
                                                      
221 Ong, S.-E.; Schenone, M.; Margolin, A. A.; Li, X.; Do, K.; Doud, M. K.; Mani, D. R.; Kuai, L.; Wang, X.; Wood, 
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linker attachment site on 2.334, which does not perturb target-binding of the small-molecule, will be 
identified. Since the AM-AT/AM'-AT' and DG/DG' sugar subunits of 2.1 appear to be associated with its 
anti-cancer activity,99g it seems logical to locate the linker attachment site at the distal end of 2.334. One 
could imagine modifying the C3' position of 2.334 with a variety of affinity labels through a Michael 
addition/methoxide elimination sequence (Scheme 2.63).222 For instance, treatment of 2.334 with biotin 
conjugated amine 2.394 of variable chain length is expected to deliver biotin labeled hibarimicin B model 
A (2.395). 
Scheme 2.63 Preparation of biotin labeled hibarimicin B model A (2.395). 
 
 While the mechanism by which 2.1 interacts with its biological target is not known, we hypothesize 
that it could be through covalent modification (Scheme 2.64). Specifically, we imagined the D-ring 
quinone in 2.1 could be reduced to generate naphthol intermediate 2.396. Expulsion of the ether bridge in 
2.396 would then provide a highly reactive, electrophilic ortho-quinone methide intermediate 2.397, 
which could engage in covalent modification of a biological target. A crystal structure of 2.1 bound to its 
target might prove or disprove this hypothesis. 
  
                                                                                                                                                                              
J. L.; Tolliday, N. J.; Koehler, A. N.; Marcaurelle, L. A.; Golub, T. R.; Gould, R. J.; Schreiber, S. L.; Carr, S. A. 
Proc. Natl. Acad. Sci. USA, 2009, 106, 4617–4622 and references therein. 
 
222 Abel, U.; Simon, W.; Eckard, P.; Hansske, F. G. Bio. Med. Chem Lett. 2006, 16, 3292–3297. 
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Scheme 2.64 Hypothetetical interaction of hibarimicin B with its unknown biological target. 
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Experimental Section
 161 
General Procedures. All reactions were performed in oven-dried or flame-dried glassware equipped with 
a Teflon® PTFE coated stirring bar under a positive pressure of argon unless otherwise noted. Where 
necessary (so noted), reactions were performed in Schlenk tubes fitted with a PTFE stopcock or pressure 
tubes fitted with a PTFE bushing. Flash column chromatography was performed as described by Still et 
al. employing silica gel 60 (40-63 µm, Whatman).223 Preparatory thin-layer chromatography (PTLC) was 
performed using 0.50 mm silica gel 60 F254 plates purchased from EMD Chemicals. Analytical thin-layer 
chromatography (TLC) was performed using 0.25 mm silica gel 60 F254 plates or 0.25 mm silica gel RP-
18 F254s plates (so noted) purchased from EMD Chemicals. TLC plates were visualized by exposure to 
ultraviolet light (UV) and/or exposure to an aqueous solution of ceric ammonium molybdate (CAM) 
followed by heating on a hot plate. Purification and isomerization studies were performed on an Agilent 
1200 series 6120 quadrupole HPLC.  
 
Materials. Commercial reagents and solvents were used as received with the following exceptions: 
tetrahydrofuran (THF), diethyl ether (Et2O), dichloromethane (CH2Cl2), acetonitrile (MeCN), 
hexamethyldisilazane (HMDS), toluene (PhMe), benzene (PhH), and N,N-dimethylformamide (DMF) 
were degassed with argon and passed through a solvent purification system (designed by J.C. Meyer of 
Glass Contour) utilizing alumina columns as described by Grubbs et al. 224  Triethylamine, 
diisopropylethylamine, 2,2,6,6-tetramethylpiperidine, pyridine, and chlorotrimethylsilane were distilled 
over calcium hydride before use. N,N,N',N'-Tetramethylethylenediamine was distilled over potassium 
hydroxide immediately before use. Trimethylsilyl trifluoromethanesulfonate was distilled before use. The 
Celite used was Celite® 545, purchased from J.T. Baker. The molarities of n-butyllithium solutions were 
determined by titration using 1,10-phenanthroline as an indicator (average of three determinations). The 
molarity of n-propylmagnesium chloride solution was determined by titration with iodine according to the 
                                                      
223 Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 1978, 43, 2923–2925. 
 
224 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. Organometallics 1996, 15, 1518–
1520. 
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protocol of Knochel and Krasovsky (average of three determinations). 225 
Oxodiperoxymolybdenum(pyridine)(hexamethylphosphoric triamide) (MoOPH) was prepared according 
to the procedure of Vedejs and Larsen.226 Anhydrous cerium(III) chloride was obtained by drying 
cerium(III) chloride heptahydrate under reduced pressure according to the procedure of Dimitrov and 
coworkers.227 A 1.0 M solution of dimethylphenylsilyllithium in THF was prepared according to the 
procedure of Fleming and coworkers.228 Where necessary (so noted), solutions were deoxygenated by 
alternating freeze (liquid nitrogen)/evacuation/thaw cycles (FPT, five iterations). 
 
Instrumentation. 1H NMR spectra were recorded with a Varian INOVA-600, Varian INOVA-500, or 
Varian Mercury 400 spectrometer, are reported in parts per million (δ), and are calibrated using residual 
undeuterated solvent as an internal reference (CDCl3: δ 7.26 (CHCl3), CD2Cl2: δ 5.32 (CDHCl2), CD3OD: 
δ 3.31 (CD2HOD), C6D6: δ 7.15 (C6D5H). Data for 1H NMR spectra are reported as follows: chemical 
shift (δ ppm) (multiplicity, coupling constant (Hz), integration). Multiplicities are reported as follows: s = 
singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad, or combinations thereof. 13C NMR 
spectra were recorded with a Varian INOVA-600, Varian INOVA-500, or Varian Mercury 400 
spectrometer, are reported in parts per million (δ) and are referenced from the carbon resonances of the 
solvent (CDCl3: δ 77.00, CD2Cl2: δ 54.00, CD3OD: δ 49.15, C6D6: δ 128.06, DMSO-d6: 39.51). Infrared 
(IR) data were recorded on a Varian 1000 Scimitar FT-IR spectrophotometer, were referenced to a 
polystyrene standard, and are reported in frequency of absorption (cm-1). High-resolution mass spectra 
(HRMS) were recorded using electrospray ionization (ESI) mass spectroscopy experiments on an Agilent 
6210 TOF LC/MS. Optical rotations were measured on a Jasco P-2000 digital polarimeter with a sodium 
                                                      
225 Krasovsky, A.; Knochel, P. Synthesis 2006, 5, 890–891. 
 
226 Vedejs, E.; Larsen, S. Org. Synth. 1986, 64, 127–132. 
 
227 Dimitrov, V.; Kostova, K.; Genov, M. Tetrahedron Lett. 1996, 37, 6787–6790. 
 
228 Fleming I.; Newton, T. W.; Roessler, F. J. Chem. Soc., Perkin Trans. I 1981, 2527–2532. An adaptation of this 
procedure was also consulted: Lettan II, R. B.; Milgram, B. C.; Scheidt, K. A. Org. Synth. 2007, 84, 22–31. 
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lamp (average of at least four measurements for each sample). Circular dichroism (CD) spectra were 
collected on a Jasco J-710 spectropolarimeter equipped with a temperature controller (at 23 ± 0.1 °C) 
using the following standard measurement parameters: 0.5 nm step resolution, 50 nm/sec speed, 4 
accumulations, 1 sec response, 1 nm bandwidth, 1.0 cm path length. All spectra were converted to a 
uniform scale of molar ellipticity after background subtraction. Curves shown are smoothed with standard 
parameters. Microwave irradiation was accomplished using a CEM Discover microwave reactor. 
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2-Iodo-4-methylcyclohex-2-enone ((±)-1.133): 
A 2-L, 3-necked, round-bottomed flask equipped with a 500-mL equal pressure graduated 
addition funnel, and two rubber septa was charged with a solution of diisopropylamine (72.4 mL, 512 
mmol, 1.15 equiv) and THF (245 mL) and cooled to 0 °C. A solution of nBuLi in hexanes (2.60 M, 189 
mL, 490 mmol, 1.10 equiv) was added dropwise to the stirred reaction mixture over 30 min via addition 
funnel and then cooled to –78 °C. A separate 1-L round-bottomed flask was charged with 3-ethoxy-2-
cyclohexen-1-one (1.130)(62.4 g, 445 mmol, 1.00 equiv) and azeotropically dried with three portions of 
benzene. THF (450 mL) was introduced and the resultant solution was added dropwise to the cooled 
reaction mixture via cannula over 1 h. The transfer was completed with two additional portions of THF 
(50 mL). After 30 min, iodomethane (33.2 mL, 75.7 g, 534 mmol, 1.20 equiv) was added quickly to the 
cold, bright yellow mixture via syringe. After 15 min, the mixture was allowed to warm to ambient 
temperature over 12 h. A saturated aqueous ammonium chloride solution (500 mL) was added to the 
reaction mixture. The layers were separated and the aqueous layer was extracted with Et2O (3 × 500 mL). 
The combined organic layers were washed with water (2 × 500 mL) and brine (500 mL). The organic 
layer was dried over anhydrous magnesium sulfate, filtered, and carefully concentrated under reduced 
pressure to furnish alkoxy cyclohexenone (±)-1.131 as a volatile, yellow oil that was used without further 
purification. 
 A 3-L, 2-necked, round-bottomed flask was charged with a slurry of lithium aluminum hydride 
(13.0 g, 343 mmol, 0.77 equiv) and Et2O (1.00 L). A separate 1-L round-bottomed flask was charged with 
a solution of alkoxy cyclohexenone (±)-1.131 and Et2O (440 mL), which was added dropwise to the 
cooled reaction mixture via cannula over 2 h at ambient temperature. The transfer was completed with 
two additional portions of Et2O (100 mL). After 30 min, sodium sulfate decahydrate (300 g, 96.7 mmol, 
O
OEt
LDA, THF,
–78 °C, 1.5 h;
then MeI, 
–78 °C → RT
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O
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2.17 equiv) was added portion wise over 1 h. The resultant mixture was carefully acidified to pH 2-3 with 
an aqueous solution of HCl (2.0 N). The layers were separated and the organic layer was washed with a 
saturated aqueous sodium bicarbonate solution (1.0 L), and brine (1.0 L), dried over anhydrous 
magnesium sulfate, filtered, and carefully concentrated under reduced pressure to furnish 4-methyl-2-
cyclohexene-1-one (±)-1.132 a volatile, pale-yellow oil that was used without further purification. 
 A 1-L round-bottomed flask was charged with a solution of iodine (243 g, 957 mmol, 2.15 equiv), 
pyridine (340 mL) and Et2O (340 mL) and cooled to 0 °C. A separate 1-L round-bottomed flask was 
charged with a solution of (±)-1.132, pyridine (340 mL) and Et2O (340 mL), which was added dropwise 
to the stirred, cooled reaction mixture via cannula over 1 h. The transfer was completed with two 
additional portions of Et2O (50 mL). The resultant mixture was allowed to warm to ambient temperature 
over 12 h before water (1.0 L) was added. The layers were separated and the organic layer was washed 
with an aqueous solution of HCl (1.0 M, 2 × 1.0 L), water (1.0 L), an aqueous solution of sodium 
thiosulfate (10% w/v, 1.0 L mL), and brine (1.0 L), dried over anhydrous magnesium sulfate, filtered, and 
concentrated under reduced pressure. The residue was purified by flash column chromatography (silica 
gel, eluent: 10 % EtOAc in hexanes) to afford 2-iodo-4-methylcyclohex-2-enone (±)-1.133 (60.0 g, 57% 
over three steps) as a yellow oil. 
1H NMR (600 MHz, CDCl3) δ: 7.59 (dd, J = 3.1, 1.2 Hz, 1 H), 2.75 (td, J = 4.8, 16.4 Hz, 2 H), 2.71–2.63 
(m, 1 H), 2.54 (ddd, J = 4.8, 12.6, 16.4 Hz, 1 H), 2.20–2.11 (m, 1 H), 1.79–1.69 (m, 1 H), 1.18 (d, J = 7.1 
Hz, 5 H). 
13C NMR (125 MHz, CDCl3) δ: 192.0, 164.7, 103.0, 35.7, 35.6, 30.7, 19.7. 
FTIR (thin film) cm-1: 2957, 2929, 2870, 1685, 1584, 1452, 1317, 1153, 944, 805. 
HRMS (ESI) (m/z) calc’d for C7H9INaO [M+Na]+: 258.9596, found 258.9614. 
TLC (15% EtOAc in hexanes), Rf : 0.35 (UV, CAM). 
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(E)-4-Methyl-2-(prop-1-en-1-yl)cyclohex-2-enone ((±)-1.122): 
A 100-mL round-bottomed flask was charged with (±)-1.133 (1.60 g, 7.00 mmol, 1.00 equiv), 
(E)-prop-1-en-1-ylboronic acid (1.134), an aqueous sodium carbonate solution (2.0 M, 11.6 mL), and 
THF (23.3 mL) before it was equipped with a reflux condenser. The reaction mixture warmed to 60 °C 
for 10 h.  The resultant mixture was allowed to cool to ambient temperature before it was diluted with 
EtOAc (50 mL) and washed with brine (50 mL). The layers were separated and the organic layer dried 
over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was 
purified by flash column chromatography (silica gel, eluent: 5 → 10 % EtOAc in hexanes) to afford (E)-
4-methyl-2-(prop-1-en-1-yl)cyclohex-2-enone (±)-1.122 (0.80 g, 76%) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ: 6.64 (s, 1 H), 6.11 (d, J = 11.5 Hz, 1 H), 5.82–5.69 (m, 1 H), 2.69–2.58 
(m, 1 H), 2.52 (td, J = 4.5, 16.5 Hz, 1 H), 2.37 (ddd, J = 4.7, 12.7, 17.1 Hz, 1 H), 2.09 (dd, J = 4.8, 12.8 
Hz, 1 H), 1.70 (s, 3 H), 1.17 (d, J = 7.1 Hz, 3 H). 
13C NMR (100 MHz, CDCl3) δ: 199.1, 153.1, 134.2, 128.2, 123.9, 37.2, 31.6, 30.8, 20.7, 14.5. 
FTIR (thin film) cm-1: 3023, 2957,3932, 2971, 1676, 1454, 1411, 1345, 1177, 1125, 1110, 937, 723. 
HRMS (ESI) (m/z) calc’d for C10H14NaO [M+Na]+: 173.0942, found 173.0937. 
TLC (15% EtOAc in hexanes), Rf : 0.43 (UV, CAM). 
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O-Allyl β-ketoester (±)-1.145: 
A 2-L round-bottomed flask was charged with a solution of phenylselenyl chloride (67.2 g, 351 
mmol, 1.11 equiv) and CH2Cl2 (500 mL) and cooled to 0 °C before pyridine (35 mL, 433 mmol, 1.37 
equiv) was added via syringe. A separate 500 mL round-bottomed flask was charged with methyl 2-
hydroxy-5-methylcyclohex-1-enecarboxylate ((±)-1.141) (53.8 g, 316 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. CH2Cl2 (132 mL) was introduced and the resultant 
solution was added dropwise to the reaction mixture via cannula over 2 h. The transfer was completed 
with two additional portions of CH2Cl2 (25 mL). After 1 h, the reaction mixture was allowed to warm to 
ambient temperature and poured into an aqueous solution of HCl (10% w/v, 500 mL). The layers were 
separated and the organic layer was washed with an aqueous solution of HCl (10% w/v, 2 × 500 mL), a 
saturated aqueous sodium bicarbonate solution (1.0 L), and brine, dried over anhydrous sodium sulfate, 
filtered, and concentrated under reduced pressure to furnish α-phenylseleno β-ketoester (±)-S1.1 as a 
bright red syrup that was used without further purification. 
A 3-L, 2-necked, round-bottomed flask equipped with a 250-mL equal pressure graduated 
addition funnel and a rubber septa was charged with a solution of α-phenylseleno β-ketoester (±)-S1.1 and 
CH2Cl2 (632 mL) and cooled to 0 °C before an aqueous solution of hydrogen peroxide (30% wt., 64.5 
mL, 2.00 equiv) was added dropwise via equal pressure graduated addition funnel over 2 h. Stirring 
continued for an addition 1 h before sodium sulfite (40.0 g, 1.00 equiv) was carefully added to decompose 
any excess hydrogen peroxide. After stirring for 30 min, a saturated aqueous sodium bicarbonate solution 
OH
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(500 mL) was added to the reaction mixture, which was subsequently allowed to warm to ambient 
temperature. The layers were separated and the aqueous layer was extracted with EtOAc (3 × 500 mL). 
The combined organic layers were washed with a saturated aqueous sodium bicarbonate solution (500 
mL) and brine (1.0 L), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced 
pressure to yield enone (±)-1.142 as a yellow oil that was used without further purification. 
A 2-L, 2-necked, round-bottomed flask equipped with a 500-mL equal pressure graduated 
addition funnel, a reflux condenser and a rubber septa was charged with magnesium turnings (36.9 g, 1.52 
mol, 4.80 equiv). A separate 500 mL round-bottomed flask was charged with alkyl bromide 1.143 (86.9 g, 
379 mmol, 1.20 equiv) and azeotropically dried with three portions of benzene. THF (380 mL) was 
introduced and the resultant solution added dropwise to the magnesium turnings via cannula over 1 h at a 
rate to maintain reflux. After the addition was complete, reflux was maintained for an additional 2 h. The 
reaction mixture was then cooled to –78 °C before a solution of copper(I) bromide dimethyl sulfide 
complex (15.7 g, 76.5 mmol, 0.250 equiv) and dimethyl sulfide (150 mL) was added dropwise via 
addition funnel over 30 min. A separate 500 mL round-bottomed flask was then charged with enone (±)-
1.142 and azeotropically dried with three portions of benzene. THF (380 mL) was introduced and the 
resultant solution was cooled to –78°C before being transferred dropwise via a dry-ice wrapped cannula 
to the stirred, cooled reaction mixture over 30 min. The transfer was completed with two additional 
portions of THF (25 mL). The resultant slurry stirred for 1.5 h before a saturated aqueous ammonium 
chloride solution (500 mL) was added to the reaction mixture, which was subsequently allowed to warm 
to ambient temperature. The resultant heterogeneous mixture was filtered through a pad of Celite, which 
was rinsed with water (100 mL) and EtOAc (2 × 200 mL). The layers of the filtrate were separated and 
the aqueous layer was extracted with EtOAc (3 × 500 mL). The combined organic layers were washed 
with a saturated aqueous sodium bicarbonate solution (1.0 L) and brine (1.0 L), dried over anhydrous 
sodium sulfate, filtered, and concentrated under reduced pressure to yield β-ketoester (±)-1.144 as a dark 
brown oil that was used without further purification. 
A 2-L, 2-necked, round-bottomed flask equipped with a 250-mL equal pressure graduated 
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addition funnel and a rubber septa was charged with a dispersion of sodium hydride (60% wt. in mineral 
oil, 25.3 g, 632 mmol, 2.00 equiv) and DMF (632 mL) and cooled to 0 °C. A separate 500 mL round-
bottomed flask was charged with β-ketoester (±)-1.144 and azeotropically dried with three portions of 
benzene. DMF (100 mL) was introduced and the resultant solution transferred dropwise to the stirred, 
cooled reaction mixture via cannula to the over 30 min. The transfer was completed with two additional 
portions of DMF (25 mL). The resultant reaction mixture was subsequently allowed to warm to ambient 
temperature. After 45 min, the reaction mixture was re-cooled to 0 °C. Allyl bromide (164 mL, 1.90 mol, 
6.00 equiv) was then added dropwise to the stirred reaction mixture via addition funnel over 30 min. After 
30 min, the reaction mixture was allowed to warm to ambient temperature and stirred for an additional 2 
h. An ice/water mixture was then slowly added to the stirred reaction mixture, which was then allowed to 
warm to ambient temperature. The mixture was diluted with Et2O (500 mL) and the layers were 
separated. The aqueous layer was further extracted with Et2O (3 × 400 mL). The combined organic layers 
were then washed with water (3 × 1.0 L) and brine (1.0 L), dried over anhydrous magnesium sulfate, 
filtered, and concentrated under reduced pressure. The residue was then purified by flash column 
chromatography (silica gel, eluent: gradient, 5% → 15% EtOAc in hexanes) to afford O-allyl β-ketoester 
(±)-1.145  (47.2 g, 42% over four steps, 10:1 d.r.) as a pale yellow oil. 
1H NMR (600 MHz, CDCl3) δ: 7.36–7.30 (m, 4 H), 7.29–7.24 (m, 1 H), 5.93 (tdd, J = 5.1, 10.5, 17.1 Hz, 
1 H), 5.36 (dd, J = 1.2, 17.2 Hz, 1 H), 5.19 (dd, J = 0.8, 10.5 Hz, 1 H), 4.48 (s, 2 H), 4.41–4.33 (m, 2 H), 
3.71 (s, 3 H), 3.49–3.39 (m, 2 H), 2.38–2.32 (m, 1 H), 2.26–2.17 (m, 2 H), 1.84–1.73 (m, 2 H), 1.71–1.62 
(m, 1 H), 1.61–1.47 (m, 2 H), 1.47–1.40 (m, 1 H), 1.34 (dddd, J = 4.8, 8.4, 10.4, 13.5 Hz, 1 H), 0.93 (d, J 
= 6.7 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 169.0, 158.5, 138.6, 133.8, 128.2, 127.5, 127.4, 116.8, 112.7, 72.7, 70.5, 
68.7, 51.2, 41.4, 31.0, 28.6, 27.3, 24.8, 22.7, 18.5. 
FTIR (thin film) cm-1: 2931, 2855, 1712, 1453, 1433, 1369, 1262, 1193, 1168, 1102, 928, 738, 698. 
HRMS (ESI) calc’d for C22H30KO4 [M+K]+: 397.1776, found 397.1793. 
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TLC (15% EtOAc in hexanes), Rf: 0.29 (UV, CAM). 
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C-Allyl β-ketoester (±)-1.146 and (±)-1.184: 
A 7-mL microwave vial was charged with O-allyl β-ketoester (±)-1.145 (3.5 g, 9.76 mmol) then 
sealed and irradiated in a microwave reactor (200 watt power) to 185 °C and held at that temperature for 
15 min. The resulting yellow oil was then purified by flash column chromatography (silica gel, eluent: 
gradient, 10% → 15% EtOAc in hexanes) to afford C-allyl β-ketoester (±)-1.146 (1.49 g, 43%) and (±)-
1.184 (1.55 g, 44%) as a colorless oils. 
C-Allyl β-ketoester (±)-1.146: 
1H NMR (600 MHz, CDCl3) δ: 7.38–7.31 (m, 4 H), 7.30–7.27 (m, 1 H), 5.65 (ddd, J = 1.3, 5.1, 12.6 Hz, 
1 H), 5.07 (d, J = 12.6 Hz, 1 H), 5.05 (d, J = 5.1 Hz, 1 H), 4.49 (s, 2 H), 3.66 (s, 3 H), 3.44–3.39 (m, 2 H), 
2.96 (tdd, J = 1.3, 5.6, 14.3 Hz, 1 H), 2.70 (dt, J = 6.4, 14.3 Hz, 1 H), 2.48 (dd, J = 8.7, 14.4 Hz, 1 H), 
2.42 (ddd, J = 3.1, 4.4, 15.0 Hz, 1 H), 2.13–2.05 (m, 1 H), 1.91 (tdd, J = 3.2, 6.5, 13.4 Hz, 1 H), 1.73–
1.58 (m, 3 H), 1.53–1.45 (m, 1 H), 1.33 (dddd, J = 1.2, 5.4, 11.4, 25.2 Hz, 2 H), 1.03 (d, J = 6.6 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 207.5, 171.4, 138.6, 134.3, 128.3, 127.5, 127.5, 118.6, 72.9, 70.4, 64.6, 
52.0, 49.2, 40.0, 36.4, 33.9, 33.6, 30.4, 27.2, 20.3. 
FTIR (thin film) cm-1: 2931, 2856, 1712, 1453, 1432, 1363, 1262, 1100, 920, 737, 698. 
HRMS (ESI) calc’d for C22H30NaO4 [M+Na]+: 381.2042, found 381.2069. 
TLC (15% EtOAc in hexanes), Rf: 0.32 (UV, CAM). 
C-Allyl β-ketoester (±)-1.184: 
1H NMR (600 MHz, CDCl3) δ: 7.37–7.30 (m, 4 H), 7.28 (d, J = 7.0 Hz, 1 H), 5.84 (dddd, J = 5.6, 8.3, 
10.0, 17.2 Hz, 1 H), 5.04 (d, J = 17.2 Hz, 1 H), 5.00 (d, J = 10.0 Hz, 1 H), 4.47 (s, 2 H), 3.71 (s, 3 H), 
3.44–3.33 (m, 2 H), 2.45–2.37 (m, 2 H), 2.28 (ddd, J = 5.9, 13.4, 15.0 Hz, 1 H), 2.13 (td, J = 5.7, 9.1 Hz, 
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1 H), 1.96–1.88 (m, 1 H), 1.87–1.78 (m, 1 H), 1.71–1.61 (m, 1 H), 1.57–1.43 (m, 2 H), 1.39–1.31 (m, 2 
H), 1.07 (d, J = 6.6 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 208.2, 172.9, 138.4, 133.8, 128.2, 127.4, 127.4, 117.5, 72.7, 70.1, 65.3, 
51.9, 48.7, 38.8, 34.4, 32.6, 32.4, 28.6, 27.1, 20.3. 
FTIR (thin film) cm-1: 2950, 2929, 2857, 1735, 1709, 1453, 1433, 1219, 1101, 919, 738, 699. 
HRMS (ESI) calc’d for C22H31O4 [M+H]+: 359.2217, found 359.2250. 
TLC (15% EtOAc in hexanes), Rf: 0.22 (UV, CAM). 
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C-Propenyl β-ketoester (±)-1.138: 
 A 50-mL round-bottomed flask was charged with C-allyl β-ketoester (±)-1.146 (4.85 g, 13.5 
mmol, 1.00 equiv) and azeotropically dried with three portions of benzene. PhMe (135 mL), potassium 
carbonate (3.75g, 27.1 mmol, 2.00 equiv), and palladium(II) chloride diacetonitrile complex (175 mg, 
0.68 mmol, 0.05 equiv) were sequentially introduced and the resultant vigorously stirred heterogeneous 
mixture was heated to 80 °C. After 12 h, the resultant black reaction mixture was allowed to cool to 
ambient temperature and filtered through a pad of Celite, which was rinsed with EtOAc (3 × 100 mL) and 
concentrated under reduced pressure. The residue was then purified by flash column chromatography 
(silica gel, eluent: 15% EtOAc in hexanes) to afford C-propenyl β-ketoester (±)-1.138 (3.38 g, 70%, 20:1 
E:Z) as a colorless oil. 
1H NMR (600 MHz, CDCl3) δ: 7.36–7.30 (m, 4 H), 7.29–7.26 (m, 1 H), 5.64–5.59 (m, J = 16.7 Hz, 1 H), 
5.56 (qd, J = 5.4, 16.7 Hz, 1 H), 4.47 (s, 2 H), 3.70 (s, 3 H), 3.45–3.35 (m, 2 H), 2.60 (dt, J = 6.5, 14.5 Hz, 
1 H), 2.34 (td, J = 3.6, 15.3 Hz, 1 H), 2.09 (ddd, J = 3.0, 6.7, 9.9 Hz, 1 H), 1.91–1.84 (m, 1 H), 1.83–1.75 
(m, 4 H), 1.74 –1.65 (m, 1 H), 1.63–1.41 (m, 3 H), 1.34–1.25 (m, 1 H), 1.06 (d, J = 6.6 Hz, 3 H) 
13C NMR (125 MHz, CDCl3) δ: 207.7, 172.2, 138.5, 132.1, 128.3, 127.5, 127.4, 125.3, 72.7, 70.3, 68.4, 
52.3, 49.3, 38.0, 33.4, 33.2, 29.7, 28.6, 20.1, 18.8. 
FTIR (thin film) cm-1: 2948, 2856, 1736, 1708, 1453, 1433, 1361, 1236, 1100, 738, 699. 
HRMS (ESI) calc’d for C22H31O4 [M+H]+: 359.2217, found 359.2248. 
TLC (15% EtOAc in hexanes), Rf: 0.28 (UV, CAM). 
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Allylic alcohol (±)-1.149: 
A 500-mL round-bottomed flask was charged with C-propenyl β-ketoester (±)-1.138 (3.38 g, 9.44 
mmol, 1.00 equiv) and azeotropically dried with three portions of benzene. PhMe (95 mL) was introduced 
and the resultant solution was cooled to –78 °C. A solution of vinylmagnesium bromide in THF (0.93 M, 
51 mL, 47.2 mmol, 5.00 equiv) was then added dropwise via syringe over 15 min to the stirred reaction 
mixture. After an additional 1 h, a saturated aqueous ammonium chloride solution (100 mL) was added. 
The resultant mixture was subsequently allowed to warm to ambient temperature. The mixture was 
diluted with EtOAc (50 mL) and the layers were separated. The aqueous layer was extracted with EtOAc 
(3 × 50 mL). The combined organic layers were washed with a saturated aqueous sodium bicarbonate 
solution (300 mL) and brine (300 mL), dried over anhydrous sodium sulfate, filtered, and concentrated 
under reduced pressure. The residue was then purified by flash column chromatography (silica gel, eluent: 
15% EtOAc in hexanes) to afford allylic alcohol (±)-1.149 (3.26 g, 89%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.38–7.30 (m, 4 H), 7.28 (d, J = 2.6 Hz, 1 H), 6.32 (dd, J = 10.7, 16.8 Hz, 
1 H), 5.66 (dd, J = 1.3, 15.7 Hz, 1 H), 5.47 (qd, J = 6.4, 15.8 Hz, 1 H), 5.35 (dd, J = 1.6, 16.8 Hz, 1 H), 
5.08 (dd, J = 1.6, 10.7 Hz, 1 H), 4.49 (s, 2 H), 3.60 (s, 3 H), 3.48 (s, 1 H), 3.46–3.36 (m, 2 H), 2.01–1.91 
(m, 1 H), 1.91–1.76 (m, 2 H), 1.74 (dd, J = 1.2, 6.3 Hz, 3 H), 1.64–1.55 (m, 3 H), 1.52–1.43 (m, 1 H), 
1.35–1.15 (m, 2 H), 1.13–1.02 (m, 1 H), 1.00 (d, J = 6.2 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 174.6, 140.3, 138.8, 129.2, 128.2, 128.2, 127.4, 127.3, 126.1, 113.8, 75.2, 
72.5, 70.9, 64.1, 51.4, 45.5, 35.3, 34.6, 31.5, 31.1, 20.7, 18.9. 
FTIR (thin film) cm-1: 3498, 3027, 2935, 2856, 1736, 1702, 1453, 1361, 1453, 1361, 1226, 1101, 995, 
928, 736, 698. 
HRMS (ESI) calc’d for C24H35O4 [M+H]+: 387.2530, found 387.2532. 
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TLC (20% EtOAc in hexanes), Rf: 0.38 (UV, CAM). 
1D NOESY data (500 MHz, CDCl3): 
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Cyclohexenone (±)-1.147: 
A 10-mL round-bottomed flask was charged with allylic alcohol (±)-1.149 (112 mg, 0.290 mmol, 
1.00 equiv) and azeotropically dried with three portions of benzene. PhMe (2.90 mL) was introduced and 
the resultant solution was cooled to –78 °C. A solution of tert-butylzinc bromide in THF (0.50 M, 0.870 
mL, 0.435 mmol, 1.5 equiv) was added dropwise via syringe to the stirred reaction mixture, which was 
subsequently allowed to warm to 0 °C over 1 h. The reaction mixture was then quickly transferred to a 
separate 50-mL Schlenk tube containing a stirred solution of PhMe (18.9 mL) and THF (7.25 mL) at 
ambient temperature via a cannula. The transfer was completed with two additional portions of PhMe 
(500 µL). The Schlenk tube was sealed and heated to 50 °C. After 1 h, the reaction mixture was allowed 
to cool to ambient temperature. Glacial acetic acid (35 µL, 0.609 mmol, 2.10 equiv) was added via 
syringe and the reaction mixture stirred for 10 min before being poured into brine (50 mL). The layers 
were separated and the aqueous layer was extracted with Et2O (3 × 50 mL). The combined organic layers 
were dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The 
residue was then purified by flash column chromatography (silica gel, eluent: gradient, 5% → 15% 
EtOAc in hexanes) to afford cyclohexenone (±)-1.147 (60.5 mg, 53%) as a colorless oil. 
1H NMR (600 MHz, CDCl3) δ: 7.37–7.30 (m, 4 H), 7.29–7.26 (m, 1 H), 6.43 (s, 1 H), 4.47 (s, 2 H), 3.64 
(s, 3 H), 3.40 (dt, J = 2.2, 6.4 Hz, 2 H), 2.61–2.52 (m, 2 H), 2.49 (td, J = 4.5, 16.6 Hz, 1 H), 2.37–2.30 (m, 
2 H), 2.25 (ddd, J = 6.6, 9.5, 15.8 Hz, 1 H), 2.05 (ddd, J = 4.7, 9.7, 14.1 Hz, 1 H), 1.70–1.63 (m, 2 H), 
1.62–1.53 (m, 2 H), 1.53–1.28 (m, 4 H), 1.14 (d, J = 7.2 Hz, 3 H), 0.79 (d, J = 6.7 Hz, 3 H). 
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13C NMR (125 MHz, CDCl3) δ: 199.2, 174.4, 151.2, 139.3, 138.6, 128.3, 127.6, 127.5, 72.9, 70.4, 51.4, 
37.5, 35.7, 31.9, 31.5, 30.8, 29.6, 27.7, 25.5, 20.9, 15.9. 
FTIR (thin film) cm-1: 2950, 2930, 2860, 1736, 1670, 1453, 1171, 1101, 738, 698. 
HRMS (ESI) calc’d for C24H35O4 [M+H]+: 387.2530, found 387.2572. 
TLC (20% EtOAc in hexanes), Rf: 0.33 (UV, CAM). 
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Bicycle (±)-1.152: 
A 100-mL Schlenk tube was charged with allylic alcohol (±)-1.149 (857 mg, 2.22 mmol, 1.00 
equiv) and azeotropically dried with three portions of benzene. THF (11.1 mL) and PhMe (33.3 mL) were 
introduced and the resultant solution was cooled to –78 °C. A solution of tert-butylzinc bromide in THF 
(0.50 M, 6.66 mL, 3.33 mmol, 1.5 equiv) was added dropwise via syringe over 2 min to the stirred 
reaction mixture, which was subsequently allowed to warm to 0 °C over 1 h. Freshly distilled pivalic 
anhydride (1.89 mL, 11.1 mmol, 5.00 equiv) was then added dropwise via syringe to the stirred reaction 
mixture. The Schlenk tube was sealed and heated to 40 °C. After 24 h the reaction mixture was allowed to 
cool to ambient temperature. Glacial acetic acid (266 µL, 4.66 mmol, 2.10 equiv) was added via syringe 
and the reaction mixture stirred for 10 min before being poured into brine (100 mL). The layers were 
separated and the aqueous layer was extracted with Et2O (3 × 50 mL). The combined organic layers were 
dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue 
was then purified by flash column chromatography (silica gel, eluent: gradient, 1% → 5% EtOAc in 
CH2Cl2) to afford bicycle (±)-1.152 (186 mg, 42%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.38–7.31 (m, 4 H), 7.30–7.25 (m, 1 H), 5.98 (s, 1 H), 4.50 (s, 2 H), 3.53–
3.44 (m, 2 H), 3.37 (dd, J = 4.0, 7.6 Hz, 1 H), 2.68 (ddd, J = 1.8, 7.7, 14.9 Hz, 1 H), 2.58–2.43 (m, 2 H), 
2.38 (td, J = 7.4, 14.4 Hz, 1 H), 1.93 (ddd, J = 4.2, 5.9, 14.0 Hz, 1 H), 1.84–1.77 (m, 1 H), 1.72–1.61 (m, 
2 H), 1.60–1.48 (m, 2 H), 1.45–1.34 (m, 1 H), 1.29–1.20 (m, 1 H), 1.14 (d, J = 7.3 Hz, 3 H), 1.02 (d, J = 
6.7 Hz, 3 H). 
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13C NMR (125 MHz, CDCl3) δ: 206.8, 202.9, 142.8, 140.1, 138.6, 128.3, 127.5, 127.5, 72.9, 70.1, 61.4, 
45.8, 43.6, 41.9, 31.4, 31.3, 27.4, 27.3, 26.4, 21.9, 21.2 
FTIR (thin film) cm-1: 2950, 2927, 2868, 1707, 1685, 1454, 1105, 737, 698. 
HRMS (ESI) calc’d for C23H30NaO3 [M+Na]+: 377.2087, found 377.2087. 
TLC (20% EtOAc in hexanes), Rf: 0.22 (UV, CAM). 
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Isopropyl bicycle (±)-1.157: 
A 50-mL round-bottomed flask was charged with bicycle (±)-1.152 (254 mg, 0.717 mmol, 1.00 
equiv) and azeotropically dried with three portions of benzene. THF (18 mL) was introduced and the 
resultant solution was cooled to –78 °C. A solution of potassium hexamethyldisilazide in THF (0.527 M, 
1.22 mL, 0.644 mmol, 0.90 equiv) was then added dropwise via syringe over 2 min to the stirred reaction 
mixture. After 30 min, additional solution of potassium hexamethyldisilazide in THF (0.527 M, 0.271 
mL, 0.143 mmol, 0.20 equiv) was then added dropwise via syringe to the stirred reaction mixture. After 
10 min, the reaction mixture was transferred to a separate 50-mL round-bottomed flask containing a 
stirred –78 °C solution of N-(5-chloro-2-pyridyl)bis(trifluoromethanesulfonimide) (337 mg, 0.858 mmol, 
1.20 equiv) and THF (1.8 mL) dropwise via a dry-ice wrapped cannula over 10 min. The transfer was 
completed with two additional portions of THF (2 mL). After 2.5 h, a saturated aqueous ammonium 
chloride solution (50 mL) was added to the reaction mixture, which was subsequently allowed to warm to 
ambient temperature.  The mixture was diluted with EtOAc (50 mL) and the layers were separated. The 
aqueous layer was extracted with EtOAc (3 × 50 mL). The combined organic layers were washed with a 
saturated aqueous sodium bicarbonate solution (300 mL) and brine (300 mL), dried over anhydrous 
sodium sulfate, filtered, and concentrated under reduced pressure to yield bicyclic alkenyl triflate (±)-
1.156 as a tan oil that was used without further purification. 
A 25-mL round-bottomed flask was charged with anhydrous lithium chloride (91.1 mg, 2.15 
mmol, 3.00 equiv), flame dried under high vacuum and allowed to cool to ambient temperature under 
vacuum. The process was repeated three times. [1,1′-
bis(diphenylphosphino)ferrocene]dichloropalladium(II) (52.5 mg, 0.072 mmol, 0.10 equiv) was 
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introduced and the flask was evacuated and then backfilled with argon. The process was repeated three 
times. A separate 5-mL round-bottomed flask was charged with alkenyl triflate (±)-1.156 and 
azeotropically dried with three portions of benzene. THF (1 mL) was introduced and the resultant solution 
was transferred dropwise via cannula to the reaction mixture. The transfer was completed with three 
additional portions of THF (500 µL). A 10-mL round-bottomed flask was charged with anhydrous zinc 
chloride (391 mg, 2.87 mmol, 4.00 equiv), flame dried under high vacuum and allowed to cool to ambient 
temperature under vacuum. The process was repeated three times. The flask was evacuated and then 
backfilled with argon three times. THF (5.74 mL) was introduced and the resultant solution was cooled to 
0 °C. A solution of isopropylmagnesium bromide in THF (1.56 M, 1.84 mL, 2.87 mmol, 4.00 equiv) was 
then added dropwise via syringe to the stirred reaction mixture. After 1 h, the reaction mixture was 
transferred to the flask containing alkenyl triflate (±)-1.156 dropwise via a cannula. The transfer was 
completed with two additional portions of THF (500 µL). The resultant reaction mixture was heated to 40 
°C. After 2 h, the reaction mixture was allowed to cool to ambient temperature and a saturated aqueous 
ammonium chloride solution (5 mL) was added. The mixture was diluted with EtOAc (5 mL) and the 
layers were separated. The aqueous layer was extracted with EtOAc (3 × 5 mL). The combined organic 
layers were washed with a saturated aqueous sodium bicarbonate solution (25mL) and brine (25 mL), 
dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was 
then purified by flash column chromatography (silica gel, eluent: 10% EtOAc in hexanes) to afford 
isopropyl bicycle (±)-1.157 (109 mg, 40% over two steps) as a colorless solid. Crystals suitable for X-ray 
diffraction were obtained by cooling a saturated solution of (±)-1.157 in pentane to –20 °C for 48 h. 
1H NMR (500 MHz, CDCl3) δ: 7.38–7.31 (m, 4 H), 7.30–7.26 (m, 1 H), 5.53 (br. s., 1 H), 5.38 (t, J = 9.0 
Hz, 1 H), 4.50 (s, 2 H), 3.52–3.42 (m, 2 H), 3.05 (br. s., 1 H), 2.60–2.46 (m, 2 H), 2.40 (t, J = 9.6 Hz, 1 H), 
2.27–2.17 (m, 1 H), 2.16–2.06 (m, 1 H), 1.86–1.60 (m, 2 H), 1.57–1.36 (m, 2 H), 1.06 (d, J = 7.6 Hz, 3 H), 
1.01 (d, J = 6.6 Hz, 3 H), 0.97 (d, J = 6.6 Hz, 3 H), 0.93 (d, J = 6.7 Hz, 3 H). 
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13C NMR (125 MHz, CDCl3) δ: 213.4 (br), 145.5, 141.0, 138.7, 133.8, 128.3, 127.5, 127.4, 122.3, 72.8, 
70.3, 48.3, 46.8, 41.3, 35.5, 31.6, 30.1, 28.3, 27.2, 25.2, 23.3, 22.3, 21.3, 20.0. 
FTIR (thin film) cm-1: 3300 (br), 2957, 2927, 2870, 1795, 1453, 1095, 735, 678. 
HRMS (ESI) calc’d for C26H37O2 [M+Na]+: 381.2788, found 381.2807. 
TLC (20% EtOAc in hexanes), Rf: 0.51 (UV, CAM). 
X-Ray Crystal Structure: 
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C-Allyl β-ketoester (±)-1.184: 
A 1-L round-bottomed flask was charged with O-allyl β-ketoester (±)-1.145 (7.42 g, 20.7 mmol, 
1 equiv) and azeotropically dried with three portions of benzene. Heptane (400 mL) and N,N’-
diphenylguanidinium catalyst 1.183 (6.70 g, 6.20 mmol, 0.30 equiv) were introduced and the resultant 
vigorously stirred heterogeneous reaction mixture was heated to 85 °C. After 18 h, the reaction was 
concentrated under reduced pressure. The residue was then purified by flash column chromatography  
(silica gel, eluent: gradient, 10% → 15% EtOAc in hexanes) to afford C-allyl β-ketoester (±)-1.184 (4.63 
g, 62%) and C-allyl β-ketoester (±)-1.146 (925 mg, 13%) as colorless oils. 
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C-Propenyl β-ketoester (±)-1.178: 
A 50-mL round-bottomed flask was charged with C-allyl β-ketoester (±)-1.184 (2.88 g, 8.04 
mmol, 1.00 equiv) and azeotropically dried with three portions of benzene. PhMe (100 mL), potassium 
carbonate (3.33 g, 24.1 mmol, 3.00 equiv), and palladium(II) chloride diacetonitrile complex (1.05 g, 5.02 
mmol, 0.50 equiv) were sequentially introduced and the resultant vigorously stirred heterogeneous 
mixture was heated to 90 °C. After 12 h, the reaction mixture was allowed to cool to ambient temperature 
and an additional portion of palladium(II) chloride diacetonitrile complex (1.05 g, 5.02 mmol, 0.50 equiv) 
was added and the reaction mixture was reheated to 90 °C. After 6 h, the reaction mixture was allowed to 
cool to ambient temperature and filtered through a pad of Celite, which was rinsed with EtOAc (3 × 100 
mL) and concentrated under reduced pressure. The residue was then purified by flash column 
chromatography (silica gel, eluent: 15% EtOAc in hexanes) to afford C-propenyl β-ketoester (±)-1.178 
(1.61 g, 56%, 20:1 E:Z) as a colorless oil. 
1H NMR (600 MHz, CDCl3) δ: 7.35–7.30 (m, 4 H), 7.29–7.26 (m, 1 H), 5.56 (dd, J = 1.7, 16.1 Hz, 1 H), 
5.30 (qd, J = 6.4, 16.1 Hz, 1 H), 4.47 (s, 2 H), 3.70 (s, 3 H), 3.42–3.33 (m, 2 H), 2.48 (dt, J = 6.0, 13.5 Hz, 
1 H), 2.42 (ddd, J = 3.2, 4.7, 13.6 Hz, 1 H), 2.04–1.91 (m, 2 H), 1.82–1.75 (m, 1 H), 1.73 (dd, J = 1.5, 6.4 
Hz, 3 H), 1.71–1.60 (m, 3 H), 1.51–1.42 (m, 1 H), 1.36 (ddt, J = 5.0, 11.8, 13.2 Hz, 1 H), 1.12 (ddd, J = 
2.3, 5.4, 11.0 Hz, 1 H), 1.04 (d, J = 6.5 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 206.5, 170.5, 138.6, 128.4, 128.3, 127.9, 127.5, 127.4, 72.8, 70.4, 68.4, 
53.1, 52.0, 39.9, 34.9, 34.3, 31.9, 27.6, 20.0, 18.3. 
FTIR (thin film) cm-1: 2923, 2853, 1715, 1453, 1242, 1151, 962, 738, 699. 
HRMS (ESI) calc’d for C22H31O4 [M+H]+: 359.2217, found 359.2313. 
TLC (15% EtOAc in hexanes), Rf: 0.26 (UV, CAM).  
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Allylic alcohol (±)-S1.2: 
A 500-mL round-bottomed flask was charged with C-propenyl β-ketoester (±)-1.178 (303 mg, 
0.840 mmol, 1.00 equiv) and azeotropically dried with three portions of benzene. PhMe (8.4 mL) was 
introduced and the resultant solution was cooled to –78 °C. A solution of vinylmagnesium bromide in 
THF (1.0 M, 4.2 mL, 4.2 mmol, 5.00 equiv) was then added dropwise via syringe over 5 min to the stirred 
reaction mixture. After an additional 2 h, a saturated aqueous ammonium chloride solution (25 mL) was 
added. The resultant mixture was subsequently allowed to warm to ambient temperature. The mixture was 
diluted with EtOAc (25 mL) and the layers were separated. The aqueous layer was extracted with EtOAc 
(3 × 20 mL). The combined organic layers were washed with a saturated aqueous sodium bicarbonate 
solution (100 mL) and brine (100 mL), dried over anhydrous sodium sulfate, filtered, and concentrated 
under reduced pressure. The residue was then purified by flash column chromatography (silica gel, eluent: 
gradient, 5 → 15% EtOAc in hexanes) to afford allylic alcohol (±)-S1.2 (259 mg, 80%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 8.06–7.98 (m, 3 H), 7.59–7.51 (m, 1 H), 7.48–7.38 (m, 2 H), 6.20 (dd, J = 
10.9, 16.9 Hz, 1 H), 5.42 (dd, J = 1.9, 17.1 Hz, 1 H), 5.35 (d, J = 5.0 Hz, 1 H), 5.34 (d, J = 4.0 Hz, 1 H), 
5.21 (dd, J = 1.9, 10.9 Hz, 1 H), 4.64 (br. s., 1 H), 4.24 (t, J = 6.2 Hz, 2 H), 3.73 (s, 3 H), 1.91–1.73 (m, 3 
H), 1.71–1.55 (m, 8 H), 1.53–1.41 (m, 1 H), 1.37–1.23 (m, 3 H), 1.02 (d, J = 6.3 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 176.5, 166.6, 138.2, 132.8, 130.4, 130.0, 129.5, 128.3, 127.5, 116.1, 76.0, 
65.1, 62.4, 51.7, 47.8, 37.5, 34.7, 32.1, 31.4, 28.6, 20.9, 18.3. 
FTIR (thin film) cm-1: 3478 (br), 2949, 2932, 2860, 1716.7, 1451, 1274, 1217, 1115, 714. 
HRMS (ESI) calc’d for C24H34NaO4 [M+Na]+: 409.2349, found 409.2338. 
TLC (20% EtOAc in hexanes), Rf: 0.40 (UV, CAM). 
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1D NOESY data (500 MHz, CDCl3): 
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cis-Cyclodecene (±)-1.188: 
A 25-mL Schlenk tube was charged with C-propenyl β-ketoester (±)-1.178 (150 mg, 0.418 mmol, 
1.00 equiv) and azeotropically dried with three portions of benzene. PhMe (4.2 mL) was introduced and 
the resultant solution was cooled to –78 °C. A solution of vinylmagnesium bromide in THF (1.2 M, 523 
µL, 0.627 mmol, 1.5 equiv) was added dropwise via syringe over 2 min to the stirred reaction mixture, 
which was subsequently allowed to warm to 0 °C over 1 h. The resultant reaction mixture was transferred 
to a 100-mL Schlenk tube containing a solution of PhMe (29.2 mL) and THF (7.84 mL) at ambient 
temperature quickly via cannula. The Schlenk tube was sealed and stirred at ambient temperature for 12 h. 
Glacial acetic acid (50.0 µL, 0.878 mmol, 2.10 equiv) was added via syringe and the reaction mixture 
stirred for 10 min before being poured into brine (10 mL). The layers were separated and the aqueous 
layer was extracted with Et2O (3 × 15 mL). The combined organic layers were dried over anhydrous 
magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was then purified by 
flash column chromatography (silica gel, eluent: gradient, 5% → 15% EtOAc in hexanes) to afford 
bicycle (±)-1.188 (97.4 mg, 65%) as a colorless oil. 
1H NMR (600 MHz, CDCl3) δ: 8.07–7.96 (m, 2 H), 7.59–7.50 (m, 1 H), 7.48–7.41 (m, 2 H), 6.47 (d, J = 
11.6 Hz, 1 H), 4.23 (d, J = 5.4 Hz, 0 H), 4.22 (d, J = 5.4 Hz, 1 H), 3.70 (s, 3 H), 2.82 (ddd, J = 3.9, 12.9, 
17.0 Hz, 1 H), 2.71 (tq, J = 5.9, 11.5 Hz, 1 H), 2.44 (dt, J = 2.6, 13.0 Hz, 1 H), 2.31 (qd, J = 5.5, 10.9 Hz, 
1 H), 2.25 (ddd, J = 2.4, 6.8, 12.9 Hz, 1 H), 2.20 (dt, J = 4.3, 10.8 Hz, 1 H), 2.13 (tt, J = 4.3, 13.2 Hz, 1 
H), 2.03–1.95 (m, 2 H), 1.74–1.63 (m, 3 H), 1.62–1.53 (m, 1 H), 1.43 (td, J = 6.3, 12.1 Hz, 1 H), 1.28–
1.16 (m, 1 H), 1.05 (d, J = 6.9 Hz, 3 H), 1.03 (d, J = 6.3 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 214.6, 167.5, 166.5, 149.0, 133.3, 132.7, 130.4, 129.5, 128.3, 65.1, 51.4, 
42.9, 39.9, 36.4, 33.8, 30.2, 29.8, 29.4, 27.4, 27.3, 20.7, 16.5. 
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FTIR (thin film) cm-1: 2955, 2926, 2871, 1712, 1451, 1274, 1116, 714. 
HRMS (ESI) calc’d for C24H34NaO4 [M+Na]+: 409.2349, found 409.2340. 
TLC (20% EtOAc in hexanes), Rf: 0.52 (UV, CAM). 
1D NOESY data (600 MHz, CDCl3): 
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Allylic alcohol (±)-1.189: 
A 15-mL, 2-necked, round-bottomed flask equipped with a fritted glass tube connected to a 
second 25-mL, 2-necked, round-bottomed flask and a septa was charged with a solution of tetravinyltin229 
(158 µL, 0.698 mmol, 1.25 equiv) and dibutyl ether (1.4 ml). A solution of phenyllithium in dibutyl ether 
(1.85 M, 1.21 mL, 2.23 mmol, 5.00 equiv) was quickly added via syringe to the stirred reaction mixture at 
ambient temperature. After 30 min, the heterogeneous reaction mixture was filtered into the second 50 
mL, 2-necked, round-bottomed flask under positive argon pressure. The transfer was completed with two 
additional portions of dibutyl ether (1 mL). The resultant clear yellow solution was cooled to –78 °C. A 
separate 25-mL round-bottomed flask was charged with C-propenyl β-ketoester (±)-1.178 (200 mg, 0.558 
mmol, 1.00 equiv) and azeotropically dried with three portions of benzene. Dibutyl ether (5.60 mL) was 
introduced and the resultant solution was cooled to –78 °C and transferred dropwise via a dry-ice 
wrapped cannula to the stirred, cooled solution of vinyl lithium over 30 min. The transfer was completed 
with three additional portions of dibutyl ether (1 mL). After 6 h, a saturated aqueous ammonium chloride 
solution (5 mL) was added to the reaction mixture, which was subsequently allowed to warm to ambient 
temperature. The mixture was diluted with EtOAc (25 mL) and a saturated aqueous ammonium chloride 
solution (25 mL) and the layers were separated. The aqueous layer was extracted with EtOAc (3 × 20 
mL). The combined organic layers were washed with a saturated aqueous sodium bicarbonate solution 
(50 mL) and brine (50 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under 
reduced pressure. The residue was then purified by flash column chromatography (silica gel, eluent: 
gradient, 5 → 7% EtOAc in hexanes) to afford allylic alcohol (±)-1.189 (62.0 mg, 29%) and allylic 
                                                      
229 Wade, P. A.; Bereznak, J. F.; Palfey, B. A.; Carroll, P. J.; Dailey, W. P.; Sivasubramanian, S. J. Org. Chem. 
1990, 55, 3045–3051. 
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alcohol (±)-S1.2 (55.0 mg, 26%) as colorless oils. 
1H NMR (500 MHz, CDCl3) δ: 7.36–7.29 (m, 4 H), 7.29–7.27 (m, 1 H), 5.82 (d, J = 8.4 Hz, 1 H), 5.80 (d, 
J = 6.6 Hz, 1 H), 5.78–5.76 (m, 1 H), 5.61 (qd, J = 6.3, 16.3 Hz, 1 H), 5.15 (d, J = 17.1 Hz, 1 H), 5.03 (d, 
J = 10.7 Hz, 1 H), 4.46 (s, 2 H), 3.68 (s, 3 H), 3.34 (appt, J = 6.8 Hz, 2 H), 2.38–2.25 (m, 1 H), 2.04–1.91 
(m, 1 H), 1.79 (dd, J = 1.2, 6.2 Hz, 3 H), 1.75–1.54 (m, 4 H), 1.53–1.44 (m, 3 H), 1.41–1.30 (m, 1 H), 
1.23–1.12 (m, 1 H), 0.97 (d, J = 6.6 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 173.5, 143.2, 138.6, 130.5, 128.2, 127.9, 127.4, 127.4, 113.3, 73.4, 72.6, 
70.7, 61.6, 51.5, 42.8, 33.2, 32.8, 30.4, 29.9, 28.2, 21.3, 18.5. 
FTIR (thin film) cm-1: 3524 (br), 2947, 2918, 2854, 1721, 1453, 1207, 1098, 986, 926, 735, 698. 
HRMS (ESI) calc’d for C24H34NaO4 [M+Na]+: 409.2349, found 409.2356. 
TLC (20% EtOAc in hexanes), Rf: 0.52 (UV, CAM). 
1D NOESY data (500 MHz, CDCl3): 
 
  
Me
BnO
H
H OH
2% nOe
12
4a
(±)-1.189
MeH
O OMe
1% nOe
H
 191 
 
2-Allyl-3-methoxy-6-methylcyclohex-2-enone ((±)-1.202): 
A 5-L, 3-necked, round-bottomed flask equipped with 250-mL equal pressure graduated addition 
funnel, 500-mL equal pressure graduated addition funnel and a rubber septa was charged with a solution 
of diisopropylamine (110 mL, 785 mmol, 1.10 equiv) and THF (800 mL) and cooled to –78 °C. A 
solution of nBuLi in hexanes (2.66 M, 295 mL, 785 mmol, 1.10 equiv) was added dropwise to the stirred 
reaction mixture over 1 h via 500-mL equal pressure graduated addition funnel. The resultant mixture was 
warmed to 0 °C for 30 min and then re-cooled to –78 °C. A separate 2-L round-bottomed flask was 
charged with a solution of 2-allyl-3-methoxycyclohex-2-enone (1.201)86 (118 g, 712 mmol, 1.00 equiv) 
and THF (720 mL) and was added dropwise to the cooled, stirred reaction mixture via cannula over 2 h. 
The transfer was completed with two additional portions of THF (50 mL). After 30 min, iodomethane 
(89.0 mL, 203 g, 1.43 mol, 2.00 eqiuv) was added dropwise to cooled, stirred reaction mixture via 250-
mL equal pressure graduated addition funnel over 30 min. After 15 min, the mixture was allowed to warm 
to 0 °C over 2 h. A saturated aqueous ammonium chloride solution (1.50 L) was added to the reaction 
mixture. The layers were separated and the aqueous layer was extracted with EtOAc (3 × 500 mL). The 
combined organic layers were washed with saturated aqueous sodium bicarbonate solution (700 mL) and 
brine (700 mL). The organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated 
under reduced pressure to furnish 2-allyl-3-methoxy-6-methylcyclohex-2-enone (±)-1.202 as a yellow oil 
that was purified by distillation (oil bath 120 °C, b.p 90-95 °C, 0.92 mmHg) to afford pure 2-allyl-3-
methoxy-6-methylcyclohex-2-enone (±)-1.202 (87.4 g, 68%) as a clear oil. 
1H NMR (500 MHz, CDCl3) δ: 5.75 (tdd, J = 6.3, 10.2, 16.9 Hz, 1 H), 4.93 (qd, J = 1.7, 17.1 Hz, 1 H), 
4.84 (qd, J = 1.5, 10.1 Hz, 1 H), 3.77 (s, 3 H), 3.04–2.90 (m, J = 6.0, 6.0 Hz, 2 H), 2.63 (td, J = 5.3, 18.3 
Hz, 1 H), 2.52 (qd, J = 5.0, 17.2 Hz, 1 H), 2.30–2.18 (m, 1 H), 2.06 (qd, J = 4.8, 13.2 Hz, 1 H), 1.71–1.60 
(m, 1 H), 1.11 (d, J = 6.9 Hz, 3 H). 
O
OMe
LDA, THF,
 –78 °C, 2.5 h;
then MeI, 
–78 → 0 °C, 2.5 h
(68%)
O
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13C NMR (125 MHz, CDCl3) δ: 199.9, 171.1, 136.6, 116.3, 113.7, 55.0, 39.3, 28.6, 26.5, 24.0, 15.4. 
FTIR (thin film) cm-1: 3077, 2933, 2862, 1644, 1462, 1424, 1252, 1120, 990, 908. 
HRMS (ESI) calc’d for C11H17O2 [M+H]+: 181.1223, found 181.1245. 
TLC (60% EtOAc in hexanes), Rf: 0.56 (UV, CAM). 
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2-Allyl-3-methoxycyclohex-2-enone ((±)-1.196): 
A 3-L, 2-necked, round-bottomed flask equipped with 500-mL equal pressure graduated addition 
funnel and a septa was charged with a solution of 2-allyl-3-methoxy-6-methylcyclohex-2-enone (±)-1.202 
(40 g, 222 mmol, 1.00 equiv) and CH2Cl2 (1.10 L) and cooled to 0 °C. A solution of diisobutylaluminum 
hydride (50 mL, 39.9 g, 278 mmol, 1.25 equiv) and CH2Cl2 (300 mL) was added dropwise to the cooled, 
stirred reaction mixture over 2 h. After 30 min, an aqueous solution of HCl (10% w/v, 800 mL) was 
carefully added to the reaction mixture which was subsequently allowed to warm to ambient temperature. 
The layers were separated and the aqueous layer was extracted with CH2Cl2 (3 × 500 mL). The combined 
organic layers were washed with saturated aqueous sodium bicarbonate solution (1.0 L) and brine (1.0 L). 
The organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced 
pressure to furnish 2-allyl-3-methoxycyclohex-2-enone (±)-1.196 as a yellow oil that was purified by 
distillation (oil bath 130 °C, b.p 125 °C, 40.0 mmHg) to afford pure 2-allyl-3-methoxycyclohex-2-enone 
(±)-1.196 (31.7 g, 95%) as a clear oil. 
1H NMR (500 MHz, CDCl3) δ: 6.52 (dd, J = 1.3, 2.6 Hz, 1 H), 5.86–5.75 (m, 1 H), 5.09–4.97 (m, 2 H), 
2.97–2.88 (m, 2 H), 2.60–2.54 (m, 1 H), 2.51 (td, J = 4.8, 16.7 Hz, 1 H), 2.35 (ddd, J = 4.9, 12.7, 17.3 Hz, 
1 H), 2.07 (dqd, J = 1.5, 4.8, 13.2 Hz, 1 H), 1.63 (ddt, J = 3.9, 9.4, 13.2 Hz, 1 H), 1.14 (d, J = 7.0 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 198.5, 151.3, 136.5, 135.6, 115.9, 37.0, 33.1, 31.2, 30.9, 20.4. 
FTIR (thin film) cm-1: 2960, 2930, 2873, 1670, 1456, 1417, 1372, 1177, 1124, 1016, 910, 731. 
HRMS (ESI) calc’d for C10H14NaO [M+Na]+: 173.0937, found 173.0952. 
TLC (50% EtOAc in hexanes), Rf: 0.74 (UV, CAM). 
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Alkyl bromide 1.203: 
A 3-L, 3-necked, round-bottomed flask equipped with 500-mL equal pressure graduated addition 
funnel, an internal temperature probe, and a septa was charged with a solution of ethyl 4-bromobutanoate 
(S1.3) (80.5 mL, 110 g, 563 mmol, 1.00 equiv) and CH2Cl2 (1.13 L) and cooled to –78 °C. A solution of 
diisobutylaluminum hydride (125 mL, 100 g, 703 mmol, 1.25 equiv) and CH2Cl2 (370 mL) was added 
dropwise via 500-mL equal pressure graduated addition funnel to the cooled, stirred reaction mixture over 
2 h. It was critical to maintain an internal temperature below –68 °C during the addition process. After 
addition was complete, the reaction mixture was carefully poured into an aqueous solution of HCl (10% 
w/v, 1.0 L) at 0 °C. The resultant mixture was subsequently allowed to warm to ambient temperature. The 
layers were separated and the aqueous layer was extracted with CH2Cl2 (2 × 500 mL). The combined 
organic layers were washed with saturated aqueous sodium bicarbonate solution (1.0 L) and brine (1.0 L). 
The organic layer was dried over anhydrous magnesium sulfate, filtered, and carefully concentrated under 
reduced pressure to furnish 4-bromobutanal (S1.4) as a volatile, clear oil that was used without further 
purification. 
A 2-L, 2-necked, round-bottomed flask equipped with a Dean-Stark apparatus, a reflux condenser, 
and a rubber septa was charged with a solution of 4-bromobutanal (S1.4), PhH (1.40 L), and benzyl 
alcohol (67.0 mL, 69.9 g, 648 mmol, 2.30 equiv). para-Toluenesulfonic acid monohydrate (2.70 g, 14.0 
mmol, 0.05 equiv) was introduced to the reaction mixture in one portion. The resultant reaction mixture 
was heated to reflux for 4 h and allowed to cool to ambient temperature. A saturated aqueous sodium 
bicarbonate solution (1.0 L) was added and the layers were separated. The organic layer was washed with 
brine (1.0 L) and dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. 
The residue was purified by flash column chromatography (silica gel, eluent: gradient, 15% EtOAc in 
hexanes) to afford alkyl bromide 1.203 (181 g, 92 %) as a colorless oil. 
S1.3
reflux, 4 h
(92%, 2 steps)
BnOH, PTSA, PhH
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1H NMR (500 MHz, CDCl3) δ: 7.43–7.28 (m, 10 H), 4.78 (t, J = 5.4 Hz, 1 H), 4.69 (d, J = 11.8 Hz, 2 H), 
4.58 (d, J = 11.9 Hz, 2 H), 3.43 (t, J = 6.5 Hz, 2 H), 2.04–1.89 (m, 4 H). 
13C NMR (125 MHz, CDCl3) δ: 138.0, 128.4, 127.8, 127.7, 101.2, 67.4, 33.6, 31.9, 27.9. 
FTIR (thin film) cm-1: 3031, 2958, 2874, 1497, 1454, 1346, 1122, 1045, 905, 897. 
HRMS (ESI) calc’d for C18H21BrNaO2 [M+Na]+: 371.0617, found 371.0621. 
TLC (15% EtOAc in hexanes), Rf: 0.60 (UV, CAM). 
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C-Allyl cis-decalin (±)-1.205 and (±)-1.206: 
A 2-L, 2-necked, round-bottomed flask equipped two rubber septa was charged with magnesium 
turnings (12.2 g, 500 mmol, 3.00 equiv). THF (170 mL) was introduced and 1,2-dibromoethane (100 µL) 
was added via syringe to the vigorously stirred reaction mixture. A separate 250 mL round-bottomed flask 
was charged with alkyl bromide 1.203 (87.3 g, 250 mmol, 1.50 equiv) and azeotropically dried with three 
portions of benzene. THF (100 mL) was introduced and the resultant solution added dropwise to the 
magnesium turnings via cannula over 2 h. The resultant reaction mixture stirred vigourously at ambient 
temperature. After 12 h, the reaction mixture was cooled to –30 °C and copper(I) iodide (63.5g, 333 
mmol, 2.00 equiv) was added in a single portion to the cold reaction mixture. After 30 min, the resultant 
slurry was cooled further to –78 °C. A separate 500 mL round-bottomed flask was charged with 2-allyl-3-
methoxycyclohex-2-enone ((±)-1.196) (25.0 g, 167 mmol, 1.00 equiv) and azeotropically dried with three 
portions of benzene. THF (230 mL) and TMSCl (53.4 mL, 63.5 g, 500 mmol, 3.00 equv) were introduced 
and the resultant solution was cooled to –78 °C before being transferred dropwise via a dry-ice wrapped 
cannula to the stirred, cooled reaction mixture over 30 min. The transfer was completed with two 
additional portions of THF (50 mL). The resultant slurry stirred for 3 h at –78 °C before triethylamine 
(81.5 mL, 500 mmol, 3.00 equiv) was added dropwise via syringe and the resultant reaction mixture 
allowed to warm to ambient temperature. After 12 h a mixture of ammonium hydroxide in saturated 
aqueous ammonium chloride solution (10% v/v, 500 mL) was carefully added to the yellow reaction 
mixture. The resultant heterogeneous mixture was filtered through a pad of Celite, which was rinsed with 
Et2O (2 × 200 mL) and H2O (2 × 200 mL). The layers of the filtrate were separated and the aqueous layer 
was extracted with Et2O (2 × 500 mL). The combined organic layers were washed with water (1.0 L) and 
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O
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Me
then CuI,
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brine (1.0 L), dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure 
to yield silyl enol ether 1.204 as a tan oil that was used without further purification. 
A 2-L round-bottomed flask was charged with silyl enol ether 1.204 and azeotropically dried with 
three portions of benzene. CH2Cl2 (530 mL) was introduced and the resultant solution cooled to –78 °C. 
A separate 200-mL round-bottomed flask was charged with a solution of titanium (IV) tetrachloride (12.2 
mL, 111 mmol, 1.05 equiv) and CH2Cl2 (111 mL) and the resultant solution cooled to –78 °C before 
being transferred dropwise via a dry-ice wrapped cannula to the stirred, cooled reaction mixture over 20 
min. After 1 h, saturated aqueous sodium bicarbonate solution (500 mL) was added and the reaction 
mixture warmed to ambient temperature. The resultant heterogeneous mixture was filtered through a pad 
of Celite, which was rinsed with CH2Cl2 (2 × 200 mL) and H2O (2 × 200 mL). The layers of the filtrate 
were separated and the aqueous layer was extracted with CH2Cl2 (3 × 100 mL). The combined organic 
layers were washed with water (500 mL) and brine (500 mL), filtered, and concentrated under reduced 
pressure to yield a mixture of C-allyl cis-decalin (±)-1.205, (±)-1.206 and protodebrominated alkyl 
bromide 1.203 which was hydrolyzed to facilitate purification. 
Accordingly, a 500-mL round-bottomed flask was charged with a solution of the product residue, 
THF (100 mL) and water (100 mL). para-Toluenesulfonic acid monohydrate (1.00 g, 5.30 mmol, 0.05 
equiv) was introduced to the stirred reaction mixture in one portion at ambient temperature. After 12 h, 
the reaction mixture was diluted with EtOAc (200 mL) and the layers were separated. The aqueous layer 
was extracted with EtOAc (3 × 100 mL). The combined organic layers were dried over anhydrous 
magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by flash 
column chromatography (silica gel, eluent: gradient, 5% EtOAc in hexanes) to afford C-allyl cis-decalin 
(±)-1.205 (23.5 g, 45%, over two steps) and (±)-1.206 (7.70 g, 15%, over two steps) as colorless oils. 
C-Allyl cis-decalin (±)-1.205: 
1H NMR (500 MHz, CDCl3) δ: 7.36–7.30 (m, 2 H), 7.29–7.22 (m, 3 H), 5.59–5.48 (m, 1 H), 5.06–4.97 
(m, 2 H), 4.45 (d, J = 11.3 Hz, 1 H), 4.19 (d, J = 11.3 Hz, 1 H), 3.45 (br. s., 1 H), 2.74–2.62 (m, 1 H), 
2.52–2.32 (m, 3 H), 2.25 (dd, J = 9.3, 13.5 Hz, 1 H), 1.90 (d, J = 14.3 Hz, 1 H), 1.84–1.66 (m, 3 H), 1.59–
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1.43 (m, 3 H), 1.38–1.30 (m, 1 H), 1.25 (ddt, J = 5.5, 11.2, 12.9 Hz, 1 H), 0.92 (d, J = 6.6 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 216.1, 138.5, 134.9, 128.2, 127.5, 127.3, 117.7, 82.8, 71.7, 54.6, 41.9, 
41.8, 38.0, 32.2, 28.3, 24.8, 22.3, 20.9, 14.8. 
FTIR (thin film) cm-1: 3066, 3031, 2934, 2866, 1697, 1452, 1061, 915, 734, 698. 
HRMS (ESI) calc’d for C21H28NaO2 [M+Na]+: 335.1982, found 335.1977. 
TLC (15% EtOAc in hexanes), Rf: 0.45 (UV, CAM). 
1D NOESY data (500 MHz, CDCl3): 
 
C-Allyl cis-decalin (±)-1.206: 
1H NMR (500 MHz, CDCl3) δ: 7.36–7.29 (m, 2 H), 7.29–7.23 (m, 3 H), 5.71 (dtd, J = 4.3, 10.0, 17.1 Hz, 
1 H), 5.08 (d, J = 17.2 Hz, 1 H), 5.02 (d, J = 10.1 Hz, 1 H), 4.56 (d, J = 12.2 Hz, 1 H), 4.32 (d, J = 12.2 
Hz, 1 H), 3.98 (dd, J = 4.6, 10.5 Hz, 1 H), 3.14–3.06 (m, 1 H), 2.36 - 2.24 (m, 2 H), 2.18 (td, J = 3.3, 14.3 
Hz, 1 H), 2.11–1.96 (m, 2 H), 1.94–1.85 (m, 1 H), 1.72–1.64 (m, 1 H), 1.62–1.42 (m, 5 H), 1.37–1.25 (m, 
1 H), 0.88 (d, J = 6.4 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 211.8, 138.4, 135.8, 128.2, 127.6, 127.5, 116.6, 76.3, 70.0, 56.9, 46.0, 
38.5, 34.9, 30.7, 28.6, 25.9, 21.4, 19.6, 19.0. 
FTIR (thin film) cm-1: 3069, 3030, 2945, 2870, 1708, 1637, 1454, 1097, 908, 739. 
HRMS (ESI) calc’d for C21H28NaO2 [M+Na]+: 335.1982, found 335.1940. 
TLC (10% EtOAc in hexanes), Rf: 0.23 (UV, CAM). 
1D NOESY data (500 MHz, CDCl3): 
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C-Propenyl cis-decalin (±)-1.207: 
A 350-mL pressure vessel was charged with a solution of C-allyl cis-decalin (±)-1.205 (3.70 g, 
11.9 mmol, 1.00 equiv) and ethanol (60.0 mL). Potassium carbonate (3.30 g, 2.00 equiv) and rhodium(III) 
chloride hydrate (248 mg, 0.10 equiv) were introduced. The pressure vessel was sealed and the vigorously 
stirred reaction mixture was heated to 85 °C. After 4.5 h, the reaction mixture was cooled to ambient 
temperature, diluted with Et2O (200 mL), and filtered through a pad of Celite, which was rinsed with Et2O 
(3 × 50 mL) and concentrated under reduced pressure. The residue was then purified by flash column 
chromatography (silica gel, eluent: 5% EtOAc in hexanes) to afford C-propenyl cis-decalin (±)-1.207 
(2.14 g, 58%, 20:1 E:Z) as a colorless oil and recovered starting material C-allyl cis-decalin (±)-1.205 
(639 mg, 17%). 
1H NMR (500 MHz, CDCl3) δ: 7.37–7.31 (m, 2 H), 7.31–7.25 (m, 3 H), 5.60 (qd, J = 6.3, 15.8 Hz, 1 H), 
5.41 (d, J = 15.5 Hz, 1 H), 4.49 (d, J = 11.4 Hz, 1 H), 4.29 (d, J = 11.3 Hz, 1 H), 3.79 (br. s., 1 H), 2.54–
2.35 (m, 3 H), 1.95–1.82 (m, 2 H), 1.80–1.66 (m, 6 H), 1.61–1.49 (m, 2 H), 1.39 (dtd, J = 6.5, 10.1, 13.3 
Hz, 1 H), 1.33–1.24 (m, 1 H), 0.98 (d, J = 6.6 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 214.8, 138.7, 133.1, 128.2, 127.4, 127.2, 126.3, 82.2, 71.8, 56.7, 45.3, 
40.1, 31.7, 28.0, 24.9, 23.5, 21.1, 18.6, 15.3. 
FTIR (thin film) cm-1: 3064, 3031, 2940, 2866, 1701, 1454, 1067, 733, 698. 
HRMS (ESI) calc’d for C21H28NaO2 [M+Na]+: 335.1982, found 335.1987. 
TLC (15% EtOAc in hexanes), Rf: 0.25 (UV, CAM). 
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C-Propenyl cis-decalin (±)-1.208: 
A 250-mL pressure vessel was charged with a solution of C-allyl cis-decalin (±)-1.206 (2.55 g, 
8.17 mmol, 1.00 equiv) and ethanol (41.0 mL). Potassium carbonate (4.50 g, 4.00 equiv) and rhodium(III) 
chloride hydrate (85.0 mg, 0.05 equiv) were introduced. The pressure vessel was sealed and the 
vigorously stirred reaction mixture was heated to 90 °C. After 1.5 h, the reaction mixture was cooled to 
ambient temperature, diluted with Et2O (150 mL), and filtered through a pad of Celite, which was rinsed 
with Et2O (3 × 50 mL) and concentrated under reduced pressure. The residue was then purified by flash 
column chromatography (silica gel, eluent: 10% EtOAc in hexanes) to afford C-propenyl cis-decalin (±)-
1.208 (2.38 g, 93%, 20:1 E:Z) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.39– 7.15 (m, 5 H), 5.78 (dd, J = 1.5, 16.3 Hz, 1 H), 5.38 (qd, J = 6.4, 
16.2 Hz, 1 H), 4.56 (d, J = 12.0 Hz, 1 H), 4.33 (d, J = 12.0 Hz, 1 H), 3.93 (dd, J = 3.3, 7.6 Hz, 1 H), 2.35 
(td, J = 4.4, 15.4 Hz, 1 H), 2.19 (ddd, J = 5.4, 12.0, 15.4 Hz, 1 H), 1.97–1.78 (m, 3 H), 1.78–1.70 (m, J = 
1.6, 6.4 Hz, 4 H), 1.70–1.58 (m, 3 H), 1.56–1.39 (m, 2 H), 1.38–1.30 (m, 1 H), 1.03 (d, J = 6.6 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 212.6, 138.7, 132.7, 128.2, 127.7, 127.4, 125.2, 78.7, 76.8, 76.7, 70.5, 
59.4, 46.5, 37.6, 31.6, 27.7, 26.3, 21.2, 19.7, 18.5, 14.2. 
FTIR (thin film) cm-1: 3389, 3064, 3030, 2931, 2869, 1706, 1454, 1071, 737, 698. 
HRMS (ESI) calc’d for C21H28NaO2 [M+Na]+: 335.1982, found 335.1963. 
TLC (15% EtOAc in hexanes), Rf: 0.42 (UV, CAM). 
  
Me
O
OBn
(±)-1.206 (±)-1.208
RhCl3•H2O, K2CO3
EtOH, 90 °C, 1.5 h
(93%)
Me
O
OBn
Me
 201 
 
Allylic alcohol (±)-1.209: 
A 500-mL round-bottomed flask was charged with anhydrous cerium(III) chloride (12.3 g, 50.0 
mmol, 4.47 equiv) and heated to 145 °C under reduced pressure (0.05 Torr) for 1 h. The flask was 
allowed to cool to ambient temperature and flushed with argon. The flask was further cooled to 0 °C 
before THF (100 mL) was introduced via syringe over 5 min. The resultant heterogeneous, off-white 
slurry was allowed to warm to ambient temperature. After 12 h, the reaction mixture was cooled to –78 
°C before a solution of vinylmagnesium bromide in THF (1.0 M, 50.0 mL, 50.0 mmol, 4.47 equiv) was 
added dropwise via syringe over 10 min. The resultant yellow slurry was stirred for 1.5 h at –78 °C. A 
separate 100 mL round-bottomed flask was charged with C-propenyl cis-decalin (±)-1.207 (3.49 g, 11.2 
mmol, 1.00 equiv) and azeotropically dried with three portions of benzene. THF (50 mL) was introduced 
and the resultant solution was cooled to –78 °C before being transferred dropwise via a dry-ice wrapped 
cannula to the stirred, cooled reaction mixture over 30 min. The transfer was completed with two 
additional portions of THF (5 mL). After 1 h, a saturated aqueous ammonium chloride solution (300 mL) 
was added. The resultant mixture was subsequently allowed to warm to ambient temperature. The mixture 
was diluted with Et2O (50 mL) and the layers were separated. The aqueous layer was extracted with Et2O 
(3 × 300 mL). The combined organic layers were washed with a saturated aqueous sodium bicarbonate 
solution (300 mL) and brine (300 mL), dried over anhydrous magnesium sulfate, filtered, and 
concentrated under reduced pressure. The residue was then purified by flash column chromatography 
(silica gel, eluent: 10% EtOAc in hexanes) to afford allylic alcohol (±)-1.209 (3.54 g, 93%) as a white 
solid. 
1H NMR (500 MHz, CDCl3) δ: 7.44–7.32 (m, 4 H), 7.31–7.25 (m, 1 H), 6.31 (dd, J = 10.9, 17.2 Hz, 1 H), 
5.37 (qd, J = 6.3, 16.2 Hz, 1 H), 5.13 (dd, J = 1.5, 6.8 Hz, 1 H), 5.10 (dd, J = 1.5, 7.8 Hz, 1 H), 4.92 (dd, J 
THF, –78 °C, 1 h
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= 1.6, 10.9 Hz, 1 H), 4.60 (d, J = 11.9 Hz, 1 H), 4.57 (d, J = 11.9 Hz, 1 H), 4.02 (br. s., 1 H), 2.65 (ddd, J 
= 4.6, 12.0, 14.1 Hz, 1 H), 2.38 (tq, J = 5.9, 11.4 Hz, 1 H), 1.83–1.48 (m, 10 H), 1.43 (ddd, J = 2.9, 4.0, 
11.9 Hz, 1 H), 1.34 (s, 1 H), 1.25 (td, J = 2.9, 12.4 Hz, 1 H), 1.16 (ddd, J = 4.1, 13.8, 26.2 Hz, 1 H), 0.89 
(d, J = 6.5 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 144.4, 139.3, 137.9, 128.2, 127.4, 127.1, 124.0, 109.9, 78.5, 77.5, 71.1, 
49.1, 45.5, 38.1, 32.5, 28.7, 25.6, 23.6, 21.2, 18.6, 15.5. 
FTIR (thin film) cm-1: 3584, 3479 (br), 3028, 2929, 2865, 1453, 1093, 1066, 980, 914, 733, 697. 
HRMS (ESI) calc’d for C23H32NaO2 [M+Na]+: 363.2295, found 363.2296. 
TLC (15% EtOAc in hexanes), Rf: 0.26 (UV, CAM). 
1D NOESY data (500 MHz, CDCl3): 
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Allylic alcohol (±)-1.210: 
A 500-mL round-bottomed flask was charged with anhydrous cerium(III) chloride (21.6 g, 87.4 
mmol, 5.00 equiv) and heated to 145 °C under reduced pressure (0.05 Torr) for 1 h. The flask was 
allowed to cool to ambient temperature and flushed with argon. The flask was further cooled to 0 °C 
before THF (175 mL) was introduced via syringe over 5 min. The resultant heterogeneous, off-white 
slurry was allowed to warm to ambient temperature. After 12 h, the reaction vessel was equipped with a 
250-mL equal pressure graduated addition funnel and the reaction mixture was cooled to –78 °C. A 
solution of vinylmagnesium bromide in THF (1.0 M, 88.0 mL, 88.0 mmol, 5.00 equiv) was added 
dropwise via 250-mL equal pressure graduated addition funnel over 30 min. The resultant yellow slurry 
was stirred for 1.5 h at –78 °C. A separate 250 mL round-bottomed flask was charged with C-propenyl 
cis-decalin (±)-1.208 (5.46 g, 17.5 mmol, 1.00 equiv) and azeotropically dried with three portions of 
benzene. THF (88 mL) was introduced and the resultant solution was cooled to –78 °C before being 
transferred dropwise via a dry-ice wrapped cannula to the stirred, cooled reaction mixture over 1 h. The 
transfer was completed with two additional portions of THF (10 mL). After 2 h, a saturated aqueous 
ammonium chloride solution (300 mL) was added. The resultant mixture was subsequently allowed to 
warm to ambient temperature. The mixture was diluted with Et2O (100 mL) and the layers were 
separated. The aqueous layer was extracted with Et2O (3 × 300 mL). The combined organic layers were 
washed with a saturated aqueous sodium bicarbonate solution (300 mL) and brine (300 mL), dried over 
anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was then 
purified by flash column chromatography (silica gel, eluent: 10% EtOAc in hexanes) to afford allylic 
alcohol (±)-1.210 (5.49 g, 92%) as a white solid. 
1H NMR (500 MHz, CDCl3) δ: 7.37–7.27 (m, 5 H), 6.28 (ddd, J = 0.9, 11.0, 17.0 Hz, 1 H), 5.80 (d, J = 
THF, –78 °C, 1 h
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1.0 Hz, 1 H), 5.60 (qd, J = 6.2, 16.4 Hz, 1 H), 5.47 (dd, J = 1.3, 16.5 Hz, 1 H), 5.28 (dd, J = 2.3, 16.9 Hz, 
1 H), 5.05 (dd, J = 2.3, 10.9 Hz, 1 H), 4.70 (d, J = 11.1 Hz, 1 H), 4.47 (d, J = 11.0 Hz, 1 H), 4.40 (dd, J = 
4.1, 11.6 Hz, 1 H), 2.11–2.02 (m, 1 H), 1.92 (dt, J = 4.6, 13.8 Hz, 1 H), 1.82 (tt, J = 5.7, 11.8 Hz, 1 H), 
1.76–1.59 (m, 6 H), 1.58–1.39 (m, 3 H), 1.31 (ddd, J = 4.7, 14.4, 27.1 Hz, 1 H), 0.87 (d, J = 6.3 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 140.9, 137.2, 130.5, 128.5, 128.1, 127.9, 127.4, 113.5, 79.4, 78.0, 70.4, 
50.3, 44.7, 37.5, 32.4, 27.9, 27.0, 22.1, 20.5, 19.5, 18.8. 
FTIR (thin film) cm-1: 3442 (br), 3091, 3065, 3031, 2953, 2867, 1498, 1449, 1424, 1301, 1063, 979, 698. 
HRMS (ESI) calc’d for C23H32NaO2 [M+Na]+: 363.2295, found 363.2296. 
TLC (10% EtOAc in hexanes), Rf: 0.20 (UV, CAM). 
1D NOESY data (500 MHz, CDCl3): 
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Allyl alcohol (±)-1.215: 
A 1-L round-bottomed flask was charged with allyl alcohol (±)-1.209 (14.8 g, 43.5 mmol, 1.00 
equiv) and azeotropically dried with three portions of benzene. Hexanes (435 mL) was introduced and the 
resultant solution was cooled to 0 °C. Thionyl chloride (9.53 ml, 131 mmol, 3.00 equiv) and pyridine 
(17.6 ml, 218 mmol, 5.00 equiv) were sequentially added dropwise via syringe to the cooled, stirred 
reaction mixture over 10 min. The resultant reaction mixture warmed to ambient temperature over 1h. A 
saturated aqueous ammonium chloride solution (200 mL) was added and the layers were separated. The 
aqueous layer was extracted with Et2O (3 × 200 mL). The combined organic layers were washed with 
brine (2 × 250 mL), dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced 
pressure to furnish allylic chloride (±)-1.211 as a tan oil that was used without further purification. 
A 1-L round-bottomed flask was charged with allylic chloride (±)-1.211 and azeotropically dried 
with three portions of benzene before CH2Cl2 (400 mL) was introduced. Sodium bicarbonate (14.6 g, 174 
mmol, 4.00 equiv) was added to the stirred solution at ambient temperature, and the resultant 
heterogeneous mixture was cooled to –78 °C. A separate 1-L round-bottomed flask was charged with 
mCPBA (77 wt. %, 22.4 g, 100 mmol, 2.30 equiv) and diluted with CH2Cl2 (400 mL). The resultant 
solution was then transferred dropwise via cannula to the stirred, cooled reaction mixture over 1.5 h. The 
resultant heterogeneous reaction mixture was warmed to –30 °C. After 12 h, the reaction mixture was 
cautiously poured into a 2-L Erlenmeyer flask containing a stirred 1:1 mixture of saturated aqueous 
sodium bicarbonate solution (200 mL) and 10% (w/v) aqueous sodium sulfite solution (200 mL), which 
was subsequently allowed to warm to ambient temperature. The layers were separated and the aqueous 
layer was extracted with CH2Cl2 (3 × 250 mL). The combined organic layers were washed with saturated 
aqueous sodium bicarbonate solution (500 mL) and brine (500 mL), dried over anhydrous magnesium 
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sulfate, filtered, and concentrated under reduced pressure. The residue was filtered through a silica gel 
plug, which was eluted with 10% EtOAc in hexanes (3 × 500 mL) to furnish epoxy chloride (±)-1.213 as 
an impure clear oil that was used without further purification. 
A 500-mL round-bottomed flask was charged with expoxy chloride (±)-1.213 and azeotropically 
dried with three portions of benzene. Et2O (87 mL) was introduced and sodium metal (3.00 g, 131 mmol, 
3.00 equiv) was cut from a sodium lump under blanket of argon into the stirred reaction mixture at 
ambient temperature. After 24 h, the grey reaction mixture was cooled to 0 °C and methanol (40 mL) was 
added dropwise via syringe. After 1 h, saturated aqueous ammonium chloride solution (100 mL) was 
added and the layers were separated. The aqueous layer was extracted with Et2O (3 × 100 mL). The 
combined organic layers were washed with saturated aqueous sodium bicarbonate solution (250 mL)  
brine (250 mL), dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced 
pressure. The residue was then purified by flash column chromatography (silica gel, eluent: 10% EtOAc 
in hexanes) to afford allylic alcohol (±)-1.215 (11.4 g, 77% over three steps) as a clear oil. 
1H NMR (500 MHz, CDCl3) δ: 7.43–7.35 (m, 4 H), 7.35–7.29 (m, 1 H), 6.02 (dd, J = 10.8, 17.3 Hz, 1 H), 
5.62 (qd, J = 6.4, 16.1 Hz, 1 H), 5.16 (dd, J = 1.5, 12.8 Hz, 1 H), 5.13 (dd, J = 1.6, 11.9 Hz, 1 H), 5.08 (dd, 
J = 1.6, 10.8 Hz, 1 H), 4.66 (d, J = 11.4 Hz, 1 H), 4.34 (d, J = 11.6 Hz, 1 H), 3.58 (br. s., 1 H), 2.55 (q, J 
= 10.8 Hz, 1 H), 2.44 - 2.31 (m, 1 H), 2.04 (s, 1 H), 1.95 (d, J = 14.2 Hz, 1 H), 1.81 (d, J = 6.3 Hz, 3 H), 
1.79–1.72 (m, 1 H), 1.72–1.66 (m, 2 H), 1.60 (tt, J = 3.4, 13.0 Hz, 1 H), 1.53–1.42 (m, 4 H), 1.29–1.20 (m, 
1 H), 0.94 (d, J = 6.4 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 143.3, 138.7, 134.5, 128.2, 128.1, 127.2, 127.1, 112.6, 80.8, 74.2, 70.7, 
51.0, 40.2, 34.5, 30.3, 28.5, 25.0, 22.8, 21.5, 18.5, 15.3. 
FTIR (thin film) cm-1: 3538, 3028, 2946, 2922, 2865, 1453, 1363, 1317, 1068, 925, 733, 697. 
HRMS (ESI) calc’d for C23H32NaO2 [M+Na]+: 363.2295, found 363.2295. 
TLC (15% EtOAc in hexanes), Rf: 0.37 (UV, CAM). 
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Allylic alcohol (±)-1.216: 
A 500-mL round-bottomed flask was charged with allyl alcohol (±)-1.210 (5.40 g, 15.9 mmol, 
1.00 equiv) and azeotropically dried with three portions of benzene. Hexanes (160 mL) was introduced 
and the resultant solution was cooled to 0 °C. Thionyl chloride (3.47 ml, 47.7 mmol, 3.00 equiv) and 
pyridine (6.43 ml, 80.0 mmol, 5.00 equiv) were sequentially added dropwise via syringe to the cooled, 
stirred reaction mixture over 10 min. The resultant reaction mixture warmed to ambient temperature over 
1 h. A saturated aqueous ammonium chloride solution (100 mL) was added and the layers were separated. 
The aqueous layer was extracted with Et2O (3 × 100 mL). The combined organic layers were washed with 
brine (2 × 150 mL), dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced 
pressure to furnish allylic chloride (±)-1.212 as a tan oil that was used without further purification. 
 A 500-L round-bottomed flask was charged with allylic chloride (±)-1.212 and 
azeotropically dried with three portions of benzene before CH2Cl2 (160 mL) was introduced. Sodium 
bicarbonate (4.00 g, 47.7 mmol, 4.00 equiv) was added to the stirred solution at ambient temperature, and 
the resultant heterogeneous mixture was cooled to –78 °C. A separate 500-mL round-bottomed flask was 
charged with mCPBA (77 wt. %, 8.20 g, 36.6 mmol, 2.30 equiv) and diluted with CH2Cl2 (160 mL). The 
resultant solution was then transferred dropwise via cannula to the stirred, cooled reaction mixture over 
45 min. The resultant heterogeneous reaction mixture was warmed to –30 °C. After 12 h, the reaction 
mixture was cautiously poured into a 1-L Erlenmeyer flask containing a stirred 1:1 mixture of saturated 
aqueous sodium bicarbonate solution (200 mL) and 10% (w/v) aqueous sodium sulfite solution (200 mL), 
which was subsequently allowed to warm to ambient temperature. The layers were separated and the 
aqueous layer was extracted with CH2Cl2 (3 × 250 mL). The combined organic layers were washed with 
saturated aqueous sodium bicarbonate solution (500 mL) and brine (500 mL), dried over anhydrous 
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magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was filtered through a 
silica gel plug, which was eluted with 10% EtOAc in hexanes (3 × 500 mL) to furnish epoxy chloride (±)-
1.214 as a colorless oil that was used without further purification. 
A 200-mL round-bottomed flask was charged with expoxy chloride (±)-1.214 and azeotropically 
dried with three portions of benzene. Et2O (32 mL) was introduced and sodium metal (1.10 g, 47.7 mmol, 
3.00 equiv) was cut from a sodium lump under blanket of argon into the stirred reaction mixture at 
ambient temperature. After 24 h, the grey reaction mixture was cooled to 0 °C and methanol (20 mL) was 
added dropwise via syringe. After 1 h, saturated aqueous ammonium chloride solution (50 mL) was added 
and the layers were separated. The aqueous layer was extracted with Et2O (3 × 50 mL). The combined 
organic layers were washed with saturated aqueous sodium bicarbonate solution (150 mL)  brine (150 
mL), dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The 
residue was then purified by flash column chromatography (silica gel, eluent: 10% EtOAc in hexanes) to 
afford allylic alcohol (±)-1.216 (2.97 g, 55% over three steps) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.44–7.34 (m, 4 H), 7.33–7.27 (m, 1 H), 6.31 (dd, J = 10.8, 17.2 Hz, 1 H), 
5.84 (dd, J = 1.0, 16.5 Hz, 1 H), 5.67 (qd, J = 6.2, 16.5 Hz, 1 H), 4.97 (dd, J = 1.4, 17.3 Hz, 1 H), 4.81 (dd, 
J = 1.4, 10.8 Hz, 1 H), 4.63 (d, J = 11.7 Hz, 1 H), 4.45 (d, J = 11.6 Hz, 1 H), 3.93 (dd, J = 4.2, 10.5 Hz, 1 
H), 2.14 (br. s., 1 H), 2.09–2.00 (m, 2 H), 1.85 (d, J = 6.3 Hz, 4 H), 1.75–1.53 (m, 4 H), 1.53–1.35 (m, 3 
H), 0.94 (d, J = 6.3 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 146.1, 138.7, 131.4, 128.0, 127.4, 127.1, 127.0, 108.4, 77.1, 73.6, 70.1, 
53.4, 40.7, 32.1, 29.9, 29.2, 27.9, 22.3, 20.5, 19.5, 18.5. 
FTIR (thin film) cm-1: 3544, 3087, 3065, 3030, 2933, 2866, 1451, 1359, 1210, 1073, 992, 738. 
HRMS (ESI) calc’d for C23H32NaO2 [M+Na]+: 363.2295, found 363.2293. 
TLC (15% EtOAc in hexanes), Rf: 0.19 (UV, CAM). 
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Diol S1.5: 
A 500-mL round-bottomed flask was charged with a solution of 4,4-di-tert-butylbiphenyl (4.20 g, 
16.0 mmol, 12.0 equiv) in THF (80 mL). Lithium (91.0 mg) was introduced at ambient temperature and 
the resultant suspension stirred until a green color persisted at which time the reaction mixture was cooled 
to 0 °C. After 4 h, the reaction mixture was cooled to –78 °C. A separate 25-mL round-bottomed flask 
was charged with allylic alcohol (±)-1.215 (448 mg, 1.32 mmol, 1.00 equiv) and azeotropically dried with 
three portions of benzene. THF (10 ml) was introduced and the resultant solution was transferred 
dropwise via syringe to the stirred, cooled reaction mixture. The transfer was completed with two 
additional portions of THF (2.5 mL). After 30 min, the resultant reaction mixture warmed to 0 °C over 30 
min. A saturated aqueous ammonium chloride solution (50 mL) was added and was subsequently allowed 
to warm to ambient temperature. The mixture was diluted with Et2O (50 mL) and the layers were 
separated. The aqueous layer was further extracted with EtOAc (3 × 50 mL) and the combined organic 
layers were then washed with saturated aqueous sodium bicarbonate solution (100 mL) and brine (100 
mL), dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The 
residue was then purified by flash column chromatography (silica gel, eluent: 10% EtOAc in CH2Cl2) diol 
S1.5 (323 mg, 98%) as a white solid. 
1H NMR (500 MHz, CDCl3) δ: 6.18 (dd, J = 10.8, 17.3 Hz, 1 H), 5.55 (qd, J = 6.3, 16.2 Hz, 1 H), 5.13 
(dd, J = 1.3, 17.3 Hz, 1 H), 5.08–5.01 (m, 2 H), 3.85 (br. s., 1 H), 2.51–2.40 (m, 1 H), 2.17 (tt, J = 5.7, 
11.1 Hz, 1 H), 2.01 (d, J = 2.4 Hz, 1 H), 1.75 (dd, J = 1.1, 6.4 Hz, 3 H), 1.72–1.66 (m, 2 H), 1.66–1.59 (m, 
2 H), 1.57–1.39 (m, 6 H), 1.30–1.18 (m, 1 H), 0.88 (d, J = 6.4 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 143.6, 134.4, 128.3, 112.4, 74.3, 73.0, 50.3, 39.9, 34.5, 32.3, 30.1, 29.1, 
22.8, 21.6, 18.6, 14.9. 
FTIR (thin film) cm-1: 3448 (br), 2920, 2867, 1447, 1375, 1318, 986, 923. 
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HRMS (ESI) calc’d for C16H26NaO2 [M+Na]+: 273.1825, found 273.1824. 
TLC (15% EtOAc in hexanes), Rf: 0.34 (UV, CAM). 
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Ketone (±)-1.217:  
 A 25-mL round-bottomed flask was charged with a solution of diol S1.5 (292 mg, 1.17 mmol, 
1.00 equiv) and CH2Cl2 (12 mL). Dess-Martin periodinane (4.00 g, 4.67, 8.00 equiv) was added to the 
stirred reaction mixture at ambient temperature in one portion. After 18 h, saturated aqueous sodium 
bicarbonate solution (10 ml) was added and the resultant heterogeneous mixture was filtered through a 
pad of Celite, which was rinsed with CH2Cl2 (2 × 25 mL) and H2O (2 × 25 mL). The layers of the filtrate 
were separated and the aqueous layer was extracted with CH2Cl2 (3 × 25 mL). The combined organic 
layers were washed with water (100 mL) and brine (100 mL), filtered, and concentrated under reduced 
pressure. The residue was then purified by flash column chromatography (silica gel, eluent: 15% EtOAc 
in hexanes) to afford ketone (±)-1.217 (278 mg, 96%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 6.51 (dd, J = 10.9, 17.5 Hz, 1 H), 5.35 (dd, J = 1.3, 16.1 Hz, 1 H), 5.24 
(qd, J = 6.2, 16.1 Hz, 1 H), 5.00 (dd, J = 1.5, 17.5 Hz, 1 H), 4.95 (dd, J = 1.5, 10.9 Hz, 1 H), 2.70 (dt, J = 
8.1, 13.1 Hz, 1 H), 2.20–2.03 (m, 3 H), 1.99–1.89 (m, 1 H), 1.85–1.72 (m, 3 H), 1.71 (dd, J = 1.3, 6.2 Hz, 
3 H), 1.56–1.34 (m, 5 H), 0.86 (d, J = 6.2 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 213.1, 144.8, 132.0, 130.3, 112.0, 75.4, 63.3, 46.3, 40.1, 34.1, 30.1, 29.5, 
22.6, 22.4, 19.4, 18.3. 
FTIR (thin film) cm-1: 3021, 2948, 2875, 1695, 1447, 1310, 1227, 1127, 976, 917, 824, 683, 664, 576, 
545. 
HRMS (ESI) calc’d for C16H24NaO2 [M+Na]+: 271.1669, found 271.1670. 
TLC (15% EtOAc in hexanes), Rf: 0.42 (UV, CAM). 
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Enol silane (±)-1.224:  
A 25-mL round-bottomed flask was charged with ketone (±)-1.217 (273 mg, 1.10 mmol, 1.00 
equiv) and azeotropically dried with three portions of benzene. Pyridine (6 mL) was introduced, and the 
resultant solution cooled to 0 °C. Freshly distilled trimethylsilyl trifluoromethanesulfonate (1.20 mL, 6.60 
mmol, 6.00 equiv) was added dropwise via syringe to a stirred solution, which was subsequently allowed 
to warm to ambient temperature. After 12 h, saturated aqueous sodium bicarbonate solution (5 mL) and 
Et2O (5 mL) were then added to the reaction mixture. The layers were separated, and the aqueous layer 
was further extracted with EtOAc (3 × 15 mL). The combined organic layers were then washed with 
saturated aqueous sodium bicarbonate solution (50 mL) and brine (50 mL), dried over anhydrous sodium 
sulfate, filtered, and concentrated under reduced pressure. The residue was then purified by flash column 
chromatography (silica gel, eluent: 5% EtOAc in hexanes) to afford enol silane (±)-1.224 (399 mg, 93%) 
as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 6.16 (dd, J = 10.9, 17.9 Hz, 1 H), 5.58 (dd, J = 1.5, 15.7 Hz, 1 H), 5.38 
(qd, J = 6.4, 15.7 Hz, 1 H), 4.95 (dd, J = 1.1, 17.8 Hz, 1 H), 4.82 (dd, J = 1.3, 10.9 Hz, 1 H), 4.63 (dd, J = 
2.8, 4.4 Hz, 1 H), 2.06–1.96 (m, 1 H), 1.91 (dd, J = 2.9, 10.0 Hz, 1 H), 1.83 (td, J = 5.6, 17.4 Hz, 1 H), 
1.74 (dd, J = 1.5, 6.4 Hz, 3 H), 1.67–1.56 (m, 3 H), 1.55–1.42 (m, 4 H), 0.91 (d, J = 5.8 Hz, 3 H), 0.13 (s, 
9 H), 0.06 (s, 9 H). 
13C NMR (125 MHz, CDCl3) δ: 151.1, 145.4, 135.9, 125.7, 109.8, 102.9, 77.0, 54.7, 42.0, 30.7, 29.8, 
28.1, 20.8, 20.2, 19.8, 18.2, 2.4, 0.5. 
FTIR (thin film) cm-1: 2949, 1651, 1247, 1190, 1050, 1015, 911, 839, 753. 
HRMS (ESI) calc’d for C22H40NaO2Si2 [M+Na]+: 415.2459, found 415.2467. 
TLC (15% EtOAc in hexanes), Rf: 0.81 (UV, CAM). 
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Silyl ether (±)-1.224:  
A 10-mL round-bottomed flask was charged with enol silane (±)-1.224 (130 mg, 330 µmol, 1.00 
equiv) and azeotropically dried with three portions of benzene. THF (2 mL) was introduced and the 
resultant solution transferred dropwise via syringe to a 25-mL round-bottomed flask containing a stirred 
mixture of potassium tert-butoxide (56 mg, 0.580 mmol, 1.50 equiv) and THF (2 ml) at 0 °C. The transfer 
was completed with two additional portions of THF (1 mL) After 2 h, saturated aqueous ammonium 
chloride solution (5 mL) and Et2O (5 mL) were added to the reaction mixture, and the layers were 
separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the combined organic layers were 
washed with saturated aqueous sodium bicarbonate solution (25 mL) and brine (25 mL), dried over 
anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was then 
purified by flash column chromatography (silica gel, eluent: 5% EtOAc in hexanes) to afford silyl ether 
(±)-1.225 (106 mg, quantitative) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 6.10 (dd, J = 11.0, 17.7 Hz, 1 H), 5.44 (dd, J = 1.6, 16.4 Hz, 1 H), 5.13 
(dd, J = 1.5, 17.7 Hz, 1 H), 5.08 (dd, J = 1.5, 11.0 Hz, 1 H), 5.03 (qd, J = 6.4, 16.4 Hz, 1 H), 2.72 (ddd, J 
= 8.0, 12.6, 14.1 Hz, 1 H), 2.10 (td, J = 2.7, 11.6 Hz, 1 H), 2.07–1.98 (m, 2 H), 1.96–1.86 (m, 1 H), 1.83–
1.67 (m, 7 H), 1.53–1.41 (m, 2 H), 1.41–1.29 (m, J = 6.2 Hz, 1 H), 0.86 (d, J = 6.4 Hz, 3 H), 0.03 (s, 9 H). 
13C NMR (125 MHz, CDCl3) δ: 213.1, 142.7, 134.6, 128.4, 113.9, 77.6, 64.6, 47.1, 39.9, 32.1, 30.3, 29.6, 
22.8, 21.9, 19.5, 18.3, 2.5. 
FTIR (thin film) cm-1: 3089, 3021, 2953, 1705, 1448, 1249, 1083, 919, 754, 656. 
HRMS (ESI) calc’d for C22H40NaO2Si2 [M+Na]+: 415.2459, found 415.2467. 
TLC (15% EtOAc in hexanes), Rf: 0.81 (UV, CAM). 
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Tricycle (±)-1.230:  
A 2-mL vial was charged with a solution of ketone (±)-1.225 (12.0 mg, 37.5 µmol) and PhMe 
(400 µL), sealed with a Teflon cap, and heated to 240 °C. After 12 h, the reaction mixture was cooled to 
ambient temperature and concentrated under reduced pressure. The residue was then purified by flash 
column chromatography (silica gel, eluent: 5% EtOAc in hexanes) to afford tricycle (±)-1.230 (6.7 mg, 
56%) as a colorless oil. 
1H NMR (500 MHz, C6D6) δ: 3.10 (q, J = 10.0 Hz, 1 H), 2.66 (t, J = 3.8 Hz, 1 H), 2.60–2.49 (m, 1 H), 
2.37–2.25 (m, 1 H), 2.09 (tdd, J = 1.8, 4.1, 12.8 Hz, 1 H), 2.06–2.00 (m, 1 H), 1.79 (dt, J = 6.8, 13.1 Hz, 1 
H), 1.71–1.61 (m, 2 H), 1.61–1.55 (m, 1 H), 1.50–1.23 (m, 7 H), 0.87 (d, J = 6.6 Hz, 3 H), 0.74 (d, J = 5.9 
Hz, 3 H), 0.27 (s, 9 H). 
13C NMR (125 MHz, CDCl3) δ: 211.3, 142.4, 114.0, 52.8, 48.9, 47.0, 43.8, 34.9, 32.4, 30.6, 30.3, 29.5, 
28.0, 23.2, 20.6, 18.9, 0.6. 
FTIR (thin film) cm-1: 3075, 2962, 1703, 1441, 1248, 1092, 917, 812, 756. 
HRMS (ESI) calc’d for C19H33O2Si [M+H]+: 321.2244, found 321.2234. 
TLC (10% EtOAc in hexanes), Rf: 0.23 (UV, CAM). 
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trans-Decalin (±)-1.228:  
A 10-mL round-bottomed flask was charged with ketone (±)-1.225 (12.4 mg, 39.0 µmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. CH2Cl2 (400 µL) was introduced and the resultant 
solution was cooled to –78 °C. A solution of boron trifluoride diethyl etherate in CH2Cl2 (1.0 M, 39.0 µL, 
39.0 µmol, 1.00 equiv) was added to the stirred, cooled reaction mixture, which was subsequently 
warmed to ambient temperature. After 12 h, saturated aqueous sodium bicarbonate solution (3 mL) and 
Et2O (3 mL) were added to the reaction mixture, and the layers were separated. The aqueous layer was 
extracted with Et2O (3 × 10 mL) and the combined organic layers were washed with saturated aqueous 
sodium bicarbonate solution (25 mL) and brine (25 mL), dried over anhydrous magnesium sulfate, 
filtered, and concentrated under reduced pressure. The residue was then purified by flash column 
chromatography (silica gel, eluent: gradient, 30% → 40% EtOAc in hexanes) to afford trans-decalin (±)-
1.228 (6.9 mg, 71%) as a colorless oil.  
1H NMR (500 MHz, CDCl3) δ: 5.50 (t, J = 6.0 Hz, 1 H), 5.36 (dd, J = 1.5, 16.3 Hz, 1 H), 5.13 (qd, J = 
6.3, 16.3 Hz, 1 H), 4.29–4.15 (m, 2 H), 2.76–2.64 (m, 1 H), 2.60 (td, J = 3.3, 14.0 Hz, 1 H), 2.33–2.22 (m, 
1 H), 2.07–1.73 (m, 9 H), 1.59 (br. s., 2 H), 1.12–0.96 (m, 1 H), 0.89 (d, J = 5.6 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 212.4, 143.7, 135.0, 129.2, 125.6, 64.2, 59.2, 53.0, 38.8, 36.0, 31.2, 27.1, 
23.2, 21.0, 19.5, 18.4. 
FTIR (thin film) cm-1: 3408, 2938, 2875, 1704, 1448, 1384, 1254. 
HRMS (ESI) calc’d for C16H24NaO2 [M+Na]+: 271.1669, found 271.1685. 
TLC (40% EtOAc in hexanes), Rf: 0.18 (UV, CAM). 
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1D NOESY data (500 MHz, CDCl3): 
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cis-Decalin (±)-1.226:  
A 10-mL round-bottomed flask was charged with ketone (±)-1.225 (13.0 mg, 41.0 µmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. CH2Cl2 (400 µL) was introduced and the resultant 
solution was cooled to 0 °C. A solution of titanium(IV) chloride in CH2Cl2 (1.0 M, 41.0 µL, 41.0 µmol, 
1.00 equiv) was added to the stirred, cooled reaction mixture, which was subsequently warmed to ambient 
temperature. After 12 h, saturated aqueous sodium bicarbonate solution (3 mL) and Et2O (3 mL) were 
added to the reaction mixture, and the layers were separated. The aqueous layer was extracted with Et2O 
(3 × 10 mL) and the combined organic layers were washed with saturated aqueous sodium bicarbonate 
solution (25 mL) and brine (25 mL), dried over anhydrous magnesium sulfate, filtered, and concentrated 
under reduced pressure. The residue was then purified by flash column chromatography (silica gel, eluent: 
gradient, 30% → 40% EtOAc in hexanes) to afford cis-decalin (±)-1.226 (8.5 mg, 83%) as a colorless oil.  
1H NMR (500 MHz, CDCl3) δ: 5.56 (t, J = 7.8 Hz, 1 H), 5.37 (dd, J = 1.3, 16.4 Hz, 1 H), 5.14 (qd, J = 6.4, 
16.3 Hz, 1 H), 4.24 (t, J = 10.4 Hz, 1 H), 4.03 (dd, J = 6.6, 11.4 Hz, 1 H), 2.76–2.62 (m, 2 H), 2.28 (dd, J 
= 4.3, 15.0 Hz, 1 H), 2.07–1.74 (m, 9 H), 1.67–1.57 (m, 2 H), 1.17–1.03 (m, 1 H), 0.90 (d, J = 5.7 Hz, 3 
H). 
13C NMR (125 MHz, CDCl3) δ: 211.9, 147.3, 134.7, 129.6, 122.0, 64.3, 53.0, 40.5, 38.8, 35.8, 31.2, 26.9, 
23.1, 20.9, 19.4, 18.3. 
FTIR (thin film) cm-1: 3408 (br), 2938, 2875, 1704, 1448, 1384, 1254. 
HRMS (ESI) calc’d for C16H24NaO2 [M+Na]+: 271.1669, found 271.1648. 
TLC (15% EtOAc in hexanes), Rf: 0.27 (UV, CAM). 
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1D NOESY data (500 MHz, CDCl3): 
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Tricycle (±)-1.235:  
A 5-mL round-bottomed flask was charged with a suspension of potassium hydride (14.0 mg, 350 
µmol, 5.00 equiv) and THF (400 µL). Iodine (9.0 mg, 40.0 µmol, 0.50 equiv) was introduced to the 
stirred reaction mixture at ambient temperature and stirred for 10 min. A separate 5-mL round-bottomed 
flask was charged with allylic alcohol (±)-1.215 (24.0 mg, 71.0 µmol, 1.00 equiv) and 18-crown-6 (93.0 
mg, 350 µmol, 5.00 equiv) and azeotropically dried with three portions of benzene. THF (500 µL) was 
introduced and the resultant solution transferred dropwise via syringe to the 5-mL round-bottomed flask 
containing the stirred mixture of activated potassium hydride at ambient temperature. 
The transfer was completed with two additional portions of THF (200 µL). After 10 min, ethanol (100 
µL) was added to the stirred reaction mixture. After an additional 20 min, saturated aqueous ammonium 
chloride solution (1 mL) and Et2O (1 mL) were added to the reaction mixture, and the layers were 
separated. The aqueous layer was extracted with Et2O (3 × 5 mL) and the combined organic layers were 
washed with saturated aqueous sodium bicarbonate solution (15 mL) and brine (15 mL), dried over 
anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was then 
purified by flash column chromatography (silica gel, eluent: gradient, 5% → 15% EtOAc in hexanes) to 
afford tricycle (±)-1.235 (8.0 mg, 52%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 5.46 (t, J = 3.8 Hz, 1 H), 2.45–2.26 (m, 2 H), 2.14–1.91 (m, 5 H), 1.76–
1.67 (m, 1 H), 1.66–1.29 (m, 7 H), 1.00 (d, J = 6.1 Hz, 3 H), 0.95 (d, J = 6.2 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 212.4, 141.0, 118.3, 56.4, 54.5, 44.6, 41.3, 37.7, 35.6, 35.0, 30.8, 26.4, 
25.6, 19.8, 19.5. 
FTIR (thin film) cm-1: 2929, 2870, 1713, 1457, 1375, 1161. 
HRMS (ESI) calc’d for C15H22NaO [M+Na]+: 241.1563, found 241.1551. 
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TLC (15% EtOAc in hexanes), Rf: 0.40 (UV, CAM). 
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Tricycle (±)-1.235:  
A 5-mL, 2-necked, round-bottomed flask was charged with a suspension of potassium hydride 
(34.5 mg, 860 µmol, 5.00 equiv) and THF (900 µL). Iodine (22 mg, 86 µmol, 0.50 equiv) was introduced 
to the stirred reaction mixture at ambient temperature and stirred for 10 min. A separate 5-mL round-
bottomed flask was charged with allylic alcohol (±)-1.235 (58.5 mg, 172 µmol, 1.00 equiv) and 18-
crown-6 (227 mg, 860 µmol, 5.00 equiv) and azeotropically dried with three portions of benzene. THF 
(500 µL) was introduced and the resultant solution transferred dropwise via syringe to the 5-mL round-
bottomed flask containing the stirred mixture of activated potassium hydride at ambient temperature. 
The transfer was completed with two additional portions of THF (250 µL). After 10 min, ethanol (100 
µL) was added to the reaction mixture. After an additional 20 min, saturated aqueous ammonium chloride 
solution (1 mL) and Et2O (1 mL) were added to the reaction mixture, and the layers were separated. The 
aqueous layer was extracted with Et2O (3 × 5 mL) and the combined organic layers were washed with 
saturated aqueous sodium bicarbonate solution (15 mL) and brine (15 mL), dried over anhydrous 
magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was then purified by 
flash column chromatography (silica gel, eluent: gradient, 5% → 15% EtOAc in hexanes) to afford 
tricycle (±)-1.235 (21.0 mg, 56%) as a colorless oil. 
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Bicycle (±)-1.243:  
A 25-mL round-bottomed flask was charged with allylic alcohol (±)-1.215 (200 mg, 588 µmol, 
1.00 equiv) and azeotropically dried with three portions of benzene. THF (2 mL) and tert-
butyldimethylsilyl chloride (443 mg, 2.94 mmol, 5.00 equiv) were introduced. A solution of sodium 
bis(trimethylsilyl)amide in THF (0.73 M, 4.0 mL, 2.94 mmol, 5.00 equiv) was added to the stirred 
reaction mixture at ambient temperature. After 14 h, saturated aqueous ammonium chloride solution (4 
mL) and Et2O (5 mL) were added to the reaction mixture, and the layers were separated. The aqueous 
layer was extracted with Et2O (3 × 15 mL) and the combined organic layers were washed with saturated 
aqueous sodium bicarbonate solution (25 mL) and brine (25 mL), dried over anhydrous magnesium 
sulfate, filtered, and concentrated under reduced pressure.  
A 25-mL round-bottomed flask was charged with a solution of the reaction residue, THF (3.00 
mL) and water (300 µL). para-Toluenesulfonic acid monohydrate (600 mg, 3.15 mmol, 5.36 equiv) was 
added to the stirred reaction mixture at ambient temperature. After 1 h, saturated aqueous sodium 
bicarbonate solution (4 mL) and Et2O (5 mL) were added to the reaction mixture, and the layers were 
separated. The aqueous layer was extracted with Et2O (3 × 15 mL) and the combined organic layers were 
washed with saturated aqueous sodium bicarbonate solution (25 mL) and brine (25 mL), dried over 
anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was then 
purified by flash column chromatography (silica gel, eluent: gradient, 5% → 15% EtOAc in hexanes) to 
afford bicycle (±)-1.243 (159 mg, 80%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.45–7.35 (m, 5 H), 7.34–7.28 (m, 1 H), 4.73 (dd, J = 11.2, 19.5 Hz, 2 H), 
4.49 (t, J = 2.3 Hz, 1 H), 4.46 (d, J = 11.6 Hz, 1 H), 3.43 (ddd, J = 1.0, 7.0, 17.0 Hz, 1 H), 2.41 (ddt, J = 
4.6, 6.4, 11.0 Hz, 1 H), 2.32–2.13 (m, 3 H), 2.07–1.95 (m, 3 H), 1.94–1.64 (m, 5 H), 1.63–1.54 (m, 1 H), 
1.36–1.18 (m, 3 H), 0.89 (d, J = 6.6 Hz, 3 H), 0.85 (d, J = 6.7 Hz, 3 H). 
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13C NMR (125 MHz, CDCl3) δ: 216.0, 138.9, 135.6, 128.3, 127.7, 127.4, 73.6, 70.4, 52.5, 42.9, 42.0, 
36.2, 34.0, 33.1, 32.0, 30.8, 30.6, 21.5, 20.7, 16.1. 
FTIR (thin film) cm-1: 2929, 2866, 1703, 1454, 1052, 1028, 735, 699. 
HRMS (ESI) calc’d for C23H32NaO2 [M+Na]+: 363.2295, found 363.2292. 
TLC (10% EtOAc in hexanes), Rf: 0.29 (UV, CAM). 
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Bicycle (±)-1.244:  
A 10-mL, 2-necked, round-bottomed flask was charged with allylic alcohol (±)-1.216 (97.1 mg, 
290 µmol, 1.00 equiv) and azeotropically dried with three portions of benzene. THF (1 mL) and tert-
butyldimethylsilyl chloride (216 mg, 1.43 mmol, 5.00 equiv) were introduced. A solution of sodium 
bis(trimethylsilyl)amide in THF (0.73 M, 1.95 mL, 1.43 mmol, 5.00 equiv) was added to the stirred 
reaction mixture at ambient temperature. The reaction vessel was equipped with a reflux condenser and 
heated to reflux. After 12 h, the reaction mixture cooled to ambient temperature and saturated aqueous 
ammonium chloride solution (3 mL) and Et2O (3 mL) were added to the reaction mixture, and the layers 
were separated. The aqueous layer was extracted with Et2O (3 × 10 mL) and the combined organic layers 
were washed with saturated aqueous sodium bicarbonate solution (15 mL) and brine (15 mL), dried over 
anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure.  
A 25-mL round-bottomed flask was charged with a solution of the reaction residue, THF (4.00 
mL) and water (400 µL). para-Toluenesulfonic acid monohydrate (100 mg, 526 µmol, 1.80 equiv) was 
added to the stirred reaction mixture at ambient temperature. After 1 h, saturated aqueous sodium 
bicarbonate solution (5 mL) and Et2O (5 mL) were added to the reaction mixture, and the layers were 
separated. The aqueous layer was extracted with Et2O (3 × 15 mL) and the combined organic layers were 
washed with saturated aqueous sodium bicarbonate solution (25 mL) and brine (25 mL), dried over 
anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was then 
purified by flash column chromatography (silica gel, eluent: gradient, 5% → 15% EtOAc in hexanes) to 
afford bicycle (±)-1.244 (19.8 mg, 45%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.43–7.34 (m, 5 H), 7.34–7.28 (m, 1 H), 4.75 (d, J = 11.8 Hz, 1 H), 4.66 
(d, J = 10.9 Hz, 1 H), 4.54 (d, J = 11.7 Hz, 1 H), 4.33 (dd, J = 4.2, 10.8 Hz, 1 H), 3.50 (tt, J = 5.5, 11.2 Hz, 
1 H), 2.50 (dd, J = 7.8, 16.9 Hz, 1 H), 2.43 (t, J = 12.9 Hz, 1 H), 2.34–2.24 (m, 1 H), 2.19 (dd, J = 11.6, 
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16.7 Hz, 1 H), 2.03–1.96 (m, J = 6.0, 13.5 Hz, 1 H), 1.95–1.69 (m, 6 H), 1.67–1.54 (m, 2 H), 1.46 (tdd, J 
= 3.5, 13.6, 26.6 Hz, 1 H), 1.40–1.23 (m, 2 H), 0.89 (s, 3 H), 0.84 (d, J = 6.4 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 214.0, 139.6, 138.7, 133.8, 128.3, 127.8, 127.5, 79.2, 70.9, 54.7, 42.9, 
41.6, 37.0, 33.9, 32.7, 32.5, 31.6, 30.7, 21.2, 20.5, 20.1. 
FTIR (thin film) cm-1: 3064, 3031, 2928, 2866, 1703, 1454, 1051, 1028, 957, 734, 699. 
HRMS (ESI) calc’d for C23H32NaO2 [M+Na]+: 363.2295, found 363.2322. 
TLC (10% EtOAc in hexanes), Rf: 0.67 (UV, CAM). 
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Alkenyl triflate (±)-1.245:  
A 10-mL round-bottomed flask was charged with bicycle (±)-1.244 (28.0 mg, 82.0 µmol, 1.00 
equiv) and azeotropically dried with three portions of benzene. THF (200 µL) was introduced and the 
resultant solution cooled to –78 °C. In a separate 10-mL round-bottomed flask, a solution of n-
butyllithium in hexanes (2.44 M, 51.0 µL, 123 µmol, 1.5 equiv) was added dropwise via syringe to a 
stirred solution of hexamethyldisilazane (26.0 µL, 123 µmol, 1.5 equiv) in THF (400 µL) at –20 °C. After 
30 min, the reaction mixture was cooled to –78 °C. The cold solution of bicycle (±)-1.244 in THF was 
then added dropwise via a dry-ice wrapped cannula to the stirred, cooled reaction mixture over 5 min and 
the transfer was completed with an additional portion of THF (200 µL). The resultant solution warmed to 
–60 °C. After 45 min, reaction mixture was cooled to –78 °C and a freshly prepared solution of N-phenyl-
bis(trifluoromethanesulfonimide) (88.0 mg, 250 µmol, 3.00 equiv) in THF (400 µL) was added dropwise 
via syringe over 2 min and the resultant reaction mixture warmed to ambient temperature. After 2h, 
saturated aqueous ammonium chloride solution (5 mL) was added to the stirred reaction mixture, which 
was subsequently diluted with Et2O (10 mL) and the layers were separated. The aqueous layer was further 
extracted with Et2O (3 × 10 mL) and the combined organic layers were then washed with saturated 
aqueous sodium bicarbonate solution (25 mL) and brine (25 mL), dried over anhydrous magnesium 
sulfate, filtered, and concentrated under reduced pressure. The residue was then purified by flash column 
chromatography (silica gel, eluent: 3% EtOAc in hexanes) to afford alkenyl triflate (±)-1.245 (18.0 mg, 
47%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.39–7.32 (m, 4 H), 7.32–7.26 (m, 1 H), 5.58 (dd, J = 4.7, 12.5 Hz, 1 H), 
5.24 (dd, J = 1.2, 11.0 Hz, 1 H), 4.62 (d, J = 12.2 Hz, 1 H), 4.56 (d, J = 12.1 Hz, 1 H), 3.79 (dd, J = 3.6, 
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11.5 Hz, 1 H), 2.58–2.41 (m, 3 H), 2.23–2.00 (m, 4 H), 1.91 (td, J = 3.6, 13.3 Hz, 1 H), 1.87–1.76 (m, 2 
H), 1.66–1.46 (m, 3 H), 1.38–1.19 (m, 4 H), 1.01–0.97 (m, 6 H). 
13C NMR (125 MHz, CDCl3) δ: 150.5, 140.4, 138.8, 128.4, 127.6, 127.4, 125.4, 118.6, 76.2, 71.3, 41.6, 
35.8, 32.3, 31.1, 30.4, 29.1, 29.0, 27.7, 21.8, 20.0, 16.9. 
FTIR (thin film) cm-1: 2930, 2864, 1454, 1413,1209, 1141, 1094, 938, 883, 735. 
HRMS (ESI) calc’d for C24H31F3NaO4S [M+Na]+: 495.1787, found 495.1804. 
TLC (15% EtOAc in hexanes), Rf: 0.54 (UV, CAM). 
1D TOCSY data (500 MHz, CDCl3): 
 
1D NOESY data (500 MHz, CDCl3): 
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Bis-enone (±)-1.249 and (±)-1.250:  
A 10-mL Schlenk tube was charged with a solution of ketone (±)-1.217 (103 mg, 415 µmol) and 
PhMe (5 mL), sealed, and heated to 110 °C. After 20 h, the reaction mixture was cooled to ambient 
temperature and concentrated under reduced pressure. The residue was then purified by flash column 
chromatography (silica gel, eluent: 15% EtOAc in hexanes) to afford bis-enone (±)-1.250 (59.0 mg, 57%) 
and bis-enone (±)-1.249 (15.2 mg, 15%) as colorless oils. 
Bis-enone (±)-1.250: 
1H NMR (500 MHz, CDCl3) δ: 6.33 (dd, J = 10.6, 17.3 Hz, 1 H), 6.20 (d, J = 17.6 Hz, 1 H), 5.81 (d, J = 
10.5 Hz, 1 H), 5.50 (t, J = 7.4 Hz, 1 H), 2.63–2.47 (m, 2 H), 2.46–2.30 (m, 2 H), 2.29–2.13 (m, 3 H), 
1.93–1.66 (m, 5 H), 1.50–1.40 (m, 1 H), 1.38–1.27 (m, 1 H), 0.98 (t, J = 7.4 Hz, 3 H), 0.88 (d, J = 6.5 Hz, 
3 H). 
13C NMR (125 MHz, CDCl3) δ: 205.5, 200.9, 140.8, 138.4, 136.4, 128.0, 49.8, 42.7, 37.8, 33.9, 28.5, 
26.8, 22.3, 21.0, 16.1, 14.3. 
FTIR (thin film) cm-1: 2954, 2927, 2874, 1685, 1385. 
HRMS (ESI) calc’d for C16H24NaO2 [M+Na]+: 271.1669, found 271.1661. 
TLC (40% EtOAc in hexanes), Rf: 0.65 (UV, CAM). 
1D NOESY data (500 MHz, CDCl3): 
 
  
Me
Me
HO
O
(±)-1.217 (±)-1.250 (57%)
Me
Me
O
O
PhMe, 110 °C, 20 h
(±)-1.249 (15%)
Me
O
O
Me
Me
Me
O
O
H
H
3% nOe
(±)-1.250
 229 
Bis-enone (±)-1.249: 
1H NMR (500 MHz, CDCl3) δ: 6.33 (dd, J = 10.5, 17.6 Hz, 1 H), 6.29 (t, J = 7.3 Hz, 1 H), 6.19 (d, J = 
17.4 Hz, 1 H), 5.80 (dd, J = 0.8, 10.6 Hz, 1 H), 2.74 (dd, J = 5.7, 13.3 Hz, 1 H), 2.64–2.47 (m, 2 H), 2.45–
2.29 (m, 2 H), 2.21–2.00 (m, 2 H), 1.92–1.79 (m, 2 H), 1.78–1.66 (m, 3 H), 1.51–1.40 (m, 1 H), 1.37–
1.26 (m, 1 H), 1.04 (t, J = 7.4 Hz, 3 H), 0.86 (d, J = 6.6 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 204.3, 200.6, 141.2, 140.0, 136.4, 127.9, 40.8, 40.1, 38.0, 35.3, 28.3, 
25.0, 21.5, 19.4, 15.8, 13.3. 
FTIR (thin film) cm-1: 2922, 2850,1709, 1450, 1376, 1177, 1078, 942, 758. 
HRMS (ESI) calc’d for C24H31F3NaO4S [M+Na]+: 495.1787, found 495.1804. 
TLC (15% EtOAc in hexanes), Rf: 0.12 (UV, CAM). 
1D NOESY data (500 MHz, CDCl3): 
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Enol silane (±)-1.251:  
A 5-mL Schlenk tube was charged with bis-enone (±)-1.250 (53.4 mg, 215 µmol) and 
azeotropically dried with three portions of benzene. THF (2 mL), triethylamine (300 µL, 2.15 mmol, 10.0 
equiv), and chlorotrimethylsilane (273 µL, 2.15 mmol, 10.0 equiv) were sequentially introduced and the 
resultant reaction mixture was sealed and heated to 75 °C. After 7.5 h, the reaction mixture was cooled to 
ambient temperature and saturated aqueous ammonium chloride solution (2 mL) was added to the stirred 
reaction mixture, which was subsequently diluted with Et2O (5 mL) and the layers were separated. The 
aqueous layer was further extracted with Et2O (3 × 10 mL) and the combined organic layers were then 
washed with saturated aqueous sodium bicarbonate solution (25 mL) and brine (25 mL), dried over 
anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was then 
purified by flash column chromatography (silica gel, eluent: 5% EtOAc in hexanes) to afford enol silane 
(±)-1.251 (45.2 mg, 66%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 6.41–6.31 (m, 2 H), 6.22 (dd, J = 0.7, 17.5 Hz, 1 H), 5.81 (dd, J = 0.9, 
10.6 Hz, 1 H), 5.40 (qd, J = 6.6, 15.8 Hz, 1 H), 2.68–2.52 (m, 3 H), 2.14–1.98 (m, 2 H), 1.98–1.86 (m, 1 
H), 1.80–1.63 (m, 5 H), 1.61–1.43 (m, 4 H), 0.73 (d, J = 6.9 Hz, 3 H), 0.19 (s, 9 H). 
13C NMR (125 MHz, CDCl3) δ: 201.2, 147.7, 136.5, 127.8, 126.6, 121.4, 117.5, 77.3, 76.7, 38.4, 37.4, 
34.2, 30.8, 29.5, 22.6, 20.9, 18.9, 15.3, 0.7 
FTIR (thin film) cm-1: 3032, 2957, 2933, 2874, 1701, 1685, 1617, 1457, 1399, 1361, 1252, 1180, 955, 
844, 756. 
HRMS (ESI) calc’d for C19H32NaO2Si [M+Na]+: 343.2064, found 343.2052. 
TLC (10% EtOAc in hexanes), Rf: 0.28 (UV, CAM). 
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Methyl 3-O-benzyl-4,6-O-benzylidine-α-D-glucopyranoside (2.77): 
A 3-L, two-necked, round-bottomed flask was equipped with an internal thermocouple, a 500-mL 
graduated addition funnel, and two rubber septa. The reaction flask was charged with methyl α-D-
glucopyranoside (2.73) (138 g, 709 mmol, 1.00 equiv) and pyridine (709 mL). The mixture was 
vigorously stirred for 30 min to break-up the white-solid. Chlorotrimethylsilane (450 mL, 3.60 mol, 5.00 
equiv) was added dropwise via graduated addition funnel over 3 h while maintaining an internal reaction 
temperature between 40 to 45 °C. After the addition was completed, the reaction was stirred for 1.5 h at 
ambient temperature and was then diluted with Et2O (700 mL) and water (700 mL). The layers were 
separated and the aqueous layer was extracted with Et2O (2 × 500 mL). The combined organic layers 
were washed with water (1 L) and brine (1 L). The organic layer was dried over anhydrous magnesium 
sulfate, filtered, and concentrated under reduced pressure to afford methyl 2,3,4,6-tetra-O-trimethylsilyl-
α-D-glucopyranoside (2.76)230 (334 g, 98%) as a clear, colorless oil, which was used without further 
purification. 
A 250-mL round-bottomed flask was charged in a glove box with copper(II) 
trifluoromethanesulfonate (750 mg, 2.07 mmol, 0.010 equiv) and then sealed with a rubber septa. The 
flask was removed from the glove box and placed under an argon atmosphere before MeCN (90 mL) was 
added to form a clear, blue solution. A 1-L round-bottomed flask was charged with 2.76 (100 g, 207 
mmol, 1.00 equiv), CH2Cl2 (360 mL), and benzaldehyde (63.2 mL, 622 mmol, 3.00 equiv). The reaction 
solution was cooled to 0 °C, and the solution of copper(II) trifluoromethanesulfonate in MeCN was added 
dropwise over 30 min via cannula. The resultant pink solution was allowed to warm to ambient 
                                                      
230 For spectroscopic and physical characterization of 2.77 see: Franais, A.; Urban, D.; Beau, J.-M. Angew. Chem. 
Int. Ed. 2007, 46, 8662–8665. 
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temperature over 30 min, and then cooled to 0 °C. Triethylsilane (36.4 mL, 228 mmol, 1.10 equiv) was 
added dropwise over 15 min via syringe. The reaction mixture was stirred for an additional 30 min before 
a saturated aqueous sodium bicarbonate solution  (500 mL) was added. After stirring for 15 min, the 
reaction mixture was diluted with Et2O (500 mL) and the layers were separated. The aqueous layer was 
extracted with Et2O (3 × 250 mL). The combined organic layers were washed with water (750 mL) and 
brine (750 mL). The organic layer was dried over anhydrous magnesium sulfate, filtered, and 
concentrated under reduced pressure to furnish a tan solid. The solid was purified by recrystallization 
from ethanol to afford pure methyl 3-O-benzyl-4,6-O-benzylidine-α-D-glucopyranoside (2.77)230 (39.0 g, 
50%) as a white solid. 
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Methyl 3-O-benzyl-2-O-pivaloyl-α-D-glucopyranoside ((+)-2.78): 
A 1-L round-bottomed flask was charged with (–)-2.77 (28.5 g, 76.6 mmol, 1.00 equiv) and 
azeotropically distilled with benzene (3 × 100 mL). CH2Cl2 (383 mL) was added, and the resultant 
solution cooled to 0 °C. Triethylamine (21.4 mL, 153 mmol, 2.00 equiv), pivaloyl chloride (14.1 mL, 115 
mmol, 1.50 equiv), and 4-(dimethylamino)pyridine (941 mg, 7.70 mmol, 0.100 equiv) were sequentially 
added to the stirred solution, which was subsequently allowed to warm to ambient temperature over 3 h. 
A saturated aqueous solution of sodium bicarbonate (400 mL) was added and layers were separated. The 
aqueous layer was extracted with CH2Cl2 (3 × 200 mL) and the combined organic layers were washed 
with water (400 mL) and brine (400 mL). The organic layer was dried over anhydrous magnesium sulfate, 
filtered, and concentrated to furnish a yellow syrup. The product was purified by flash-column 
chromatography (silica gel, eluent: 10% EtOAc in hexanes) to afford methyl 3-O-benzyl-4,6-O-
benylidene-2-O-pivaloyl-α-D-glucopyranoside (S2.1)230 (33.2 g, 95%) as a yellow oil. 
A 500-mL round-bottomed flask was charged with a solution of S2.1 (33.2 g, 72.7 mmol, 1.00 
equiv), water (39 mL), and acetic acid (155 mL). The reaction vessel was sealed with a plastic cap and 
heated to 80 °C for 1.5 h. The reaction mixture was allowed to cool to ambient temperature and 
concentrated under reduced pressure. The resultant colorless syrup was directly purified by flash-column 
chromatography (silica gel, eluent: gradient, 40 → 80% EtOAc in hexanes) to afford methyl 3-O-benzyl-
2-O-pivaloyl-α-D-glucopyranoside ((+)-2.78) (25.2 g, 94%) as a white solid. 
1H NMR (500 MHz, CDCl3) δ: 7.36–7.23 (m, 5 H), 4.91 (d, J = 3.7 Hz, 1 H), 4.84 (d, J = 11.4 Hz, 1 H), 
4.73 (dd, J = 3.7, 9.8 Hz, 1 H), 4.68 (d, J = 11.4 Hz, 1 H), 3.90–3.82 (m, 1 H), 3.82–3.74 (m, 2 H), 3.67–
3.60 (m, 2 H), 3.35 (s, 3 H), 3.01 (br. s., 1 H), 2.55 (br. s, 1 H), 1.22 (s, 9 H). 
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13C NMR (125 MHz, CDCl3) δ: 177.9, 138.3, 128.5, 127.8, 127.6, 97.0, 79.6, 75.0, 73.6, 70.8, 70.2, 62.0, 
55.3, 38.7, 27.0. 
FTIR (thin film) cm-1: 3436, 2959, 2933, 1731, 1481, 1455, 1363, 1397, 1284, 1162, 1124, 1053, 1039. 
HRMS (ESI) (m/z) calc’d for C19H28O7Na [M+Na]+: 391.1727, found 391.1728. 
[α]D23: +73.6 (c = 0.57, CHCl3). 
TLC (20% acetone in PhMe), Rf : 0.22 (UV, CAM). 
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Methyl 2-O-pivaloyl-3-O-benzyl-6-deoxy-6-iodo-α-D-glucopyranoside ((+)-S2.2): 
A 1-L round-bottomed flask was charged with triphenylphosphine (23.3 g, 89.0 mmol, 1.30 
equiv), imidazole (14.0 g, 205 mmol, 3.00 equiv), and PhMe (342 mL). The reaction mixture was 
vigorously stirred for 30 min to break-up the solids before iodine (22.6 g, 89.0 mmol, 1.30 equiv) was 
added in one portion. The reaction mixture was stirred for 30 min before a solution of (+)-2.78 (25.2 g, 
68.4 mmol, 1.00 equiv) in PhMe (102 mL) was added via cannula. The resultant inhomogeneous reaction 
mixture was stirred for 1 h at 45 °C, and was then allowed to cool to ambient temperature. Brine (400 
mL) was added, and the resultant mixture was stirred for 15 min or until all of the solid material had fully 
dissolved.  The layers were then separated and the aqueous layer extracted with Et2O (3 × 200 mL).  The 
combined organic layers were dried over anhydrous magnesium sulfate, filtered, and concentrated. The 
resultant pale-yellow syrup was purified by flash-column chromatography (silica gel, eluent: 30% EtOAc 
in hexanes) to afford methyl 3-O-benzyl-2-O-pivaloyl-3-O-benzyl-6-deoxy-6-iodo-α-D-glucopyranoside 
((+)-S2.2) (31.7 g, 97%) as a colorless flocculent solid. 
1H NMR (500 MHz, CDCl3) δ: 7.38–7.34 (m, 2 H), 7.33–7.29 (m, 3 H), 4.94 (d, J = 3.7 Hz, 1 H), 4.88 
(d, J = 11.7 Hz, 1 H), 4.77 (dd, J = 3.8, 10.0 Hz, 1 H), 4.60 (d, J = 11.4 Hz, 1 H), 3.86 (t, J = 9.3 Hz, 1 H), 
3.55 (dd, J = 2.2, 10.6 Hz, 1 H), 3.47 (ddd, J = 2.3, 7.1, 9.4 Hz, 1 H), 3.42 (s, 3 H), 3.39 (dd, J = 2.7, 9.2 
Hz, 1 H), 3.29 (dd, J = 7.0, 10.6 Hz, 1 H), 2.23 (d, J = 2.7 Hz, 1 H), 1.24 (s, 9 H). 
13C NMR (125 MHz, CDCl3) δ: 177.8, 138.1, 128.7, 128.1, 127.7, 97.0, 79.2, 75.1, 73.7, 73.6, 69.9, 55.7, 
38.7, 27.1, 6.6. 
FTIR (thin film) cm-1: 3444, 2972, 1730, 1644, 1283, 1161, 1126, 1049. 
HRMS (ESI) (m/z) calc’d for C19H27IO6Na [M+Na]+: 501.0745, found 501.0747. 
[α]D23: +70.0 (c = 0.50, CHCl3). 
O
OBn
OMe
OPiv
OH
(+)-S2.2
I
O
OBn
OMe
OPiv
OH
(+)-2.78
HO
PPh3, imidazole,
PhMe, 0.5 h;
then I2, 0.5 h; 
then (+)-2.78,
RT → 45 °C, 1 h
(97%)
 236 
TLC (15% EtOAc in hexanes), Rf : 0.24 (UV, CAM).  
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Methyl 2-O-pivaloyl-3-O-benzyl-4-O-t-butyldimethylsilyloxy-6-deoxy-6-iodo-α-D-glucopyranoside 
((+)-2.79): 
A 500-mL round-bottomed flask was charged with (+)-S2.2 (59.8 g, 125 mmol, 1.00 equiv) 
azeotropically dried with three portions of benzene. 2,6-Lutidine (125 mL) was introduced, and the 
resultant solution was cooled to 0 °C. t-Butyldimethylsilyl trifluoromethanesulfonate (57.4 mL, 250 
mmol, 2.00 equiv) was added dropwise via syringe to the cooled, stirred reaction mixture over 10 min. 
After the addition was complete, the reaction was allowed to warm to ambient temperature over 30 min. 
The reaction mixture was then poured into a saturated aqueous sodium bicarbonate solution (600 mL) and 
diluted with Et2O (500 mL). The layers were separated and the aqueous layer was extracted with Et2O (3 
× 500 mL). The combined organic layers were washed with water (1 L) and brine (1 L). The organic layer 
was dried over anhydrous magnesium sulfate, filtered, and concentrated. The resultant pale-yellow syrup 
was purified by flash-column chromatography (silica gel, eluent: 5% EtOAc in hexanes) to afford methyl 
2-O-pivaloyl-3-O-benzyl-4-O-t-butyldimethylsilyloxy-6-deoxy-6-iodo-α-D-glucopyranoside (+)-(2.79) 
(73.0 g, 99%) as a white crystalline solid. 
1H NMR (500 MHz, CDCl3) δ: 7.32–7.21 (m, 5 H), 4.90 (d, J = 3.7 Hz, 1 H), 4.86 (d, J = 11.2 Hz, 1 H), 
4.84 (dd, J = 3.7, 9.8 Hz, 1 H), 4.69 (d, J = 11.4 Hz, 1 H), 3.84 (dd, J = 8.1, 9.7 Hz, 1 H), 3.58 (dd, J = 
2.4, 10.4 Hz, 1 H), 3.51 (ddd, J = 2.3, 7.1, 9.4 Hz, 1 H), 3.47 (t, J = 8.0 Hz, 1 H), 3.44 (s, 3 H), 3.22 (dd, J 
= 7.0, 10.4 Hz, 1 H), 1.12 (s, 9 H), 0.88 (s, 9 H), 0.09 (s, 3 H), –0.04 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 177.8, 138.4, 128.1, 127.1, 126.6, 96.8, 79.3, 74.7, 74.5, 74.3, 71.0, 55.7, 
38.7, 26.9, 25.9, 18.0, 7.4, –3.9, –4.3. 
FTIR (thin film) cm-1: 2958, 2931, 2897, 2859, 1742, 1706, 1480, 1383, 1360, 1282, 1253, 1154, 1105 
1046, 864, 839, 780. 
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HRMS (ESI) (m/z) calc’d for C25H41IO6SiNa [M+Na]+: 615.1609, found 615.1590. 
[α]D23: +91.8 (c = 1.03, CHCl3). 
M.p.: 102 °C (Et2O). 
TLC (15% EtOAc in hexanes), Rf : 0.55 (UV, CAM). 
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Alcohol 2.91: 
A 1-L round-bottomed flask was charged with (+)-2.79 (25.0 g, 42.2 mmol, 1.00 equiv), activated 
zinc powder (28.0 g, 422 mmol, 10.0 equiv), THF (338 mL), and water (85 ml). The reaction vessel was 
sealed with a plastic cap and placed into a sonication bath at 40 °C.  The reaction mixture was sonicated 
for 2 h at a bath temperature of 40 to 45 °C. The flask was then removed from the sonication bath, and its 
contents were allowed to cool to ambient temperature. The reaction mixture was filtered through a pad of 
Celite, which was rinsed with water (100 mL) and Et2O (100 mL). The filtrate was collected and the 
layers were separated. The aqueous layer was extracted with Et2O (3 × 100 mL). The organic layers were 
combined and washed with brine (500 mL). The organic layer was dried over anhydrous magnesium 
sulfate, filtered, and concentrated to provide aldehyde 2.80 as a pale-yellow syrup, which was used 
immediately without further purification. 
 A 2-L, two-necked, round-bottomed flask was charged with anhydrous cerium(III) chloride (12.5 
g, 50.7 mmol, 1.20 equiv) and equipped with a greased ground-glass vacuum adapter and rubber septum. 
The reaction vessel was heated to 145 °C under reduced pressure (0.05 Torr) for 2.5 h. The flask was 
allowed to cool to ambient temperature and was then flushed with argon.  The flask was cooled to 0 °C 
and THF (507 mL) was added over 10 min. The stirred inhomogeneous, off-white slurry was allowed to 
warm to ambient temperature over 12 h. The reaction vessel was then cooled to –78 °C, and a solution of 
vinylmagnesium bromide in THF (0.90 M, 56.3 mL, 50.7 mmol, 1.20 equiv) was added dropwise to the 
reaction mixture via syringe over 15 min. The resultant tan slurry was stirred for 2 h at –78 °C. A separate 
500-mL round-bottomed flask was charged with 2.80 (42.2 mmol, 1.00 equiv) and azeotropically dried 
with three portions of benzene. THF (211 mL) was introduced and the resultant solution was cooled to –
78 °C and was transferred dropwise via cannula to the 2-L reaction vessel over 20 min. After 2 h, a 
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saturated aqueous ammonium chloride solution (500 mL) was added to the stirred, cooled reaction 
mixture, which was subsequently allowed to warm to ambient temperature. The resultant inhomogeneous 
mixture was filtered through a pad of Celite and was rinsed with water (100 mL) and Et2O (3 × 150 mL). 
The layers of the filtrate were separated and the aqueous layer was extracted with Et2O (3× 300 mL). The 
combined organic layers were washed with a saturated aqueous sodium bicarbonate solution (500 mL) 
and brine (500 mL). The organic layer was dried over anhydrous magnesium sulfate, filtered, and 
concentrated. The resultant yellow oil was purified by flash-column chromatography (silica gel, eluent: 
gradient, 7 → 15% EtOAc in hexanes) to afford alcohol 2.91 (14.5 g, 75%, 3:1 mixture of (S)- and (R)-
epimers, respectively) as a pale-yellow syrup. In practice the two epimers were not separated prior to use 
in the subsequent ring-closing metathesis reaction. Analytical samples of the pure epimers were obtained 
by preparatory high-performance liquid chromatography (HPLC) in three portions using an Agilent 
Zorbax SB-C18 column [5µm, 250 × 4.6 mm, UV detection at 350 nM, Solvent A: MeCN, Solvent B: 
water, purified epimeric mixture, concentration 0.05 M (MeCN), injection volume 0.50 mL, gradient 
elution 90% A for 5 min then 90 → 100 % A over 10 min, flow rate: 10 mL/min]. Fractions eluting at 
6.5–7.2 min and 7.6–8.2 min were collected and concentrated, affording (R)-alcohol 2.91 and (S)-alcohol 
2.91, respectively, as pale-yellow oil.  The stereochemistry of (R)-alcohol 2.91 and (S)-alcohol 2.91 was 
assigned based on correlation to their respective ring-closing metathesis product, (R)-alcohol S2.3 and 
(S)-alcohol S2.3.  
 
(S)-Alcohol 2.91: 
1H NMR (500 MHz, CDCl3) δ: 7.38–7.27 (m, 5 H), 5.89 (ddd, J = 6.0, 10.7, 17.0 Hz, 1 H), 5.80 (ddd, J = 
5.6, 10.5, 17.1 Hz, 1 H), 5.30 (td, J = 1.5, 17.3 Hz, 1 H), 5.23 (td, J = 1.4, 17.3 Hz, 1 H), 5.17 (tdd, J = 
1.4, 2.5, 10.4 Hz, 2 H), 4.94 (dd, J = 3.4, 5.6 Hz, 1 H), 4.87 (d, J = 11.7 Hz, 1 H), 4.70 (d, J = 11.7 Hz, 1 
OBn
OPiv
OTBS
(S)-2.91
OH
13S
 241 
H), 4.31 (t, J = 6.3 Hz, 2 H), 3.69 (dd, J = 3.3, 6.7 Hz, 1 H), 2.88 (d, J = 5.6 Hz, 1 H), 1.20 (s, 9 H), 0.89 
(s, 9 H), 0.03 (s, 3 H), 0.02 (s, 3 H). 
13C NMR (100 MHz, CDCl3) δ: 177.6, 138.3, 137.02, 136.99, 128.4, 127.7, 127.6, 116.9, 116.7, 81.1, 
74.2, 74.0, 73.6, 72.8, 38.8, 27.2, 25.9, 18.2, –4.6, –4.8. 
FTIR (thin film) cm-1: 3495, 2959, 2930, 2858, 1733, 1281, 1255, 1158, 1029, 929, 837, 777, 737, 697 
cm-1. 
HRMS (ESI) (m/z) calc’d for C26H42O5SiNa [M+Na]+: 485.2694, found 485.2681. 
[α]D23: +4.80 (c = 0.94, CH2Cl2). 
TLC (15% EtOAc in hexanes), Rf : 0.40 (UV, CAM). 
 
(R)-Alcohol 2.91: 
1H NMR (500 MHz, CDCl3) δ: 7.37–7.27 (m, 5 H), 6.02 (ddd, J = 4.9, 10.7, 17.3 Hz, 1 H), 5.74 (ddd, J = 
4.6, 10.6, 17.2 Hz, 1 H), 5.31 (td, J = 1.7, 7.6 Hz, 1 H), 5.27 (td, J = 1.7, 7.3 Hz, 1 H), 5.23 (td, J = 1.6, 
10.6 Hz, 1 H), 5.13 (td, J = 1.7, 10.5 Hz, 2 H), 5.12 (dd, J = 3.1, 6.0 Hz, 1 H), 4.70 (d, J = 11.7 Hz, 1 H), 
4.67 (d, J = 11.7 Hz, 1 H), 4.45 (tddd, J = 1.6, 3.1, 4.5, 6.0 Hz, 1 H), 4.36 (tt, J = 1.7, 4.9 Hz, 1 H), 3.71 
(dd, J = 4.9, 6.8 Hz, 1 H), 2.81 (d, J = 6.1 Hz, 1 H), 1.18 (s, 9 H), 0.91–0.89 (m, 9 H), 0.021 (s, 3 H), 
0.020 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 177.6, 138.2, 136.6, 136.2, 128.4, 127.7, 127.4, 116.4, 115.7, 81.5, 
74.02, 73.96, 73.3, 71.3, 38.9, 27.3, 25.9, 18.2, –4.7, –5.1. 
FTIR (thin film) cm-1: 3498, 2958, 2930, 2858, 1732, 1462, 1281, 1256, 1147, 1029, 925, 837, 777. 
HRMS (ESI) (m/z) calc’d for C26H42O5SiNa [M+Na]+: 485. 2694, found 485.2678. 
[α]D23: +40.2 (c = 0.84, CH2Cl2). 
TLC (15% EtOAc in hexanes), Rf : 0.30 (UV, CAM). 
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Alcohol S2.3: 
A 2-L round-bottomed flask was charged with 2.91 (25.6 g, 55.3 mmol, 1.00 equiv), CH2Cl2 (1.1 
L), and bis(tricyclohexylphosphine)benzylidine ruthenium(IV) dichloride (2.28 g, 2.77 mmol, 0.050 
equiv). The resultant purple solution was stirred for 18 h at ambient temperature open to the air. The 
solvent was removed under reduced pressure to furnish a dark-purple solid. The solid was dissolved in a 
minimal amount of PhMe and purified by flash-column chromatography (silica gel, eluent: 15% EtOAc in 
hexanes) to afford alcohol S2.3 (20.4 g, 85%, 3:1 mixture of (S)- and (R)-epimers, respectively) as a white 
solid (M.p.: 98-100 °C (Et2O)). In practice the two epimers were not separated prior to use in the 
subsequent oxidation reaction. Analytical samples of the pure epimers were obtained by preparatory 
HPLC in three portions using an Agilent Zorbax SB-C18 column [5µm, 250 × 4.6 mm, UV detection at 
350 nM, Solvent A: MeCN, Solvent B: water, purified epimeric mixture, concentration 0.025 M (MeCN), 
injection volume 0.75 mL, gradient elution 90% A for 5 min then 90 → 100 % A over 12.5 min, flow 
rate: 10 mL/min]. Fractions eluting at 8.5-9.6 min and 10.0-10.7 min were collected and concentrated, 
affording (S)-alcohol S2.3 and (R)-alcohol S2.3, respectively, as white solids. 
 
(S)-Alcohol S2.3: 
1H NMR (500 MHz, C6D6) δ: 7.36 (d, J = 7.6 Hz, 2 H), 7.17 (t, J = 7.6 Hz, 2 H), 7.06 (t, J = 7.6 Hz, 1 H), 
5.52 (dd, J = 1.6, 9.8 Hz, 1 H), 5.49 (ddd, J = 1.4, 4.3, 10.1 Hz, 1 H), 5.13 (dd, J = 4.1, 10.5 Hz, 1 H), 
4.80 (d, J = 11.8 Hz, 1 H), 4.76 (d, J = 11.8 Hz, 1 H), 4.29–4.22 (m, 1 H), 4.20–4.14 (m, 1 H), 3.95 (dd, J 
= 7.1, 10.5 Hz, 1 H), 1.49 (br. s, 1 H), 1.11 (s, 9 H), 0.93 (s, 9 H), 0.01 (s, 3 H), –0.01 (s, 3 H). 
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13C NMR (125 MHz, C6D6) δ: 177.3, 139.4, 133.7, 128.5, 127.5, 127.0, 126.4, 79.3, 74.8, 73.7, 73.4, 
66.0, 39.0, 27.3, 26.0, 18.2, –4.5, –4.6. 
FTIR (thin film) cm-1: 3539, 2957, 2935, 2884, 2856, 1723, 1213, 1175, 1150, 1090, 1036, 991, 840, 
783. 
HRMS (ESI) (m/z) calc’d for C24H38O5SiNa [M+Na]+: 457.2381, found 457.2384. 
[α]D23: –1.20 (c = 1.00, CH2Cl2). 
TLC (15% EtOAc in hexanes), Rf : 0.13 (UV, CAM). 
1D NOESY data (500 MHz, C6D6): 
 
 
(R)-Alcohol S2.3: 
1H NMR (500 MHz, C6D6) δ: 7.36 (d, J = 7.3 Hz, 2 H), 7.17 (t, J = 7.3 Hz, 2 H), 7.06 (t, J = 7.3 Hz, 1 H), 
5.47 (td, J = 1.6, 10.3 Hz, 1 H), 5.38 (td, J = 1.6, 10.3 Hz, 1 H), 5.20 (dd, J = 7.8, 10.5 Hz, 1 H), 4.80 (d, J 
= 11.7 Hz, 1 H), 4.68 (d, J = 11.7 Hz, 1 H), 4.29–4.24 (m, J = 2.3, 5.0 Hz, 1 H), 4.22–4.13 (m, 1 H), 3.46 
(dd, J = 7.6, 10.5 Hz, 1 H), 2.30 (br. s, 1 H), 1.10 (s, 9 H), 0.93 (s, 9 H), –0.01 (s, 3 H), –0.03 (s, 3 H). 
13C NMR (125 MHz, C6D6) δ: 179.0, 139.2, 130.6, 128.9, 128.5, 127.5, 126.8, 82.5, 78.0, 75.1, 73.4, 
72.2, 39.0, 27.3, 26.0, 18.2, –4.58, –4.62. 
FTIR (thin film) cm-1: 3507, 2955, 2935, 2884, 2855, 1711, 1481, 1386, 1293, 1257, 1148, 974, 863, 
840, 777 cm-1. 
HRMS (ESI) (m/z) calc’d for C24H38O5SiNa [M+Na]+: 457.2381, found 457.2384. 
[α]D23: –61.1 (c = 0.70, CH2Cl2).  
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TLC (15% EtOAc in hexanes), Rf : 0.13 (UV, CAM). 
1D NOESY data (500 MHz, C6D6): 
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2-Cyclohexenone (–)-2.89: 
A 2-L round-bottomed flask was charged with S2.3 (20.3 g, 46.8, 1.00 equiv) and CH2Cl2 (467 
mL), and cooled to 0 °C. Dimethyl sulfoxide (33.2 mL, 468 mmol, 10.0 equiv) and N,N-
diisopropylethylamine (40.7 mL, 234 mL, 5.00 equiv) were added to the stirred solution via syringe. 
Sulfur trioxide pyridine complex (22.3 g, 140 mmol, 3.00 equiv) was then added to the reaction mixture 
in one portion, which was subsequently stirred at 0 °C for 1.5 h. An aqueous solution of HCl (1.0 M, 250 
mL) was added to the reaction mixture and the contents of the flask were allowed to warm to ambient 
temperature. The layers were separated and the aqueous layer was extracted with CH2Cl2 (3 × 200 mL). 
The combined organic layers were washed with an aqueous solution of HCl (1.0 M, 250 mL), water (2 × 
250 mL), a saturated aqueous sodium bicarbonate solution (250 mL), and brine (250 mL). The organic 
layer was dried over anhydrous magnesium sulfate, filtered, and concentrated to furnish a pale-yellow 
syrup. The product was purified by flash-column chromatography (silica gel, eluent: gradient, 5 → 10% 
EtOAc in hexanes) to afford 2-cyclohexenone (–)-2.89 (19.6 g, 97%) as a clear, colorless syrup. 
1H NMR (500 MHz, CDCl3) δ: 7.35–7.25 (m, 5 H), 6.77 (dd, J = 1.8, 10.3 Hz, 1 H), 6.05 (dd, J = 2.4, 
10.4 Hz, 1 H), 5.43 (d, J = 11.2 Hz, 1 H), 4.80 (s, 2 H), 4.65 (td, J = 2.1, 8.0 Hz, 1 H), 3.93 (dd, J = 8.0, 
11.4 Hz, 1 H), 1.24 (s, 9 H), 0.93 (s, 9 H), 0.14 (s, 3 H), 0.09 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 192.2, 177.5, 151.5, 137.8, 128.2, 127.5, 127.2, 126.9, 83.7, 77.0, 75.2, 
72.9, 38.8, 27.2, 25.7, 18.0, –4.7, –4.9. 
FTIR (thin film) cm-1: 2957, 2931, 2906, 2858, 1733, 1480, 1362, 1282, 1259, 1153, 1129, 1054, 1002, 
838, 779, 737, 697. 
HRMS (ESI) (m/z) calc’d for C24H37O5Si [M+H]+: 433.2405, found 433.2407. 
[α]D23: –112.3 (c = 1.10, C6H6). 
OBn
OPiv
OTBS
S2.3
OH
13
(–)-2.89
OBn
OPiv
OTBS
O
SO3•Py, DMSO, Et3N
CH2Cl2, 0 °C, 1.5 h
(97%)
 246 
TLC (15% EtOAc in hexanes), Rf : 0.42 (UV, CAM).  
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cis-Decalin (–)-2.92: 
A 500-mL round-bottomed flask was charged (–)-2.89 (3.78 g, 8.75 mmol, 1.00 equiv) 
azeotropically dried with three portions of benzene. PhMe (88 mL) was introduced and the resultant 
solution was cooled to –78 °C. A separate 25-mL round-bottomed flask was charged in a glove box with 
titanium(IV) chloride (1.66 g, 8.75 mmol, 1.00 equiv) and PhMe (9.0 mL), and then sealed with a rubber 
septa. The flask was removed from the glove box and placed under an argon atmosphere. The solution of 
titanium(IV) chloride was then added dropwise to the cooled, stirred solution of (–)-2.89 via cannula over 
10 min. The resultant yellow solution was stirred for 1 h at –78 °C. 1,3-Butadiene (ca. 6.10 mL, 70.0 
mmol, 8.00 equiv) was condensed at –78 °C in a 10-mL, two-necked, round-bottomed flask equipped 
with a dry ice-acetone condenser and a rubber septa, and added to the yellow reaction mixture via 
cannula. The stirred reaction mixture was allowed to warm to 5 °C over 3.5 h. A saturated aqueous 
solution of sodium bicarbonate (250 mL) was then added to the reaction mixture which was subsequently 
allowed to warm to ambient temperature. The resultant inhomogeneous mixture was filtered through a 
pad of Celite and rinsed with water (100 mL) and Et2O (2 × 100 mL). The layers of the filtrate were 
separated and the aqueous layer was extracted with Et2O (3× 100 mL). The combined organic layers were 
washed with brine (300 mL). The organic layer was dried over anhydrous magnesium sulfate, filtered, 
and concentrated. The resultant white solid (>10:1 mixture of syn:anti diastereomers by 1H NMR 
analysis) was purified by flash-column chromatography on silica gel (elutant: 5% EtOAc in hexanes) to 
afford pure cis-decalin (–)-2.92 (syn diastereomer) (3.23 g, 76%) as a white solid. In practice, cis-decalin 
(–)-2.92 (anti diastereomer) was not isolated. A pure sample of the cis-decalin (–)-2.92 (anti 
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diastereomer) was obtained for spectroscopic analysis and comparison through the use of aluminum(III) 
chloride rather than titanium(IV) chloride as a Lewis acid-promoter in the Diels–Alder reaction. 231 
 
cis-Decalin (–)-2.92 (syn diastereomer): 
1H NMR (500 MHz, CDCl3) δ: 7.35–7.24 (m, 5 H), 5.70–5.60 (m, 2 H), 5.27 (d, J = 9.8 Hz, 1 H), 4.78 
(d, J = 11.4 Hz, 1 H), 4.75 (d, J = 11.0 Hz, 1 H), 4.22 (dd, J = 4.7, 8.8 Hz, 1 H), 3.84 (t, J = 9.4 Hz, 1 H), 
2.90–2.81 (m, 1 H), 2.61 –2.52 (m, 1 H), 2.41–2.28 (m, 2 H), 2.12–2.04 (m, 1 H), 1.68–1.57 (m, 1 H), 
1.23 (s, 9 H), 0.92 (s, 9 H), 0.11 (s, 3 H), 0.06 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 200.4, 177.6, 138.2, 128.2, 127.5, 127.3, 124.9, 124.4, 82.2, 79.5, 75.4, 
74.9, 42.7, 38.7, 38.5, 27.2, 25.9, 23.0, 22.2, 18.1, –4.6, –4.7. 
FTIR (thin film) cm-1: 3032, 2931, 2857, 1747, 1733, 1396, 1359, 1286, 1251, 1160, 1127, 1073, 931, 
837, 778, 750, 633. 
HRMS (ESI) (m/z) calc’d for C28H42O5SiNa [M+Na]+: 509.2694, found 509.2680. 
[α]D23: –21.0 (c = 1.00, CH2Cl2). 
M.p.: 138 °C (Et2O). 
TLC (15% EtOAc in hexanes), Rf : 0.38 (UV, CAM). 
1D NOESY data (500 MHz, C6D6): 
 
  
                                                      
231 Use of aluminum(III) chloride resulted in a 3.7:1.0 (syn:anti) diastereomeric ratio and an 80% overall yield. 
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cis-Decalin (–)-2.92 (anti diastereomer): 
1H NMR (500 MHz, CDCl3) δ: 7.34–7.22 (m, 5 H), 5.73 (d, J = 10.1 Hz, 1 H), 5.70–5.64 (m, 2 H), 4.80 
(d, J = 11.2 Hz, 1 H), 4.74 (d, J = 11.2 Hz, 1 H), 4.06 (t, J = 9.2 Hz, 1 H), 3.65 (t, J = 9.2 Hz, 1 H), 2.83 
(ddd, J = 4.5, 6.9, 10.8 Hz, 1 H), 2.44 (d, J = 18.3 Hz, 1 H), 2.37–2.19 (m, 2 H), 2.09 (d, J = 18.5 Hz, 1 
H), 2.03–1.96 (m, 1 H), 1.20 (s, 9 H), 0.91 (s, 9 H), 0.03 (s, 3 H), –0.05 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 203.3, 177.6, 138.2, 128.2, 127.3, 126.9, 125.2, 123.7, 84.9, 77.6, 74.9, 
70.8, 46.0, 38.7, 36.7, 27.1, 26.0, 24.3, 23.7, 18.1, –3.7, –4.4. 
FTIR (thin film) cm-1: 3031, 2957, 2929, 2897, 2857, 1744, 1729, 1473, 1397, 1362, 1284, 1256, 1154, 
1132, 1076, 1042, 874, 837, 777, 736, 697.  
HRMS (ESI) (m/z) calc’d for C28H42O5SiNa [M+Na]+: 509.2694, found 509.2700. 
[α]D23: –121.4 (c = 1.40, CH2Cl2). 
TLC (15% EtOAc in hexanes), Rf : 0.47 (UV, CAM). 
1D NOESY data (500 MHz, C6D6): 
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Dienone (–)-2.88: 
A 350-mL glass round-bottomed pressure vessel was charged sequentially with (–)-2.92 (4.00 g, 
8.23 mmol, 1.00 equiv), MeCN (165 mL), hexamethyldisilazane (34.3 mL, 164 mmol, 20.0 equiv), 
sodium iodide (18.5 g, 124 mmol, 15.0 equiv), and chlorotrimethylsilane (10.5 mL, 82.3 mmol, 10.0 
equiv) under an argon atmosphere. The reaction vessel was sealed with a Teflon bushing and heated to 82 
°C for 3 h. The resultant orange reaction mixture was allowed to cool to ambient temperature and then 
poured into a saturated aqueous sodium bicarbonate solution (300 mL). The layers were separated and the 
aqueous layer was extracted with Et2O (3 × 200 mL). The combined organic layers were washed with 
brine (500 mL), dried over anhydrous magnesium sulfate, filtered, and concentrated to furnish enol silane 
2.95 as a yellow syrup, which was used immediately without further purification. 
 A 500-mL round-bottomed flask was charged with 2.95 (8.23 mmol, 1.00 equiv) and 
azeotropically distilled with benzene (3 × 100 mL). The residue was concentrated under reduced pressure 
(0.05 Torr, 12 h, 23 °C) and flushed with argon.  CH2Cl2 (165 mL) was added to the reaction vessel and 
the resultant mixture was stirred for 15 min or until homogeneous. 2,3-Dichloro-5,6-dicyano-1,4-
benzoquinone (5.60 g, 24.7 mmol, 3.00 equiv) was then added to the reaction solution in one portion to 
produce a dark-green, inhomogeneous mixture. The reaction mixture was stirred for 3 h at ambient 
temperature and was slowly poured into a 1-L Erlenmeyer flask containing a 1:1 mixture of a saturated 
aqueous sodium bicarbonate solution (250 mL) and an aqueous solution of sodium bisulfite (0.1 M, 250 
mL). The resultant inhomogeneous mixture was filtered through a pad of Celite and was rinsed with water 
(100 mL) and Et2O (2 × 200 mL). The layers of the filtrate were separated and the aqueous layer was 
extracted with Et2O (3 × 250 mL). The combined organic layers were washed with a saturated aqueous 
sodium bicarbonate solution (500 mL) and brine (500 mL). The organic layer was dried over anhydrous 
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magnesium sulfate, filtered, and concentrated to furnish an orange oil, which was purified by flash-
column chromatography (silica gel, eluent: gradient, 7 → 10% EtOAc in hexanes) to afford dienone (–)-
2.88 (3.10 g, 78%) as a clear, colorless oil. 
1H NMR (600 MHz, CDCl3) δ: 7.38–7.33 (m, 2 H), 7.33–7.28 (m, 3 H), 6.79 (dd, J = 3.4, 4.5 Hz, 1 H), 
6.15–6.11 (m, 1 H), 6.05 (ddd, J = 3.4, 5.3, 9.2 Hz, 1 H), 5.43 (d, J = 2.3 Hz, 1 H), 4.68 (d, J = 12.0 Hz, 1 
H), 4.48 (d, J = 12.0 Hz, 1 H), 3.81–3.79 (m, 1 H), 3.76 (t, J = 2.6 Hz, 1 H), 3.41–3.34 (m, 1 H), 2.41 
(tdd, J = 2.8, 17.1, 19.5 Hz, 1 H), 2.12 (ddd, J = 6.3, 8.2, 17.1 Hz, 1 H), 1.28 (s, 9 H), 0.79 (s, 9 H), 0.00 
(s, 3 H), –0.06 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 192.1, 177.2, 137.2, 132.9, 131.3, 129.6, 128.5, 128.0, 127.9, 124.0, 
83.6, 77.1, 71.2, 70.2, 38.7, 36.5, 27.2, 25.7, 25.5, 17.9, –4.6, –4.8. 
FTIR (thin film) cm-1: 3040, 2958, 2930, 2899, 2858, 1738, 1706, 1637, 1567, 1480, 1397, 1362, 1255, 
1155, 1119, 922, 837, 777, 699. 
HRMS (ESI) (m/z) calc’d for C28H40O5SiNa [M+Na]+ : 507.2537, found 507.2540. 
[α]D23: –42.0 (c = 0.96, C6H6). 
TLC (15% EtOAc in hexanes), Rf : 0.46 (UV, CAM). 
  
 252 
 
α-Hydroxy Ketone (+)-2.87: 
A 250-mL, two-necked, round-bottomed flask equipped with a Merlic solid addition adapter, 
containing MoOPH (6.60 g, 17.2 mmol, 2.64 equiv), was flushed with argon and charged with THF (29 
mL) and a solution of diethylzinc in PhMe (1.0 M, 8.60 mL, 8.60 mmol, 1.50 equiv) and cooled to –78 
°C. A deep-purple solution of dimethylphenylsilyllithium in THF (1.0 M, 8.60 mL, 8.60 mmol, 1.50 
equiv) was added dropwise to the reaction mixture via syringe and stirred for 30 min. A separate 100 mL 
round-bottomed flask was charged with (–)-2.88 (2.78 g, 5.74 mmol, 1.00 equiv) and azeotropically dried 
with three portions of benzene. THF (29 mL) was introduced, and the resultant solution cooled to –78 °C 
and was transferred dropwise via dry-ice wrapped cannula to the stirred, cooled reaction mixture over 10 
min. The resultant yellow solution was allowed to warm to 0 °C over 30 min before being cooled back to 
–78 °C. MoOPH was then slowly added over 5 min via the solid addition adapter to the vigorously stirred 
reaction mixture, which was then warmed to –20 °C over 20 min. A 1:1 mixture of a saturated aqueous 
ammonium chloride solution (25 mL) and a saturated aqueous solution of sodium sulfite (25 mL) was 
added to the tan, homogeneous reaction mixture, which was subsequently allowed to warm to ambient 
temperature. The layers were separated and the aqueous layer was extracted with Et2O (3 × 100 mL). The 
combined organic layers were washed with a saturated aqueous sodium bicarbonate solution (250 mL) 
and brine (250 mL). The organic layer was dried over anhydrous magnesium sulfate, filtered, and 
concentrated to furnish a yellow syrup. The product was purified by flash-column chromatography (silica 
gel, eluent: 10% EtOAc in hexanes) to afford α-hydroxy ketone (+)-2.87 (3.00 g, 82%) as a clear, 
colorless gel. 
1H NMR (500 MHz, C6D6) δ: 7.44–7.39 (m, 2 H), 7.35 (d, J = 7.6 Hz, 2 H), 7.23–7.15 (m, 5 H), 7.07 (t, J 
= 7.6 Hz, 1 H), 6.24 (d, J = 10.1 Hz, 1 H), 5.82 (dd, J = 3.9, 10.1 Hz, 1 H), 5.47 (dd, J = 2.3, 10.1 Hz, 1 
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H), 4.83 (d, J = 11.4 Hz, 1 H), 4.78 (dd, J = 5.2, 9.5 Hz, 1 H), 4.73 (d, J = 11.4 Hz, 1 H), 3.72 (t, J = 9.7 
Hz, 1 H), 3.01 (s, 1 H), 2.33–2.24 (m, 2 H), 1.78 (ddd, J = 2.5, 4.1, 6.9 Hz, 1 H), 1.31 (s, 1 H), 1.25 (s, 9 
H), 0.90 (s, 9 H), 0.29 (s, 3 H), 0.27 (s, 3 H), 0.021 (s, 3 H), 0.020 (s, 3 H). 
13C NMR (125 MHz, C6D6) δ: 201.3, 177.7, 139.1, 137.9, 134.2, 132.0, 129.6, 128.6, 128.5, 127.6, 127.1, 
126.4, 81.5, 78.3, 77.0, 75.3, 70.9, 44.6, 39.0, 27.4, 27.0, 26.3, 19.4, 18.2, –3.4, –3.5, –4.3. 
FTIR (thin film) cm-1: 3460, 2957, 2931, 2857, 1744, 1720, 1462, 1397, 1285, 1257, 1159, 1105, 838, 
776, 734, 700. 
HRMS (ESI) (m/z) calc’d for C36H52O6Si2Cl [M+Cl]–: 671.2996, found 671.2991. 
[α]D23: +101.5 (c = 1.05, C6H6). 
TLC (15% EtOAc in hexanes), Rf : 0.28 (UV, CAM). 
1D NOESY data (500 MHz, C6D6): 
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(+)-Triol S2.4: 
A 1-L round-bottomed flask was charged with anhydrous cerium(III) chloride (11.6 g, 47.2 
mmol, 15.0 equiv) and lithium chloride (4.00 g, 94.2 mmol, 30.0 equiv), and heated to 145 °C under 
reduced pressure (0.05 Torr) for 2.5 h. The flask was allowed to cool to ambient temperature and then 
was flushed with argon. The flask was cooled to 0 °C and THF (470 mL) was introduced via cannula over 
5 min. The resultant inhomogeneous, off-white slurry was allowed to warm to ambient temperature over 
12 h. The stirred reaction mixture was cooled to –78 °C and a solution of n-propylmagnesium chloride in 
Et2O (1.64 M, 23.0 mL, 37.7 mmol, 12.0 equiv) was added dropwise via syringe over 15 min. The 
resultant yellow slurry was stirred for 3 h at –78 °C. A separate 100 mL round-bottomed flask was 
charged with (+)-2.87 (2.00 g, 3.14 mmol, 1.00 equiv) and azeotropically dried with three portions of 
benzene. THF (25 mL) was introduced, and the resultant solution cooled to –78 °C and was transferred 
dropwise via dry-ice wrapped cannula to the stirred, cooled reaction mixture over 10 min. The resultant 
mixture was gradually allowed to warm to 0 °C over 2 h and stirred at 0 °C for an additional 1.5 h. A 
saturated aqueous solution of ammonium chloride (250 mL) was then carefully added to the reaction 
mixture, and the contents of the flask were allowed to warm to ambient temperature. The resultant 
inhomogeneous mixture was filtered through a pad of Celite and was rinsed with water (100 mL) and 
Et2O (3 × 150 mL). The layers of the filtrate were separated and the aqueous layer was extracted with 
Et2O (3 × 250 mL). The combined organic layers were washed with a saturated aqueous sodium 
bicarbonate solution (500 mL) and brine (500 mL). The organic layer was dried over anhydrous 
magnesium sulfate, filtered, and concentrated. The resultant yellow syrup was purified by flash-column 
chromatography (silica gel, eluent: 20% EtOAc in hexanes) to afford triol (+)-S2.4 (1.59 g, 85%) as a 
colorless gel. 
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1H NMR (600 MHz, C6D6) δ: 7.49 (d, J = 5.9 Hz, 2 H), 7.38 (d, J = 7.3 Hz, 2 H), 7.28–7.20 (m, 3 H), 
7.18 (t, J = 7.3 Hz, 2 H), 7.08 (t, J = 7.3 Hz, 1 H), 5.75 (dd, J = 3.1, 9.8 Hz, 1 H), 5.36 (d, J = 9.1 Hz, 1 
H), 4.95 (d, J = 11.7 Hz, 1 H), 4.73 (d, J = 11.7 Hz, 1 H), 4.34 (dd, J = 5.9, 9.7 Hz, 1 H), 3.95 (d, J = 8.8 
Hz, 1 H), 3.78 (t, J = 9.5 Hz, 1 H), 2.58 (dt, J = 8.6, 13.8 Hz, 1 H), 2.29 (dd, J = 3.8, 13.8 Hz, 1 H), 2.27 
(br. s., 1 H), 1.96–1.86 (m, 3 H), 1.83 (dt, J = 2.8, 12.5 Hz, 1 H), 1.72 (d, J = 7.9 Hz, 1 H), 1.71–1.65 (m, 
J = 2.9, 12.6, 12.6 Hz, 1 H), 1.56–1.45 (m, 2 H), 0.98 (s, 10 H), 0.94 (t, J = 6.9 Hz, 3 H), 0.34 (s, 3 H), 
0.33 (s, 3 H), 0.14 (s, 3 H), 0.05 (s, 3 H). 
13C NMR (100 MHz, C6D6) δ: 139.9, 138.2, 134.3, 133.6, 129.5, 128.69, 128.6, 128.2, 127.7, 127.5, 81.8, 
78.4, 75.7, 75.6, 75.0, 72.1, 48.8, 39.3, 26.43, 26.39, 19.8, 18.9, 18.2, 15.6, –3.4, –3.8, –4.2. 
FTIR (thin film) cm-1: 3558, 3469, 2957, 2929, 2894, 2857, 1471, 1428, 1250, 1114, 1029, 837, 774, 
734, 701. 
HRMS (ESI) (m/z) calc’d for C34H52O5Si2Na [M+Na]+: 619.3246, found 619.3239. 
[α]D23: +108.6 (c = 0.86, C6H6). 
TLC (15% EtOAc in hexanes), Rf : 0.25 (UV, CAM). 
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Acetonide (+)-2.108: 
A 250 mL round-bottomed flask was sequentially charged with (+)-S2.4 (3.78 g, 6.33 mmol, 1.00 
equiv), PhH (127 mL), 2-methoxypropene (12.1 mL, 127 mmol, 20.0 equiv), and pyridinium p-
toluenesulfonate (158 mg, 630 µmol, 0.100 equiv). The reaction mixture was stirred at ambient 
temperature for 4.5 h before a saturated aqueous sodium bicarbonate solution (250 mL) was added. The 
layers were separated and the aqueous layer was extracted with Et2O (3 × 100 mL). The combined 
organic layers were washed with a saturated aqueous sodium bicarbonate solution (250 mL), water (250 
mL), and brine (250 mL). The organic layer was dried over anhydrous magnesium sulfate, filtered, and 
concentrated to furnish a yellow syrup. The residue was purified by flash-column chromatography (silica 
gel, eluent: gradient, 5 → 15% EtOAc in hexanes) to afford acetonide (+)-2.108 (3.38 g, 84%) as a 
colorless flocculent solid. 
1H NMR (500 MHz, C6D6) δ: 7.53–7.49 (m, 2 H), 7.42 (d, J = 7.4 Hz, 2 H), 7.24–7.15 (m, 5 H), 7.08 (t, J 
= 7.4 Hz, 1 H), 6.07 (dd, J = 1.6, 10.3 Hz, 1 H), 5.84 (dd, J = 1.4, 10.3 Hz, 1 H), 4.96 (d, J = 11.9 Hz, 1 
H), 4.72 (d, J = 11.9 Hz, 1 H), 4.11 (dd, J = 8.2, 11.0 Hz, 1 H), 4.09 (d, J = 6.2 Hz, 1 H), 3.99 (dd, J = 
6.2, 11.2 Hz, 1 H), 2.37–2.26 (m, 3 H), 2.05–1.95 (m, 2 H), 1.78 (dtdd, J = 5.2, 7.2, 12.6, 19.9 Hz, 1 H), 
1.69–1.57 (m, 1 H), 1.54–1.46 (m, 4 H), 1.29 (s, 3 H), 0.97 (s, 9 H), 0.91 (t, J = 7.3 Hz, 3 H), 0.31 (s, 3 
H), 0.31 (s, 3 H), 0.14 (s, 3 H), 0.08 (s, 3 H). 
13C NMR (125 MHz, C6D6) δ: 139.6, 137.8, 134.4, 131.4, 130.4, 129.5, 128.6, 128.3, 128.2, 127.5, 108.9, 
87.5, 86.8, 80.6, 73.0, 72.6, 69.8, 43.0, 39.9, 27.6, 27.0, 26.4, 24.2, 20.8, 18.7, 18.6, 15.5, –4.1, –4.5, –4.9. 
FTIR (thin film) cm-1: 3467, 2958, 2930, 2860, 1639, 1461, 1380, 1252, 1208, 1114, 1032, 837, 774, 
734, 699. 
HRMS (ESI) (m/z) calc’d for C37H56O5Si2Na [M+Na]+: 659.3559, found 659.3576. 
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[α]D23: +12.3 (c = 1.18, C6H6). 
TLC (15% EtOAc in hexanes), Rf : 0.63 (UV, CAM, anis). 
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Silyl Ether (–)-2.109: 
A 250 mL round-bottomed flask was charged with (+)-2.108 (3.32 g, 5.21 mmol, 1.00 equiv), 
CH2Cl2 (105 mL), and sodium bicarbonate (1.31 g, 15.6 mmol, 3.00 equiv), and cooled to –78 °C. A 
separate 25-mL round-bottomed flask was charged with 3-chloroperbenzoic acid (77 wt. %, 2.34 g, 10.4 
mmol, 2.00 equiv) and CH2Cl2 (10 mL), and was transferred dropwise via cannula to the stirred reaction 
mixture over 5 min. The resultant inhomogeneous reaction mixture was warmed to –5 °C. After 7 h, a 
saturated aqueous sodium sulfite solution (100 mL) was added to the reaction mixture, which was 
subsequently allowed to warm to ambient temperature. The layers were separated and the aqueous layer 
was extracted with Et2O (3 × 100 mL). The combined organic layers were washed with a saturated 
aqueous sodium bicarbonate solution (400 mL), water (400 mL) and brine (400 mL). The organic layer 
was dried over anhydrous magnesium sulfate, filtered, and concentrated to furnish a colorless syrup. The 
syrup was purified by flash-column chromatography (silica gel, eluent: 5% EtOAc in hexanes) to afford 
silyl ether (–)-2.109 (2.88 g, 85%) as a colorless flocculent solid. 
1H NMR (500 MHz, C6D6) δ: 7.53–7.49 (m, 4 H), 7.22 (t, J = 7.6 Hz, 2 H), 7.19–7.15 (m, 3 H), 7.10 (t, J 
= 7.6 Hz, 1 H), 5.84–5.75 (m, 2 H), 5.10 (d, J = 11.7 Hz, 1 H), 4.81 (d, J = 11.7 Hz, 1 H), 4.71 (dd, J = 
3.9, 9.3 Hz, 1 H), 4.57 (d, J = 3.7 Hz, 1 H), 4.38 (d, J = 5.1 Hz, 1 H), 3.93 (dd, J = 5.1, 9.3 Hz, 1 H), 3.88 
(s, 1 H), 2.60–2.51 (m, 1 H), 2.43–2.34 (m, 2 H), 2.28 (ddd, J = 5.6, 12.0, 14.2 Hz, 1 H), 1.62–1.42 (m, 2 
H), 1.28 (s, 3 H), 1.26 (s, 3 H), 1.00 (s, 9 H), 0.84 (t, J = 7.2 Hz, 3 H), 0.31 (s, 3 H), 0.29 (s, 3 H), 0.20 (s, 
3 H), 0.15 (s, 3 H). 
13C NMR (125 MHz, C6D6) δ: 139.7, 137.4, 133.9, 130.3, 130.2, 128.6, 128.4, 128.3, 128.2, 127.5, 109.5, 
89.0, 87.0, 83.0, 73.8, 73.1, 71.2, 68.1, 44.0, 41.3, 29.0, 28.5, 26.3, 25.5, 18.8, 18.4, 15.4, –0.7, –4.0, –4.6. 
(+)-2.108
OBn
OTBS
H
Si
HO
Me
Ph
Me
Me
O
O Me
Me
(–)-2.109
OBn
OTBS
H
O
Me
O
Si
Me
Ph
Me
O
O Me
Me
H
mCPBA, NaHCO3
CH2Cl2, –78 → –5 °C, 
7 h
(85%)
 259 
FTIR (thin film) cm-1: 3490, 2956, 2929, 2894, 2856, 1456, 1429, 1378, 1254, 1234, 1118, 1038, 835, 
787, 736, 698. 
HRMS (ESI) (m/z) calc’d for C37H56O6Si2Na [M+Na]+ : 675.3508, found 675.3505. 
[α]D23: –77.0 (c = 0.87, C6H6). 
TLC (15% EtOAc in hexanes), Rf : 0.65 (UV, CAM, anis). 
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Allylic Alcohol (–)-S2.5: 
A 250-mL round-bottomed flask was charged with (–)-2.109 (2.83 g, 4.33 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. THF (43 mL) was introduced, and the resultant 
solution was cooled to –78 °C. A solution of tetrabutylammonium fluoride in THF (1.0 M, 6.50 mL, 6.50 
mmol, 1.50 equiv) was added dropwise via syringe to the stirred reaction mixture over 5 min. After 1.5 h, 
a saturated aqueous ammonium chloride solution (100 mL) was added to the reaction mixture, which was 
subsequently allowed to warm to ambient temperature. The layers were separated and the aqueous layer 
was extracted with Et2O (3 × 100 mL). The combined organic layers were washed with a saturated 
aqueous sodium bicarbonate solution (250 mL) and brine (250 mL). The organic layer was dried over 
anhydrous magnesium sulfate, filtered, and concentrated to furnish a yellow gel. The gel was purified by 
flash-column chromatography (silica gel, eluent: gradient, 5 → 10% EtOAc in hexanes) to afford allylic 
alcohol (–)-S2.5 (2.22 g, 99%) as a colorless gel. 
1H NMR (500 MHz, CDCl3) δ: 7.39–7.27 (m, 5 H), 5.72 (d, J = 9.6 Hz, 1 H), 5.38 (d, J = 9.8 Hz, 1 H), 
4.77 (br. s., 1 H), 4.68 (d, J = 11.9 Hz, 1 H), 4.58 (d, J = 11.9 Hz, 1 H), 4.37 (br. s, 1 H), 4.04 (br. s., 1 H), 
3.89 (br. s., 1 H), 3.70 (br. s., 1 H), 3.40 (br. s., 1 H), 2.69–2.59 (m, 1 H), 2.31 (d, J = 6.2 Hz, 1 H), 2.07 
(dt, J = 3.4, 13.5 Hz, 1 H), 1.80–1.69 (m, 2 H), 1.63 (br. s., 1 H), 1.56 (s, 3 H), 1.52–1.44 (m, 1 H), 1.41 
(s, 3 H), 0.94 (t, J = 7.2 Hz, 3 H), 0.84 (s, 9 H), –0.03 (s, 3 H), –0.05 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 137.9, 128.4, 127.8, 127.6, 127.3, 126.8, 107.4, 89.4, 79.8, 77.2, 75.5, 
75.2, 72.3, 70.1, 38.04, 37.4, 27.6, 26.0, 25.9, 25.7, 18.0, 17.7, 15.0, –5.0, –5.2. 
FTIR (thin film) cm-1: 3493, 3029, 2958, 2906, 2858, 1462, 1383, 1252, 1210, 1072, 991, 856, 775, 738, 
698. 
HRMS (ESI) (m/z) calc’d for C29H46O6SiNa [M+Na]+ : 541.2956, found 541.2973. 
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[α]D23: –43.6 (c = 0.77, C6H6). 
TLC (15% EtOAc in hexanes), Rf : 0.46 (UV, CAM). 
1D NOESY data (500 MHz, C6D6): 
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C14-hydroxy ent-AB/HG-enone (–)-2.110: 
 A 250-mL round-bottomed flask was charged with dimethyl sulfoxide (4.73 mL, 66.6 mL, 16.0 
equiv) and CH2Cl2 (45 mL), and cooled to –78 °C. A separate 25-mL round-bottomed flask was charged 
with a solution of oxalyl chloride (2.80 mL, 33.3 mmol, 8.00 equiv) and CH2Cl2 (5 mL), and was 
transferred dropwise via cannula to the 250-mL reaction vessel over 5 min. The resultant mixture was 
stirred for 1 h at –78 °C. A separate 50-mL round-bottomed flask was charged with (–)-S2.5 (2.16 g, 4.16 
mmol, 1.00 equiv) and azeotropically dried with three portions of benzene. CH2Cl2 (20 mL) was 
introduced, and the resultant solution was cooled to –78 °C and transferred to the reaction mixture 
dropwise via dry-ice wrapped cannula over 5 min. After 4 h, triethylamine (18.6 mL, 133 mmol, 32.0 
equiv) was added dropwise via syringe, down the wall of the reaction vessel, over 5 min. The reaction 
mixture was stirred at –78 °C for 5 min and was then allowed to warm to 0 °C over 30 min. A saturated 
aqueous solution of ammonium chloride (100 mL) and Et2O (100 mL) were added to the reaction 
mixture, which was subsequently allowed to warm to ambient temperature. The layers were separated and 
the aqueous layer was extracted with Et2O (3 × 100 mL). The combined organic layers were washed with 
a saturated aqueous sodium bicarbonate solution (250 mL) and brine (250 mL). The organic layer was 
dried over anhydrous magnesium sulfate, filtered, and concentrated to furnish a colorless syrup. The 
syrup was purified by flash-column chromatography (silica gel, eluent: gradient, 5 → 15% EtOAc in 
hexanes) to afford the C14-hydroxy ent-AB/HG-enone (–)-2.110 (1.97 g, 92%) as a colorless solid. 
Crystals suitable for X-ray diffraction were obtained by cooling a saturated solution of (–)-2.110 in 
pentane to –20 °C for 48 h. 
1H NMR (500 MHz, CDCl3) δ: 7.40 (d, J = 7.1 Hz, 2 H), 7.32 (t, J = 7.4 Hz, 2 H), 7.29–7.24 (m, J = 7.4, 
7.4 Hz, 1 H), 6.97 (ddd, J = 2.2, 5.4, 9.9 Hz, 1 H), 6.20 (dd, J = 2.1, 10.1 Hz, 1 H), 4.91 (d, J = 11.7 Hz, 1 
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H), 4.71 (d, J = 11.5 Hz, 1 H), 4.25 (s, 1 H), 4.15 (dd, J = 4.9, 9.5 Hz, 1 H), 4.06 (d, J = 5.9 Hz, 1 H), 3.75 
(dd, J = 5.9, 9.5 Hz, 1 H), 2.68 (tdd, J = 2.8, 11.2, 20.0 Hz, 1 H), 2.57 (td, J = 5.6, 20.0 Hz, 1 H), 2.32 (td, 
J = 5.6, 11.0 Hz, 1 H), 2.04 (ddd, J = 7.8, 10.0, 14.9 Hz, 1 H), 1.59–1.51 (m, 2 H), 1.38 (s, 3 H), 1.37 (s, 3 
H), 1.24–1.15 (m, 2 H), 0.91–0.86 (m, 9 H), 0.79 (t, J = 7.3 Hz, 3 H), 0.05 (s, 3 H), 0.04 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 201.0, 151.3, 138.7, 128.1, 127.9, 127.6, 127.3, 110.1, 88.0, 85.9, 81.7, 
76.0, 73.2, 70.1, 47.9, 37.8, 29.0, 28.4, 26.2, 25.9, 18.1, 16.1, 14.6, –4.5, –4.9. 
FTIR (thin film) cm-1: 3462, 2955, 2930, 2891, 2858, 1677, 1473, 1380, 1254, 1231, 1110, 1089, 1030, 
853, 837, 777, 735, 697. 
HRMS (ESI) (m/z) calc’d for C29H44O6SiNa [M+Na]+ : 539.2799, found 539.2796. 
[α]D23: –67.4 (c = 1.10, C6H6). 
M.p.: 99.5 °C (pentane). 
TLC (15% EtOAc in hexanes), Rf: 0.55 (UV, CAM). 
X-Ray Crystal Structure: 
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Methyl 3-O-benzyl-6-deoxy-6-iodo-α-D-glucopyranoside ((+)-2.111): 
A 1-L round-bottomed flask was charged with (–)-2.77 (37.7 g, 101 mmol, 1.00 equiv), acetic 
acid (219 mL), and water (55 mL). The reaction vessel was sealed with a plastic cap and the 
heterogeneous reaction mixture was warmed to 80 °C. After 1 h, the reaction mixture was allowed to cool 
to ambient temperature and concentrated under reduced pressure. The resultant white solid (+)-S2.6 was 
azeotropically dried with toluene (4 × 400 mL) and used immediately without further purification. An 
analytical sample of (+)-S2.6 was obtained through purification by flash column chromatography (silica 
gel, eluent: 10% MeOH in CH2Cl2) to afford methyl 3-O-benzyl-α-D-glucopyranoside ((+)-S2.6) as a 
white crystalline solid. 
A 2-L round-bottomed flask was charged with triphenylphosphine (34.5 g, 131 mmol, 1.30 
equiv), imidazole (20.6 g, 303 mmol, 3.00 equiv), and PhMe (505 mL). The reaction mixture was 
vigorously stirred for 30 min to break-up the solids before iodine (33.4 g, 131 mmol, 1.30 equiv) was 
added in one portion. After 30 min, a solution of (+)-S2.6 in CH2Cl2 (151 mL) was added via cannula to 
the stirred reaction mixture over 15 min. The resultant heterogeneous reaction mixture was warmed to 45 
°C. After 1.5 h, the reaction mixture was allowed to cool to ambient temperature. Brine (700 mL) was 
added and the resultant mixture stirred for 15 min or until all of the solid material had fully dissolved. The 
layers were separated and the aqueous layer was extracted with EtOAc (3 × 250 mL). The combined 
organic layers were dried over anhydrous sodium sulfate, filtered, and concentrated under reduced 
pressure. The resultant pale-yellow syrup was purified by flash column chromatography (silica gel, 
eluent: 30% EtOAc in hexanes) to afford methyl 3-O-benzyl-6-deoxy-6-iodo-α-D-glucopyranoside ((+)-
2.111) (30.1 g, 76% over two steps) as a white crystalline solid. 
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Methyl 3-O-benzyl-α-D-glucopyranoside ((+)-S2.6): 
1H NMR (500 MHz, CDCl3) δ: 7.39–7.32 (m, 4 H), 7.29 (t, J = 6.6 Hz, 1 H), 4.98 (d, J = 11.6 Hz, 1 H), 
4.75 (d, J = 11.6 Hz, 1 H), 4.72 (d, J = 3.7 Hz, 1 H), 3.80 (dd, J = 3.4, 11.8 Hz, 1 H), 3.76 (dd, J = 4.0, 
11.8 Hz, 1 H), 3.64 (dd, J = 3.7, 8.8 Hz, 1 H), 3.62–3.52 (m, 3 H), 3.41 (s, 3 H), 2.48 (br. s., 3 H). 
13C NMR (125 MHz, CDCl3) δ: 138.5, 128.6, 127.91, 127.88, 99.6, 82.6, 74.9, 72.7, 71.0, 70.0, 62.2, 
55.3. 
FTIR (thin film) cm-1: 3407, 3011, 2934, 1497, 1455, 1407, 1360, 1216, 1193, 1150, 1117, 1036, 909, 
841, 759, 701, 667. 
HRMS (ESI) (m/z) calc’d for C14H20NaO6 [M+Na]+: 307.1158, found 307.1177. 
[α]D23: +95.1 (c = 1.16, CHCl3). 
M.p.: 85–86 °C (CHCl3). 
TLC (60% EtOAc in hexanes), Rf : 0.10 (UV, CAM). 
Methyl 3-O-benzyl-6-deoxy-6-iodo-α-D-glucopyranoside ((+)-2.111): 
1H NMR (500 MHz, CDCl3) δ: 7.40–7.34 (m, 4 H), 7.34–7.29 (m, 1 H), 5.02 (d, J = 11.5 Hz, 1 H), 4.76 
(d, J = 3.9 Hz, 1 H), 4.69 (d, J = 11.5 Hz, 1 H), 3.69 (dt, J = 3.9, 9.3 Hz, 1 H), 3.59–3.53 (m, 2 H), 3.49 
(s, 3 H), 3.43 (ddd, J = 2.3, 7.2, 9.5 Hz, 1 H), 3.32 (dt, J = 2.5, 9.0 Hz, 1 H), 3.27 (dd, J = 7.2, 10.6 Hz, 1 
H), 2.36 (d, J = 2.7 Hz, 1 H), 2.21 (d, J = 9.3 Hz, 1 H). 
13C NMR (125 MHz, CDCl3) δ: 138.3, 128.7, 128.03, 127.95, 99.5, 82.3, 74.9, 73.2, 72.9, 70.1, 55.6, 6.8. 
FTIR (thin film) cm-1: 3448, 3028, 3009, 2908, 2838, 1497, 1454, 1408, 1363, 1216, 1197, 1146, 1122, 
1051, 944, 891, 758, 699, 667. 
HRMS (ESI) (m/z) calc’d for C14H19INaO5 [M+Na]+: 417.0169, found 417.0177. 
[α]D23: +60.7 (c = 2.27, CHCl3). 
M.p.: 80 °C (CHCl3). 
TLC (60% EtOAc in hexanes), Rf : 0.46 (UV, CAM). 
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Methyl 2-O-t-butyldimethylsilyloxy-3-O-benzyl-6-deoxy-6-iodo-α-D-glucopyranoside ((+)-S2.7): 
A 1-L round-bottomed flask was charged with (+)-2.111 (24.0 g, 61.0 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. CH2Cl2 (305 mL) was introduced, and the resultant 
solution cooled to 0 °C. Imidazole (20.8 g, 305 mmol, 5.00 equiv) and t-butyldimethylsilyl chloride (18.4 
g, 122 mmol, 2.00 equiv) were sequentially added to the stirred reaction mixture. After the addition was 
complete, the reaction mixture was allowed to warm to ambient temperature. After 4.5 h, the reaction 
mixture was poured into saturated aqueous sodium bicarbonate solution (500 mL). The layers were 
separated and the aqueous layer was extracted with EtOAc (3 × 250 mL). The combined organic layers 
were washed with brine (500 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under 
reduced pressure. The residue was purified by flash column chromatography (silica gel, eluent: 10% 
EtOAc in hexanes) to afford methyl 2-O-t-butyldimethylsilyloxy-3-O-benzyl-6-deoxy-6-iodo-α-D-
glucopyranoside ((+)-S2.7) (30.9 g, 99%) as a colorless flocculent solid. 
1H NMR (500 MHz, CDCl3) δ: 7.40–7.28 (m, 5 H), 4.99 (d, J = 11.8 Hz, 1 H), 4.67 (d, J = 3.5 Hz, 1 H), 
4.59 (d, J = 11.8 Hz, 1 H), 3.72 (dd, J = 3.5, 9.3 Hz, 1 H), 3.65 (t, J = 8.8 Hz, 2 H), 3.53 (dd, J = 2.6, 10.6 
Hz, 1 H), 3.47 (s, 3 H), 3.43 (ddd, J = 2.3, 7.3, 9.4 Hz, 1 H), 3.29–3.23 (m, 2 H), 1.99 (d, J = 2.4 Hz, 1 H), 
0.94 (s, 9 H), 0.14 (s, 3 H), 0.13 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 138.6, 128.7, 128.0, 127.9, 100.3, 81.7, 75.4, 73.9, 73.6, 70.0, 55.5, 25.8, 
18.1, 7.1, –4.5, –4.6. 
FTIR (thin film) cm-1: 3569, 3010, 2953, 2929, 2857, 1472, 1463, 1408, 1389, 1362, 1262, 1216, 1147, 
1094, 1047, 861, 838, 759, 698, 668. 
HRMS (ESI) (m/z) calc’d for C20H33INaO5Si [M+Na]+: 531.1034, found 531.1046. 
[α]D23: +25.6 (c = 1.57, CHCl3). 
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TLC (20% EtOAc in hexanes), Rf : 0.55 (UV, CAM). 
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Methyl 2-O-t-butyldimethylsilyloxy-3-O-benzyl-4-O-pivaloyl-6-deoxy-6-iodo-α-D-glucopy-ranoside 
((+)-2.112): 
A 1-L round-bottomed flask was charged with (+)-S2.7 (42.2 g, 83.0 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene before 1,2-dichloroethane (166 mL) was introduced. 
Trimethylacetyl chloride (12.8 mL, 104 mmol, 1.25 equiv) and 4-dimethylaminopyridine (15.2 g, 125 
mmol, 1.50 equiv) were added to the stirred solution at ambient temperature. The reaction vessel was 
sealed with a plastic cap and the reaction mixture was warmed to 50 °C. After 1 h, the reaction mixture 
was allowed to cool to ambient temperature and poured into an aqueous solution of HCl (1.2 M, 250 mL). 
The layers were separated and the aqueous layer was extracted with EtOAc (3 × 250 mL). The combined 
organic layers were washed with saturated aqueous potassium carbonate solution (3 × 250 mL) and brine 
(500 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The 
residue was purified by flash column chromatography (silica gel, eluent: 5% EtOAc in hexanes) to afford 
methyl 2-O-t-butyldimethylsilyloxy-3-O-benzyl–4-O-pivaloyl-6-deoxy-6-iodo-α-D-glucopyranoside ((+)-
2.112) (46.3 g, 94%) as a white crystalline solid. 
1H NMR (500 MHz, CDCl3) δ: 7.32–7.20 (m, 5 H), 4.86 (d, J = 11.6 Hz, 1 H), 4.84 (d, J = 9.3 Hz, 1 H), 
4.70 (d, J = 3.0 Hz, 1 H), 4.58 (d, J = 11.6 Hz, 1 H), 3.85–3.77 (m, 2 H), 3.76 (dt, J = 2.3, 9.6 Hz, 1 H), 
3.53 (s, 3 H), 3.20 (dd, J = 2.3, 10.7 Hz, 1 H), 3.08 (t, J = 10.2 Hz, 1 H), 1.13 (s, 9 H), 0.90 (s, 9 H), 0.07 
(s, 3 H), 0.02 (s, 3 H).  
13C NMR (125 MHz, CDCl3) δ: 177.2, 138.4, 128.1, 127.2, 126.7, 100.2, 79.5, 75.2, 73.8, 73.4, 69.6, 
55.8, 38.8, 27.0, 25.7, 18.1, 4.4, –4.5, –4.8. 
FTIR (thin film) cm-1: 2957, 2905, 2858, 1738, 1704, 1473, 1462, 1397, 1362, 1254, 1205, 1158, 1135, 
1106, 1038, 995, 958, 911, 863, 834, 779, 761, 697, 669. 
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HRMS (ESI) (m/z) calc’d for C25H41INaO6Si [M+Na]+: 615.1609, found 615.1612. 
[α]D23: +34.2 (c = 0.97, CHCl3).  
M.p.: 82–83 °C (CHCl3). 
TLC (20% EtOAc in hexanes), Rf : 0.69 (UV, CAM). 
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Enol ether (+)-2.113 
A 1-L round-bottomed flask was charged with (+)-2.112 (26.0 g, 43.9 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene before MeCN (219 mL) was introduced. 1,8-
Diazabicyclo[5.4.0]undec-7-ene (23.0 mL, 132 mmol, 3.00 equiv) was added via syringe to the stirred 
solution at ambient temperature. The reaction vessel was equipped with a reflux condenser and the 
reaction mixture was warmed to 80 °C. After 12 h, the reaction mixture was allowed to cool to ambient 
temperature and poured into saturated aqueous sodium bicarbonate solution (300 mL). The mixture was 
partitioned with EtOAc (250 mL), the layers were separated, and the aqueous layer was extracted with 
EtOAc (3 × 250 mL). The combined organic layers were dried over anhydrous sodium sulfate, filtered, 
and concentrated under reduced pressure. The residue was purified by flash column chromatography 
(silica gel, eluent: 5% EtOAc in hexanes) to afford enol ether (+)-2.113 (15.2 g, 75%) as a white 
crystalline solid. 
1H NMR (500 MHz, CDCl3) δ: 7.34–7.20 (m, 5 H), 5.43 (td, J = 2.1, 9.1 Hz, 1 H), 4.84 (d, J = 11.4 Hz, 1 
H), 4.72 (d, J = 3.2 Hz, 1 H), 4.67 (d, J = 3.7 Hz, 1 H), 4.66 (d, J = 11.4 Hz, 1 H), 4.44 (t, J = 1.7 Hz, 1 
H), 3.91 (dd, J = 3.3, 9.3 Hz, 1 H), 3.86 (t, J = 9.0 Hz, 1 H), 3.48 (s, 3 H), 1.19 (s, 9 H), 0.90 (s, 9 H), 0.09 
(s, 3 H), 0.04 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 176.9, 151.8, 138.4, 128.1, 127.2, 126.9, 101.0, 95.9, 79.6, 75.1, 73.4, 
71.0, 55.7, 38.7, 27.1, 25.7, 18.1, –4.5, –4.8. 
FTIR (thin film) cm-1: 2957, 2931, 2858, 1742, 1667, 1613, 1530, 1463, 1355, 1279, 1255, 1217, 1168, 
1138, 1097, 1044, 1025, 839, 762, 698. 
HRMS (ESI) (m/z) calc’d for C25H40NaO6Si [M+Na]+: 487.2486, found 487.2498. 
[α]D23: +163.5 (c = 1.12, CHCl3). 
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M.p. .: 52–53 °C (CHCl3). 
TLC (20% EtOAc in hexanes), Rf : 0.67 (UV, CAM). 
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2-Cyclohexenone (+)-2.90: 
A solution of mercury(II) trifluoroacetate (3.31 g, 7.76 mmol, 0.30 equiv) in water (86 mL) was 
added in one portion to a vigorously stirred solution of (+)-2.113 (15.3 g, 25.9 mmol, 1.00 equiv) in 
acetone (173 mL) at ambient temperature. The resultant heterogeneous reaction mixture was sealed with a 
plastic cap. After 20 h the acetone was removed under reduced pressure and the resultant mixture was 
extracted with EtOAc (3 × 200 mL). The combined organic layers were washed with 10% (w/v) aqueous 
potassium iodide solution (250 mL), 20% (w/v) aqueous sodium thiosulfate solution (250 mL), and brine 
(250 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to yield 
b-hydroxy ketone S2.8 as a yellow oil, which was used without further purification. 
A 1-L round-bottomed flask was charged with S2.8 and azeotropically dried with three portions 
of benzene. CH2Cl2 (129 mL) was introduced, and the resultant solution cooled to 0 °C. Triethylamine 
(27.0 mL, 207 mmol, 8.00 equiv) and methanesulfonyl chloride (8.00 mL, 103 mmol, 4.00 equiv) were 
sequentially added dropwise via syringe to the stirred reaction mixture over 10 min. After 5 min, the 
resultant brown reaction mixture was allowed to warm to ambient temperature. After 1 h, the reaction 
mixture was poured into aqueous sulfuric acid solution (0.5 M, 200 mL). The layers were separated and 
the aqueous layer was extracted with EtOAc (3 × 250 mL). The combined organic layers were washed 
with a saturated aqueous sodium bicarbonate solution (500 mL) and brine (500 mL), dried over anhydrous 
sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by flash 
column chromatography (silica gel, eluent: gradient, 5% → 10% EtOAc in hexanes) to afford 2-
cyclohexenone (+)-2.90 (8.26 g, 74% over two steps) as a clear, colorless syrup. 
(+)-2.90
BnO
PivO
TBSO
O
O
BnO OMe
TBSO
PivO
(+)-2.113
BnO OH
TBSO
O
PivO
S2.8
acetone-H2O (2:1),
20 h
MsCl, NEt3, CH2Cl2
0 °C → RT, 1 h
(74%, 2 steps)
Hg(OCOCF3)2
 273 
1H NMR (500 MHz, CDCl3) δ: 7.35–7.25 (m, 5 H), 6.76 (dd, J = 1.7, 10.4 Hz, 1 H), 6.05 (dd, J = 2.4, 
10.4 Hz, 1 H), 5.42 (d, J = 11.1 Hz, 1 H), 4.80 (s, 2 H), 4.64 (td, J = 2.1, 8.0 Hz, 1 H), 3.93 (dd, J = 8.0, 
11.2 Hz, 1 H), 1.24 (s, 9 H), 0.93 (s, 9 H), 0.14 (s, 3 H), 0.08 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 192.2, 177.5, 151.5, 137.8, 128.2, 127.5, 127.2, 127.0 , 83.7, 77.1, 75.2, 
72.9, 38.8, 27.2, 25.7, 18.0, –4.7, –4.9. 
FTIR (thin film) cm-1: 2957, 2897, 2858, 1740, 1704, 1480, 1383, 1360, 1282, 1254, 1216, 1154, 1136, 
1104, 1046, 987, 961, 864, 839, 779, 761, 697, 670. 
HRMS (ESI) (m/z) calc’d for C24H37O5Si [M+H]+: 433.2405, found 433.2410. 
[α]D23: +83.3 (c = 1.60, CHCl3). 
TLC (15% EtOAc in hexanes), Rf : 0.42 (UV, CAM). 
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cis-Decalin (+)-2.114 (syn diastereomer): 
A 500-mL round-bottomed flask was charged with (+)-2.90 (5.38 g, 12.5 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. PhMe (125 mL) was introduced, and the resultant 
solution cooled to –78 °C. A 25-mL round-bottomed flask was charged in a glove box with a solution of 
titanium(IV) chloride (2.36 g, 12.5 mmol, 1.00 equiv) in PhMe (13.0 mL), sealed with a rubber septum, 
and removed from the glove box. The solution of titanium(IV) chloride was then added dropwise via 
cannula to the stirred solution of (+)-15 over 10 min. The resultant yellow solution was stirred for 1 h at –
78 °C. 1,3-Butadiene (ca. 8.70 mL, 100 mmol, 8.00 equiv) was condensed at –78 °C in a 10-mL, two-
necked, round-bottomed flask equipped with a dry-ice acetone condenser and a rubber septum. The cold, 
neat 1,3-butadiene was transferred dropwise via a dry-ice wrapped cannula to the stirred, cooled solution 
of (+)-2.90 over 5 min. The resultant red reaction mixture was allowed to warm to 5 °C. After 5 h, a 
saturated aqueous sodium bicarbonate solution (150 mL) was added to the reaction mixture, which was 
subsequently allowed to warm to ambient temperature. The resultant heterogeneous mixture was filtered 
through a pad of Celite, which was rinsed with water (100 mL) and EtOAc (2 × 100 mL). The layers of 
the filtrate were separated and the aqueous layer was extracted with EtOAc (3 × 100 mL). The combined 
organic layers were washed with brine (300 mL), dried over anhydrous sodium sulfate, filtered, and 
concentrated under reduced pressure. The resultant off-white solid (>10:1 mixture of syn:anti 
diastereomers by 1H NMR analysis) was purified by flash column chromatography (silica gel, eluent: 5% 
EtOAc in hexanes) to afford pure cis-decalin syn diastereomer (+)-2.114 (3.85 g, 64%) as a white solid. 
1H NMR (500 MHz, CDCl3) δ: 7.34–7.24 (m, 5 H), 5.70–5.61 (m, 2 H), 5.28 (d, J = 9.8 Hz, 1 H), 4.78 
(d, J = 11.0 Hz, 1 H), 4.75 (d, J = 11.0 Hz, 1 H), 4.22 (dd, J = 4.8, 8.9 Hz, 1 H), 3.85 (t, J = 9.4 Hz, 1 H), 
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2.85 (t, J = 5.3 Hz, 1 H), 2.62–2.51 (m, 1 H), 2.42–2.27 (m, 2 H), 2.13–2.04 (m, 1 H), 1.69–1.55 (m, 1 H), 
1.23 (s, 9 H), 0.92 (s, 9 H), 0.11 (s, 3 H), 0.06 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 200.4, 177.6, 138.2, 128.2, 127.5, 127.3, 124.9, 124.4, 82.2, 79.4, 75.3, 
74.9, 42.7, 38.7, 38.4, 27.2, 25.8, 23.0, 22.2, 18.0, –4.6, –4.7. 
FTIR (thin film) cm-1: 3030, 2950, 2930, 2907, 2888, 2857, 1747, 1731, 1472, 1396, 1360, 1287, 1251, 
1216, 1159, 1106, 1072, 1031, 1012, 930, 838, 814, 777, 752, 700, 683, 633. 
HRMS (ESI) (m/z) calc’d for C28H43O5Si [M+H]+: 487.2874, found 487.2859. 
[α]D23: +19.8 (c = 1.72, CHCl3). 
M.p.: 141–146°C (CHCl3). 
TLC (15% EtOAc in hexanes), Rf : 0.38 (UV, CAM).  
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Dienone (–)-2.115: 
A 350-mL, glass, round-bottomed, pressure vessel was charged with (+)-2.114 (4.00 g, 8.23 
mmol, 1.00 equiv) and azeotropically dried with three portions of benzene before MeCN (165 mL) was 
introduced. Hexamethyldisilazane (34.3 mL, 164 mmol, 20.0 equiv), sodium iodide (18.5 g, 124 mmol, 
15.0 equiv), and chlorotrimethylsilane (10.5 mL, 82.3 mmol, 10.0 equiv) were added to the stirred 
solution at ambient temperature. The reaction vessel was sealed with a PTFE bushing and heated to 82 
°C. After 3 h, the resultant orange reaction mixture was allowed to cool to ambient temperature and was 
then cautiously poured into a stirred saturated aqueous sodium bicarbonate solution (300 mL). The 
mixture was partitioned with EtOAc (200 mL), the layers were separated, and the aqueous layer was 
extracted with EtOAc (3 × 200 mL). The combined organic layers were washed with brine (500 mL), 
dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to afford silyl enol 
ether S2.9 as a yellow syrup, which was used immediately without further purification. 
A 500-mL round-bottomed flask was charged with S2.9 and azeotropically dried with three 
portions of benzene before CH2Cl2 (165 mL) was introduced. 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone 
(5.60 g, 24.7 mmol, 3.00 equiv) was added in one portion to the stirred solution at ambient temperature to 
produce a dark-green, heterogeneous mixture. After 3 h, the reaction mixture was cautiously poured into a 
1-L Erlenmeyer flask containing a stirred 1:1 mixture of saturated aqueous sodium bicarbonate solution 
(250 mL) and 1% (w/v) aqueous sodium bisulfite solution (250 mL). The mixture was diluted with 
EtOAc (250 mL), layers were separated, and the aqueous layer was extracted with EtOAc (3 × 200 mL). 
The combined organic layers were washed with saturated aqueous sodium bicarbonate solution (500 mL) 
and brine (500 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced 
pressure to furnish an orange oil, which was purified by flash column chromatography (silica gel, eluent: 
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gradient, 7 → 10% EtOAc in hexanes) to afford dienone (–)-2.115 (3.00 g, 75% over two steps) as a 
clear, colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.38–7.33 (m, 2 H), 7.32–7.28 (m, 3 H), 6.79 (tdd, J = 0.7, 3.1, 4.1 Hz, 1 
H), 6.16–6.10 (m, 1 H), 6.05 (ddd, J = 3.3, 5.0, 9.4 Hz, 1 H), 5.43 (d, J = 2.5 Hz, 1 H), 4.68 (d, J = 11.9 
Hz, 1 H), 4.49 (d, J = 12.0 Hz, 1 H), 3.82–3.79 (m, 1 H), 3.77 (t, J = 2.6 Hz, 1 H), 3.38 (dd, J = 8.5, 18.9 
Hz, 1 H), 2.41 (tdd, J = 2.8, 17.1, 19.4 Hz, 1 H), 2.12 (ddd, J = 6.2, 8.4, 17.1 Hz, 1 H), 1.28 (s, 9 H), 0.80 
(s, 9 H), 0.00 (s, 3 H), –0.06 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 192.1, 177.2, 137.3, 132.9, 131.3, 129.6, 128.5, 128.0, 127.9, 124.0, 
83.6, 77.1, 71.3, 70.2, 38.7, 36.5, 27.2, 25.7, 25.5, 17.9, –4.6, –4.8. 
FTIR (thin film) cm-1: 3034, 2957, 2931, 2899, 2859, 1737, 1704, 1637, 1567, 1479, 1462, 1397, 1364, 
1256, 1218, 1149, 1119, 1094, 1075, 965, 922, 837, 776, 762, 700. 
HRMS (ESI) (m/z) calc’d for C28H40NaO5Si [M+Na]+: 507.2543, found 507.2539. 
[α]D23: –79.7 (c = 2.36, CHCl3). 
TLC (15% EtOAc in hexanes), Rf: 0.46 (UV, CAM). 
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α-Hydroxy ketone (–)-2.116: 
A 250-mL, two-necked, round-bottomed flask, equipped with a Merlic solid addition adapter 
containing MoOPH (4.21 g, 9.69 mmol, 3.00 equiv), was flushed with argon and charged with THF (16 
mL) and a solution of diethylzinc in PhMe (0.83 M, 5.84 mL, 4.85 mmol, 1.50 equiv) and cooled to –78 
°C. A dark-purple solution of dimethylphenylsilyllithium in THF (0.56 M, 8.66 mL, 4.85 mmol, 1.50 
equiv) was added dropwise via syringe to the stirred reaction mixture. The resultant red solution was 
stirred for 30 min at –78 °C before a solution of (–)-2.115 (1.57 g, 3.23 mmol, 1.00 equiv) in THF (16 
mL) was added dropwise via cannula over 10 min. The transfer was completed with two additional 
portions of THF (5 mL). The resultant yellow solution was allowed to warm to 0 °C over 30 min before 
being cooled to –78 °C. MoOPH was then slowly added via the solid addition adapter over 5 min to the 
vigorously stirred reaction mixture, which was subsequently allowed to warm to –20 °C over 20 min. A 
1:1 mixture of saturated aqueous ammonium chloride solution (25 mL) and saturated aqueous sodium 
sulfite solution (25 mL) was then added to the tan, homogeneous reaction mixture, which was 
subsequently allowed to warm to ambient temperature. The mixture was partitioned with EtOAc (100 
mL), the layers were separated, and the aqueous layer was extracted with EtOAc (3 × 100 mL). The 
combined organic layers were washed with saturated aqueous sodium bicarbonate solution (250 mL) and 
brine (250 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to 
furnish a yellow syrup. The product was purified by flash column chromatography (silica gel, eluent: 10% 
EtOAc in hexanes) to afford α-hydroxy ketone (–)-2.116 (1.60 g, 78%) as a clear, colorless gel. 
1H NMR (500 MHz, C6D6) δ: 7.43–7.39 (m, 2 H), 7.35 (d, J = 7.6 Hz, 1 H), 7.23–7.14 (m, 5 H), 7.07 (t, J 
= 7.7 Hz, 1 H), 6.25 (d, J = 10.2 Hz, 1 H), 5.81 (dd, J = 4.0, 10.0 Hz, 1 H), 5.40 (dd, J = 2.1, 10.0 Hz, 1 
H), 4.84 (d, J = 11.4 Hz, 1 H), 4.76 (dd, J = 5.4, 9.5 Hz, 1 H), 4.73 (d, J = 11.7 Hz, 1 H), 3.72 (t, J = 9.7 
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Hz, 1 H), 2.56 (s, 1 H), 2.30–2.23 (m, 2 H), 1.77 (ddd, J = 2.5, 4.0, 6.8 Hz, 1 H), 1.26 (s, 9 H), 0.90 (s, 9 
H), 0.28 (s, 3 H), 0.26 (s, 3 H), 0.01 (s, 6 H) 
13C NMR (125 MHz, C6D6) δ: 201.1, 177.6, 139.1, 137.8, 134.1, 132.1, 129.6, 128.6, 128.5, 127.6, 127.1, 
126.3, 81.5, 78.2, 76.9, 75.3, 70.9, 44.6, 39.0, 27.4, 27.0, 26.3, 19.4, 18.1, –3.4, –3.5, –4.3. 
FTIR (thin film) cm-1: 3449, 3026, 2956, 2930, 2904, 2857, 1743, 1718, 1644, 1480, 1461, 1428, 1397, 
1360, 1285, 1252, 1216, 1158, 1104, 1030, 1006, 985, 940, 892, 838, 815, 759, 700. 
HRMS (ESI) (m/z) calc’d for C36H52NaO6Si2 [M+Na]+: 659.3195, found 659.3197. 
[α]D23: –116.9 (c = 2.39, CHCl3). 
TLC (15% EtOAc in hexanes), Rf: 0.28 (UV, CAM). 
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Triol (–)-S2.10: 
A 2-L round-bottomed flask was charged with anhydrous cerium(III) chloride (16.0 g, 65.1 
mmol, 15.0 equiv) and lithium chloride (5.51 g, 130 mmol, 30.0 equiv), and heated to 145 °C under 
reduced pressure (0.05 Torr) for 2.5 h. The flask was allowed to cool to ambient temperature and flushed 
with argon. The flask was further cooled to 0 °C before THF (651 mL) was introduced via cannula over 
15 min. The resultant heterogeneous, off-white slurry was allowed to warm to ambient temperature. After 
12 h, the reaction mixture was cooled to –78 °C before a solution of n-propylmagnesium chloride in Et2O 
(1.75 M, 30.0 mL, 52.1 mmol, 12.0 equiv) was added dropwise via syringe over 10 min. The resultant 
yellow slurry was stirred for 3 h at –78 °C. A solution of (–)-2.116 (2.76 g, 4.34 mmol, 1.00 equiv) in 
THF (22 mL) at –78 °C was then transferred dropwise via a dry-ice wrapped cannula to the stirred, cooled 
reaction mixture over 10 min. The transfer was completed with two additional portions of THF (10 mL). 
The resultant mixture was gradually allowed to warm to 0 °C over 1 h and stirred at 0 °C for an additional 
1.5 h. Saturated aqueous ammonium chloride solution (300 mL) was then cautiously added to the reaction 
mixture, which was subsequently allowed to warm to ambient temperature. The resultant heterogeneous 
mixture was filtered through a pad of Celite and rinsed with water (100 mL) and EtOAc (3 × 150 mL). 
The layers of the filtrate were separated and the aqueous layer was extracted with EtOAc (3 × 250 mL). 
The combined organic layers were washed with saturated aqueous sodium bicarbonate solution (500 mL) 
and brine (500 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced 
pressure. The resultant yellow syrup was purified by flash column chromatography (silica gel, eluent: 
20% EtOAc in hexanes) to afford triol (–)-S2.10 (2.07 g, 80%) as a colorless gel. 
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1H NMR (500 MHz, C6D6) δ: 7.54–7.48 (m, 2 H), 7.37 (d, J = 7.4 Hz, 2 H), 7.27–7.20 (m, 3 H), 7.17 (t, J 
= 7.4 Hz, 2 H), 7.08 (t, J = 7.3 Hz, 1 H), 5.75 (dd, J = 3.6, 10.2 Hz, 1 H), 5.35 (dd, J = 2.6, 10.2 Hz, 1 H), 
4.94 (d, J = 11.8 Hz, 1 H), 4.72 (d, J = 11.8 Hz, 1 H), 4.35 (dd, J = 5.8, 9.9 Hz, 1 H), 3.95 (dd, J = 4.8, 9.1 
Hz, 1 H), 3.77 (t, J = 9.5 Hz, 1 H), 2.58 (dt, J = 8.5, 14.1 Hz, 1 H), 2.30 (dd, J = 4.5, 13.7 Hz, 1 H), 2.18 
(dd, J = 2.3, 4.6 Hz, 1 H), 1.93 (td, J = 3.2, 8.3 Hz, 1 H), 1.88 (td, J = 5.1, 14.6 Hz, 1 H), 1.82 (dt, J = 2.1, 
12.2 Hz, 1 H), 1.78–1.63 (m, 2 H), 1.56–1.44 (m, 1 H), 0.99 (s, 9 H), 0.93 (t, J = 7.1 Hz, 3 H), 0.34 (s, 3 
H), 0.33 (s, 3 H), 0.15 (s, 3 H), 0.05 (s, 3 H). 
13C NMR (125 MHz, C6D6) δ: 139.9, 138.3, 134.3, 133.7, 129.5, 128.7, 128.6, 128.2, 127.6, 127.5, 81.8, 
78.4, 75.7, 75.6, 75.1, 72.1, 48.8, 39.3, 26.5, 26.4, 19.8, 18.9, 18.2, 15.6, –3.4, –3.7, –4.2, –4.2. 
FTIR (thin film) cm-1: 3461, 3069, 3024, 2957, 2931, 2895, 2857, 1471, 1428, 1253, 1217, 1115, 970, 
836, 736, 701. 
HRMS (ESI) (m/z) calc’d for C34H52NaO5Si2 [M+Na]+: 619.3251, found 619.3264. 
[α]D23: –102.5 (c = 2.06, CHCl3). 
TLC (15% EtOAc in hexanes), Rf: 0.25 (UV, CAM). 
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Acetonide (+)-2.117: 
A 100 mL round-bottomed flask was charged with (–)-S2.10 (1.79 g, 3.00 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene before dry benzene (60 mL) was introduced. 2-
Methoxypropene (5.75 mL, 60.0 mmol, 20.0 equiv) and pyridinium p-toluenesulfonate (75.4 mg, 0.300 
mmol, 0.100 equiv) were sequentially added to the vigorously stirred solution at ambient temperature. 
After 190 min, saturated aqueous sodium bicarbonate solution (30 mL) was added to the stirred reaction 
mixture. The layers were separated and the aqueous layer was extracted with EtOAc (3 × 50 mL). The 
combined organic layers were washed with saturated aqueous sodium bicarbonate solution (150 mL) and 
brine (150 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure to 
furnish a yellow syrup. The product was purified by flash column chromatography (silica gel, eluent: 
gradient, 5 → 10% EtOAc in hexanes) to afford acetonide (+)-2.117 (1.57 g, 82%) as a colorless 
flocculent solid. 
1H NMR (500 MHz, C6D6) δ: 7.53–7.49 (m, 2 H), 7.43 (d, J = 7.0 Hz, 2 H), 7.25–7.16 (m, 5 H), 7.08 (t, J 
= 7.3 Hz, 1 H), 6.06 (dd, J = 2.0, 10.0 Hz, 1 H), 5.84 (dd, J = 1.9, 10.2 Hz, 1 H), 4.98 (d, J = 11.9 Hz, 1 
H), 4.73 (d, J = 11.8 Hz, 1 H), 4.12 (dd, J = 8.1, 11.1 Hz, 1 H), 4.09 (d, J = 6.2 Hz, 1 H), 3.99 (dd, J = 
6.1, 11.1 Hz, 1 H), 2.36–2.28 (m, 2 H), 2.05–1.97 (m, 2 H), 1.78 (dtdd, J = 5.2, 7.2, 12.6, 19.9 Hz, 1 H), 
1.71–1.59 (m, 1 H), 1.52 (dd, J = 4.0, 14.3 Hz, 1 H), 1.48 (s, 3 H), 1.29 (s, 3 H), 0.97 (s, 9 H), 0.91 (t, J = 
7.3 Hz, 3 H), 0.32 (s, 3 H), 0.31 (s, 3 H), 0.15 (s, 3 H), 0.09 (s, 3 H). 
13C NMR (125 MHz, C6D6) δ: 139.6, 137.8, 134.4, 131.4, 130.4, 129.5, 128.4, 128.3, 128.2, 127.5, 108.9, 
87.5, 86.8, 80.6, 73.0, 72.6, 69.8, 43.0, 39.9, 27.6, 27.0, 26.4, 24.2, 20.8, 18.7, 18.6, 15.4, –4.08, –4.14, –
4.5, –4.9. 
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FTIR (thin film) cm-1: 3483, 3458, 3007, 2957, 2929, 2856, 1461, 1428, 1380, 1253, 1209, 1113, 1086, 
1032, 871, 849, 835, 812, 760, 736, 700, 669. 
HRMS (ESI) (m/z) calc’d for C37H56NaO5Si2 [M+Na]+: 659.3558, found 659.3536. 
[α]D23: +10.2 (c = 1.13, CHCl3). 
TLC (15% EtOAc in hexanes), Rf: 0.63 (UV, CAM, anis). 
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Silyl ether (+)-2.118: 
A 200 mL round-bottomed flask was charged with (+)-2.117 (1.73 g, 2.71 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene before CH2Cl2 (54 mL) was introduced. Sodium 
bicarbonate (683 mg, 8.13 mmol, 3.00 equiv) was added to the stirred solution at ambient temperature, 
and the resultant heterogeneous mixture was cooled to –78 °C. A separate 25-mL round-bottomed flask 
was charged with mCPBA (77 wt. %, 1.22 g, 5.43 mmol, 2.00 equiv) and diluted with CH2Cl2 (10 mL). 
The resultant solution was then transferred dropwise via cannula to the stirred, cooled reaction mixture 
over 5 min. The transfer was completed with two additional portions of CH2Cl2 (5 mL). The resultant 
heterogeneous reaction mixture was warmed to –5 °C. After 4 h, saturated aqueous sodium sulfite 
solution (50 mL) was added to the reaction mixture, which was subsequently allowed to warm to ambient 
temperature. The layers were separated and the aqueous layer was extracted with EtOAc (3 × 100 mL). 
The combined organic layers were washed with saturated aqueous sodium bicarbonate solution (200 mL), 
water (200 mL), and brine (200 mL), dried over anhydrous sodium sulfate, filtered, and concentrated 
under reduced pressure to furnish a colorless syrup. The product was purified by flash column 
chromatography (silica gel, eluent: 5% EtOAc in hexanes) to afford silyl ether (+)-2.118 (1.55 g, 88%) as 
a colorless flocculent solid. 
1H NMR (500 MHz, CDCl3) δ: 7.61–7.57 (m, 2 H), 7.44–7.36 (m, 5 H), 7.31 (t, J = 7.4 Hz, 2 H), 7.24 (t, 
J = 7.4 Hz, 1 H), 5.82 (dd, J = 3.6, 9.9 Hz, 1 H), 5.67 (ddd, J = 1.6, 3.3, 9.4 Hz, 1 H), 4.86 (d, J = 11.9 
Hz, 1 H), 4.68 (d, J = 11.7 Hz, 1 H), 4.34 (d, J = 4.7 Hz, 1 H), 4.26 (dd, J = 4.5, 9.4 Hz, 1 H), 4.05 (d, J = 
5.6 Hz, 1 H), 3.65 (dd, J = 5.4, 9.4 Hz, 1 H), 3.53 (s, 1 H), 2.31 (td, J = 5.6, 18.7 Hz, 1 H), 2.20–2.10 (m, 
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1 H), 2.03–1.93 (m, 2 H), 1.59–1.51 (m, 1 H), 1.40–1.23 (m, 8 H), 0.90 (s, 9 H), 0.78 (t, J = 7.3 Hz, 3 H), 
0.48 (s, 3 H), 0.45 (s, 3 H), 0.06 (s, 3 H), 0.05 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 139.0, 137.3, 133.5, 130.2, 129.9, 128.0, 127.94, 127.85, 127.09, 127.08, 
109.3, 88.0, 86.4, 82.1, 73.2, 72.9, 70.5, 67.3, 43.1, 40.3, 29.0, 28.3, 25.9, 24.8, 18.2, 18.1, 15.0, –0.5, –
0.7, –4.5, –4.8. 
FTIR (thin film) cm-1: 3504, 3027, 3006, 2956, 2930, 2892, 2856, 1461, 1429, 1378, 1368, 1291, 1254, 
1234, 1118, 1102, 1060, 1040, 959, 918, 867, 852, 836, 760, 699. 
HRMS (ESI) (m/z) calc’d for C37H56NaO6Si2 [M+Na]+: 675.3508, found 675.3514 . 
[α]D23: +79.8 (c = 1.19, CHCl3). 
TLC (15% EtOAc in hexanes), Rf: 0.65 (UV, CAM).  
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Allylic alcohol (+)-S2.11: 
A 50-mL round-bottomed flask was charged with (+)-2.118 (1.55 g, 2.37 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. THF (24 mL) was introduced, and the resultant 
solution cooled to –78 °C. A solution of tetrabutylammonium fluoride in THF (1.0 M, 3.56 mL, 3.56 
mmol, 1.50 equiv) was added dropwise via syringe to the stirred, cooled reaction mixture over 5 min. 
After 1.5 h, saturated aqueous ammonium chloride solution (10 mL) was added to the reaction mixture, 
which was subsequently allowed to warm to ambient temperature. The layers were separated and the 
aqueous layer was extracted with EtOAc (3 × 50 mL). The combined organic layers were washed with a 
saturated aqueous sodium bicarbonate solution (100 mL) and brine (100 mL), dried over anhydrous 
sodium sulfate, filtered, and concentrated under reduced pressure to furnish a yellow oil. The product was 
purified by flash column chromatography (silica gel, eluent: gradient, 5 → 10% EtOAc in hexanes) to 
afford allylic alcohol (+)-S2.11 (1.23 g, quantitative) as a colorless gel. 
1H NMR (500 MHz, CDCl3) δ: 7.38–7.28 (m, 5 H), 5.74–5.69 (m, 1 H), 5.40–5.36 (m, 1 H), 4.79–4.75 
(m, 1 H), 4.68 (d, J = 11.9 Hz, 1 H), 4.58 (d, J = 12.1 Hz, 1 H), 4.39–4.36 (m, 1 H), 4.03 (d, J = 1.9 Hz, 1 
H), 3.90–3.87 (m, 1 H), 3.70 (t, J = 2.1 Hz, 1 H), 3.40 (s, 1 H), 2.64 (ddd, J = 2.9, 6.9, 18.3 Hz, 1 H), 2.31 
(dd, J = 2.1, 7.4 Hz, 1 H), 2.07 (ddd, J = 3.8, 12.5, 14.3 Hz, 1 H), 1.79–1.70 (m, 2 H), 1.62–1.55 (m, 4 H), 
1.52–1.45 (m, 1 H), 1.41 (s, 3 H), 0.94 (t, J = 7.2 Hz, 3 H), 0.84 (s, 9 H), –0.03 (s, 3 H), –0.05 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 137.9, 128.4, 127.8, 127.6, 127.3, 126.8, 107.3, 89.4, 79.8, 77.2, 75.4, 
75.2, 72.3, 70.1, 38.0, 37.4, 27.6, 26.0, 25.9, 25.7, 17.9, 17.7, 15.0, –5.0, –5.2. 
FTIR (thin film) cm-1: 3517, 3498, 3028, 3008, 2951, 2929, 2901, 2858, 1429, 1384, 1336, 1298, 1215, 
1110, 1072, 1030, 991, 939, 857, 837, 760, 670. 
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HRMS (ESI) (m/z) calc’d for C29H46NaO6Si [M+Na]+: 541.2956, found 541.2930. 
[α]D23: +34.2 (c = 1.01, CHCl3). 
TLC (15% EtOAc in hexanes), Rf: 0.46 (UV, CAM). 
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Enone (+)-2.119: 
 A 100-mL round-bottomed flask was charged with dimethyl sulfoxide (2.70 mL, 37.9 mL, 16.0 
equiv) and CH2Cl2 (26 mL), and cooled to –78 °C. A solution of oxalyl chloride (1.60 mL, 19.0 mmol, 
8.00 equiv) in CH2Cl2 (3 mL) was added dropwise via cannula to the stirred reaction mixture. After 1 h, a 
solution of (+)-2.11 (1.23 g, 2.37 mmol, 1.00 equiv) in CH2Cl2 (20 mL) was transferred dropwise via 
cannula to the stirred, cooled reaction mixture over 5 min. After 4 h, triethylamine (10.6 mL, 75.8 mmol, 
32.0 equiv) was slowly added via syringe down the wall of the reaction vessel over 5 min. After 5 min, 
the reaction mixture was allowed to warm to 0 °C. After 30 min, saturated aqueous ammonium chloride 
solution (30 mL) was added to the stirred reaction mixture, which was subsequently allowed to warm to 
ambient temperature. The mixture was partitioned with EtOAc (50 mL), the layers were separated, and 
the aqueous layer was extracted with EtOAc (3 × 50 mL). The combined organic layers were washed with 
saturated aqueous sodium bicarbonate solution (250 mL) and brine (250 mL), dried over anhydrous 
sodium sulfate, filtered, and concentrated under reduced pressure to furnish a colorless syrup. The product 
was purified by flash column chromatography (silica gel, eluent: gradient, 5 → 10% EtOAc in hexanes) 
to afford enone (+)-2.119 (1.15 g, 94%) as a colorless solid.  
1H NMR (500 MHz, CDCl3) δ: 7.40 (d, J = 7.1 Hz, 2 H), 7.33 (t, J = 7.3 Hz, 2 H), 7.26 (t, J = 7.4 Hz, 1 
H), 6.97 (ddd, J = 2.3, 5.1, 10.1 Hz, 1 H), 6.20 (ddd, J = 0.9, 2.8, 10.2 Hz, 1 H), 4.91 (d, J = 11.8 Hz, 1 
H), 4.71 (d, J = 11.7 Hz, 1 H), 4.25 (s, 1 H), 4.16 (dd, J = 5.0, 9.4 Hz, 1 H), 4.06 (d, J = 5.7 Hz, 1 H), 3.75 
(dd, J = 5.8, 9.6 Hz, 1 H), 2.68 (tdd, J = 2.6, 11.2, 19.9 Hz, 1 H), 2.57 (td, J = 6.0, 20.1 Hz, 1 H), 2.32 (td, 
J = 5.6, 10.9 Hz, 1 H), 2.04 (ddd, J = 7.9, 9.9, 15.0 Hz, 1 H), 1.55 (td, J = 7.9, 15.8 Hz, 1 H), 1.38 (s, 3 
H), 1.37 (s, 3 H), 1.21–1.14 (m, 2 H), 0.89 (s, 9 H), 0.80 (t, J = 7.4 Hz, 3 H), 0.05 (s, 3 H), 0.04 (s, 3 H). 
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13C NMR (125 MHz, CDCl3) δ: 200.9, 151.3, 138.7, 128.0, 127.9, 127.6, 127.2, 110.1, 88.0, 85.9, 81.6, 
76.0, 73.1, 70.1, 47.9, 37.7, 29.0, 28.4, 26.2, 25.9, 18.0, 16.1, 14.6, –4.6, –4.9. 
FTIR (thin film) cm-1: 3465, 3006, 2955, 2930, 2889, 2856, 1678, 1460, 1380, 1255, 1231, 1214, 1110, 
1031, 1006, 917, 854, 838, 761, 698. 
HRMS (ESI) (m/z) calc’d for C29H44NaO6Si [M+Na]+: 539.2799, found 539.2797. 
[α]D23: +71.5 (c = 1.18, CHCl3). 
M.p.: 99–100 °C (Et2O). 
TLC (15% EtOAc in hexanes), Rf: 0.55 (UV, CAM).  
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AB/HG-Enone (+)-2.68: 
A 100-mL round-bottomed flask was charged with (+)-2.119 (1.15 g, 2.23 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. THF (45 mL) was introduced, and the resultant 
solution cooled to 0 °C. A freshly prepared solution of lithium hexamethyldisilazide in THF (1.0 M, 4.45 
mL, 4.45 mmol, 2.00 equiv) was added dropwise via syringe to the stirred reaction mixture over 2 min. 
After 30 min, a solution of trimethylsilyl trifluoromethanesulfonate (1.21 mL, 6.69 mmol, 3.00 equiv) in 
PhMe (6.7 mL) was added dropwise via cannula to the stirred, cooled reaction mixture over 5 min.  After 
30 min, the reaction was warmed to ambient temperature. After an additional 30 min, saturated aqueous 
ammonium chloride solution (25 mL) was added to the reaction mixture. The layers were separated and 
the aqueous layer was extracted with EtOAc (3 × 50 mL). The combined organic layers were washed with 
saturated aqueous sodium bicarbonate solution (100 mL) and brine (100 mL), dried over anhydrous 
sodium sulfate, filtered, and concentrated under reduced pressure to furnish a yellow oil. The product was 
purified by flash column chromatography (silica gel, eluent: 5% EtOAc in hexanes) to afford AB/HG-
enone (+)-2.68 (1.30 g, 99%) as a colorless solid. 
1H NMR (500 MHz, CDCl3) δ: 7.41 (d, J = 7.3 Hz, 2 H), 7.33 (t, J = 7.4 Hz, 2 H), 7.26 (t, J = 7.4 Hz, 1 
H), 6.88 (ddd, J = 2.3, 5.1, 10.3 Hz, 1 H), 6.11 (dd, J = 2.1, 10.0 Hz, 1 H), 4.91 (d, J = 11.6 Hz, 1 H), 4.70 
(d, J = 11.6 Hz, 1 H), 4.15 (dd, J = 5.0, 9.4 Hz, 1 H), 4.07 (d, J = 5.7 Hz, 1 H), 3.74 (dd, J = 5.7, 9.5 Hz, 1 
H), 2.65 (tdd, J = 2.6, 11.0, 19.7 Hz, 1 H), 2.57 (td, J = 5.8, 19.9 Hz, 1 H), 2.34 (td, J = 5.7, 11.0 Hz, 1 
H), 1.91 (ddd, J = 5.4, 12.3, 14.6 Hz, 1 H), 1.70 (ddd, J = 3.7, 12.8, 14.6 Hz, 1 H), 1.36 (s, 6 H), 1.24–
1.14 (m, 2 H), 0.90 (s, 9 H), 0.80 (t, J = 7.4 Hz, 3 H), 0.16 (s, 9 H), 0.06 (s, 3 H), 0.05 (s, 3 H). 
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13C NMR (125 MHz, CDCl3) δ: 199.3, 149.1, 138.7, 129.4, 128.1, 128.0, 127.3, 109.9, 87.1, 86.2, 82.0, 
81.1, 73.3, 70.4, 49.1, 38.3, 28.9, 28.4, 26.7, 25.9, 18.1, 16.7, 14.6, 2.2, –4.5, –4.6. 
FTIR (thin film) cm-1: 3010, 2955, 2931, 2897, 2857, 1689, 1462, 1380, 1251, 1231, 1126, 1034, 925, 
851, 761. 
HRMS (ESI) (m/z) calc’d for C32H52NaO6Si2 [M+Na]+: 611.3195, found 611.3223. 
[α]D23: +72.2 (c = 1.09, CHCl3). 
TLC (15% EtOAc in hexanes), Rf: 0.69 (UV, CAM). 
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α-Boc-pyranone (+)-2.287 and β-Boc-pyranone (–)-2.309: 
 A 2-L round-bottomed flask was charged with (S)-1-(furan-2-yl)ethanol (2.308)232 and diluted 
with THF (455 mL) and H2O (155 mL). The resultant solution was cooled to 0 °C and sodium 
bicarbonate (65.1 g, 775 mmol, 1.83 equiv), sodium acetate trihydrate (106 g, 779 mmol, 1.84 equiv), and 
N-bromosuccinimide (76.8 g, 432 mmol, 1.02 equiv) were sequentially added in single portions to the 
reaction vessel. The resultant inhomogeous yellow reaction mixture stirred for 1 h at 0 °C open to the air. 
Saturated aqueous sodium bicarbonate solution (800 mL) was then added to the reaction mixture, which 
was subsequently allowed to warm to ambient temperature. The layers were separated and the aqueous 
layer was extracted with Et2O (3 × 600 mL). The combined organic layers were dried over anhydrous 
magnesium sulfate, filtered, and concentrated under reduced pressure to afford (2S)-6-hydroxy-2-methyl-
2H-pyran-3(6H)-one (S2.12)233 as yellow oil, which was used immediately without further purification. 
 A 2-L round-bottomed flask was charged with S2.12 and azeotropically dried with three portions 
of benzene. Benzene (846 mL), di-tert-butyl dicarbonate (141 g, 648 mmol, 1.53 equiv), and anhydrous 
sodium acetate (38.5 g, 470 mmol, 1.11 equiv) were introduced. The reaction vessel was equipped with a 
reflux condenser and the reaction mixture was warmed to 80 °C. After 2.5 h, the reaction mixture was 
allowed to cool to ambient temperature and poured into saturated aqueous sodium bicarbonate solution (1 
L). The layers were separated, and the aqueous layer was extracted with Et2O (3 × 600 mL). The 
combined organic layers were dried over anhydrous magnesium sulfate, filtered, and concentrated under 
reduced pressure. The residue was purified by flash column chromatography (silica gel, eluent: 7% 
                                                      
232 (S)-1-(furan-2-yl)ethanol (2.308) was prepared in 90-g batches through the reported procedure: Ohkuma, T.; 
Koizumi, M.; Yoshida, M.; Noyori, R. Org. Lett. 2000, 2, 1749–1751. 
 
233 For spectroscopic and physical characterization, see: Shan, S.; Xing, Y.; O’Doherty, G. A. J. Org. Chem., 2009, 
74, 5961–596 
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EtOAc in hexanes) to afford α-Boc-pyranone (+)-2.287 (25.7 g, 27%) and β-Boc-pyranone (–)-2.309 
(47.7 g, 49%) as a colorless solids. 
 
α-Boc-pyranone (+)-2.287: 
1H NMR (400 MHz, CDCl3) δ: 6.87 (dd, J = 3.7, 10.2 Hz, 1 H), 6.34 (d, J = 3.6 Hz, 1 H), 6.20 (d, J = 
10.2 Hz, 1 H), 4.65 (q, J = 6.7 Hz, 1 H), 1.52 (s, 9 H), 1.41 (d, J = 6.7 Hz, 3 H). 
13C NMR (100 MHz, CDCl3) δ: 195.7, 151.8, 140.9, 128.3, 89.1, 83.6, 72.1, 27.6, 15.2. 
FTIR (thin film) cm-1: 2985, 2941, 2878, 1751, 1703, 1476, 1454, 1396, 1372, 1333, 1278, 1258, 1159, 
1105, 1091, 1058, 1030, 944, 860, 842, 759. 
HRMS (ESI) (m/z) calc’d for C11H16NaO5 [M+Na]+: 251.0890, found 251.0896. 
[α]D23: +89.1 (c = 1.38, CHCl3). 
TLC (20% EtOAc in hexanes), Rf: 0.45 (UV, CAM). 
 
β-Boc-pyranone (–)-2.309: 
1H NMR (500 MHz, CDCl3) δ: 6.89 (dd, J = 2.6, 10.4 Hz, 1 H), 6.37 (s, 1 H), 6.21 (d, J = 10.4 Hz, 1 H), 
4.38 (q, J = 7.1 Hz, 1 H), 1.55–1.49 (m, 12 H). 
13C NMR (125 MHz, CDCl3) δ: 195.9, 151.7, 142.8, 128.2, 89.9, 83.6, 75.7, 27.6, 18.6. 
FTIR (thin film) cm-1: 2986, 2940, 2878, 1754, 1703m 1477, 1454, 1372, 1278, 1256, 1162, 1128, 1069, 
1033, 940, 855, 761, 667. 
HRMS (ESI) (m/z) calc’d for C11H16NaO5 [M+Na]+: 251.0890, found 251.0897. 
[α]D23: –41.8 (c = 1.08, CHCl3). 
TLC (20% EtOAc in hexanes), Rf: 0.38 (UV, CAM). 
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α-Boc-pyranone (–)-2.311 and β-Boc-pyranone (+)-2.282: 
 A 2-L round-bottomed flask was charged with (R)-1-(furan-2-yl)ethanol (2.310)234 and diluted 
with THF (547 mL) and H2O (186 mL). The resultant solution was cooled to 0 °C and sodium 
bicarbonate (78.2 g, 931 mmol, 1.83 equiv), sodium acetate trihydrate (127 g, 936 mmol, 1.84 equiv), and 
N-bromosuccinimide (92.3 g, 519 mmol, 1.02 equiv) were sequentially added in single portions to the 
reaction vessel. The resultant inhomogeous yellow reaction mixture stirred for 1 h at 0 °C open to the air. 
Saturated aqueous sodium bicarbonate solution (800 mL) was then added to the reaction mixture, which 
was subsequently allowed to warm to ambient temperature. The layers were separated and the aqueous 
layer was extracted with Et2O (3 × 600 mL). The combined organic layers were dried over anhydrous 
magnesium sulfate, filtered, and concentrated under reduced pressure to afford (2R)-6-hydroxy-2-methyl-
2H-pyran-3(6H)-one (S2.13)235 as yellow oil, which was used immediately without further purification. 
 A 2-L round-bottomed flask was charged with S2.13 and azeotropically dried with three portions 
of benzene. Benzene (1.02 L), di-tert-butyl dicarbonate (170 g, 778 mmol, 1.53 equiv), and anhydrous 
sodium acetate (46.3 g, 565 mmol, 1.11 equiv) were introduced. The reaction vessel was equipped with a 
reflux condenser and the reaction mixture was warmed to 80 °C. After 2.5 h, the reaction mixture was 
allowed to cool to ambient temperature and poured into saturated aqueous sodium bicarbonate solution (1 
L). The layers were separated, and the aqueous layer was extracted with Et2O (3 × 600 mL). The 
combined organic layers were dried over anhydrous magnesium sulfate, filtered, and concentrated under 
reduced pressure. The residue was purified by flash column chromatography (silica gel, eluent: 7% 
                                                      
234 (R)-1-(furan-2-yl)ethanol (2.310) was prepared in 90-g batches through the reported procedure: Ohkuma, T.; 
Koizumi, M.; Yoshida, M.; Noyori, R. Org. Lett. 2000, 2, 1749–1751. 
 
235 For spectroscopic and physical characterization see: Shan, S.; Xing, Y.; O’Doherty, G. A. J. Org. Chem., 2009, 
74, 5961–596. 
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EtOAc in hexanes) to afford α-Boc-pyranone (–)-2.311 (30.5 g, 26%) and β-Boc-pyranone (+)-2.282 
(53.1 g, 46%) as a colorless solids. 
 
α-Boc-pyranone (–)-2.311: 
1H NMR (500 MHz, CDCl3) δ: 6.87 (dd, J = 3.7, 10.2 Hz, 1 H), 6.34 (d, J = 3.7 Hz, 1 H), 6.20 (d, J = 
10.2 Hz, 1 H), 4.65 (q, J = 6.8 Hz, 1 H), 1.53 (s, 9 H), 1.42 (d, J = 6.8 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 195.7, 151.8, 140.9, 128.4, 89.2, 83.6, 72.2, 27.6, 15.2. 
FTIR (thin film) cm-1: 2985, 2942, 2877, 1751, 1703, 1476, 1451, 1396, 1372, 1333, 1278, 1257, 1159, 
1106, 1090, 1058, 1030, 945, 861, 841, 760. 
HRMS (ESI) (m/z) calc’d for C11H16NaO5 [M+Na]+: 251.0890, found 251.0889. 
[α]D23: –100.5 (c = 1.15, CHCl3). 
TLC (20% EtOAc in hexanes), Rf: 0.45 (UV, CAM). 
 
β-Boc-pyranone (+)-2.282: 
1H NMR (500 MHz, CDCl3) δ: 6.89 (dd, J = 2.6, 10.4 Hz, 1 H), 6.37 (s, 1 H), 6.21 (d, J = 10.4 Hz, 1 H), 
4.38 (q, J = 7.1 Hz, 1 H), 1.55–1.49 (m, 12 H). 
13C NMR (125 MHz, CDCl3) δ: 195.9, 151.7, 142.8, 128.2, 89.9, 83.6, 75.7, 27.6, 18.6. 
FTIR (thin film) cm-1: 2985, 2941, 2877, 1753, 1703, 1477, 1454, 1372, 1277, 1255, 1161, 1128, 1068, 
1032, 1007, 941, 855, 791, 761. 
HRMS (ESI) (m/z) calc’d for C11H16NaO5 [M+Na]+: 251.0890, found 251.0884. 
[α]D23: +44.5 (c = 1.54, CHCl3). 
TLC (20% EtOAc in hexanes), Rf: 0.38 (UV, CAM). 
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β-Benzyl acetal (+)-2.312: 
 A 500-mL round-bottomed flask was charged with β-Boc-pyranone ((–)-2.309) (20.0 g, 87.6 
mmol, 1.00 equiv) and azeotropically dried with three portions of benzene. CH2Cl2 (88 mL) and benzyl 
alcohol (18.1 mL, 175 mmol, 2.0 equiv) were introduced and the resultant solution cooled to 0 °C. A 
separate 100-mL round-bottomed flask was charged with tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (1.13 g, 1.10 mmol, 0.0125 equiv) and triphenylphosphine (1.15 g, 4.38 mmol, 0.05 
equiv) and the flask was evacuated and then backfilled with argon. The process was repeated three times 
before CH2Cl2 (56 ml) was introduced. The resultant red reaction mixture was cooled to 0 °C and 
transferred dropwise via cannula to the 500-mL reaction vessel over 10 min. After 12 h, saturated aqueous 
sodium bicarbonate solution (200 mL) was added to the reaction mixture, which was subsequently 
allowed to warm to ambient temperature. The layers were separated and the aqueous layer was extracted 
with Et2O (3 × 100 mL). The combined organic layers were dried over anhydrous magnesium sulfate, 
filtered, and concentrated under reduced pressure. The residue was purified by flash column 
chromatography (silica gel, eluent: 8% EtOAc in hexanes) to afford β-benzyl acetal (+)-2.312 (15.7 g, 
82%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.44–7.29 (m, 5 H), 6.91 (dd, J = 1.7, 10.3 Hz, 1 H), 6.14 (dd, J = 1.0, 
10.3 Hz, 1 H), 5.40 (s, 1 H), 4.95 (d, J = 11.7 Hz, 1 H), 4.69 (d, J = 11.7 Hz, 1 H), 4.24 (q, J = 6.8 Hz, 1 
H), 1.53 (d, J = 6.9 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ:196.8, 146.5, 136.8, 128.5, 128.1, 128.03, 127.99, 94.3, 75.2, 70.1, 17.2. 
FTIR (thin film) cm-1: 3385, 3064, 3032, 2987, 2939, 2873, 2825, 1698, 1498, 1455, 1374, 1302, 1223, 
1165, 1148, 1116, 1099, 1058, 1036, 1024, 907, 803, 755, 736, 699. 
HRMS (ESI) (m/z) calc’d for C13H14NaO3 [M+Na]+: 241.0835, found 241.0830. 
O
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[α]D23: +32.0 (c = 1.71, CHCl3). 
TLC (20% EtOAc in hexanes), Rf: 0.375 (UV, CAM).  
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Allylic alcohol 2.313a/2.313b: 
A 500-mL round-bottomed flask was charged with (+)-2.312 (19.0 g, 87.2 mmol, 1.00 equiv), 
CH2Cl2 (90 mL), MeOH (90 mL) and cerium(III) chloride heptahydrate (13.0 g, 34.9 mmol, 0.40 equiv). 
The resultant yellow mixture was stirred at ambient temperature until homogeneous and then cooled to –
78 °C. Sodium borohydride (4.95 g, 131 mmol, 1.50 equiv) was added to the stirred reaction mixture in a 
single portion. After 3 h, saturated aqueous sodium bicarbonate solution (250 mL) was carefully added to 
the cold reaction mixture, which was subsequently allowed to warm to ambient temperature. The resultant 
heterogeneous mixture was filtered through a pad of Celite and rinsed with water (100 mL) and Et2O (3 × 
50 mL). The layers of the filtrate were separated and the aqueous layer was extracted with Et2O (3 × 200 
mL). The combined organic layers were dried over anhydrous magnesium sulfate, filtered, and 
concentrated under reduced pressure. The resultant yellow syrup was purified by flash column 
chromatography (silica gel, eluent: 20% EtOAc in hexanes) to afford an inseparable mixture of allylic 
alcohols 2.313a and 2.313b (17.5 g, 91%, 2.313a:2.313b = 1.7:1) as a colorless oil.236 
1H NMR (400 MHz, CDCl3) allylic alcohol 2.313a δ: 7.42–7.27 (m, 5 H), 6.17 (ddd, J = 1.3, 5.1, 10.0 Hz, 
1 H), 5.87 (d, J = 10.1 Hz, 1 H), 5.13 (d, J = 1.1 Hz, 1 H), 4.92 (d, J = 11.9 Hz, 1 H), 4.66 (d, J = 11.9 Hz, 
1 H), 3.75 (dq, J = 2.1, 6.5 Hz, 1 H), 3.71–3.68 (m, 1 H), 1.74 (d, J = 11.1 Hz, 1 H), 1.34 (d, J = 6.5 Hz, 3 
H); allylic alcohol 2.313b δ: 7.42–7.27 (m, 5 H), 5.98 (td, J = 2.1, 10.2 Hz, 1 H), 5.82 (td, J = 1.4, 10.2 
Hz, 1 H), 5.19 (q, J = 1.6 Hz, 1 H), 4.87 (d, J = 11.8 Hz, 1 H), 4.62 (d, J = 11.9 Hz, 1 H), 3.97–3.89 (m, 1 
H), 3.68–3.64 (m, 1 H), 1.69 (d, J = 7.9 Hz, 1 H), 1.40 (d, J = 6.4 Hz, 3 H). 
                                                      
236 Stereochemical assignment based on previous report: Iyer, A. K. V.; Zhou, M.; Azad, N.; Elbaz, H.; Wang, L.; 
Rogalsky, D. K.; Rojanasakul, Y.; O' Doherty, G. A.; Langenhan, J. M. ACS Med. Chem. Lett., 2010, 1, 326–330. 
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13C NMR (100 MHz, CDCl3) allylic alcohol 2.313a δ: 137.4, 131.3, 130.5, 128.4 (2C), 127.9 (2C), 127.7, 
96.9, 71.4, 69.9, 64.7, 16.6; allylic alcohol 2.313b δ: 137.6, 132.1, 128.6, 128.3 (2C), 127.9 (2C), 127.6, 
95.5, 74.3, 69.2, 68.2, 18.4. 
FTIR (thin film) cm-1: 3410, 3064, 3033, 2980, 2935, 2871, 1498, 1454, 1408, 1379, 1320, 1254, 1172, 
1136, 1109, 1053, 1025, 1010, 983, 909, 868, 790, 736, 698. 
HRMS (ESI) (m/z) calc’d for C13H16NaO3 [M+Na]+: 243.0992, found 243.1008. 
[α]D23: +32.0 (c = 1.71, CHCl3). 
TLC (20% EtOAc in hexanes), Rf: 0.20 (UV, CAM). 
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Dihydropyran (+)-2.314: 
A 500-mL round-bottomed flask was charged with triphenylphosphine (17.9 g, 68.2 mmol, 1.5 
equiv) and THF (91 mL) and cooled to –15 °C. A solution of diethyl azodicarboxylate in PhMe (40 wt. 
(silica gel, eluent:, 29.0 mL, 27.7 g, 63.6 mmol, 1.40 equiv) was added via dropwise via syringe over 5 
min. A separate 100-mL round-bottomed flask was charged with 2.313 and azeotropically dried with 
three portions of benzene. THF (35 mL) was introduced and the resultant solution was added dropwise to 
the cooled reaction mixture via cannula over 5 min. The transfer was completed with two additional 
portions of THF (5 mL). After 15 min a solution of 2-nitrobenzenesulfonylhydrazide237 (14.8 g, 68.2 
mmol, 1.50 equiv) in THF (74 mL), prepared in a separate 250-mL round-bottomed flask, was added 
dropwise to the cooled reaction mixture via cannula over 15 min. The reaction mixture stirred for 1 h at –
15 °C and then was allowed to warm to ambient temperature over 12 h. The solvent was removed under 
reduced pressure to furnish a brown residue, which was dissolved in MeOH (100 mL) and H2O (100 mL) 
and extracted with pentanes (3 × 100 mL). The combined organic layers were dried over anhydrous 
sodium sulfate, filtered, and concentrated under reduced pressure. The resultant residue was purified by 
flash column chromatography (silica gel, eluent: 5% EtOAc in hexanes) to afford dihydropyran (+)-2.314 
(9.12 g, 82%) as a colorless oil. 
1H NMR (400 MHz, CDCl3) δ: 7.41–7.27 (m, 5 H), 5.68 (tdd, J = 2.3, 4.9, 7.4 Hz, 1 H), 5.63–5.55 (m, 1 
H), 4.94 (d, J = 12.1 Hz, 1 H), 4.74 (dd, J = 3.5, 7.8 Hz, 1 H), 4.62 (d, J = 12.1 Hz, 1 H), 4.41–4.27 (m, 1 
H), 2.32–2.22 (m, 1 H), 2.22–2.12 (m, 1 H), 1.32 (d, J = 6.8 Hz, 3 H) . 
13C NMR (100 MHz, CDCl3) δ: 137.8, 130.8, 128.3, 127.9, 127.6, 122.4, 97.7, 70.6, 69.7, 30.9, 21.1. 
                                                      
237 2-Nitrobenzenesulfonylhydrazide was prepared according to the reported procedure: Myers, A. G.; Zheng, B.; 
Movassaghi, M. J. Org. Chem. 1997, 62, 7507. 
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FTIR (thin film) cm-1: 3034, 2977, 2931, 2911, 2836, 1498, 1455, 1432, 1392, 1365, 1312, 1204, 1158, 
1107, 1081, 1028, 881, 780, 752, 698, 681, 619. 
HRMS (ESI) (m/z) calc’d for C13H16NaO2 [M+Na]+: 227.1043, found 227.1000. 
[α]D23: +127.1 (c = 1.18, CHCl3). 
TLC (5% EtOAc in hexanes), Rf: 0.33 (UV, CAM). 
  
 302 
 
Diol (+)-2.305: 
A 100-mL round-bottomed flask was charged with dihydropyran (+)-2.314 (3.0 g, 14.7 mmol, 
1.00 equiv), CH2Cl2 (29.4 mL) and a solution of NMO in H2O (50% wt., 6.09 mL, 6.88 g, 29.4 mmol, 
2.00 equiv) and cooled to 0 °C. OsO4 (38.1 mg, 15.0 µmol, 0.01 equiv) was added in a single portion and 
the resultant yellow solution warmed to ambient temperature. After 6 h, a mixture of saturated aqueous 
sodium bicarbonate solution and saturated aqueous sodium thiosulfate solution (10:1, 40 mL) and Florisil 
(5 g) were added to the stirred reaction mixture. The resultant heterogeneous mixture was filtered through 
a pad of Celite and rinsed with Et2O (3 × 50 mL). The layers of the filtrate were separated and the 
aqueous layer was extracted with Et2O (3 × 25 mL). The combined organic layers were dried over 
anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The resultant yellow oil 
was purified by flash column chromatography (silica gel, eluent: gradient, 35 → 40% EtOAc in hexanes) 
to afford diol (+)-2.305 (3.69 g, 82%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.38–7.27 (m, 5 H), 4.91 (dd, J = 1.8, 9.2 Hz, 1 H), 4.90 (d, J = 11.7 Hz, 1 
H), 4.57 (d, J = 11.8 Hz, 1 H), 4.14 (br. s., 1 H), 3.76 (qd, J = 6.2, 9.1 Hz, 1 H), 3.40–3.31 (m, 1 H), 2.26–
2.18 (m, 1 H), 2.14 (d, J = 13.9 Hz, 1 H), 2.07–1.97 (m, 1 H), 1.85–1.76 (m, 1 H), 1.61–1.55 (m, 1 H), 
1.35 (d, J = 6.2 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 137.5, 128.3, 127.9, 127.7, 96.9, 72.9, 70.5, 69.5, 67.8, 37.6, 18.1. 
FTIR (thin film) cm-1: 3416, 2973, 2933, 2884, 1639, 1454, 1365, 1216, 1163, 1137, 1074, 1006, 910, 
867, 822, 757, 699, 666. 
HRMS (ESI) (m/z) calc’d for C13H18NaO4 [M+Na]+: 261.1097, found 261.1074. 
[α]D23: +70.3 (c = 1.55, CHCl3). 
TLC (40% EtOAc in hexanes), Rf: 0.12 (UV, CAM). 
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Alcohol (+)-2.316: 
 A 100-mL round-bottomed flask was charged with a solution of diol (+)-2.305 (2.38 g, 9.45 
mmol, 1.00 equiv) and benzene (19 mL). Trimethyl orthoformate (6.04 mL, 47.3 mmol, 5.00 equiv) and 
para-toluenesulfonic acid monohydrate (90.0 mg, 0.473 mmol, 0.05 equiv) were sequentially introduced 
to the stirred reaction mixture at ambient tempurature. After 30 min, the solvent was removed under 
reduced pressure to afford orthoester 2.315 as a tan residue, which was immediately dissolved in THF 
(11.3 mL) and H2O (11.3 mL). para-Toluenesulfonic acid monohydrate (4.49 g, 23.6 mmol, 2.50 equiv) 
was introduced in a single portion to the stirred reaction mixture at ambient temperature. After 30 min, 
saturated aqueous sodium bicarbonate (50 mL) was added to the reaction mixture. The layers were 
separated, and the aqueous layer was extracted with EtOAc (3 × 50 mL). The combined organic layers 
were dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue 
was purified by flash column chromatography (silica gel, eluent: gradient, 35 → 45% EtOAc in hexanes) 
to afford alcohol (+)-2.316 (2.58 g, 97%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.35 (d, J = 4.3 Hz, 5 H), 5.30 (q, J = 3.2 Hz, 1 H), 4.91 (d, J = 11.9 Hz, 1 
H), 4.83 (dd, J = 2.0, 9.4 Hz, 1 H), 4.57 (d, J = 11.8 Hz, 1 H), 3.73 (qd, J = 6.3, 9.2 Hz, 1 H), 3.47 (ddd, J 
= 3.3, 6.0, 9.1 Hz, 1 H), 2.15 (td, J = 2.4, 14.2 Hz, 1 H), 2.11 (s, 3 H), 1.99–1.92 (m, 1 H), 1.88 (ddd, J = 
3.0, 9.6, 14.3 Hz, 1 H), 1.36 (d, J = 6.2 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 171.2, 137.5, 128.3, 127.7, 127.6, 96.9, 72.0, 70.8, 70.4, 70.2, 35.5, 21.0, 
18.0. 
FTIR (thin film) cm-1: 3460, 3012, 2981, 2935, 2879, 2739, 1498, 1454, 1372, 1246, 1217, 1164, 1143, 
1078, 1007, 867, 758, 699. 
HRMS (ESI) (m/z) calc’d for C15H20NaO5 [M+Na]+: 303.1203, found 303.1182. 
OBnO Me
2.315
PhH, 30 min OBnO Me
(+)-2.316
PTSA, THF-H2O (1:1)
30 min
(97%, 2 steps)OBnO Me
(+)-2.305
OH
OH CH3(COCH3)3,PTSA
O
O OMe
Me
OAc
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[α]D23: +47.3 (c = 1.06, CHCl3). 
TLC (40% EtOAc in hexanes), Rf: 0.24 (UV, CAM). 
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Benzyl ether (+)-S2.14: 
 A 25-mL round-bottomed flask was charged with alcohol (+)-2.316 (429 mg, 1.53 mmol, 1.00 
equiv) and azeotropically dried with three portions of benzene. CH2Cl2 (10.2 mL), cyclohexane (5.1 mL), 
benzyl 2,2,2-trichloroacetimidate (854 µL, 4.59 mmol, 3.00 equiv), and 4 Å MS (100 mg) were 
introduced and the resultant mixture stirred at ambient temperature. After 1 h, the reaction mixture was 
cooled to –20 °C and freshly distilled trifluoromethanesulfonic acid (108 µL, 1.22 mmol, 0.80 equiv) was 
added dropwise via syringe. The resultant reaction mixture was allowed to warm to –10 °C. After 12 h, a 
saturated aqueous sodium bicarbonate solution (10 mL) was added and the resultant mixture was 
subsequently allowed to warm to ambient temperature, filtered through a pad of Celite, and rinsed with 
hexanes (3 × 20 mL). The layers of the filtrate were separated and the aqueous layer was extracted with 
hexanes (3 × 20 mL). The combined organic layers were dried over anhydrous sodium sulfate, filtered, 
and concentrated under reduced pressure. The residue was purified by flash column chromatography 
(silica gel, eluent: gradient, 10 → 15% EtOAc in hexanes) to afford an benzyl ether (+)-S2.14 (464 mg, 
82%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.37–7.27 (m, 10 H), 5.61 (q, J = 2.6 Hz, 1 H), 4.91 (d, J = 11.8 Hz, 1 H), 
4.87 (dd, J = 1.6, 9.5 Hz, 1 H), 4.67 (d, J = 11.2 Hz, 1 H), 4.57 (d, J = 11.8 Hz, 1 H), 4.40 (d, J = 11.2 Hz, 
1 H), 3.87 (qd, J = 6.2, 9.2 Hz, 1 H), 3.18 (dd, J = 2.9, 9.3 Hz, 1 H), 2.15–2.06 (m, 4 H), 1.82 (ddd, J = 
2.8, 9.7, 14.1 Hz, 1 H), 1.31 (d, J = 6.2 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 170.2, 137.6, 137.5, 128.4, 128.3, 128.2, 127.9, 127.8, 127.7, 97.1, 78.5, 
71.5, 70.5, 69.3, 66.0, 35.8, 21.1, 18.3. 
FTIR (thin film) cm-1: 3478, 3031, 3009, 2972, 2932, 2876, 1741, 1497, 1455, 1365, 1308, 1241, 1216, 
1165, 1150, 1089, 1028, 1008, 910, 866, 755, 699. 
OBnO Me OBnO Me
(+)-S2.14(+)-2.316
OAc
OBn
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HRMS (ESI) (m/z) calc’d for C22H26NaO5 [M+Na]+: 393.1672, found 393.1659. 
[α]D23: +26.4 (c = 1.52, CHCl3). 
TLC (15% EtOAc in hexanes), Rf: 0.32 (UV, CAM). 
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Alcohol (+)-2.318: 
 A 50-mL round-bottomed flask was charged with a solution of benzyl ether (+)-S2.14 (1.0 g, 2.70 
mmol, 1.00 equiv) and azeotropically dried with three portions of benzene. CH2Cl2 (13.5 mL) was 
introduced and the resultant solution was cooled to –78 °C. A freshly prepared solution of 
diisobutylaluminum hydride in CH2CH2 (1.0 M, 5.40 mL, 5.40 mmol, 2.00 equiv) was added dropwise via 
syringe to the stirred reaction mixture. After 1 h, saturated aqueous sodium bicarbonate solution (15 mL) 
was added to the cold reaction mixture, which was subsequently allowed to warm to ambient temperature. 
The resultant heterogeneous mixture was filtered through a pad of Celite and rinsed with water (25 mL) 
and Et2O (3 × 20 mL). The layers of the filtrate were separated and the aqueous layer was extracted with 
Et2O (3 × 25 mL). The combined organic layers were dried over anhydrous magnesium sulfate, filtered, 
and concentrated under reduced pressure. The residue was purified by flash column chromatography 
(silica gel, eluent: gradient, 25 → 30% EtOAc in hexanes) to afford alcohol (+)-2.318 (880 mg, 99%) as a 
colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.42–7.26 (m, 10 H), 4.93 (dd, J = 1.6, 9.5 Hz, 1 H), 4.89 (d, J = 11.8 Hz, 
1 H), 4.64 (d, J = 11.5 Hz, 1 H), 4.57 (d, J = 6.8 Hz, 1 H), 4.54 (d, J = 6.5 Hz, 1 H), 4.24 (d, J = 2.8 Hz, 1 
H), 3.84 (qd, J = 6.2, 9.2 Hz, 1 H), 3.17 (dd, J = 2.8, 9.3 Hz, 1 H), 2.39 (d, J = 1.2 Hz, 1 H), 2.25–2.16 (m, 
1 H), 1.77–1.67 (m, 1 H), 1.33 (d, J = 6.2 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 137.7, 137.4, 128.5, 128.3, 128.1, 127.91, 127.86, 127.6, 97.0, 80.5, 71.7, 
70.6, 68.1, 64.6, 36.7, 18.2. 
FTIR (thin film) cm-1: 3031, 2974, 2934, 2875, 1741, 1498, 1455, 1370, 1317, 1242, 1218, 1167, 1153, 
1093, 1073, 1030, 1014, 945, 912, 866, 756, 700, 667. 
HRMS (ESI) (m/z) calc’d for C20H24NaO4 [M+Na]+: 351.1567, found 351.1551. 
[α]D23: +17.0 (c = 1.32, CHCl3). 
OBnO Me OBnO Me
(+)-2.318(+)-S2.14
OH
OBn
–78 °C, 1 h
(99%)
OAc
OBn DIBAL, CH2Cl2
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TLC (30% EtOAc in hexanes), Rf: 0.24 (UV, CAM). 
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Thiophenyl glycoside (2.63): 
 A 100-mL round-bottomed flask was charged with alcohol (+)-2.318 (880 mg, 2.68 mmol, 1.00 
equiv) and azeotropically dried with three portions of benzene. CH2Cl2 (26.8 mL) and thiophenol (5.50 
mL, 53.6 mmol, 20.0 equiv) were introduced and the resultant solution was cooled to –78 °C. A freshly 
prepared solution of tin(IV) tetrachloride in CH2CH2 (1.0 M, 4.02 mL, 4.02 mmol, 1.5 equiv) was added 
dropwise via syringe to the stirred reaction mixture over 5 min. After 1 h, saturated aqueous sodium 
bicarbonate solution (30 mL) was added to the cold reaction mixture, which was subsequently allowed to 
warm to ambient temperature. The resultant heterogeneous mixture was filtered through a pad of Celite 
and rinsed with water (25 mL) and Et2O (3 × 30 mL). The layers of the filtrate were separated and the 
aqueous layer was extracted with Et2O (3 × 25 mL). The combined organic layers washed with brine (100 
mL) and dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The 
resultant yellow oil was purified by flash column chromatography (silica gel, eluent: gradient, 20 → 30% 
EtOAc in hexanes) to afford an anomeric mixture of thiophenyl glycosides 2.63 (746 mg, 84%, α:β = 
2:1), as a colorless oil. α- and β-thiophenyl glycosides 2.63a and 2.63b were inseparable by silica gel 
chromatography.238 
1H NMR (500 MHz, CDCl3) α-thiophenyl glycoside 2.63a δ: 7.51–7.18 (m, 8 H), 5.44 (d, J = 6.2 Hz, 1 
H), 4.68 (d, J = 11.8 Hz, 1 H), 4.58 (d, J = 11.8 Hz, 1 H), 4.50 (qd, J = 6.3, 9.3 Hz, 1 H), 4.28–4.24 (m, 1 
H), 3.19 (dd, J = 3.0, 9.3 Hz, 1 H), 2.59 (s, 1 H), 2.39 (dd, J = 2.9, 14.9 Hz, 1 H), 2.32–2.24 (m, 1 H), 
1.29 (d, J = 6.3 Hz, 3 H); β-thiophenyl glycoside 2.63b δ: 7.51–7.17 (m, 8 H), 5.19 (dd, J = 1.8, 11.8 Hz, 
1 H), 4.66–4.61 (m, 1 H), 4.54 (d, J = 11.6 Hz, 1 H), 4.23 (q, J = 2.9 Hz, 1 H), 3.84 (qd, J = 6.3, 9.5 Hz, 1 
                                                      
238 Stereochemical assignment of anomeric position based on JDG1-DG2. 
OBnO Me OPhS Me
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H), 3.16 (dd, J = 2.9, 9.5 Hz, 1 H), 2.43 (s, 1 H), 2.3 –2.24 (m, 1 H), 1.87 (tdd, J = 2.3, 11.9, 14.0 Hz, 1 
H), 1.31 (d, J = 6.4 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) α-thiophenyl glycoside 2.63a δ: 137.9, 137.5, 130.2, 128.7, 128.5, 128.0, 
127.8, 126.4, 82.5, 80.1, 71.2, 63.5, 63.0, 36.4, 17.8; β-thiophenyl glycoside 2.63b δ:137.3, 134.3, 131.1, 
128.7, 128.5, 128.1, 127.9, 127.0, 80.0, 79.3, 71.5, 70.9, 64.4, 37.1, 18.4. 
FTIR (thin film) cm-1: 3056, 3045, 3032, 3015, 2872, 1564, 1481, 1454, 1439, 1086, 1076, 1027, 987, 
972, 911, 857, 739, 692, 656. 
HRMS (ESI) (m/z) calc’d for C19H22NaO3S [M+Na]+: 353.1182, found 353.1215. 
TLC (30% EtOAc in hexanes), Rf: 0.43 (UV, CAM). 
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Tribenzyl ether (–)-2.319: 
 100-mL round-bottomed flask was charged with diol (+)-2.305 (909 mg, 3.62 mmol, 1.00 equiv) 
and azeotropically dried with three portions of benzene. THF (36.2 mL) was introduced and the resultant 
solution was cooled to 0 °C. A dispersion of sodium hydride (60% wt. in mineral oil, 724 mg, 18.1 mmol, 
5.00 equiv) was added in a single portion to the stirred reaction mixture. After 30 min, benzyl bromide, 
was added dropwise via syringe. After an additional 30 min, the reaction mixture was allowed to warm to 
ambient temperature. After 20 h, the reaction mixture was poured into a 250-mL Erlenmeyer flask 
containing saturated aqueous ammonium chloride solution (50 mL) and diluted with EtOAc (50 mL). The 
layers were separated and the aqueous layer was extracted with EtOAc (3 × 25 mL). The combined 
organic layers washed with saturated aqueous sodium bicarbonate solution (100 mL) and brine (100 mL) 
and dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The resultant 
tan residue was purified by flash column chromatography (silica gel, eluent: 10% EtOAc in hexanes) to 
afford tribenzyl ether (–)-2.319 (1.43 g, 94%) as a colorless oil.  
1H NMR (600 MHz, CDCl3) δ: 7.41–7.23 (m, 15 H), 4.95 (d, J = 9.4 Hz, 1 H), 4.90 (d, J = 11.7 Hz, 1 H), 
4.66 (d, J = 12.6 Hz, 1 H), 4.63 (d, J = 12.3 Hz, 1 H), 4.60–4.52 (m, 2 H), 4.43 (d, J = 11.7 Hz, 1 H), 
4.09–4.02 (m, 1 H), 4.00 (br. s., 1 H), 3.16 (d, J = 9.1 Hz, 1 H), 2.24 (dd, J = 1.7, 13.8 Hz, 1 H), 1.61 (dd, 
J = 10.6, 12.6 Hz, 1 H), 1.33 (d, J = 5.9 Hz, 3 H). 
13C NMR (100 MHz, CDCl3) δ: 138.5, 138.0, 137.8, 128.3, 127.85, 127.79, 127.69, 127.66, 127.55, 
127.54, 97.3, 80.7, 71.5, 71.3, 71.1, 70.5, 69.1, 35.2, 18.4. 
FTIR (thin film) cm-1: 3028, 2929, 2868, 1496, 1453, 1362, 1344, 1316, 1207, 1164, 1148, 1088, 1056, 
1026, 1000, 735, 696. 
HRMS (ESI) (m/z) calc’d for C27H30NaO4 [M+Na]+: 441.2036, found 441.2058. 
[α]D23: –20.0 (c = 1.75, CH2Cl2). 
OBnO Me OBnO Me
(–)-2.319(+)-2.305
OBn
OBn
OH
OH NaH, THF, 0 °C,
30 min; then BnBr
0 °C → RT, 20 h
(94%)
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TLC (20% EtOAc in hexanes), Rf: 0.48 (UV, CAM). 
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Glycal (–)-2.320: 
 A 250-mL round-bottomed flask was charged with a solution of tribenzyl ether (–)-2.319 (1.33 g, 
3.18 mmol, 1.00 equiv), water (16 mL), and acetic acid (48 mL). The reaction vessel was sealed with a 
plastic cap and heated to 80 °C for 1.5 h. The reaction mixture was allowed to cool to ambient 
temperature and concentrated under reduced pressure. The resultant colorless syrup was filtered through 
pad of silica (eluent: 50% EtOAc in hexanes) and the filtrate was concentrated under reduced pressure to 
yield the hemiacetal S2.15 (1.04 g) as a colorless oil, which was used immediately without further 
purification. 
 A 100-mL round-bottomed flask was charged with hemiacetal S2.15 and azeotropically dried 
with three portions of benzene. THF (125 mL) was introduced, and the resultant solution cooled to 0 °C. 
Et3N (2.20 mL, 15.8 mmol, 5.00 equiv) and methanesulfonyl chloride (733 µL, 9.46 mmol, 3.00 equiv) 
were sequentially added dropwise via syringe to the stirred reaction solution and subsequently allowed to 
warm to ambient temperature. After 1 h, saturated aqueous ammonium chloride solution (30 mL) was 
added and the mixture was diluted with EtOAc (30 mL). The layers were separated and the aqueous layer 
was extracted with EtOAc (3 × 25 mL). The combined organic layers washed with saturated aqueous 
sodium bicarbonate solution (100 mL) and brine (100 mL) and dried over anhydrous sodium sulfate, 
filtered, and concentrated under reduced pressure. The resultant tan residue was purified by flash column 
chromatography (silica gel, eluent: 5% EtOAc in hexanes) to afford glycal (–)-2.320 (501 mg, 51% over 
two steps) as a colorless oil.  
1H NMR (500 MHz, CDCl3) δ: 7.42–7.27 (m, 10 H), 6.41 (d, J = 6.0 Hz, 1 H), 4.90 (t, J = 5.8 Hz, 1 H), 
4.76–4.71 (m, 1 H), 4.69 (d, J = 11.8 Hz, 1 H), 4.64 (d, J = 12.2 Hz, 1 H), 4.47 (d, J = 11.8 Hz, 1 H), 4.25 
(qd, J = 6.3, 10.2 Hz, 1 H), 3.97 (dd, J = 3.7, 5.5 Hz, 1 H), 3.35 (dd, J = 3.5, 10.0 Hz, 1 H), 1.39 (d, J = 
6.3 Hz, 3 H). 
OHO Me
S2.15
80 °C, 90 min
O Me
(–)-2.320
MsCl, Et3N, THF
0 °C → RT, 1 h
(51%, 2 steps)OBnO Me
(–)-2.319
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OBn
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 314 
13C NMR (125 MHz, CDCl3) δ: 146.7, 138.7, 137.9, 128.3, 128.0, 127.9, 127.7, 127.6, 98.2, 78.6, 71.1, 
70.24, 70.16, 65.3, 17.7. 
FTIR (thin film) cm-1: 3062, 3029, 2932, 2864, 1640, 1496, 1453, 1274, 1235, 1206, 1173,  1119, 1090, 
1064, 1027, 886, 801, 735, 697, 616, 597, 515, 439. 
HRMS (ESI) (m/z) calc’d for C20H22NaO3 [M+Na]+: 333.1461, found 333.1475. 
[α]D23: –307 (c = 1.13, CH2Cl2). 
TLC (10% EtOAc in hexanes), Rf: 0.43 (UV, CAM). 
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Glycosyl acetate (–)-2.322: 
 A 100-mL round-bottomed flask was charged with glycal (–)-2.320 and azeotropically dried with 
three portions of benzene. CH2Cl2 (31 mL) was introduced, and the resultant solution cooled to –78 °C. 
Acetic acid (211 µL, 3.68 mmol, 2.00 equiv) and N-iodosuccinamide (688 mg, 3.06 mmol, 1.66 equiv) 
were sequentially added to the stirred reaction solution. The reaction mixture was subsequently allowed to 
warm to 0 °C over 90 min. Saturated aqueous sodium thiosulfate solution (30 mL) was added and the 
mixture was diluted with EtOAc (30 mL). The layers were separated and the aqueous layer was extracted 
with EtOAc (3 × 25 mL). The combined organic layers washed with saturated aqueous sodium 
bicarbonate solution (100 mL) and brine (100 mL) and dried over anhydrous sodium sulfate, filtered, and 
concentrated under reduced pressure. The resultant residue was purified by flash column chromatography 
(silica gel, eluent: 10% EtOAc in hexanes) to afford glycosyl acetate (–)-2.322 (872 mg, 96%) as a 
colorless oil.  
1H NMR (500 MHz, CDCl3) δ: 7.39–7.28 (m, 10 H), 6.12 (s, 1 H), 4.63 (d, J = 11.8 Hz, 1 H), 4.57 (d, J = 
12.3 Hz, 1 H), 4.55–4.47 (m, 3 H), 4.40 (qd, J = 6.3, 8.5 Hz, 1 H), 4.03 (t, J = 2.9 Hz, 1 H), 3.88 (dd, J = 
2.6, 8.9 Hz, 1 H), 2.02 (s, 3 H), 1.31 (d, J = 6.3 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 169.5, 137.6, 137.5, 128.42, 128.40, 128.0, 127.92, 127.89, 127.8, 94.9, 
76.1, 75.2, 72.1, 71.6, 66.8, 23.9, 20.9, 17.6.  
FTIR (thin film) cm-1: 3029, 2975, 2932, 2869, 1737, 1614, 14961454, 1371, 1220, 1144, 1087, 1066, 
1027, 1005, 949, 923, 736, 696, 600, 470. 
HRMS (ESI) (m/z) calc’d for C22H25INaO5 [M+Na]+: 519.0639, found 519.0648. 
[α]D23: –37.4 (c = 1.02, CH2Cl2). 
TLC (20% EtOAc in hexanes), Rf: 0.42 (UV, CAM). 
  
O Me OAcO Me
(–)-2.322(–)-2.320
OBn
OBn
OBn
OBn NIS, HOAc, CH2Cl2,–78 → 0 °C
90 min
(96%)
I
 316 
 
Glycosyl trichloroacetimidate 2.64: 
 A 5-mL round-bottomed flask was charged with a solution of (–)-2.322 (49.5 mg, 100 µmol, 1.00 
equiv) and MeOH (1 mL). Hydrazine monohydrate (19.0 µL, 250 µmol, 2.50 equiv) was added dropwise 
via syringe to the stirred reaction solution. After 30 min, the reaction mixture was poured into 25-mL 
Erlenmeyer flask containing saturated aqueous sodium bicarbonate solution (5 mL) and diluted with 
EtOAc (5 mL). The layers were separated and the aqueous layer was extracted with EtOAc (3 × 5 mL). 
The combined organic layers washed with saturated aqueous sodium bicarbonate solution (10 mL) and 
brine (10 mL) and dried over anhydrous sodium sulfate, filtered, and concentrated under reduced 
pressure. The resultant tan residue was filtered through pad of silica gel (eluent: 30% EtOAc in hexanes) 
and the filtrate was concentrated to yield the hemiacetal 2.380 (45.0 mg) as a colorless oil, which was 
used immediately without further purification. 
 A 5-mL round-bottomed flask was charged with hemiacetal 2.380 and azeotropically dried with 
three portions of benzene. CH2Cl2 (1 mL) and freshly distilled trichloroacetonitrile (100 µL, 1.00 mmol, 
10.0 equiv) were introduced, and the resultant solution cooled to –10 °C. DBU (3.0 µL, 20.0 µmol, 0.20 
equiv) was added via syringe. After 1h, the reaction mixture was allowed to warm to 0 °C. After an 
additional 1 h the reaction mixture was concentrated under reduced pressure. The resultant tan residue 
filtered through a pad of neutral alumina (eluent: 25% EtOAc in hexanes) to afford glycosyl 
trichloroacetimidate 2.64 (56 mg, 93% over two steps, 3:1 anomeric mixture, ca. 95% purity) as a tan oil 
that was used immediately without further purification. 
Partial data for the 3:1 mixture glycosyl trichloroacetimidates 2.64: 
1H NMR (600 MHz, CDCl3) δ: 8.62 (s, 1 H), 7.40–7.27 (m, 10 H), 6.32 (s, 1 H), 5.58 (d, J = 1.3 Hz, 1 H), 
4.76 (dd, J = 1.9, 4.4 Hz, 1 H), 4.74 (d, J = 11.7 Hz, 1 H), 4.67–4.63 (m, 1 H), 4.53 (d, J = 11.7 Hz, 1 H), 
OHO Me
2.380
MeOH, 30 min
O Me
2.64
Cl3CCN, DBU
CH2Cl2, –10 → 0 °C, 
2 h
(93%, 2 steps)
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4.48 (d, J = 11.9 Hz, 1 H), 4.21 (qd, J = 6.4, 8.5 Hz, 1 H), 4.12–4.09 (m, 1 H), 3.96 (dd, J = 2.7, 8.6 Hz, 1 
H), 1.36 (d, J = 6.5 Hz, 3 H). 
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β-Benzyl acetal (–)-2.323: 
 A 500-mL round-bottomed flask was charged with β-Boc-pyranone (+)-2.282 (20.0 g, 87.6 
mmol, 1.00 equiv) and azeotropically dried with three portions of benzene. CH2Cl2 (88 mL) and benzyl 
alcohol (18.1 mL, 175 mmol, 2.0 equiv) were introduced and the resultant solution cooled to 0 °C. A 
separate 100-mL round-bottomed flask was charged with tris(dibenzylideneacetone)dipalladium(0)-
chloroform adduct (1.13 g, 1.10 mmol, 0.0125 equiv) and triphenylphosphine (1.15 g, 4.38 mmol, 0.05 
equiv) and the flask was evacuated and then backfilled with argon. The process was repeated three times 
before CH2Cl2 (56 ml) was introduced. The resultant red reaction mixture was cooled to 0 °C and 
transferred dropwise via cannula to the 500-mL reaction vessel over 10 min. After 12 h, saturated aqueous 
sodium bicarbonate solution (200 mL) was then added to the reaction mixture, which was subsequently 
allowed to warm to ambient temperature. The layers were separated and the aqueous layer was extracted 
with Et2O (3 × 100 mL). The combined organic layers were dried over anhydrous magnesium sulfate, 
filtered, and concentrated under reduced pressure. The residue was purified by flash column 
chromatography (silica gel, eluent: 8% EtOAc in hexanes) to afford β-benzyl acetal (–)-2.323 (16.0 g, 
84%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.42–7.29 (m, 5 H), 6.91 (dd, J = 1.9, 10.3 Hz, 1 H), 6.14 (dd, J = 1.4, 
10.3 Hz, 1 H), 5.40 (s, 1 H), 4.95 (d, J = 11.8 Hz, 1 H), 4.69 (d, J = 11.8 Hz, 1 H), 4.24 (q, J = 6.8 Hz, 1 
H), 1.53 (d, J = 6.9 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 196.8, 146.5, 136.8, 128.5, 128.1, 128.04, 128.00, 94.3, 75.2, 70.1, 17.2. 
FTIR (thin film) cm-1: 3360, 3065, 3032, 2987, 2939, 2873, 2833, 1699, 1498, 1455, 1374, 1339, 1323, 
1302, 1259, 1221, 1165, 1149, 1116, 1099, 1058, 1024, 907, 803, 757, 699, 668. 
HRMS (ESI) (m/z) calc’d for C13H14NaO3 [M+Na]+: 241.0835, found 241.0828. 
[α]D23: –33.7 (c = 1.71, CHCl3). 
O
O
BocO Me O
O
BnO Me
(–)-2.323(+)-2.282
β β
Pd2(dba)3•CHCl3
PPh3, BnOH,
CH2Cl2, 0 ºC, 12 h
(84%)
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TLC (20% EtOAc in hexanes), Rf: 0.375 (UV, CAM).  
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Allylic alcohol S2.16a/S2.16b: 
A 1-L round-bottomed flask was charged with (–)-2.323 (42.4 g, 194 mmol, 1.00 equiv), CH2Cl2 
(194 mL), MeOH (194 mL) and cerium(III) chloride heptahydrate (28.9 g, 77.7 mmol, 0.40 equiv). The 
resultant yellow mixture was stirred at ambient temperature until homogeneous and then cooled to –78 
°C. Sodium borohydride (11.0 g, 291 mmol, 1.50 equiv) was added to the stirred reaction mixture in a 
single portion. After 3 h, saturated aqueous sodium bicarbonate solution (500 mL) was carefully added to 
the cold reaction mixture, which was subsequently allowed to warm to ambient temperature. The resultant 
heterogeneous mixture was filtered through a pad of Celite and rinsed with water (200 mL) and Et2O (3 × 
100 mL). The layers of the filtrate were separated and the aqueous layer was extracted with Et2O (3 × 200 
mL). The combined organic layers were dried over anhydrous magnesium sulfate, filtered, and 
concentrated under reduced pressure. The resultant yellow syrup was purified by flash column 
chromatography (silica gel, eluent: 20% EtOAc in hexanes) to afford an inseparable mixture of allylic 
alcohols S2.16a and S2.16b (17.5 g, 91%, S2.16a:S2.16b = 1.7:1) as a colorless oil.236 
1H NMR (500 MHz, CDCl3) allylic alcohol S2.16a δ:  7.39–7.27 (m, 5 H), 6.17 (dd, J = 5.1, 10.0 Hz, 1 
H), 5.87 (d, J = 10.1 Hz, 1 H), 5.15–5.12 (m, 1 H), 4.91 (d, J = 11.8 Hz, 1 H), 4.66 (d, J = 11.8 Hz, 1 H), 
3.75 (dq, J = 2.1, 6.4 Hz, 1 H), 3.72–3.68 (m, 1 H), 1.72 (d, J = 11.1 Hz, 1 H), 1.34 (d, J = 6.4 Hz, 3 H); 
allylic alcohol S2.16b δ:  7.40–7.27 (m, 5 H), 6.01–5.96 (m, 1 H), 5.82 (dd, J = 1.1, 10.2 Hz, 1 H), 5.21–
5.18 (m, 1 H), 4.87 (d, J = 11.8 Hz, 1 H), 4.62 (d, J = 11.9 Hz, 1 H), 3.93 (t, J = 6.6 Hz, 1 H), 3.68–3.65 
(m, 1 H), 1.68 (d, J = 7.6 Hz, 1 H), 1.40 (d, J = 6.4 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) allylic alcohol S2.16a δ: 137.4, 131.3, 130.4, 128.3(2C), 127.9 (2C), 127.7, 
96.9, 71.4, 69.9, 64.6, 16.6; allylic alcohol S2.16b δ: 137.6, 132.2, 128.5 (2C), 128.3, 127.9 (2C), 127.6, 
95.5, 74.3, 69.2, 68.2, 18.3. 
O
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OH
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S2.16a(–)-2.323
NaBH4, CeCl3•7H2O
CH2Cl2-MeOH (1:1), 
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4
O
OH
BnO Me
S2.16b
4
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FTIR (thin film) cm-1: 3410, 3033, 2980, 2935, 2872, 1656, 1498, 1454, 1408, 1379, 1320, 1253, 1211, 
1172, 1136, 1109, 1053, 1010, 983, 909, 868, 790, 736, 698. 
HRMS (ESI) (m/z) calc’d for C13H16NaO3 [M+Na]+: 243.0992, found 243.0997. 
TLC (20% EtOAc in hexanes), Rf: 0.20 (UV, CAM). 
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Dihydropyran (–)-2.324: 
A 2-L, two-necked, round-bottomed flask was equipped with an internal thermocouple, a 250-mL 
graduated addition funnel, and a rubber septa. The reaction flask was charged with triphenylphosphine 
(69.8 g, 266 mmol, 1.5 equiv) and THF (350 mL) and cooled to –15 °C. A solution of diethyl 
azodicarboxylate in PhMe (40% wt., 113 mL, 108 g, 248 mmol, 1.40 equiv) was added via dropwise via 
graduated addition funnel over 15 min. A separate 250-mL round-bottomed flask was charged with S2.16 
and azeotropically dried with three portions of benzene. THF (120 mL) was introduced and the resultant 
solution was added dropwise to the cooled reaction mixture via cannula over 10 min. The transfer was 
completed with three additional portions of THF (10 mL). After 15 min a solution of 2-
nitrobenzenesulfonylhydrazide237 (57.8 g, 266 mmol, 1.50 equiv) in THF (250 mL), prepared in a separate 
500-mL round-bottomed flask, was added dropwise to the cooled reaction mixture via cannula over 15 
min. The reaction mixture stirred for 1 h at –15 °C and then was allowed to warm to ambient temperature 
over 12 h. The solvent was removed under reduced pressure to furnish a brown residue, which was 
dissolved in MeOH (200 mL) and H2O (200 mL) and extracted with pentanes (3 × 350 mL). The 
combined organic layers were dried over anhydrous sodium sulfate, filtered, and concentrated under 
reduced pressure. The resultant residue was purified by flash column chromatography (silica gel, eluent: 
5% EtOAc in hexanes) to afford dihydropyran (–)-2.324 (29.7 g, 82%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.40–7.27 (m, 5 H), 5.72–5.64 (m, 1 H), 5.59 (dd, J = 1.0, 10.1 Hz, 1 H), 
4.94 (d, J = 12.1 Hz, 1 H), 4.74 (dd, J = 3.4, 8.0 Hz, 1 H), 4.62 (d, J = 12.1 Hz, 1 H), 4.38–4.29 (m, 1 H), 
2.31–2.22 (m, 1 H), 2.22–2.14 (m, 1 H), 1.32 (d, J = 6.8 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 137.9, 130.9, 128.3, 127.9, 127.5, 122.4, 97.7, 70.6, 69.7, 30.9, 21.1. 
FTIR (thin film) cm-1: 3033, 2978, 2931, 2937, 1498, 1455, 1432, 1392, 1366, 1313, 1205, 1184, 1158, 
1135, 1107, 1080, 1045, 1028, 970, 881, 780, 753, 698, 680, 619. 
OBnO Me
(–)-2.324
O
OH
BnO Me
S2.16
PPh3 DEAD, 
THF, –15 ºC;
then S2.16; then NBSH, 
–15 °C → RT, 12 h
(82%)
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HRMS (ESI) (m/z) calc’d for C13H16NaO2 [M+Na]+: 227.1043, found 227.1000. 
[α]D23: –134 (c = 1.12, CHCl3). 
TLC (5% EtOAc in hexanes), Rf: 0.33 (UV, CAM). 
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Diol (–)-S2.17: 
A 250-mL round-bottomed flask was charged with dihydropyran (–)-2.324 (5.0 g, 24.5 mmol, 
1.00 equiv), CH2Cl2 (49.0 mL) and a solution of NMO in H2O (50% wt., 10.2 mL, 11.5 g, 49.0 mmol, 
2.00 equiv) and cooled to 0 °C. OsO4 (63.0 mg, 256 µmol, 0.01 equiv) was added in a single portion and 
the resultant yellow solution warmed to ambient temperature. After 6 h, a mixture of saturated aqueous 
sodium bicarbonate solution and saturated aqueous sodium thiosulfate solution (10:1, 50 mL) and Florisil 
(5 g) were added to the stirred reaction mixture. The resultant heterogeneous mixture was filtered through 
a pad of Celite and rinsed with Et2O (3 × 50 mL). The layers of the filtrate were separated and the 
aqueous layer was extracted with Et2O (3 × 30 mL). The combined organic layers were dried over 
anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The resultant yellow oil 
was purified by flash column chromatography (silica gel, eluent: gradient, 35 → 40% EtOAc in hexanes) 
to afford diol (–)-S2.17 (5.45 g, 89%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.40–7.27 (m, 5 H), 4.91 (dd, J = 1.7, 9.2 Hz, 1 H), 4.90 (d, J = 11.8 Hz, 1 
H), 4.57 (d, J = 11.8 Hz, 1 H), 4.16–4.09 (m, 1 H), 3.75 (qd, J = 6.1, 9.2 Hz, 1 H), 3.40–3.31 (m, 0 H), 
2.26 (br. s., 1 H), 2.14 (d, J = 13.9 Hz, 1 H), 2.07 (br. s., 1 H), 1.80 (ddd, J = 2.8, 9.4, 13.9 Hz, 1 H), 1.34 
(d, J = 6.2 Hz, 1 H). 
13C NMR (125 MHz, CDCl3) δ: 137.4, 128.3, 127.9, 127.7, 96.9, 72.8, 70.5, 69.4, 67.7, 37.5, 18.1. 
FTIR (thin film) cm-1: 3418, 3032, 3014, 2973, 2933, 2883, 1498, 1454, 1365, 1216, 1164, 1137, 1075, 
1007, 910, 867, 822, 758, 699, 667. 
HRMS (ESI) (m/z) calc’d for C13H18NaO4 [M+Na]+: 261.1097, found 261.1099. 
[α]D23: –69.0 (c = 1.17, CHCl3). 
TLC (40% EtOAc in hexanes), Rf: 0.12 (UV, CAM). 
  
OBnO Me OBnO Me
(–)-S2.17(–)-2.324
OH
OHOsO4, NMO
CH2Cl2-H2O (9.7:1),
0 °C → RT, 6 h
(89%)
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Alcohol (–)-2.325: 
 A 100-mL round-bottomed flask was charged with a solution of diol (–)-S2.17 (5.06 g, 20.1 
mmol, 1.00 equiv) and benzene (40.3 mL). Trimethyl orthoformate (12.9 mL, 101 mmol, 5.00 equiv) and 
para-toluenesulfonic acid monohydrate (192 mg, 1.01 mmol, 0.05 equiv) were sequentially introduced to 
the stirred reaction mixture at ambient temperature. After 30 min, the solvent was removed under reduced 
pressure to afford orthoester S2.18 as a tan residue, which was immediately dissolved in THF (24.0 mL) 
and H2O (24.0 mL). para-Toluenesulfonic acid monohydrate (9.60 g, 50.4 mmol, 2.50 equiv) was 
introduced in a single portion to the stirred reaction mixture at ambient temperature. After 30 min, 
saturated aqueous sodium bicarbonate (100 mL) was added to the reaction mixture. The layers were 
separated, and the aqueous layer was extracted with EtOAc (3 × 100 mL). The combined organic layers 
were dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue 
was purified by flash column chromatography (silica gel, eluent: gradient, 30 → 45% EtOAc in hexanes) 
to afford alcohol (–)-2.325 (5.51 g, 98%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.38–7.27 (m, 5 H), 5.30 (q, J = 3.2 Hz, 1 H), 4.92 (d, J = 11.8 Hz, 1 H), 
4.83 (dd, J = 2.0, 9.5 Hz, 1 H), 4.57 (d, J = 11.8 Hz, 1 H), 3.73 (qd, J = 6.2, 9.2 Hz, 1 H), 3.47 (ddd, J = 
3.2, 6.0, 9.2 Hz, 1 H), 2.15 (qd, J = 2.3, 14.4 Hz, 1 H), 2.11 (s, 3 H), 2.00–1.95 (m, 1 H), 1.88 (ddd, J = 
2.9, 9.5, 14.3 Hz, 1 H), 1.36 (d, J = 6.3 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 171.2, 137.5, 128.3, 127.8, 127.7, 96.9, 72.1, 70.9, 70.4, 70.3, 35.6, 21.1, 
18.0. 
FTIR (thin film) cm-1: 3436, 2974, 2934, 2879, 1740, 1454, 1372, 1244, 1217, 1164, 1137, 1076, 1006, 
947, 912, 867, 757, 699, 666. 
HRMS (ESI) (m/z) calc’d for C15H20KO5 [M+K]+: 319. 0942, found 319. 0943. 
OBnO Me
S2.18
PhH, 30 min
OBnO Me
(–)-2.325
PTSA, THF-H2O (1:1)
30 min
(98%, 2 steps)OBnO Me
(–)-S2.17
OH
OH CH3(COCH3)3,PTSA
O
O OMe
Me
OAc
OH
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[α]D23: –45.6 (c = 1.03, CHCl3). 
TLC (40% EtOAc in hexanes), Rf: 0.24 (UV, CAM). 
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Disaccharide (+)-2.326: 
  A 100-mL round-bottomed flask was charged with (–)-2.325 (7.81 g, 27.9 mmol, 1.00 equiv) and 
α-Boc-pyranone (+)-2.287 (12.7 g, 55.8 mmol, 2.00 equiv) and azeotropically dried with three portions of 
benzene. CH2Cl2 (28 mL) was introduced and the resultant solution cooled to 0 °C. A separate 10-mL 
round-bottomed flask was charged with tris(dibenzylideneacetone)dipalladium(0)-chloroform adduct (361 
mg, 349 µmol, 0.0125 equiv) and triphenylphosphine (366 mg, 1.39 mmol, 0.05 equiv) and the flask was 
evacuated and then backfilled with argon. The process was repeated three times before CH2Cl2 (3.5 ml) 
was introduced. The resultant red reaction mixture was cooled to 0 °C and transferred dropwise via 
cannula to the 100-mL reaction vessel over 2 min. After 12 h, saturated aqueous sodium bicarbonate 
solution (30 mL) was then added to the reaction mixture, which was subsequently allowed to warm to 
ambient temperature. The layers were separated and the aqueous layer was extracted with Et2O (3 × 30 
mL). The combined organic layers were dried over anhydrous magnesium sulfate, filtered, and 
concentrated under reduced pressure. The residue was purified by flash column chromatography (silica 
gel, eluent: gradient, 10 → 30% EtOAc in hexanes) to afford disaccharide (+)-2.326 (10.5 g, 97%) as a 
yellow oil. 
1H NMR (500 MHz, CDCl3) δ: 7.39–7.27 (m, 5 H), 6.77 (dd, J = 3.4, 10.2 Hz, 1 H), 6.09 (d, J = 10.2 Hz, 
1 H), 5.49 (q, J = 3.2 Hz, 1 H), 5.27 (d, J = 3.4 Hz, 1 H), 4.91 (d, J = 11.8 Hz, 1 H), 4.84 (dd, J = 2.1, 9.4 
Hz, 1 H), 4.57 (d, J = 11.8 Hz, 1 H), 4.50 (q, J = 6.8 Hz, 1 H), 3.94 (qd, J = 6.3, 9.2 Hz, 1 H), 3.51 (dd, J 
= 3.1, 9.3 Hz, 1 H), 2.20–2.12 (m, 1 H), 2.06 (s, 3 H), 1.38–1.34 (m, 6 H). 
13C NMR (125 MHz, CDCl3) δ: 196.4, 170.0, 142.0, 137.4, 128.3, 127.74, 127.68, 127.5, 97.0, 95.3, 80.4, 
70.7, 70.5, 69.6, 69.0, 36.0, 21.1, 18.1, 14.9. 
FTIR (thin film) cm-1: 2982, 2936, 2881, 1741, 1701, 1454, 1400, 1373, 1316, 1241, 1165, 1089, 1054, 
1010, 846, 755, 699. 
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HRMS (ESI) (m/z) calc’d for C21H26NaO7 [M+Na]+: 413.1571, found 413.1565. 
[α]D23: +23.0 (c = 1.53, CHCl3). 
TLC (40% EtOAc in hexanes), Rf: 0.375 (UV, CAM). 
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Ketone (–)-2.327: 
 A 100-mL round-bottomed flask was charged with enone (+)-2.326 (2.30 g, 5.89 mmol, 1.00 
equiv) and EtOH (58.9 mL). Palladium on carbon (10 wt. % loading (dry basis), 1.13 g, 1.06 mmol, 0.18 
equiv) was added in a single portion to the stirred solution, which was subsequently sparged with 
hydrogen gas for 5 min. The stirred reaction mixture was maintained under a balloon of hydrogen gas. 
After 12 h, the balloon was removed and the stirred reaction mixture was sparged with argon gas. After 5 
min, the reaction mixture was filtered through a pad of Celite and rinsed with EtOAc (3 × 25 mL). The 
filtrate was concentrated under reduced pressure to yield the hemiacetal S2.19 as a colorless oil, which 
was used immediately without further purification. 
 A 250-mL round-bottomed flask was charged with hemiacetal S2.19 and azeotropically dried 
with three portions of benzene. CH2Cl2 (58.9 mL) was introduced and the resultant solution stirred at 
ambient temperature. tert-Butyldimethylsilyl chloride (2.66 g, 17.7 mmol, 3.00 equiv), imidazole (2.00 g, 
29.5 mmol, 5.00 equiv), and 4-(dimethylamino)pyridine (144 mg, 1.18 mmol, 0.20 equiv) were 
sequentially added to the reaction vessel in single portions. After 8 h, saturated aqueous sodium 
bicarbonate solution (100 mL) was added to the reaction mixture and the layers were separated. The 
aqueous layer was extracted with Et2O (3 × 50 mL). The combined organic layers were dried over 
anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was 
purified by flash column chromatography (silica gel, eluent: gradient, 15 → 20% EtOAc in hexanes) to 
afford ketone (–)-2.327 (1.77 g, 72%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 5.41 (q, J = 3.1 Hz, 1 H), 5.07 (t, J = 5.8 Hz, 1 H), 5.04 (dd, J = 1.9, 9.3 
Hz, 1 H), 4.28 (q, J = 6.8 Hz, 1 H), 3.87 (qd, J = 6.3, 9.5 Hz, 1 H), 3.46 (dd, J = 3.1, 9.6 Hz, 1 H), 2.40 (d, 
J = 7.7 Hz, 1 H), 2.39 (d, J = 7.9 Hz, 1 H), 2.30 (qd, J = 5.7, 14.3 Hz, 1 H), 2.10 (s, 3 H), 2.04 (ddd, J = 
O
OAc
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2.1, 3.5, 14.2 Hz, 1 H), 1.94 (dtd, J = 5.8, 8.0, 14.2 Hz, 1 H), 1.80 (ddd, J = 2.7, 9.3, 14.3 Hz, 1 H), 1.28 
(d, J = 3.8 Hz, 3 H), 1.26 (d, J = 3.2 Hz, 3 H), 0.90 (s, 9 H), 0.12 (s, 3 H), 0.11 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 210.7, 170.1, 99.1, 92.7, 78.6, 71.3, 70.4, 69.3, 38.6, 33.3, 28.0, 25.7, 
21.1, 18.07, 18.05, 14.6, –4.2, –5.2. 
FTIR (thin film) cm-1: 2956, 2934, 2885, 2859, 1739, 1392, 1370, 1319, 1244, 1217, 1175, 1154, 1117, 
1093, 1069, 1012, 941, 857, 839, 781, 761, 692, 668. 
HRMS (ESI) (m/z) calc’d for C20H36NaO7Si [M+Na]+: 439.2123, found 439.2102. 
[α]D23: –75.2 (c = 1.02, CHCl3). 
TLC (40% EtOAc in hexanes), Rf: 0.63 (UV, CAM). 
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Allylic Alcohol (–)-2.328: 
A 2-L round-bottomed flask was charged with anhydrous cerium(III) chloride (15.7 g, 63.8 
mmol, 15.0 equiv) and lithium chloride (5.40 g, 128 mmol, 30.0 equiv), and heated to 145 °C under 
reduced pressure (0.05 Torr) for 2.5 h. The flask was allowed to cool to ambient temperature and flushed 
with argon. The flask was further cooled to 0 °C before THF (640 mL) was introduced via cannula over 
15 min. The resultant heterogeneous, off-white slurry was allowed to warm to ambient temperature. After 
12 h, the reaction mixture was cooled to –78 °C before a solution of isopropenylmagnesium bromide in 
THF (0.5 M, 102 mL, 51.0 mmol, 12.0 equiv) was added dropwise via syringe over 15 min. The resultant 
yellow slurry was stirred for 3 h at –78 °C. A solution of (–)-2.327 (1.77 g, 4.25 mmol, 1.00 equiv) in 
THF (9.0 mL) at –78 °C was then transferred dropwise via a dry-ice wrapped cannula to the stirred, 
cooled reaction mixture over 10 min. The transfer was completed with two additional portions of THF 
(5.0 mL). The resultant mixture was gradually allowed to warm to 0 °C over 30 min and stirred at 0 °C 
for an additional 1.5 h. Saturated aqueous ammonium chloride solution (300 mL) was then cautiously 
added to the reaction mixture, which was subsequently allowed to warm to ambient temperature. The 
resultant heterogeneous mixture was filtered through a pad of Celite and rinsed with water (100 mL) and 
EtOAc (3 × 150 mL). The layers of the filtrate were separated and the aqueous layer was extracted with 
EtOAc (3 × 250 mL). The combined organic layers were washed with saturated aqueous sodium 
bicarbonate solution (500 mL) and brine (500 mL), dried over anhydrous sodium sulfate, filtered, and 
concentrated under reduced pressure. The resultant yellow syrup was purified by flash column 
chromatography (silica gel, eluent: 20% EtOAc in hexanes) to afford allylic alcohol (–)-2.328 (1.61 g, 
91%) as a colorless oil. 
–78 °C, 3 h; 
then (–)-2.327, 
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1H NMR (500 MHz, CDCl3) δ: 5.18–5.10 (m, 2 H), 4.96 (d, J = 3.3 Hz, 1 H), 4.91 (s, 1 H), 4.14 (s, 1 H), 
4.09 (q, J = 6.5 Hz, 1 H), 3.83 (qd, J = 6.3, 9.5 Hz, 1 H), 3.34 (dd, J = 3.0, 9.6 Hz, 1 H), 2.32 (s, 1 H), 
2.17–1.99 (m, 4 H), 1.76 (s, 5 H), 1.51 (ddd, J = 2.8, 3.7, 13.3 Hz, 1 H), 1.24 (d, J = 6.2 Hz, 3 H), 1.02 (d, 
J = 6.4 Hz, 3 H), 0.90 (s, 9 H), 0.12 (s, 3 H), 0.11 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 147.2, 111.2, 98.6, 92.5, 80.4, 73.3, 68.6, 68.3, 67.9, 39.6, 29.7, 25.8, 
25.6, 19.5, 18.14, 18.11, 14.2, –4.2, –5.2. 
FTIR (thin film) cm-1: 3492, 2955, 2932, 2896, 1448, 1383, 1308, 1252, 1213, 1176, 1124, 1090, 1078, 
1030, 996, 978, 929, 861, 839, 782, 757, 669. 
HRMS (ESI) (m/z) calc’d for C21H40NaO6Si [M+Na]+: 439.2486, found 439.2462. 
[α]D23: –43.4 (c = 1.44, CHCl3). 
TLC (40% EtOAc in hexanes), Rf: 0.49 (UV, CAM). 
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Phenylthionocarbonate (–)-2.329: 
 A 25-mL round-bottomed flask was charged with allylic alcohol (–)-2.328 (591 mg, 1.42 mmol, 
1.00 equiv) and azeotropically dried with three portions of benzene. Benzene (7.1 mL) was introduced 
and the resultant solution stirred at ambient temperature. N-Hydroxysuccinimide (49.0 mg, 43.0 µmol, 
0.30 equiv), pyridine (689 µL, 8.52 mmol, 6.00 equiv), and O-phenyl chlorothionoformate (558 µL, 5.68 
mmol, 4.00 equiv) were sequentially added to the reaction vessel. After 24 h, additional N-
hydroxysuccinimide (24.5 mg, 21.5 µmol, 0.15 equiv), pyridine (345 µL, 4.26 mmol, 3.00 equiv), and O-
phenyl chlorothionoformate (279 µL, 2.84 mmol, 2.00 equiv) were sequentially added to the reaction 
mixture. After an additional 12 h, saturated aqueous sodium bicarbonate solution (10 mL) was added to 
the stirred reaction mixture. The mixture was diluted with EtOAc (25 mL), and the layers were separated. 
the aqueous layer was extracted with EtOAc (3 × 40 mL). The combined organic layers were washed with 
saturated aqueous sodium bicarbonate solution (2 × 50 mL), and brine (50 mL), dried over anhydrous 
sodium sulfate, filtered, and concentrated under reduced pressure. The residue was then purified by flash 
column chromatography (silica gel, eluent: gradient, 15% → 30% EtOAc in hexanes) to afford 
phenylthionocarbonate (–)-2.329 (668 mg, 85%) as a yellow foam. 
1H NMR (600 MHz, CDCl3) δ:  7.31 (t, J = 8.1 Hz, 2 H), 7.20 (t, J = 7.2 Hz, 1 H), 6.95 (d, J = 7.8 Hz, 2 
H), 5.59 (q, J = 2.7 Hz, 1 H), 5.02 (s, 1 H), 4.93 (dd, J = 1.8, 9.2 Hz, 1 H), 4.81 (d, J = 3.4 Hz, 1 H), 4.78–
4.75 (m, 1 H), 4.05 (q, J = 6.4 Hz, 1 H), 3.77 (qd, J = 6.2, 9.6 Hz, 1 H), 3.39 (dd, J = 2.9, 9.5 Hz, 1 H), 
2.32 (qd, J = 2.1, 14.8 Hz, 1 H), 2.09 (dt, J = 4.6, 13.7 Hz, 1 H), 1.99–1.88 (m, 2 H), 1.74 (ddd, J = 2.4, 
9.3, 14.6 Hz, 1 H), 1.65–1.61 (m, 1 H), 1.38 (ddd, J = 1.9, 4.5, 13.5 Hz, 1 H), 1.18 (d, J = 6.3 Hz, 3 H), 
0.89 (d, J = 6.4 Hz, 3 H), 0.80 (s, 9 H), 0.02 (s, 3 H), 0.01 (s, 3 H). 
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13C NMR (125 MHz, CDCl3) δ: 193.9, 153.1, 147.4, 129.5, 126.6, 121.7, 111.0, 99.7, 92.6, 81.3, 78.8, 
73.5, 69.8, 68.3, 37.3, 29.6, 25.74, 25.66, 19.7, 18.10, 18.08, 14.2, –4.2, –5.2. 
FTIR (thin film) cm-1: 3500, 2955, 2933, 2897, 2858, 1762, 1643, 1592, 1491, 1446, 1360, 1296, 1263, 
1198, 1174, 1128, 1071, 1028, 1004, 978, 928, 905, 853, 840, 804, 782, 756, 690. 
HRMS (ESI) (m/z) calc’d for C28H44NaO7SSi [M+Na]+: 575.2469, found 575.2440. 
[α]D23: –40.7 (c = 1.60, CHCl3). 
TLC (70% EtOAc in hexanes), Rf: 0.47 (UV, CAM). 
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α-Hydroxy ketone (–)-2.330: 
 A 10-mL round-bottomed flask was charged with phenylthionocarbonate (–)-2.329 (318 mg, 575 
µmol, 1.00 equiv), CH2Cl2 (2.90 mL), and a solution of NMO in H2O (50 wt. %, 358 µL, 405 mg, 1.73 
mmol, 3.00 equiv). OsO4 (38.1 mg, 15.0 µmol, 0.01 equiv) was added in a single portion to the stirred 
reaction mixture at ambient temperature. After 13 h, a mixture of saturated aqueous sodium bicarbonate 
solution and saturated aqueous sodium thiosulfate solution (10:1, 5 mL) and Florisil (1 g) were added to 
the stirred reaction mixture. The resultant heterogeneous mixture was filtered through a pad of Celite and 
rinsed with Et2O (3 × 10 mL). The layers of the filtrate were separated and the aqueous layer was 
extracted with Et2O (3 × 5 mL). The combined organic layers were dried over anhydrous magnesium 
sulfate, filtered, and concentrated under reduced pressure. The resultant yellow oil was filtered through 
pad of silica gel (eluent: 3% MeOH in CH2Cl2) and the filtrate was concentrated to yield triol S2.20 (305 
mg) as a brown oil, which was used immediately without further purification. 
 A 25-mL round-bottomed flask was charged with triol S2.20 and azeotropically dried with three 
portions of benzene. MeOH (2.6 mL) and benzene (2.6 mL) were introduced and the resultant solution 
cooled to 0 °C. Lead(IV) acetate (346 mg, 780 µmol, 1.50 equiv) was added in a single portion to the 
stirred, cooled reaction mixture. After 30 min, the reaction mixture was diluted with Et2O (20 mL) and 
filtered through a pad of Celite and rinsed with Et2O (3 × 25 mL). The filtrate was concentrated under 
reduced pressure to yield a tan residue that was purified by flash column chromatography (silica gel, 
eluent: gradient, 10% → 12% EtOAc in CH2Cl2) to afford α-hydroxy ketone (–)-2.330 (197 mg, 62%) as 
a colorless foam. 
1H NMR (500 MHz, CDCl3) δ:  7.44 (t, J = 8.3 Hz, 2 H), 7.32 (t, J = 7.3 Hz, 1 H), 7.10 (d, J = 8.1 Hz, 2 
H), 5.76 (q, J = 2.6 Hz, 1 H), 5.04 (dd, J = 1.3, 9.0 Hz, 1 H), 4.99 (d, J = 2.9 Hz, 1 H), 4.36 (q, J = 6.3 Hz, 
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1 H), 3.88 (qd, J = 6.2, 9.5 Hz, 1 H), 3.73 (s, 1 H), 3.55 (dd, J = 2.9, 9.5 Hz, 1 H), 2.40 (td, J = 2.3, 14.5 
Hz, 1 H), 2.30 (dt, J = 4.5, 13.3 Hz, 1 H), 2.23 (s, 3 H), 2.10 (tt, J = 4.1, 13.7 Hz, 1 H), 1.88 (ddd, J = 2.3, 
9.3, 14.5 Hz, 1 H), 1.82–1.74 (m, 1 H), 1.51 (ddd, J = 2.0, 4.0, 12.8 Hz, 1 H), 1.29 (d, J = 6.2 Hz, 3 H), 
0.94 (d, J = 6.3 Hz, 3 H), 0.91 (s, 9 H), 0.13 (s, 3 H), 0.12 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 209.9, 194.1, 153.1, 129.6, 126.7, 121.7, 99.4, 92.7, 81.5, 78.7, 78.5, 69.8, 
66.8, 37.5, 27.7, 25.8, 24.9, 24.7, 18.2, 18.1, 14.9, –4.1, –5.1. 
FTIR (thin film) cm-1: 3472, 2933, 2894, 2882, 2858, 1706, 1490, 1354, 1295, 1261, 1220, 1196, 1174, 
1128, 1090, 1070, 1019, 994, 930, 852, 838, 782, 690. 
HRMS (ESI) (m/z) calc’d for C27H42NaO8SSi [M+Na]+: 577.2262, found 577.2234. 
[α]D23: –32.2 (c = 0.55, CHCl3). 
TLC (10% EtOAc in CH2Cl2), Rf: 0.23 (UV, CAM). 
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Glycosyl trichloroacetimidate 2.62: 
Hydrogen fluoride pyridine (197 µL) was slowly added to a stirred solution of α-hydroxy ketone 
(–)-2.330 (54.6 mg, 98.0 µmol, 1.00 equiv) in pyridine (1.5 mL) in a polyethylene vessel at 0 °C. After 2 
h, the reaction mixture was cautiously poured into a vigorously stirred mixture of saturated aqueous 
sodium bicarbonate solution (10 mL), EtOAc (20 mL), and ice at 0 °C. After gas evolution ceased, the 
layers were separated. The organic layer was washed with a saturated aqueous sodium bicarbonate 
solution (3 × 10 mL), and brine (10 mL), dried over anhydrous sodium sulfate, filtered, and concentrated 
under reduced pressure. The residue was filtered through a pad of silica gel (eluent: 65% EtOAc in 
hexanes) to afford hemiacetal 2.361 as an colorless foam, which was used without further purification.  
A 2-mL vial was charged with 2.361 and azeotropically dried with three portions of benzene. 
CH2Cl2 (930 µL), freshly distilled trichloroacetonitrile (93 µL, 930 µmol, 10.0 equiv), and cesium 
carbonate (6.0 mg, 18.6 µmol, 0.20 equiv) were sequential introduced. The vial was sealed with a PTFE 
coated cap and the resultant solution stirred at ambient temperature. After 12 h, the tan reaction mixture 
was diluted with CH2Cl2 (1 mL), filtered through a pad of Celite, and with CH2Cl2 (3 × 2 mL). The filtrate 
was concentrated under reduced pressure to afford glycosyl trichloroacetimidate 2.62 (52.7 mg, 92% over 
two steps, 10:1 anomeric mixture, ca. 95% purity) as a tan foam that was used immediately without 
further purification. 
Partial data for the 10:1 mixture glycosyl trichloroacetimidates 2.62: 
1H NMR (500 MHz, CD2Cl2) δ: 8.64 (s, 1 H), 7.45 (t, J = 7.4 Hz, 2 H), 7.33 (t, J = 7.3 Hz, 1 H), 7.14 (d, 
J = 7.8 Hz, 2 H), 6.22 (dd, J = 2.5, 7.5 Hz, 1 H), 5.89 (td, J = 2.9, 6.0 Hz, 1 H), 5.02 (d, J = 3.1 Hz, 1 H), 
4.41 (q, J = 6.4 Hz, 1 H), 4.15 (quin, J = 6.7 Hz, 1 H), 3.82 (dd, J = 2.8, 7.4 Hz, 1 H), 3.62 (s, 1 H), 2.70 
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(ddd, J = 2.6, 6.0, 14.0 Hz, 1 H), 2.33 (dt, J = 4.5, 13.4 Hz, 1 H), 2.25–2.17 (m, 4 H), 2.07 (tt, J = 4.1, 
13.6 Hz, 1 H), 1.83–1.74 (m, 1 H), 1.55–1.47 (m, 1 H), 1.40 (d, J = 6.6 Hz, 3 H), 0.92 (d, J = 6.3 Hz, 3 H).  
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Alyllic Alcohol (–)-S2.22: 
 A 5-mL round-bottomed flask was charged with enone (+)-2.326 (50 mg, 127 µmol, 1.00 equiv) 
and EtOH (1.3 mL). Palladium on carbon (5 wt. % loading (dry basis), 244 mg, 5.7 µmol, 0.04 equiv) was 
added in a single portion to the stirred solution, which was subsequently sparged with hydrogen gas for 5 
min. The stirred reaction mixture was maintained under a balloon of hydrogen gas. After 45 min, the 
balloon was removed and the stirred reaction mixture was sparged with argon gas. After 5 min, the 
reaction mixture was filtered through a pad of Celite and rinsed with EtOAc (3 × 5 mL). The filtrate was 
concentrated under reduced pressure to yield the ketone S2.21 as a colorless oil, which was used without 
further purification. 
A 10-mL round-bottomed flask was charged with anhydrous cerium(III) chloride (188 mg, 0.76 
mmol, 6.00 equiv) and lithium chloride (32.0 mg, 0.76 mmol, 6.00 equiv), and heated to 145 °C under 
reduced pressure (0.05 Torr) for 2.5 h. The flask was allowed to cool to ambient temperature and flushed 
with argon. The flask was further cooled to 0 °C before THF (3.8 mL) was introduced via syringe over 2 
min. The resultant heterogeneous, off-white slurry was allowed to warm to ambient temperature. After 12 
h, the reaction mixture was cooled to –78 °C before a solution of isopropenylmagnesium bromide in THF 
(0.5 M, 1.66 mL, 0.70 mmol, 5.50 equiv) was added dropwise via syringe over 15 min. The resultant 
yellow slurry was stirred for 3 h at –78 °C. A solution of S2.21 in THF (0.6 mL) at –78 °C was then 
transferred dropwise via syringe. The transfer was completed with two additional portions of THF (0.3 
mL). The resultant mixture was gradually allowed to warm to 0 °C over 30 min and stirred at 0 °C for an 
additional 30 min. Saturated aqueous ammonium chloride solution (3 mL) was then added to the reaction 
mixture, which was subsequently allowed to warm to ambient temperature. The resultant heterogeneous 
mixture was filtered through a pad of Celite and rinsed with water (10 mL) and EtOAc (3 × 10 mL). The 
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layers of the filtrate were separated and the aqueous layer was extracted with EtOAc (3 × 15 mL). The 
combined organic layers were washed with saturated aqueous sodium bicarbonate solution (25 mL) and 
brine (25 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. 
The resultant yellow syrup was purified by flash column chromatography (silica gel, eluent: gradient, 
30% → 35% EtOAc in hexanes) to afford allylic alcohol (–)-S2.22 (43.6 mg, 88%) as a colorless solid. 
1H NMR (500 MHz, CDCl3) δ: 7.38–7.27 (m, 5 H), 5.12 (s, 1 H), 4.97 (d, J = 3.2 Hz, 1 H), 4.93 (dd, J = 
1.7, 9.6 Hz, 1 H), 4.92–4.87 (m, 2 H), 4.57 (d, J = 11.9 Hz, 1 H), 4.17 (q, J = 2.4 Hz, 1 H), 4.09 (q, J = 
6.4 Hz, 1 H), 3.85 (qd, J = 6.2, 9.3 Hz, 1 H), 3.37 (dd, J = 2.9, 9.3 Hz, 1 H), 2.33 (br. s., 1 H), 2.21–2.01 
(m, 4 H), 1.81 (ddd, J = 2.6, 9.3, 12.9 Hz, 1 H), 1.76 (s, 4 H), 1.54–1.48 (m, 1 H), 1.30 (d, J = 6.3 Hz, 3 
H), 1.02 (d, J = 6.4 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 147.2, 137.7, 128.3, 127.9, 127.6, 111.2, 98.6, 96.9, 80.5, 73.3, 70.5, 
68.6, 68.3, 67.5, 37.0, 29.6, 25.5, 19.5, 18.1, 14.2. 
FTIR (thin film) cm-1: 3556, 3495, 2986, 2936, 1498, 1453, 1383, 1364, 1308, 1275, 1214, 1166, 1124, 
1086, 1055, 1029, 999, 978, 932, 906, 866, 847, 758, 699. 
HRMS (ESI) (m/z) calc’d for C22H32NaO6 [M+Na]+: 415.2091, found 415.2117. 
[α]D23: –98.4 (c = 1.45, CHCl3). 
TLC (40% EtOAc in hexanes), Rf: 0.24 (UV, CAM). 
X-Ray Crystal Structure: 
  
 341 
 
Aryl bromide 2.340: 
A 50-mL round-bottomed flask was charged with 2.339239 (1.55 g, 7.30 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. DMF (14.6 mL) was introduced, and the resultant 
solution stirred at ambient temperature. N-Bromosuccinamide (1.43 g, 8.00 mmol, 1.10 equiv) was added 
to the reaction mixture in a single portion. After 1 h, saturated aqueous sodium sulfite solution (15 mL) 
and Et2O (15 mL) were added to the yellow reaction mixture. The layers were separated, and the aqueous 
layer was further extracted with Et2O (3 × 25 mL). The combined organic layers were then washed with 
H2O (4 × 50 mL) and brine (50 mL), dried over anhydrous magnesium sulfate, filtered, and concentrated 
under reduced pressure. The residue was then purified by flash column chromatography (silica gel, eluent: 
gradient, 10% → 15% EtOAc in hexanes) to afford aryl bromide 2.340 (1.59 g, 75%) as a white solid. 
1H NMR (500 MHz, CDCl3) δ: 6.69 (s, 1 H), 5.20 (s, 2 H), 3.84 (s, 3 H), 3.74 (s, 3 H), 3.54 (s, 3 H), 2.36 
(s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 152.1, 150.3, 142.8, 132.8, 106.4, 99.6, 95.8, 60.5, 56.3, 55.9, 16.3. 
FTIR (thin film) cm-1: 2995, 2934, 2827, 1579, 1475, 1421, 1331, 1233, 1214, 1194, 1151, 1087, 1040, 
1015, 999, 935, 817, 793. 
HRMS (ESI) (m/z) calc’d for C11H15BrNaO4 [M+Na]+: 313.0046, found 313.0061. 
M.p.: 61 °C (EtOAc). 
TLC (30% EtOAc in hexanes), Rf: 0.44 (UV, CAM). 
  
                                                      
239 Trialkoxytoluene 2.339 was prepared from vanillin in five steps on multigram scale following literature 
procedures: (a) Sinhababu, A. K.; Borchardt, R. T. Syn. Comm. 1983, 13, 677–683. (b) Liau, B. B.; Milgram, B. C.; 
Shair, M. D. J. Am. Chem. Soc., 2012, 134, 16765–16772. 
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ortho-Toluate 2.341: 
A 200-mL round-bottomed flask was charged with 2.340 (1.59 g, 5.46 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. THF (55 mL) was introduced, and the resultant 
solution cooled to –78 °C. A solution of n-butyllithium in hexanes (2.53 M, 2.48 mL, 6.28 mmol, 1.15 
equiv) was then added dropwise via syringe to the stirred reaction mixture. After 1.5 h, methyl 
chloroformate (633 µL, 8.19 mmol, 1.50 equiv) was added dropwise via syringe to the stirred reaction 
mixture, which was subsequently allowed to gradually warm to ambient temperature over 2.5 h. Saturated 
aqueous sodium bicarbonate solution (50 mL) and Et2O (100 mL) were then added to the reaction 
mixture. The layers were separated, and the aqueous layer was further extracted with EtOAc (3 × 50 mL). 
The combined organic layers were then washed with saturated aqueous sodium bicarbonate solution (100 
mL) and brine (100 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced 
pressure. The residue was then purified by flash column chromatography (silica gel, eluent: gradient, 15% 
→ 30% EtOAc in hexanes) to afford ortho-toluate 2.341 (1.39 g, 94%) as a white solid. 
1H NMR (600 MHz, CDCl3) δ: 6.62 (s, 1 H), 5.13 (s, 2 H), 3.89 (s, 3 H), 3.85 (s, 3 H), 3.73 (s, 3 H), 3.48 
(s, 3 H), 2.21 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 168.1, 154.1, 150.8, 142.1, 130.1, 117.7, 98.6, 95.5, 60.3, 56.1, 55.8, 
52.0, 12.8. 
FTIR (thin film) cm-1: 2995, 2949, 2828, 1725, 1597, 1489, 1453, 1330, 1266, 1212, 1152, 1087, 1043, 
1003, 938, 840, 894, 794, 772. 
HRMS (ESI) (m/z) calc’d for C13H18KO6 [M+K]+: 309.0735, found 309.0740. 
M.p.: 44–45 °C (Et2O). 
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TLC (30% EtOAc in hexanes), Rf: 0.44 (UV, CAM).  
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Benzylic bromide 2.342: 
A 200-mL round-bottomed flask was charged with 2.341 (1.49g, 5.51 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. CCl4 (55 mL), N-bromosuccinamide (1.18 g, 6.62 
mmol, 1.20 equiv), and 2,2′-azobis(2-methylpropionitrile) (181 mg, 1.10 mmol, 0.20 equiv) were 
introduced, and the resultant stirred solution was heated to reflux. After 3 h the stirred reaction mixture 
was allowed to cool to ambient temperature before triethylamine (2.30 ml, 16.5 mmol, 3.00 equiv) was 
added to the reaction mixture which was subsequently concentrated under reduced pressure. The residue 
was then purified by flash column chromatography (silica gel, eluent: gradient, 15% → 30% EtOAc in 
hexanes) to afford benzylic bromide 2.342 (1.46 g, 76%) as a white flocculent solid. 
1H NMR (500 MHz, CDCl3) δ: 6.75 (s, 1 H), 5.14 (s, 2 H), 4.64 (s, 2 H), 3.93 (s, 3 H), 3.90 (s, 3 H), 3.87 
(s, 3 H), 3.50 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 167.0, 154.4, 151.6, 142.2, 130.2, 116.6, 101.5, 95.7, 61.0, 56.2, 55.9, 
52.3, 23.8. 
FTIR (thin film) cm-1: 2947, 1720, 1595, 1488, 1453, 1431, 1402, 1333, 1269, 1236, 1215, 1195, 1152, 
1102, 1089, 1048, 1024, 980, 947. 
HRMS (ESI) (m/z) calc’d for C13H17BrNaO6 [M+Na]+: 371.0101, found 371.0082. 
TLC (30% EtOAc in hexanes), Rf: 0.26 (UV, CAM). 
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Aldehyde 2.343: 
A 200-mL round-bottomed flask was charged with 2.342 (1.00 g, 2.86 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene before dimethyl sulfoxide (57.2 mL) was introduced. 
Diisopropylamine (1.47 mL, 8.59 mmol, 3.00 equiv) was added dropwise via syringe to the stirred 
solution at ambient temperature, which was subsequently warmed to 70 °C. After 2 h, the reaction 
mixture was cooled to ambient temperature before a saturated aqueous ammonium chloride solution (100 
mL) was cautiously added to the stirred reaction mixture. The mixture was partitioned with EtOAc (100 
mL) and the layers were separated. The aqueous layer was further extracted with EtOAc (3 × 75 mL) and 
the combined organic layers were then washed with saturated aqueous ammonium chloride solution (3 × 
200 mL), water (3 × 200 mL), and brine (200 mL), dried over anhydrous sodium sulfate, filtered, and 
concentrated under reduced pressure. The residue was then purified by flash column chromatography 
(silica gel, eluent: gradient, 30% → 40% → 50% EtOAc in hexanes) to afford aldehyde 2.343 (625 mg, 
77%) as a white solid. 
1H NMR (500 MHz, CDCl3) δ: 10.36 (s, 1 H), 7.02 (s, 1 H), 5.16 (s, 2 H), 3.96–3.89 (m, 9 H), 3.49 (s, 3 
H). 
13C NMR (125 MHz, CDCl3) δ: 188.9, 167.3, 154.4, 150.6, 147.4, 127.2, 115.2, 106.4, 95.5, 62.6, 56.3, 
56.2, 52.6. 
FTIR (thin film) cm-1: 3006, 2952, 2911, 2883, 2860, 2833, 1729, 1682, 1593, 1491, 1433, 1381, 1330, 
1289, 1262, 1239, 1212, 1192, 1165, 1150, 1102, 1085, 1032, 979, 943, 918, 839, 810, 772, 612. 
HRMS (ESI) (m/z) calc’d for C13H16NaO7 [M+Na]+: 307.0788, found 307.0803. 
M.p.: 79–80 °C (EtOAc). 
TLC (40% EtOAc in hexanes), Rf: 0.23 (UV, CAM).  
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Dibenzyl-protected aldehyde 2.345: 
A 200-mL round-bottomed flask was charged with 2.343 (625 mg, 2.20 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. CH2Cl2 (44 mL) was introduced, and the resultant 
solution cooled to –78 °C. A solution of boron trichloride in CH2Cl2 (1.0 M, 6.60 mL, 6.60 mmol, 3.00 
equiv) was then added dropwise via syringe to the stirred reaction mixture, which was subsequently 
allowed to warm to 0 °C. After 1 h, water (100 mL) and Et2O (50 mL) were added to the stirred reaction 
mixture, which was subsequently warmed to ambient temperature. The layers were separated, and the 
aqueous layer was further extracted with EtOAc (3 × 50 mL). The combined organic layers were then 
washed with water (3 × 100 mL) and brine (100 mL), dried over anhydrous magnesium sulfate, filtered, 
and concentrated under reduced pressure to afford crude hydroquinone 2.344 as a yellow flocculent solid, 
which was used without further purification. 
A 100-mL round-bottomed flask was charged with 2.344 and azeotropically dried with three 
portions of benzene. DMF (22.0 mL) was introduced, and the resultant solution cooled to 0 °C. Benzyl 
bromide (2.62 mL, 22.0 mmol, 10.0 equiv) and potassium carbonate (4.26 g, 30.8 mmol, 14.0 equiv) were 
then sequentially added to the stirred reaction mixture, which was subsequently allowed to warm to 
ambient temperature and then heated to 60 °C. After 1 h the stirred reaction mixture was allowed to cool 
to ambient temperature before saturated aqueous ammonium chloride solution (50 mL) and Et2O (50 mL) 
were added. The layers were separated, and the aqueous layer was further extracted with Et2O (3 × 50 
mL). The combined organic layers were then washed with saturated aqueous ammonium chloride solution 
(2 × 100 mL), water (3 × 100 mL) and brine (100 mL), dried over anhydrous magnesium sulfate, filtered, 
and concentrated under reduced pressure. The residue was then purified by flash column chromatography 
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(silica gel, eluent: gradient, 30% → 40% EtOAc in hexanes) to afford dibenzyl-protected aldehyde 2.345 
(863 mg, 97% over two steps) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 10.18 (s, 1 H), 7.42–7.29 (m, 10 H), 6.76 (s, 1 H), 5.13 (s, 2 H), 5.06 (s, 2 
H), 3.90 (s, 3 H), 3.86 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 189.0, 167.4, 154.4, 152.0, 145.0, 136.1, 136.0, 128.6, 128.54, 128.51, 
128.48, 128.0, 127.8, 127.0, 114.9, 104.8, 76.7, 71.7, 56.2, 52.5. 
FTIR (thin film) cm-1: 3029, 2946, 2872, 1730, 1691, 1593, 1491, 1442, 1366, 1333, 1263, 1197, 1168, 
1073, 1024, 948, 829, 777, 740, 699. 
HRMS (ESI) (m/z) calc’d for C24H22NaO6 [M+Na]+: 429.1309, found 429.1303. 
TLC (40% EtOAc in hexanes), Rf: 0.39 (UV, CAM). 
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Cyanophthalide 2.338: 
A 100-mL round-bottomed flask was charged with 2.345 (572 mg, 1.41 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. Chloroform (28 mL) was introduced, and the 
resultant solution stirred at ambient temperature. Triethylamine (392 µL, 2.81 mmol, 2.00 equiv) and 
acetone cyanohydrin (257 µL, 2.81 mmol, 2.00 equiv) were sequentially added to the reaction vessel 
dropwise via syringe. After 1 h, saturated aqueous ammonium chloride solution (30 mL) was added to the 
reaction mixture, which was stirred vigorously for 10 min. The layers were then separated, and the 
aqueous layer was further extracted with CH2Cl2 (3 × 30 mL). The combined organic layers were dried 
over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was 
then purified by flash column chromatography (silica gel, eluent: gradient, 30% → 40% EtOAc in 
hexanes) to afford cyanophthalide 2.338 (458 g, 81%) as a white flocculent solid. 
1H NMR (500 MHz, CDCl3) δ: 7.48 (d, J = 7.4 Hz, 2 H), 7.45–7.31 (m, 8 H), 6.61 (s, 1 H), 5.32 (s, 2 H), 
5.10 (s, 2 H), 3.92 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 164.9, 159.6, 155.1, 136.44, 136.40, 135.5, 135.2, 128.82, 128.78, 
128.77, 128.7, 128.3, 126.9, 113.9, 104.0, 101.0, 75.0, 71.5, 62.9, 56.6. 
FTIR (thin film) cm-1:2947, 2843, 1724, 1598, 1492, 1451, 1431, 1417, 1376, 1337, 1265, 1235, 1198, 
1165, 1087, 1073, 1053, 995, 985, 855, 821, 776, 741, 699. 
HRMS (ESI) (m/z) calc’d for C24H19NNaO5 [M+Na]+: 424.1155, found 424.1136. 
TLC (40% EtOAc in hexanes), Rf: 0.31 (UV, CAM). 
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Tetracycle (+)-2.346: 
A 10-mL Schlenk tube was charged with 2.338 (67.7 mg, 169 µmol, 1.50 equiv) and AB-/HG-
enone (+)-2.68 (66.2 mg, 112 µmol, 1.00 equiv), which were then azeotropically dried with five portions 
of benzene. THF (2.25 mL) was then introduced, and the resultant solution was deoxygenated and then 
cooled to –78 °C. A solution of freshly prepared deoxygenated lithium hexamethyldisilazide in THF (1.0 
M, 506 µL, 506 µmol, 4.50 equiv) was then added dropwise via syringe to the stirred reaction mixture, 
which was subsequently allowed to warm to 0 °C over 30 min. After 12 h, a solution of acetic acid (100 
µL) in THF (600 µL) was added via syringe rapidly down the vessel-wall to the vigorously stirred purple 
reaction mixture. After the reaction mixture turned fluorescent orange, a saturated aqueous ammonium 
chloride solution (2 mL) was added. The resultant mixture was subsequently allowed to warm to ambient 
temperature. The mixture was diluted with EtOAc (10 mL) and water H2O (10 mL), and the layers were 
separated. The aqueous layer was further extracted with EtOAc (3 × 15 mL). The combined organic 
layers were then washed with saturated aqueous sodium bicarbonate solution (30 mL) and brine (30 mL), 
dried over anhydrous so sodium sulfate, filtered, and concentrated under reduced pressure. The residue 
was then purified by flash column chromatography (silica gel, eluent: gradient, 15% → 20% → 25%  
EtOAc in hexanes) to afford tetracycle (+)-2.346240 (91.0 mg, 84%) as an orange flocculent solid. 
1H NMR (600 MHz, CD2Cl2) δ: 14.36 (s, 1 H), 9.58 (s, 1 H), 7.65 (d, J = 7.5 Hz, 2 H), 7.55–7.32 (m, 12 
H), 7.28 (t, J = 7.3 Hz, 1 H), 6.72 (s, 1 H), 5.26 (s, 3 H), 5.11 (s, 3 H), 4.88 (d, J = 11.6 Hz, 1 H), 4.69 (d, 
J = 11.5 Hz, 1 H), 4.25 (dd, J = 4.6, 8.9 Hz, 1 H), 4.20 (d, J = 4.3 Hz, 1 H), 4.03 (s, 3 H), 3.91 (dd, J = 4.3, 
8.9 Hz, 1 H), 3.31 (dd, J = 6.1, 17.9 Hz, 1 H), 2.99 (dd, J = 13.5, 17.9 Hz, 1 H), 2.40 (td, J = 5.4, 13.0 Hz, 
                                                      
240 Minor oxidation of (+)-2.346 occurs during purification and handling. Purification of highly oxygenated 
naphthalenes by flash column chromatography is difficult due to their adherence to silica gel (streaking). 
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1 H), 1.98 (ddd, J = 3.8, 12.6, 14.1 Hz, 1 H), 1.86 (ddd, J = 5.0, 12.1, 14.3 Hz, 1 H), 1.58–1.48 (m, 1 H), 
1.43–1.29 (m, 1 H), 1.25 (s, 3 H), 1.19 (s, 3 H), 0.92 (s, 9 H), 0.86 (t, J = 7.3 Hz, 3 H), 0.19 (s, 9 H), 0.09 
(s, 3 H), 0.08 (s, 3 H). 
13C NMR (125 MHz, CD2Cl2) δ: 203.1, 159.3, 157.6, 152.5, 140.1, 139.4, 137.2, 136.1, 134.8, 129.6, 
129.2, 129.0, 128.9, 128.5, 128.20, 128.18, 127.63, 127.58, 124.9, 120.1, 111.6, 111.1, 109.8, 97.2, 87.4, 
86.8, 83.4, 81.5, 77.5, 73.4, 72.1, 71.7, 56.8, 47.8, 40.2, 28.2, 27.6, 26.1, 21.4, 18.4, 17.8, 15.0, 2.3, –4.2, 
–4.5. 
FTIR (thin film) cm-1: 3327, 2954, 2935, 2896, 2856, 1712, 1602, 1499, 1457, 1440, 1401, 1378, 1343, 
1311, 1250, 1231, 1216, 1168, 1116, 1082, 1035, 961, 912, 847, 803, 755, 698, 668. 
HRMS (ESI) (m/z) calc’d for C55H70NaO11Si2 [M+Na]+: 985.4349, found 985.4334. 
[α]D23: +93.9 (c = 1.85, CH2Cl2). 
TLC (15% EtOAc in hexanes), Rf: 0.45 (UV, CAM). 
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Pentacycle (–)-2.348: 
A 10-mL round-bottomed flask was charged with (+)-2.346 (91.0 mg, 94.0 µmol, 1.00 equiv) and 
was azeotropically dried with three portions of benzene. CH2Cl2 (1.88 mL) was introduced and the 
resultant solution was cooled to –10 °C. A solution of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (32.2 
mg, 142 µmol, 1.5 equiv) in CH2Cl2 (500 µL) was added dropwise via cannula to the stirred reaction 
mixture. The transfer was completed with two additional portions of CH2Cl2 (100 µL). After 20 min, a 1:1 
mixture of 1% (w/v) aqueous sodium bisulfite solution (0.1 M, 2.5 mL) and saturated aqueous sodium 
bicarbonate solution (2.5 mL) was added to the reaction mixture. The mixture was diluted with EtOAc 
(10 mL), and the layers were separated. The aqueous layer was further extracted with EtOAc (3 × 5 mL).  
The combined organic layers were washed with a 1:1 mixture of 1% (w/v) aqueous sodium bisulfite 
solution (0.1 M) and saturated aqueous sodium bicarbonate solution (2 × 10 mL), saturated aqueous 
sodium bicarbonate solution (10 mL), and brine (10 mL), dried over anhydrous sodium sulfate, filtered, 
and concentrated under reduced pressure to afford naphthazarin 2.347, which was used immediately 
without further purification. 
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A 250-mL round-bottomed flask was charged with 2.347 and azeotropically dried with five 
portions of benzene. 1,2-dichloroethane was then introduced (91.0 mL), and the resultant solution was 
cooled to 0 °C. A solution of anhydrous HCl in Et2O (2.0 M, 2.35 mL, 4.70 mmol, 50.0 equiv) was added 
dropwise via syringe to the stirred solution. After 80 min, saturated aqueous sodium bicarbonate solution 
(50 mL) was added. The resultant mixture was subsequently allowed to warm to ambient temperature. 
The layers were separated and the aqueous layer was extracted with EtOAc (3 × 40 mL). The combined 
organic layers were washed with saturated aqueous sodium bicarbonate solution (2 × 100 mL), and brine 
(100 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The 
residue was then purified by flash column chromatography (silica gel, eluent: gradient, 15% → 20% → 
25%  EtOAc in hexanes) to afford pentacycle (–)-2.348 (68.3 mg, 79% over two steps) as an orange film. 
1H NMR (500 MHz, CD2Cl2) δ: 13.93 (s, 1 H), 9.68 (s, 1 H), 7.66 (d, J = 7.4 Hz, 2 H), 7.55 (d, J = 6.1 
Hz, 2 H), 7.51–7.34 (m, 10 H), 7.30 (t, J = 7.3 Hz, 1 H), 6.81 (s, 1 H), 5.86 (s, 1 H), 5.28 (s, 2 H), 5.14 (d, 
J = 10.3 Hz, 1 H), 5.11 (d, J = 10.2 Hz, 1 H), 4.94 (d, J = 11.6 Hz, 1 H), 4.90 (d, J = 11.5 Hz, 1 H), 4.18 
(dd, J = 3.8, 7.5 Hz, 1 H), 4.10 (d, J = 6.1 Hz, 1 H), 4.05 (s, 3 H), 3.75 (t, J = 7.7 Hz, 1 H), 2.43 (d, J = 
3.7 Hz, 1 H), 1.92–1.75 (m, 1 H), 1.72–1.56 (m, 1 H), 1.27–1.15 (m, 1 H), 1.02 (dt, J = 3.7, 13.2 Hz, 1 H), 
0.95 (s, 9 H), 0.81 (t, J = 7.3 Hz, 3 H), 0.27 (s, 9 H), 0.14 (s, 3 H), 0.07 (s, 3 H). 
13C NMR (125 MHz, CD2Cl2) δ: 202.6, 160.3, 157.9, 153.5, 140.1, 139.3, 137.2, 136.2, 136.1, 129.9, 
129.6, 129.3, 129.1, 128.8, 128.5, 128.2, 127.9, 127.8, 125.5, 122.3, 112.2, 108.4, 98.5, 88.2, 87.6, 85.1, 
77.8, 75.5, 74.5, 72.6, 72.4, 69.9, 58.3, 57.0, 35.8, 26.2, 18.4, 16.8, 15.2, 2.1, –4.0, –4.1. 
FTIR (thin film) cm-1: 3319, 2955, 2931, 2857, 1714, 1650, 1624, 1598, 1498, 1464, 1442, 1402, 1376, 
1317, 1253, 1232, 1217, 1094, 1065, 1026, 954, 888, 841, 756, 698. 
HRMS (ESI) (m/z) calc’d for C52H64NaO11Si2 [M+Na]+: 943.3879, found 943.3835. 
[α]D23: –20.6 (c = 2.31, CH2Cl2). 
TLC (30% EtOAc in hexanes), Rf: 0.52 (UV, CAM). 
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Phenol 2.349: 
A 250-mL round-bottomed flask was charged with 2.341 (1.38 g, 5.10 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. CH2Cl2 (102 mL) was introduced, and the resultant 
solution cooled to 0 °C. Trifluoroacetic acid (1.95 mL, 25.5 mmol, 5.00 equiv) was then added dropwise 
via syringe to the stirred reaction mixture, which was subsequently allowed to warm to ambient 
temperature. After 2 h, saturated aqueous sodium bicarbonate solution (100 mL) was added to the stirred 
reaction mixture. The layers were separated, and the aqueous layer was further extracted with CH2Cl2 (3 × 
75 mL). The combined organic layers were then dried over anhydrous magnesium sulfate, filtered, and 
concentrated under reduced pressure to afford phenol 2.349 (1.15 g, quantitatve) as a white flocculent 
solid, which was used without further purification. 
1H NMR (600 MHz, CDCl3) δ: 11.56 (s, 1 H), 6.37 (s, 1 H), 3.92 (s, 3 H), 3.86 (s, 3 H), 3.68 (s, 3 H), 
2.45 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 168.3, 154.0, 152.3, 141.5, 136.8, 130.5, 128.5, 127.8, 127.0, 117.2, 97.0, 
71.4, 60.4, 55.8, 52.0, 12.9. 
FTIR (thin film) cm-1: 2942, 2839, 1725, 1596, 1491, 1450, 1415, 1385, 1335, 1266, 1229, 1197, 1163, 
1111, 1060, 1005, 943, 852, 842, 791, 773, 740, 698. 
HRMS (ESI) (m/z) calc’d for C18H20NaO5 [M+Na]+: 339.1203, found 339.1198. 
M.p.: 64–65 °C (Et2O). 
TLC (30% EtOAc in hexanes), Rf: 0.40 (UV, CAM). 
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Benzyl Ether 2.350: 
A 100-mL round-bottomed flask was charged with 2.349 (1.15 g, 5.08 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. DMF (51 mL) was introduced, and the resultant 
solution cooled to 0 °C. Benzyl bromide (3.00 mL, 25.4 mmol, 5.00 equiv) and potassium carbonate (4.91 
g, 35.6 mmol, 7.00 equiv) were then sequentially added to the stirred reaction mixture, which was 
subsequently allowed to warm to ambient temperature and then heated to 60 °C. After 1 h the stirred 
reaction mixture was allowed to cool to ambient temperature before saturated aqueous ammonium 
chloride solution (25 mL) and Et2O (25 mL) were added. The layers were separated, and the aqueous 
layer was further extracted with EtOAc (3 × 50 mL). The combined organic layers were then washed with 
saturated aqueous ammonium chloride solution (2 × 100 mL), water (3 × 100 mL) and brine (100 mL), 
dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was 
then purified by flash column chromatography (silica gel, eluent: gradient, 15% → 30% EtOAc in 
hexanes) to afford benzyl ether 2.350 (1.44 g, 89%) as a white flocculent solid. 
1H NMR (500 MHz, CDCl3) δ: 7.43–7.34 (m, 4 H), 7.33–7.28 (m, 1 H), 6.40 (s, 1 H), 5.08 (s, 2 H), 3.87 
(s, 3 H), 3.81 (s, 3 H), 3.72 (s, 3 H), 2.23 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 172.2, 161.1, 158.2, 140.6, 133.9, 104.6, 98.3, 60.5, 55.7, 51.9, 14.7. 
FTIR (thin film) cm-1: 2945, 2843, 1647, 1600, 1481, 1446, 1373, 1326, 1249, 1222, 1165, 1067, 1042, 
953, 823, 797, 778, 669, 609, 453. 
HRMS (ESI) (m/z) calc’d for C11H14NaO5 [M+Na]+: 249.0733, found 249.0740. 
M.p.: 60–61 °C (Et2O). 
TLC (30% EtOAc in hexanes), Rf: 0.44 (UV, CAM). 
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Phenol 2.353: 
A 100-mL round-bottomed flask was charged with 2.342 (502 mg, 1.44 mmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. CH2Cl2 (28.8 mL) was introduced, and the resultant 
solution cooled to –78 °C. Trifluoroacetic acid (550 µL, 7.18 mmol, 5.00 equiv) was then added dropwise 
via syringe to the stirred reaction mixture, which was subsequently allowed to warm to 0 °C. After 30 
min, saturated aqueous sodium bicarbonate solution (30 mL) was added to the stirred reaction mixture. 
The layers were separated, and the aqueous layer was further extracted with CH2Cl2 (3 × 30 mL). The 
combined organic layers were then dried over anhydrous magnesium sulfate, filtered, and concentrated 
under reduced pressure. The residue was then purified by flash column chromatography (silica gel, eluent: 
gradient, 15% → 30% EtOAc in hexanes) to afford phenol 2.353 (374 mg, 85%) as a white flocculent 
solid. 
1H NMR (500 MHz, CDCl3) δ: 11.63 (s, 1 H), 6.49 (s, 1 H), 5.00 (s, 2 H), 4.00 (s, 3 H), 3.89 (s, 3 H), 
3.88 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 170.9, 161.5, 158.2, 141.4, 132.4, 102.8, 101.4, 61.1, 55.9, 52.3, 26.0. 
FTIR (thin film) cm-1: 2953, 1651, 1602, 1487, 1446, 1428, 1389, 1338, 1298, 1258, 1233, 1053, 1016, 
967, 956, 859, 816, 804, 778, 676, 610, 593, 535, 460, 430. 
HRMS (ESI) (m/z) calc’d for C11H13BrNaO5 [M+Na]+: 326.9839, found 326.9826. 
M.p.: 114–116 °C (Et2O). 
TLC (30% EtOAc in hexanes), Rf: 0.56 (UV, CAM). 
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Benzyl ether 3.354: 
A 25-mL round-bottomed flask was charged with 3.353 (274 mg, 898 µmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. THF (4.5 mL), benzyl alcohol (372 µL, 3.59 mmol, 
4.00 equiv), and triphenylphosphine (942 mg, 3.59 mmol, 4.00 equiv) were introduced, and the resultant 
solution cooled to 0 °C. Diisopropyl azodicarboxylate (744 µL, 3.59 mmol, 4.00 equiv) was then added 
dropwise via syringe to the stirred reaction mixture, which was subsequently allowed to warm to ambient 
temperature. After 48 h, brine (8 mL) and Et2O (8 mL) were added to the stirred reaction mixture. The 
layers were separated, and the aqueous layer was further extracted with Et2O (3 × 15 mL). The combined 
organic layers were then dried over anhydrous magnesium sulfate, filtered, and concentrated under 
reduced pressure. The residue was then purified through two flash column chromatography operations 
(silica gel, eluent: gradient, 25% → 30% EtOAc in hexanes) and (silica gel, eluent: 5% EtOAc in CH2Cl2) 
to afford benzyl ether 3.354 (210 mg, 59%) as a white flocculent solid. 
1H NMR (500 MHz, CDCl3) δ: 7.44–7.35 (m, 4 H), 7.32 (t, J = 6.9 Hz, 1 H), 6.51 (s, 1 H), 5.09 (s, 2 H), 
4.66 (s, 2 H), 3.91 (s, 3 H), 3.89 (s, 3 H), 3.83 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 167.1, 154.4, 153.1, 141.6, 136.5, 130.6, 128.5, 128.0, 127.0, 116.2, 99.9, 
71.7, 61.1, 55.9, 52.3, 23.8. 
FTIR (thin film) cm-1: 2920, 2851, 1721, 1594, 1490, 1451, 1431, 1413, 1383, 1337, 1268, 1234, 1221, 
1199, 1142, 1086, 1072, 1030, 950. 
HRMS (ESI) (m/z) calc’d for C18H19BrNaO5 [M+Na]+: 417.0308, found 417.0295. 
TLC (30% EtOAc in hexanes), Rf: 0.375 (UV, CAM). 
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Benzyl fluoride 2.355: 
A 25-mL round-bottomed flask was charged with 2.354 (360 mg, 910 µmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. The flask was equipped with a reflux condenser and 
then purged with argon before MeCN (9.1 mL) was introduced. Tetrabutylammonium 
difluorotriphenylsilicate (1.48 g, 2.73 mmol, 3.00 equiv) was then added in a single portion to the stirred 
reaction mixture, which was subsequently heated to 82 °C. After 18 h, the reaction mixture was allowed 
to cool to ambient temperature and saturated aqueous sodium bicarbonate solution (7 mL) and Et2O (7 
mL) were added. The layers were separated, and the aqueous layer was further extracted with EtOAc (3 × 
10 mL). The combined organic layers were then washed with water (25 mL) and brine (25 mL), dried 
over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was then 
purified by flash column chromatography (silica gel, eluent: gradient, 15% → 20% EtOAc in hexanes) to 
afford benzyl fluoride 2.355 (283 mg, 93%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.44–7.35 (m, 4 H), 7.31 (t, J = 6.8 Hz, 1 H), 6.57 (s, 1 H), 5.55 (s, 1 H), 
5.45 (s, 1 H), 5.10 (s, 2 H), 3.89 (s, 3 H), 3.82 (s, 3 H), 3.80 (s, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 167.2, 154.3 (J = 1.8 Hz), 152.8 (J = 2.3 Hz), 142.0 (J = 4.1 Hz), 136.5, 
128.5, 128.2 (J = 15.6 Hz), 127.9, 127.0, 116.6 (J = 2.7 Hz), 100.5 (J = 3.2 Hz), 77.0 (J = 164 Hz), 71.7, 
61.8, 55.9, 52.3. 
FTIR (thin film) cm-1: 3064, 3033, 3019, 2983, 2941, 2892, 1795, 1629, 1609, 1514, 1456, 1440, 1358, 
1337, 1264, 1236, 1202, 1159, 1093, 1057, 1014, 997, 984, 968, 908, 836, 758, 729, 704, 650, 551, 452. 
HRMS (ESI) (m/z) calc’d for C18H19FNaO5 [M+Na]+: 357.1109, found 357.1101. 
TLC (40% EtOAc in hexanes), Rf: 0.50 (UV, CAM). 
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Thioether 2.357: 
A 5-mL vial was charged with benzyl ether 2.354 (210 mg, 531 µmol, 1.00 equiv) and 
azeotropically dried with three portions of benzene. DMF (2.7 mL), freshly distilled thiophenol (71 µL, 
691 µmol, 1.30 equiv), and cesium carbonate (225 mg, 691 µmol, 1.30 equiv) were sequential introduced. 
The vial was sealed with a PTFE coated cap and the resultant solution stirred at ambient temperature. 
After 12 h, the reaction mixture was diluted with Et2O (10 mL), washed with H2O (3 × 5 mL) and brine (5 
mL). The organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated under 
reduced pressure. The residue was then purified by flash column chromatography (silica gel, eluent: 
gradient, 20% → 30% EtOAc in hexanes) to afford thioether 2.357 (196 mg, 87%) as a colorless oil. 
1H NMR (500 MHz, CDCl3) δ: 7.44–7.35 (m, 6 H), 7.31 (t, J = 7.2 Hz, 1 H), 7.26 (t, J = 7.2 Hz, 2 H), 
7.18 (t, J = 7.0 Hz, 1 H), 6.46 (s, 1 H), 5.08 (s, 2 H), 4.30 (s, 2 H), 3.81 (s, 3 H), 3.80 (s, 3 H), 3.70 (s, 3 
H). 
13C NMR (125 MHz, CDCl3) δ: 167.6, 154.2, 153.0, 141.6, 136.7, 136.6, 130.8, 130.4, 128.7, 128.4, 
127.8, 127.0, 126.4, 116.3, 98.7, 71.6, 61.3, 55.8, 52.1, 30.6. 
FTIR (thin film) cm-1: 2943, 2836, 1717, 1594, 1487, 1450, 1430, 1335, 1268, 1239, 1198, 1150, 1070, 
1031, 741, 696. 
HRMS (ESI) (m/z) calc’d for C24H24NaO5S [M+Na]+: 447.1237, found 447.1231. 
TLC (30% EtOAc in hexanes), Rf: 0.40 (UV, CAM). 
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Naphthalene (+)-2.359: 
A 10-mL round-bottomed flask was charged with 2.357 (133 mg, 314 µmol, 3.00 equiv) and AB-
/HG-enone (+)-2.68 (61.7 mg, 105 µmol, 1.00 equiv), which were then azeotropically dried with three 
portions of benzene. THF (2.1 mL) was then introduced, and the resultant solution cooled to –78 °C. A 
solution of freshly prepared lithium hexamethyldisilazide in THF (1.0 M, 630 µL, 630 µmol, 6.00 equiv) 
was then added dropwise via syringe to the stirred reaction mixture, which was subsequently allowed to 
warm to 0 °C over 30 min. After 3 h, a saturated aqueous ammonium chloride solution (3 mL) was added. 
The resultant mixture was subsequently allowed to warm to ambient temperature. The mixture was 
diluted with EtOAc (10 mL) and H2O (5 mL), and the layers were separated. The aqueous layer was 
further extracted with EtOAc (3 × 5 mL). The combined organic layers were then washed with saturated 
aqueous sodium bicarbonate solution (20 mL), and brine (30 mL), dried over anhydrous sodium sulfate, 
filtered, and concentrated under reduced pressure. The residue was then purified by flash column 
chromatography (silica gel, eluent: gradient, 1% → 2% → 4% EtOAc in CH2Cl2-hexanes (1:1)) to afford 
impure tetracycle 2.358241,242 (97.5 mg) as an orange flocculent solid and recovered 2.357 (78.2 mg) as a 
colorless oil. 
                                                      
241  Minor oxidation of 2.358 occurs during purification and handling. Purification of highly oxygenated 
naphthalenes by flash column chromatography is difficult due to their adherence to silica gel (streaking). 
 
242 A significant loss of material is observed upon purification of highly oxygenated naphthalenes utilizing 
preparatory thin-layer chromatography, therefore 2.358 was carried forward to remove the minor impurities more 
easily at a subsequent stage without severe detriment to the overall yield. 
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A 25-mL round-bottomed flask was charged with 2.358 (97.5 mg, 99.3 µmol, 1.00 equiv) and 
2,6-di-t-butyl-4-methylpyridine (40.8 mg, 199 µmol, 2.00 equiv) and was then azeotropically dried with 
three portions of benzene. MeCN (9.93 mL) was introduced, and the resultant solution cooled to 0 °C. A 
solution of dimethyl(methylthio)sulfonium tetrafluoroborate (21.4 mg, 109 µmol, 1.10 equiv) in MeCN 
(300 µL) was then added dropwise via syringe to the stirred reaction mixture. The transfer was completed 
with two additional portions of MeCN (200 µL). After 30 min, the stirred reaction mixture was allowed to 
warm to ambient temperature over 1 h before saturated aqueous sodium bicarbonate solution (10 mL) was 
added. The mixture was partitioned with EtOAc (20 mL) and the layers were separated. The aqueous 
layer was further extracted with EtOAc (3 × 10 mL). The combined organic layers were then washed with 
brine (40 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. 
The residue was then purified by flash column chromatography (silica gel, eluent: gradient, 15% → 20% 
EtOAc in hexanes) to afford naphthalene (+)-2.359243 (27.0 mg, 75% over two steps) as an orange film. 
1H NMR (500 MHz, CD2Cl2) δ: 15.00 (s, 1 H), 7.65 (d, J = 7.4 Hz, 2 H), 7.49–7.40 (m, 4 H), 7.36 (t, J = 
7.6 Hz, 3 H), 7.29 (t, J = 7.1 Hz, 1 H), 7.23 (s, 1 H), 6.65 (s, 1 H), 5.24 (s, 2 H), 4.88 (d, J = 11.7 Hz, 1 H), 
4.69 (d, J = 11.7 Hz, 1 H), 4.28–4.21 (m, 2 H), 3.97 (s, 3 H), 3.87–3.80 (m, 4 H), 3.48 (t, J = 15.4 Hz, 1 
H), 3.20 (dd, J = 5.1, 16.9 Hz, 1 H), 2.46 (td, J = 4.9, 13.7 Hz, 1 H), 2.13 (ddd, J = 3.9, 12.1, 14.3 Hz, 1 
H), 1.81 (ddd, J = 5.1, 12.2, 14.3 Hz, 1 H), 1.65–1.50 (m, 1 H), 1.49–1.35 (m, 1 H), 1.27 (s, 3 H), 1.14 (s, 
3 H), 0.93 (s, 9 H), 0.89 (t, J = 7.3 Hz, 3 H), 0.18 (s, 9 H), 0.09 (s, 6 H). 
13C NMR (125 MHz, CD2Cl2) δ: 203.2, 167.2, 157.0, 153.7, 139.5, 139.2, 137.6, 136.4, 135.4, 129.1, 
128.7, 128.4, 128.3, 127.9, 127.7, 111.8, 110.7, 109.8, 109.6, 97.1, 87.8, 86.3, 83.4, 81.9, 73.3, 72.1, 71.7, 
61.3, 56.8, 49.3, 40.9, 28.0, 27.7, 27.5, 26.3, 18.6, 18.4, 15.3, 2.3, –4.1, –4.2. 
FTIR (thin film) cm-1: 2958, 2932, 2855, 1621, 1598, 1580, 1462, 1371, 1306, 1250, 1109, 1076, 1032, 
843, 779, 741, 700, 561. 
HRMS (ESI) (m/z) calc’d for C49H67O10Si2 [M+H]+: 871.4267, found 871.4285. 
                                                      
243 Minor oxidation of (+)-2.359 occurs during purification and handling. 
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[α]D23: +60.0 (c = 0.97, CH2Cl2). 
TLC (20% EtOAc in hexanes), Rf: 0.37 (UV, CAM). 
  
 362 
 
Triol (–)-2.360: 
 A 50-mL Schlenk tube was charged with (+)-2.359 (73.5 mg, 84.4 µmol, 1.00 equiv) and 1,2-
dichloroethane (15.0 mL) and the resultant solution was deoxygenated. A freshly deoxygenated solution 
of trifluoroacetic acid (3.75 mL) and H2O (3.75 mL) was added to the reaction vessel via syringe. The 
Schlenk tube was sealed and the resultant reaction mixture was vigorously stirred at ambient temperature. 
After 3 h, saturated aqueous sodium bicarbonate solution (10 mL) was added. The mixture was 
partitioned with EtOAc (20 mL) and the layers were separated. The aqueous layer was further extracted 
with EtOAc (3 × 10 mL). The combined organic layers were then washed with saturated aqueous sodium 
bicarbonate solution (40 mL) and brine (40 mL), dried over anhydrous sodium sulfate, filtered, and 
concentrated under reduced pressure. The resultant orange film was purified by semi-preparatory HPLC 
on a Agilent Prep-Sil column [10 µm, 30.0 × 250 mm, UV detection at 254 nm, 23 ± 2 °C column 
temperature, solvent A: EtOAc, solvent B: hexanes, gradient elution with 10% → 30% A over 35 min, 
flow rate: 30.0 mL/min]. Fractions eluting at 24–26 min concentrated under reduced pressure to afford 
triol (–)-2.360 (40.8 mg, 58%) as a orange film. 
1H NMR (600 MHz, CD2Cl2) δ: 15.19 (s, 1 H), 7.64 (d, J = 7.6 Hz, 2 H), 7.45 (t, J = 7.5 Hz, 2 H), 7.42–
7.34 (m, 5 H), 7.31 (t, J = 7.0 Hz, 1 H), 7.25 (s, 1 H), 6.65 (s, 1 H), 5.24 (s, 2 H), 5.03 (d, J = 11.6 Hz, 1 
H), 4.69 (d, J = 11.6 Hz, 1 H), 4.26 (t, J = 6.5 Hz, 1 H), 3.97 (s, 3 H), 3.85 (s, 3 H), 3.83 - 3.78 (m, 2 H), 
3.67 (t, J = 15.2 Hz, 1 H), 3.22 (dd, J = 5.6, 17.0 Hz, 1 H), 2.59 (td, J = 5.6, 13.2 Hz, 1 H), 2.24 (br. s., 1 
H), 2.09 (br. s., 1 H), 1.86 (dt, J = 4.6, 13.3 Hz, 1 H), 1.72 (dt, J = 4.3, 13.4 Hz, 1 H), 1.50 (ddd, J = 6.4, 
12.8, 18.8 Hz, 1 H), 1.21 (ddd, J = 6.4, 12.4, 19.0 Hz, 1 H), 1.00 (s, 9 H), 0.84 (t, J = 7.2 Hz, 3 H), 0.19 - 
0.15 (m, 12 H), 0.13 (s, 3 H). 
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13C NMR (125 MHz, CD2Cl2) δ: 203.5, 167.4, 157.0, 153.8, 140.1, 139.7, 137.6, 136.4, 135.4, 129.12, 
129.08, 128.5, 128.4, 128.3, 127.8, 112.1, 110.5, 110.0, 97.2, 82.4, 82.0, 80.1, 76.0, 75.1, 72.8, 72.1, 61.3, 
56.8, 49.5, 38.5, 28.5, 26.4, 18.7, 18.6, 15.2, 2.3, –3.9, –4.2. 
FTIR (thin film) cm-1: 3219, 2951, 2927, 2906, 2882, 2835, 1566, 1467, 1443, 1410, 1318, 1300, 1251, 
1209, 1165, 1106, 1065, 1037, 915, 806, 744, 699, 676, 649, 584, 548, 479, 454. 
HRMS (ESI) (m/z) calc’d for C46H63O10Si2 [M+H]+: 831.3954, found 831.3913. 
[α]D23: –2.3 (c = 1.46, CH2Cl2). 
TLC (20% EtOAc in hexanes), Rf: 0.42 (UV, CAM). 
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2-Deoxy-β-glycoside (–)-2.363: 
A 2-mL vial was charged with hemiacetal 2.361 (28.0 mg, 64.0 µmol, 2.5 equiv) and 
azeotropically dried with three portions of benzene. CH2Cl2 (640 µL), freshly distilled 
trichloroacetonitrile (64.2 µL, 640 µmol, 25.0 equiv), and cesium carbonate (4.2 mg, 12.8 µmol, 0.50 
equiv) were sequential introduced. The vial was sealed with a PTFE coated cap and the resultant solution 
stirred at ambient temperature. After 12 h, the tan reaction mixture was diluted with CH2Cl2 (1 mL), 
filtered through a pad of Celite, and with CH2Cl2 (3 × 2 mL). The filtrate was concentrated under reduced 
pressure to afford glycosyl trichloroacetimidate 2.62 as a tan foam that was used immediately without 
further purification. 
 A 1-mL vial was charged with freshly prepared glycosyl trichloroacetimidate 2.62 and pentacyle 
(–)-2.348 (24.0 mg, 25.0 µmol, 1.00 equiv) and azeotropically dried with four portions of benzene. 
CH2Cl2 was then introduced (500 µL), and the resultant solution was cooled to –78 °C. A freshly prepared 
solution of distilled tert-butyldimethylsilyl trifluoromethanesulfonate in CH2Cl2 (1.0 M, 64.0 µL, 64.0 
µmol, 2.50 equiv) was added to the stirred reaction mixture dropwise via syringe. After 5 h, triethylamine 
(100 µL, 717 µmol, 28.7 equiv) was added to the stirred, dark green reaction mixture. After 5 min, a 
saturated aqueous sodium bicarbonate solution (400 µL) was added and the resultant mixture was allowed 
to warm to ambient temperature. The mixture was diluted with aqueous sodium bicarbonate solution (5 
mL) and EtOAc (5 mL) and the layers were separated. The aqueous layer was extracted with EtOAc (3 × 
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5 mL). The combined organic layers were washed with brine (15 mL) and dried over anhydrous sodium 
sulfate, filtered, and concentrated under reduced pressure. The residue was then purified by flash column 
chromatography (silica gel, eluent: gradient, 2% → 5% → 20%  EtOAc in CH2Cl2) to afford 2-iodo-β-
glycoside (–)-2.363 (31.0 mg, 93%) as an orange film. 
1H NMR (600 MHz, CD2Cl2) δ: 13.90 (s, 1 H), 9.64 (s, 1 H), 7.65 (d, J = 7.6 Hz, 2 H), 7.53 (d, J = 6.9 
Hz, 2 H), 7.49–7.40 (m, 10 H), 7.38 (t, J = 7.6 Hz, 1 H), 7.35–7.29 (m, 3 H), 7.24 (t, J = 7.4 Hz, 1 H), 
7.08 (d, J = 8.5 Hz, 2 H), 6.80 (s, 1 H), 5.88 (s, 1 H), 5.72 (q, J = 3.0 Hz, 1 H), 5.30–5.24 (m, 2 H), 5.16 
(d, J = 11.3 Hz, 1 H), 5.14–5.09 (m, 2 H), 4.91 (d, J = 3.4 Hz, 1 H), 4.87 (dd, J = 1.6, 9.7 Hz, 1 H), 4.83 
(d, J = 11.3 Hz, 1 H), 4.30–4.24 (m, 2 H), 4.15 (dd, J = 3.9, 7.6 Hz, 1 H), 4.05 (s, 3 H), 3.89 (t, J = 7.6 Hz, 
1 H), 3.80 (qd, J = 6.1, 9.7 Hz, 1 H), 3.56 (s, 1 H), 3.46 (dd, J = 3.0, 9.7 Hz, 1 H), 2.46 (ddd, J = 2.1, 3.4, 
14.9 Hz, 1 H), 2.41 (d, J = 3.9 Hz, 1 H), 2.25 (dt, J = 4.5, 13.4 Hz, 1 H), 2.19 (s, 3 H), 2.04–1.97 (m, 2 H), 
1.92 (ddd, J = 2.4, 9.8, 14.7 Hz, 1 H), 1.74 (t, J = 12.9 Hz, 3 H), 1.47 (ddd, J = 2.6, 4.3, 13.1 Hz, 1 H), 
1.19–1.05 (m, 2 H), 0.99 (d, J = 6.2 Hz, 3 H), 0.90 (s, 9 H), 0.88 (d, J = 6.4 Hz, 3 H), 0.84 (t, J = 6.9 Hz, 
3 H), 0.29 (s, 9 H), 0.02 (s, 3 H), 0.00 (s, 3 H). 
13C NMR (125 MHz, CD2Cl2) δ: 210.6, 202.2, 194.8, 160.0, 157.7, 153.6, 153.3, 140.7, 139.2, 137.0, 
136.1, 135.9, 129.9, 129.7, 129.4, 129.1, 128.9, 128.3, 128.1, 127.6, 127.1, 127.0, 126.8, 125.4, 122.1, 
122.0, 112.0, 108.3, 100.0, 99.1, 98.3, 87.6, 85.7, 85.2, 82.2, 82.0, 79.3, 78.9, 77.6, 74.7, 72.6, 72.2, 70.2, 
69.9, 67.2, 57.9, 56.8, 36.1, 35.9, 28.2, 25.9, 25.3, 25.0, 18.2, 17.8, 16.8, 15.1, 15.0, 2.0, –4.2, –4.4. 
FTIR (thin film) cm-1: 3480, 3320, 3066, 3033, 2955, 2933, 2858, 1709, 1623, 1597, 1491, 1471, 1402, 
1374, 1318, 1265, 1213, 1198, 1123, 1075, 1075, 1021, 957, 888, 845, 775, 760, 735, 696, 608, 559, 498, 
464. 
HRMS (ESI) (m/z) calc’d for C73H91O18SSi2 [M+Na]+: 1343.5459, found 1343.5429. 
[α]D23: –48.2 (c = 0.58, CH2Cl2). 
TLC (20% EtOAc in CH2Cl2), Rf: 0.75 (UV, CAM). 
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Pentabenzyl-protected monomer (+)-2.370: 
A 10-mL Schlenk tube was charged 2-iodo-β-glycoside (–)-2.363 (126 mg, 93.8 µmol, 1.00 
equiv) and 2,2′-azobis(2-methylpropionitrile) (308 mg, 1.88 mmol, 20.0 equiv) and azeotropically dried 
with three portions of benzene. Benzene (2.0 mL) and tributyltin hydride (2.0 mL) were introduced, and 
the resultant solution was deoxygenated. The reaction vessel was then sealed, and the stirred reaction 
mixture was warmed to 80 °C. After 1 h, the reaction mixture was allowed to cool to ambient temperature 
and was then quickly passed through a plug of silica gel (eluent: gradient, 15% → 100% EtOAc in 
CH2Cl2) to afford impure 2,3-dideoxy-β-glycoside 2.369 as an orange film, which was used without 
further purification. 
 A 10-mL Schlenk tube was charged 2.369 and azeotropically dried with three portions of 
benzene. DMF (4.77 mL) and freshly distilled benzyl bromide (176 µL, 1.48 µmol, 15.8 equiv) were 
introduced, and the resultant solution was deoxygenated. The reaction vessel was sealed, and place in the 
liquid nitrogen cooled well of a glovebox until the reaction mixture was frozen. Cesium carbonate (723 
mg, 2.22 mmol, 23.7 equiv) was quickly introduced in one portion. The reaction vessel was sealed then 
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immediately removed from the glovebox and placed in an ice-water bath. After 3 h, H2O (2 mL) and 
EtOAc (2 mL) were added to the vigorously stirred reaction mixture, which was subsequently allowed to 
warm to ambient temperature. The mixture was further diluted with H2O (10 mL) and EtOAc (10 mL) 
and the layers were separated. The aqueous layer was extracted with EtOAc (3 × 5 mL). The combined 
organic layers were washed with brine (25 mL) and dried over anhydrous sodium sulfate, filtered, and 
concentrated under reduced pressure. The residue was then purified by flash column chromatography 
(silica gel, eluent: gradient, 10% → 20% → 100%  EtOAc in CH2Cl2) to afford penta-benzyl protected 
monomer (+)-2.370 (66.7 mg, 52%) as an orange film. 
1H NMR (600 MHz, CD2Cl2) δ: 7.62 (dd, J = 1.8, 7.6 Hz, 2 H), 7.46 (d, J = 7.6 Hz, 4 H), 7.39–7.26 (m, 
14 H), 7.24 (t, J = 7.3 Hz, 1 H), 7.22–7.18 (m, 1 H), 7.16–7.13 (m, 4 H), 6.80 (s, 1 H), 6.14 (s, 1 H), 5.20–
5.15 (m, 3 H), 5.04–4.96 (m, 3 H), 4.90 (d, J = 10.3 Hz, 1 H), 4.86–4.79 (m, 3 H), 4.67 (d, J = 10.0 Hz, 1 
H), 4.58 (dd, J = 1.8, 9.1 Hz, 1 H), 4.32 (d, J = 7.6 Hz, 1 H), 4.24 (q, J = 6.5 Hz, 1 H), 4.19 (dd, J = 3.8, 
7.6 Hz, 1 H), 3.93 (d, J = 7.6 Hz, 1 H), 3.82 (s, 3 H), 3.47 (s, 1 H), 3.24 (qd, J = 6.1, 9.1 Hz, 1 H), 3.12 (dt, 
J = 4.7, 9.7 Hz, 1 H), 2.49 (d, J = 3.8 Hz, 1 H), 2.22–2.18 (m, 4 H), 1.94–1.89 (m, 2 H), 1.88–1.82 (m, 1 
H), 1.65–1.55 (m, 3 H), 1.39 (s, 1 H), 0.99 (d, J = 5.9 Hz, 3 H), 0.91–0.85 (m, 4 H), 0.84–0.78 (m, 12 H), 
0.30 (s, 9 H), 0.01 (s, 3 H), 0.00 (s, 3 H). 
13C NMR (125 MHz, CD2Cl2) δ: 211.3, 195.5, 158.6, 156.1, 154.2, 144.7, 140.9, 138.4, 138.1, 138.0, 
137.3, 136.8, 135.8, 129.6, 129.4, 129.1, 128.7, 128.61, 128.58, 128.5, 128.4, 128.3, 128.2, 128.1, 128.06, 
128.05, 127.5, 127.0, 118.7, 118.5, 102.9, 101.3, 99.3, 88.9, 86.1, 85.1, 81.2, 80.0, 79.2, 78.7, 77.9, 77.8, 
75.5, 74.8, 73.2, 72.8, 71.2, 67.0, 57.9, 56.8, 36.1, 32.0, 30.4, 28.4, 26.1, 25.45, 25.39, 18.4, 18.3, 17.0, 
15.1, 15.0, 2.4, –4.1, –4.2. 
FTIR (thin film) cm-1: 3475, 3065, 3033, 2952, 2934, 2857, 1691, 1596, 1557, 1498, 1455, 1374, 1338, 
1253, 1121, 1100, 1056, 1022, 986, 889, 846, 777, 735, 698, 553, 493, 465. 
HRMS (ESI) (m/z) calc’d for C80H98NaO16Si2 [M+Na]+: 1393.6286, found 1393.6289. 
[α]D23: +39.5 (c = 1.30, CH2Cl2). 
TLC (10% EtOAc in CH2Cl2), Rf: 0.62 (UV, CAM).  
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Thiophenyl Glycoside (–)-2.375a and (–)-2.375b: 
 A 25-mL round-bottomed flask was charged with alcohol (–)-2.319 (197 mg, 471 µmol, 1.00 
equiv) and azeotropically dried with three portions of benzene. CH2Cl2 (4.71 mL) and thiophenol (83 µL, 
707 µmol, 20.0 equiv) were introduced and the resultant solution was cooled to –78 °C. A freshly 
prepared solution of tin(IV) tetrachloride in CH2CH2 (1.0 M, 83 µL, 707 µmol, 1.5 equiv) was added 
dropwise via syringe to the stirred reaction mixture. After 75 min, saturated aqueous sodium bicarbonate 
solution (5 mL) was added to the cold reaction mixture, which was subsequently allowed to warm to 
ambient temperature. The resultant heterogeneous mixture was filtered through a pad of Celite and rinsed 
with water (15 mL) and Et2O (3 × 10 mL). The layers of the filtrate were separated and the aqueous layer 
was extracted with Et2O (3 × 15 mL). The combined organic layers washed with brine (50 mL) and dried 
over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The resultant 
yellow oil was purified by flash column chromatography (silica gel, eluent: gradient, 5 → 10 → 50% 
EtOAc in hexanes) to afford α-thiophenyl glycoside (–)-2.375a (32 mg, 16%) and β-thiophenyl glycoside 
(–)-2.375b (126 mg, 64%) as a colorless oils.244 
 
α-Thiophenyl Glycoside (–)-2.375a: 
1H NMR (600 MHz, CDCl3) δ: 7.50 (d, J = 7.8 Hz, 2 H), 7.48 (d, J = 7.3 Hz, 2 H), 7.39–7.25 (m, 10 H), 
7.21 (t, J = 7.2 Hz, 1 H), 5.44 (d, J = 6.2 Hz, 1 H), 4.87 (d, J = 12.3 Hz, 1 H), 4.69 (qd, J = 6.3, 9.1 Hz, 1 
H), 4.60 (d, J = 12.5 Hz, 1 H), 4.55 (d, J = 11.9 Hz, 1 H), 4.40 (d, J = 11.9 Hz, 1 H), 4.01–3.93 (m, 1 H), 
                                                      
244 Stereochemical assignment of anomeric position based on JDG1'-DG2'. 
OBnO Me OPhS Me
(–)-2.375a/(–)-2.375b(–)-2.319
OBn
OBn
CH2Cl2, –78 °C,
75 min
(80%, α:β = 1:4)
OBn
OBn PhSH, SnCl4
OPhS Me
(–)-2.375a
OBn
OBn
α
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3.15 (dd, J = 2.7, 9.3 Hz, 1 H), 2.52 (dd, J = 3.2, 14.7 Hz, 1 H), 2.12 (ddd, J = 2.4, 6.3, 14.7 Hz, 1 H), 
1.32 (d, J = 6.3 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 138.4, 138.3, 138.1, 130.4, 128.7, 128.3, 128.0, 127.7, 127.6, 127.5, 
126.5, 83.4, 80.3, 70.9, 70.8, 69.5, 64.5, 34.2, 18.1. 
FTIR (thin film) cm-1: 3060, 3029, 2927, 2857, 1453, 1223, 1159, 1099, 1087, 1027, 1007, 739, 696. 
HRMS (ESI) (m/z) calc’d for C26H28NaO3S [M+Na]+: 443.1651, found 443.1669. 
[α]D23: –293 (c = 1.60, CH2Cl2). 
TLC (15% EtOAc in hexanes), Rf: 0.32 (UV, CAM). 
 
β-Thiophenyl glycoside (–)-2.375b: 
1H NMR (600 MHz, CDCl3) δ: 7.49 (d, J = 7.3 Hz, 2 H), 7.40–7.22 (m, 13 H), 4.69 (d, J = 12.3 Hz, 1 H), 
4.64 (d, J = 12.2 Hz, 1 H), 4.55 (d, J = 11.7 Hz, 1 H), 4.42 (d, J = 11.7 Hz, 1 H), 4.08 (qd, J = 6.2, 9.4 Hz, 
1 H), 4.01–3.97 (m, 1 H), 3.14 (dd, J = 2.6, 9.5 Hz, 1 H), 2.35–2.27 (m, 1 H), 1.76 (ddd, J = 2.3, 12.0, 
13.8 Hz, 1 H), 1.33 (d, J = 6.2 Hz, 3 H). 
13C NMR (125 MHz, CDCl3) δ: 138.3, 137.9, 134.5, 130.8, 128.7, 128.3, 127.8, 127.75, 127.71, 127.6, 
126.9, 80.6, 79.4, 71.8, 71.5, 71.2, 71.0, 35.7, 18.6. 
FTIR (thin film) cm-1: 3028, 2920, 2872, 1496, 1479, 1453, 1439, 1379, 1367, 1356, 1306, 1292, 1090, 
1027, 1006, 917, 740, 698. 
HRMS (ESI) (m/z) calc’d for C26H28NaO3S [M+Na]+: 443.1656, found 443.1669. 
[α]D23: –56.5 (c = 1.41, CH2Cl2). 
TLC (15% EtOAc in hexanes), Rf: 0.47 (UV, CAM). 
  
OPhS Me
(–)-2.375b
OBn
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Model DG/DG' α-glycoside (–)-2.377: 
A 5-mL round-bottomed flask was charged with (–)-2.375b (16.6 mg, 39.5 µmol, 1.00 equiv) and 
2,6-di-t-butyl-4-methylpyridine (36.5 mg, 158 µmol, 4.5 equiv) and was then azeotropically dried with 
three portions of benzene. CH2Cl2 (790 µL), 2,4-dimethyl-3-pentanol (8.3 µL, 59.2 µmol, 1.50 equiv),  
and 4 Å MS (100 mg) were introduced, the resultant solution cooled to 0 °C, and the reaction vessel was 
wrapped with aluminum foil. After 30 min, silver hexafluorophosphate (39.9 mg, 158 µmol, 4.00 equiv) 
was then added in a single portion to the stirred reaction mixture. After 1 h, pyridine (160 µL, 1.98 mmol, 
50.0 equiv) was added to the stirred reaction mixture. After 30 min, the heterogeneous mixture was 
filtered through a plug of Celite and rinsed with EtOAc (3 × 5 mL). The filtrate was concentrated under 
reduced pressure and the resultant residue was purified by flash column chromatography (silica gel, 
eluent: 10% EtOAc in hexanes) to afford model DG/DG' α-glycoside (–)-2.377 (14.0 mg, 83%) as a 
colorless oil. 
1H NMR (600 MHz, CDCl3) δ: 7.42 (d, J = 7.2 Hz, 2 H), 7.35–7.30 (m, 6 H), 7.29–7.26 (m, 2 H), 4.82–
4.78 (m, 2 H), 4.63 (d, J = 11.9 Hz, 1 H), 4.55 (d, J = 12.3 Hz, 1 H), 4.48–4.41 (m, 2 H), 3.91 (q, J = 3.1 
Hz, 1 H), 3.14 (dd, J = 2.9, 9.1 Hz, 1 H), 3.06 (t, J = 5.0 Hz, 1 H), 2.40 (ddd, J = 1.0, 3.9, 14.6 Hz, 1 H), 
1.91–1.78 (m, 2 H), 1.63 (ddd, J = 3.1, 4.7, 14.7 Hz, 1 H), 1.23 (d, J = 6.5 Hz, 3 H), 0.98–0.88 (m, 12 H). 
13C NMR (125 MHz, CDCl3) δ: 138.8, 138.4, 128.3, 128.2, 127.9, 127.8, 127.5, 127.3, 97.6, 89.3, 80.0, 
70.5, 69.9, 69.0, 63.7, 31.5, 31.0, 30.1, 20.6, 20.4, 18.5, 17.9, 17.8. 
FTIR (thin film) cm-1: 2958, 2929, 2870, 1496, 1453, 1383, 1365, 1339, 1226, 1204, 1147, 1097, 1005, 
735, 697. 
HRMS (ESI) (m/z) calc’d for C27H38NaO4 [M+Na]+: 449.2662, found 449.2653. 
[α]D23: –138.6 (c = 1.63, CH2Cl2). 
OPhS Me OO Me
(–)-2.377(–)-2.375b
OBn
OBn
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α
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TLC (10% EtOAc in hexanes), Rf: 0.39 (UV, CAM).  
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2-Iodo glycoside (–)-2.382: 
 A 5-mL round-bottomed flask was charged with hemiacetal 2.380 (31.3 mg, 69.0 µmol, 1.00 
equiv) and azeotropically dried with three portions of benzene. CH2Cl2 (690 µL) and freshly distilled 
trichloroacetonitrile (69 µL, 690 µmol, 10.0 equiv) were introduced, and the resultant solution cooled to –
10 °C. DBU (2.0 µL, 13.8 µmol, 0.20 equiv) was added via syringe. After 1h, the reaction mixture was 
allowed to warm to 0 °C. After an additional 1 h the reaction mixture was concentrated under reduced 
pressure. The resultant tan residue filtered through a plug of neutral alumina (eluent: 25% EtOAc in 
hexanes) to afford glycosyl trichloroacetimidate 2.64 as a tan oil that was used immediately without 
further purification. 
A 5-mL round-bottomed flask was charged with 2.64 and was azeotropically dried with three 
portions of benzene. CH2Cl2 (1.38 mL), 2,4-dimethyl-3-pentanol (14.5 µL, 104 µmol, 1.50 equiv), and 4 
Å MS (100 mg) were introduced, and the resultant solution stirred at ambient temperature. After 30 min, 
the reaction mixture was cooled to –78 °C and a freshly prepared solution of tert-butyldimethylsilyl 
trifluoromethanesulfonate in CH2Cl2 (1.0 M, 69.0 µL, 69 µmol, 1.00 equiv) was added dropwise via 
syringe to the cooled, stirred reaction mixture. After 1 h, triethylamine (100 µL, 717 µmol, 10.4 equiv) 
was added to the stirred reaction mixture. After 5 min, a saturated aqueous sodium bicarbonate solution (3 
mL) was added and the heterogeneous mixture was filtered through a pad of Celite and rinsed with H2O 
(10 mL) and EtOAc (3 × 5 mL). The layers of the filtrate were separated and the aqueous layer was 
extracted with EtOAc (3 × 5 mL). The combined organic layers were washed with brine (30 mL) and 
dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was 
O Me
2.64
OBn
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O
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I
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then purified by flash column chromatography (silica gel, eluent: 3% EtOAc in hexanes) to afford 2-iodo-
α-glycoside (–)-2.382 (31.6 mg, 83%) as a white flocculent solid. 
1H NMR (500 MHz, CDCl3) δ: 7.42–7.27 (m, 10 H), 5.08 (s, 1 H), 4.74 (d, J = 12.1 Hz, 1 H), 4.60 (d, J = 
2.4 Hz, 1 H), 4.58–4.51 (m, 2 H), 4.49–4.41 (m, 2 H), 4.01 (t, J = 3.1 Hz, 1 H), 3.85 (dd, J = 2.9, 9.2 Hz, 
1 H), 3.06 (t, J = 4.9 Hz, 1 H), 1.93–1.76 (m, 2 H), 1.25 (d, J = 6.3 Hz, 3 H), 0.96–0.86 (m, 12 H). 
13C NMR (125 MHz, CDCl3) δ: 137.9, 137.9, 128.33, 128.28, 128.1, 128.0, 127.74, 127.66, 102.8, 90.5, 
76.0, 75.9, 71.5, 71.4, 64.3, 30.9, 30.1, 26.8, 20.5, 20.3, 18.3, 17.8, 17.6. 
FTIR (thin film) cm-1: 2958, 2928, 2871, 1496, 1453, 1384, 1364, 1098, 1069, 1006, 735, 697. 
HRMS (ESI) (m/z) calc’d for C27H37INaO4 [M+Na]+: 575.1629, found 575.1632. 
[α]D23: –49.8 (c = 1.41, CH2Cl2). 
TLC (10% EtOAc in hexanes), Rf: 0.47 (UV, CAM). 
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Model DG/DG' α-glycoside (–)-2.377: 
A 5-mL Schlenk tube was charged with 2-iodo-α-glycoside (–)-2.382 (30.6 mg, 55.4 µmol) and 
2,2′-azobis(2-methylpropionitrile) (90.0 mg, 554 µmol, 10.0 equiv) and azeotropically dried with three 
portions of benzene. Benzene (550 µL) and tributyltin hydride (550 µL) were introduced, the reaction 
vessel was sealed, and the stirred reaction mixture was warmed to 80 °C. After 1 h, the reaction mixture 
was allowed to cool to ambient temperature and was then directly purified by flash column 
chromatography (silica gel, eluent: gradient, 1% → 5% EtOAc in hexanes) to afford model DG/DG' α-
glycoside (–)-2.377 (21.7 mg, 92%) as a colorless oil. 
  
OO Me
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α
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Bis-glycosylated monomer (–)-2.385:  
A 10-mL Schlenk tube was charged 2-iodo-β-glycoside (–)-2.363 (32.8 mg, 24.4 µmol, 1.00 
equiv) and azeotropically dried with three portions of benzene. MeCN (300 µL) was introduced, and the 
resultant solution was deoxygenated. The solvent was then removed under reduced pressure. A second 
10-mL Schlenk tube was charged sequentially with MeCN (4.4 mL), triethylamine trihydrofluoride (795 
µL, 4.88 mmol, 200 equiv), and triethylamine (130 µL, 1.27 mmol, 52.1 equiv). The resultant solution 
was deoxygenated and transferred to the reaction vessel containing (–)-2.363 via syringe. The reaction 
vessel was sealed and the resultant orange reaction mixture stirred at ambient temperature. After 36 h, 
aqueous potassium sodium phosphate pH 7.00 buffered solution (0.05 M, 5.0 mL) was added to the 
reaction mixture. The resultant mixture was diluted with EtOAc (5 mL) and the layers were separated. 
The aqueous layer was extracted with EtOAc (3 × 5 mL). The combined organic layers were washed with 
brine (20 mL) and dried over anhydrous sodium sulfate, filtered, and concentrated under reduced 
pressure. The residue was quickly passed through a plug of silica gel (eluent: gradient, 30% → 40% → 
50%  EtOAc in hexanes) to afford impure pentaol 2.364 (19.8 mg, 17.1 µmol) as an orange film that was 
used without further purification. 
 A 5-mL round-bottomed flask was charged with 2.364 and azeotropically dried with three 
portions of benzene. CH2Cl2 (700 µL) and 4 Å MS (60 mg) were introduced and the resultant mixture 
HF•Et3N, Et3N
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stirred at ambient temperature. After 15 min, the reaction mixture was cooled to –78 °C and a freshly 
prepared solution of tert-butyldimethylsilyl trifluoromethanesulfonate in CH2Cl2 (1.0 M, 64.0 µL, 64 
µmol, 1.00 equiv) was added dropwise via syringe to the cooled, stirred reaction mixture. A separate 1-
mL vial was charged with freshly prepared glycosyl trichloroacetimidate 2.64 (38.2 mg, 63.8 µmol, 3.73 
equiv) and azeotropically dried with three portions of benzene. CH2Cl2 (382 µL) was introduced and the 
resultant solution was transferred dropwise to the reaction vessel containing 2.364 via syringe over 1 h. 
After an additional 30 min, triethylamine (250 µL, 1.79 mmol, 105 equiv) was added to the reaction 
mixture. After 5 min, a saturated aqueous sodium bicarbonate solution (1.0 mL) was added and the 
resultant mixture was allowed to warm to ambient temperature. The mixture was diluted with aqueous 
sodium bicarbonate solution (5 mL) and EtOAc (5 mL) and the layers were separated. The aqueous layer 
was extracted with EtOAc (3 × 5 mL). The combined organic layers were washed with brine (15 mL) and 
dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was 
quickly passed through a plug of silica gel (eluent: gradient, 20% → 30% → 50% EtOAc in hexanes) to 
afford impure 2-iodo-α-glycoside 2.383 (15.2 mg, 9.54 µmol) as an orange film that was used without 
further purification. 
A 5-mL Schlenk tube was charged with 2-iodo-α-glycoside 2.383 and 2,2′-azobis(2-
methylpropionitrile) (31.0 mg, 191 µmol, 20.0 equiv) and azeotropically dried with three portions of 
benzene. Benzene (300 µL) and tributyltin hydride (300 µL) were introduced, and the resultant solution 
was deoxygenated. The reaction vessel was then sealed, and the stirred reaction mixture was warmed to 
80 °C. After 1 h, the reaction mixture was allowed to cool to ambient temperature and was then quickly 
passed through a plug of silica gel (eluent: gradient, 30% → 50% EtOAc in hexanes) to afford impure 
2,3-dideoxy-α-glycoside (–)-2.385. The residue was further purified by preparatory thin-layer 
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chromatography (eluent: 50% EtOAc in hexanes) to afford bis-glycosylated monomer (–)-2.385 (8.5 mg, 
27% over three steps).245 
1H NMR (600 MHz, CD2Cl2) δ: 13.24 (s, 1 H), 9.67 (s, 1 H), 7.63 (d, J = 7.2 Hz, 2 H), 7.48–7.30 (m, 15 
H), 7.30–7.23 (m, 3 H), 7.22–7.16 (m, 5 H), 6.80 (s, 1 H), 5.87 (s, 1 H), 5.28 (d, J = 11.9 Hz, 1 H), 5.26 
(d, J = 11.9 Hz, 1 H), 5.13 (d, J = 11.4 Hz, 1 H), 5.09 (d, J = 10.1 Hz, 1 H), 5.05 (d, J = 10.3 Hz, 1 H), 
4.97 (dd, J = 1.6, 4.5 Hz, 1 H), 4.87 (d, J = 3.4 Hz, 1 H), 4.78 (d, J = 12.2 Hz, 1 H), 4.74 (d, J = 11.4 Hz, 
1 H), 4.54 (dd, J = 1.9, 9.3 Hz, 1 H), 4.50 (d, J = 11.7 Hz, 1 H), 4.47 (d, J = 12.2 Hz, 1 H), 4.34 (d, J = 
11.9 Hz, 1 H), 4.27 (d, J = 7.7 Hz, 1 H), 4.25 (q, J = 6.4 Hz, 1 H), 4.20 (qd, J = 6.5, 8.7 Hz, 1 H), 4.12 (s, 
1 H), 4.08 (dd, J = 3.7, 8.5 Hz, 1 H), 4.03 (s, 3 H), 3.99 (t, J = 8.2 Hz, 1 H), 3.84 (q, J = 3.2 Hz, 1 H), 
3.47 (s, 1 H), 3.30 (qd, J = 6.1, 9.0 Hz, 1 H), 3.18 (ddd, J = 4.8, 9.2, 10.4 Hz, 1 H), 3.07 (dd, J = 2.9, 8.7 
Hz, 1 H), 2.66 (d, J = 4.0 Hz, 1 H), 2.23–2.16 (m, 5 H), 2.15–2.10 (m, 1 H), 1.95 (td, J = 4.0, 13.5 Hz, 1 
H), 1.94–1.89 (m, 1 H), 1.74 (dt, J = 2.6, 13.4 Hz, 1 H), 1.68–1.60 (m, 2 H), 1.59–1.52 (m, 2 H), 1.51–
1.45 (m, 1 H), 1.43 (ddd, J = 2.4, 4.5, 13.0 Hz, 1 H), 1.22–1.15 (m, 1 H), 1.14–1.07 (m, J = 6.1 Hz, 4 H), 
0.95 (d, J = 6.6 Hz, 3 H), 0.88 (d, J = 6.4 Hz, 3 H), 0.80 (t, J = 7.3 Hz, 3 H). 
13C NMR (125 MHz, CD2Cl2) δ: 211.3, 201.5, 160.0, 158.0, 153.8, 140.8, 140.0, 139.6, 139.1, 137.1, 
136.3, 136.0, 129.7, 129.3, 129.2, 129.1, 128.8, 128.76, 128.68, 128.6, 128.5, 128.24, 128.21, 127.9, 
127.8, 127.4, 126.0, 122.1, 111.9, 107.4, 102.8, 99.3, 99.2, 98.4, 85.3, 84.6, 84.3, 81.1, 80.4, 80.0, 79.2, 
79.0, 77.7, 75.51, 75.46, 72.4, 71.0, 70.5, 70.0, 67.0, 64.5, 57.0, 55.9, 35.4, 32.5, 31.8, 30.4, 28.4, 25.43, 
25.40, 18.5, 18.1, 17.2, 15.2, 15.0. 246 
FTIR (thin film) cm-1: 3466, 3318, 3064, 3031, 2961, 1932, 2871, 1705, 1653, 1598, 1497, 1455, 1374, 
1322, 1256, 1219, 1164, 1123, 1076, 1056, 1020, 987, 918, 736, 698, 553. 
                                                      
245 Data for anomeric positions of bis-glycosylated monomer (–)-2.385: 1H NMR (600 MHz, CD2Cl2): AM1' δ = 
4.54 (dd, J1,2a = 9.3, J1,2b = 1.9, 1 H); DG1' δ = 4.97 (dd, J1,2a = 4.5, J1,2b = 1.6, 1 H). 13C NMR (125 MHz, CD2Cl2): 
AM1' δ  = 102.76; DG1' δ = 99.24. Reported data for anomeric positions of hibarimicin B: 1H NMR (400 MHz, 
CDCl3): AM1' δ  = 4.460 (dd, J1,2a = 9.0, J1,2b = 1.8, 1 H); DG1' δ = 5.350 (dd, J1,2a = 3.0, J1,2b = <1.0, 1 H). 13C 
NMR (100 MHz, CDCl3): AM1' δ  = 103.24; DG1' δ = 98.95. 
 
246 Due to the presence of multiple benzyl groups, one carbon resonance of (–)-2.385 is unresolved as determined 
by comparison with related structures. 
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HRMS (ESI) (m/z) calc’d for C77H87O19 [M+H]+: 1315.5836, found 1315.5811. 
[α]D23: –30.0 (c = 0.35, CH2Cl2). 
TLC (50% EtOAc in hexanes), Rf: 0.40 (UV, CAM). 
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Unsymmetrical biaryl (±)-34: 
A 50-mL round-bottomed flask was charged with 2.388a247 (210 mg, 291 µmol, 1.00 equiv) and 
azeotropically dried with four portions of benzene. THF (10 mL) was introduced, and the resultant 
solution cooled to –78 °C. In a separate 10-mL round-bottomed flask, a solution of n-butyllithium in 
hexanes (2.73 M, 266 µL, 727 µmol, 2.50 equiv) was added dropwise via syringe to a stirred solution of 
2,2,6,6-tetramethylpiperidine (135 µL, 800 µmol, 2.75 equiv) in THF (1.2 mL) at 0 °C. After 30 min, the 
resultant solution of lithium 2,2,6,6-tetramethylpiperidide was cooled to –78 °C and transferred dropwise 
via a dry-ice wrapped cannula to the stirred, cooled solution of 2.388a over 5 min. The transfer was 
completed with an additional portion of THF (1 mL). After 30 min, a solution of S-phenyl 
benzenethiosulfonate (76.5 mg, 306 µmol, 1.05 equiv) in THF (1.5 mL) was added via syringe rapidly 
down the vessel wall to the vigorously stirred deep red reaction mixture, whereupon the reaction mixture 
quickly turns yellow. After 10 sec, a solution of acetic acid (50 µL) in THF (1.0 mL) was rapidly added to 
the reaction mixture, followed immediately by addition of saturated aqueous ammonium chloride solution 
(5 mL). The resultant mixture was subsequently allowed to warm to ambient temperature. The mixture 
was diluted with Et2O (20 mL) and EtOAc (20 mL) and the layers were separated. The combined organic 
layers were then washed with saturated aqueous ammonium chloride solution (30 mL) and brine (30 mL), 
dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was 
                                                      
247 Racemic (±)-2.388 was prepared according to the procedures described in ref. 239b. The enantiomers were 
separated by chiral semi-preparatory HPLC on a RegisCell column [5 µm, 21.1 × 250 mm, UV detection at 254 nm, 
23 ± 2 °C column temperature, solvent A: isopropyl alcohol, solvent B: hexanes, sample concentration 0.14 M 
(isopropyl alcohol:hexanes, 1:1), injection volume 0.70 mL, gradient elution with 40% A (0 → 25 min) and 70% (25 
→ 40 min), flow rate: 10.0 mL/min]. Fractions eluting at 12–16 min were concentrated under reduced pressure to 
afford 2.388a and fractions eluting at 21–28 min were concentrated under reduced pressure to afford 2.388b. 
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then purified by flash column chromatography (silica gel, eluent: gradient, 1% → 2% EtOAc in 9:1 
benzene/hexanes) to afford unsymmetrical biaryl 2.67a (165 mg, 69%) as a white flocculent solid 
(inseparable ~2:1 mixture of C6'-epimers).248 
  
                                                      
248 Spectroscopic data was identical to the racemate ((±)-2.388). CD spectra for 2.388a and 2.67a were not recorded. 
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Octacycle (–)-2.128: 
A 10-mL Schlenk tube was charged with 2.67a (68.8 mg, 83.5 µmol, 1.00 equiv) and AB-/HG-
enone (+)-2.68 (148 mg, 251 µmol, 3.01 equiv), which were then azeotropically dried with five portions 
of benzene. THF (2.78 mL) was then introduced, and the resultant solution was deoxygenated and then 
cooled to –78 °C. A solution of freshly prepared deoxygenated lithium hexamethyldisilazide in THF (1.0 
M, 835 µL, 835 µmol, 10.0 equiv) was then added dropwise via syringe to the stirred reaction mixture, 
which was subsequently allowed to warm to 0 °C over 30 min. After 20 h, a solution of deoxygenated 
potassium hexamethyldisilazide in THF (1.0 M, 2.09 mL, 2.09 mmol, 25.0 equiv) was added dropwise 
via cannula to the vigorously stirred purple reaction mixture, which was subsequently allowed to warm to 
ambient temperature. After 12 h, the reaction mixture was cooled to –50 °C before a solution of acetic 
acid (200 µL) in THF (1.0 mL) was added via syringe rapidly down the vessel-wall to the vigorously 
stirred purple reaction mixture. After the reaction mixture turned fluorescent orange, a saturated aqueous 
ammonium chloride solution (2 mL) was added. The resultant mixture was subsequently allowed to warm 
to ambient temperature. The mixture was diluted with Et2O (20 mL), hexanes (20 mL) and saturated 
aqueous ammonium chloride solution (10 mL), and the layers were separated. The organic layers were 
then washed with saturated aqueous ammonium chloride solution (20 mL), saturated aqueous sodium 
bicarbonate solution (20 mL), and brine (30 mL), dried over anhydrous sodium sulfate, filtered, and 
concentrated under reduced pressure. The residue was then purified by flash column chromatography 
BnO
TBSO
H
O
nPr O
O
OMe
Me SiMe3
BnO
OMe
BnO
OMe
MeO
OBn O
OMe
2.67a
O
O
NC
SPh
(+)-2.68
OBn
OMe
OBn
OMe
MeO
BnO
OO
nPr
BnO
TBSO
OH
HO O O nPr
OBn
OTBS
H
O
O
O
OMe
Me
Me
Me
H
OH
(–)-2.128
SiMe3
SiMe3
SPh
H
+ then KHMDS,
0 °C → RT, 12 h
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(69%)
 382 
(silica gel, eluent: gradient, 5% → 6% → 10% EtOAc in hexanes) to afford octacycle (–)-2.128249 (111.8 
mg, 69%) as an orange flocculent solid. 
  
                                                      
249 For spectroscopic and physical characterization of octacycle (–)-2.128, see Ref. 239b. 
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Pentaol (–)-2.389: 
 A 10-mL Schlenk tube was charged with (–)-2.133250 (15.5 mg, 8.8 µmol, 1.00 equiv) and 1,2-
dichloroethane (3.0 mL) and the resultant solution was deoxygenated. A freshly deoxygenated solution of 
trifluoroacetic acid (750 µL) and H2O (750 µL) was added to the reaction vessel via syringe. The Schlenk 
tube was sealed and the resultant reaction mixture was vigorously stirred at ambient temperature. After 2 
h, saturated aqueous sodium bicarbonate solution (10 mL) was added. The mixture was partitioned with 
EtOAc (5 mL) and the layers were separated. The aqueous layer was further extracted with EtOAc (3 × 5 
mL). The combined organic layers were then washed with saturated aqueous sodium bicarbonate solution 
(20 mL) and brine (20 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under 
reduced pressure. The residue was purified by preparatory thin-layer chromatography (eluent: 50% 
EtOAc in hexanes) to afford pentaol (–)-2.389 (7.7 mg, 50%). 
1H NMR (600 MHz, CD2Cl2) δ: 15.07 (s, 1 H), 13.73 (s, 1 H), 9.59 (s, 1 H), 7.51–7.28 (m, 17H), 7.14–
7.08 (m, 6 H), 7.08–7.03 (m, 2 H), 5.89 (s, 1 H), 5.14 (d, J = 10.6 Hz, 1 H), 5.08 (d, J = 3.6 Hz, 1 H), 5.06 
(d, J = 5.1 Hz, 1 H), 5.02 (d, J = 10.3 Hz, 1 H), 5.00 (d, J = 10.6 Hz, 1 H), 5.00–4.94 (m, 2 H), 4.94–4.87 
(m, 3 H), 4.73 (d, J = 11.5 Hz, 1 H), 4.29 (dd, J = 5.3, 8.9 Hz, 1 H), 4.17 (dd, J = 3.9, 7.6 Hz, 1 H), 4.10 (t, 
J = 7.7 Hz, 1 H), 3.90 (s, 3 H), 3.87–3.81 (m, 8 H), 3.8–3.71 (m, 2 H), 3.31 (dd, J = 5.8, 17.0 Hz, 1 H), 
                                                      
250 (–)-2.133 was prepared from (–)-2.128 following the protocol detailed in Ref. 239b. 
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(50%)ClCH2CH2Cl-TFA-H2O (4:1:1), 2 h
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2.64 (td, J = 5.5, 13.5 Hz, 1 H), 2.44 (d, J = 3.6 Hz, 1 H), 2.27 (d, J = 1.8 Hz, 1 H), 2.15 (s, 1 H), 1.95–
1.84 (m, 2 H), 1.74 (ddd, J = 4.2, 12.4, 14.2 Hz, 1 H), 1.69–1.59 (m, 1 H), 1.58–1.48 (m, 1 H), 1.36–1.18 
(m, 4 H), 1.07 (dt, J = 4.1, 13.1 Hz, 1 H), 1.02 (s, 9 H), 0.94 (s, 9 H), 0.85 (t, J = 7.4 Hz, 3 H), 0.81 (t, J = 
7.4 Hz, 3 H), 0.25 (s, 9 H), 0.19 (s, 3 H), 0.18 (s, 9 H), 0.16 (s, 3 H), 0.13 (s, 3 H), 0.07 (s, 3 H). 
13C NMR (125 MHz, CD2Cl2) δ: 204.9, 203.7, 165.7, 158.5, 154.6, 153.3, 152.7, 143.8, 143.0, 140.3, 
140.1, 140.0, 139.7, 138.6, 138.4, 135.8, 135.7, 129.9, 129.7, 129.5, 129.2, 128.8, 128.7, 128.52, 128.47, 
128.33, 128.26, 128.0, 127.93, 127.91, 127.86, 127.8, 125.3, 125.0, 122.6, 121.7, 118.7, 116.1, 113.3, 
110.7, 109.9, 88.1, 87.9, 85.1, 82.6, 82.0, 80.3, 78.1, 76.4, 76.2, 76.0, 75.5, 75.0, 74.5, 72.8, 72.6, 69.9, 
61.8, 61.3, 61.2, 58.6, 49.8, 38.6, 35.8, 30.3, 28.6, 26.4, 26.2, 18.8, 18.6, 18.4, 16.8, 15.19, 15.16, 2.3, 2.1, 
–3.9, –4.0, –4.1, –4.2. 
FTIR (thin film) cm-1: 3457, 3346, 3032, 2955, 2931, 2857, 1617, 1588, 1559, 1497, 1455, 1409, 1372, 
1308, 1252, 1211, 1173, 1116, 1078, 886, 839, 751, 697. 
HRMS (ESI) (m/z) calc’d for C98H125O21Si4 [M+H]+: 1749.7785, found 1749.7732. 
[α]D23: –258.6 (c = 0.46, CH2Cl2). 
TLC (30% EtOAc in hexanes), Rf: 0.64 (UV, CAM). 
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